0001213900-22-025253.txt : 20220510 0001213900-22-025253.hdr.sgml : 20220510 20220510170045 ACCESSION NUMBER: 0001213900-22-025253 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220510 DATE AS OF CHANGE: 20220510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZION OIL & GAS INC CENTRAL INDEX KEY: 0001131312 STANDARD INDUSTRIAL CLASSIFICATION: OIL AND GAS FIELD EXPLORATION SERVICES [1382] IRS NUMBER: 200065053 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33228 FILM NUMBER: 22910809 BUSINESS ADDRESS: STREET 1: 12655 NORTH CENTRAL EXPRESSWAY STREET 2: SUITE 1000 CITY: DALLAS STATE: TX ZIP: 75243 BUSINESS PHONE: 2142214610 MAIL ADDRESS: STREET 1: 12655 NORTH CENTRAL EXPRESSWAY STREET 2: SUITE 1000 CITY: DALLAS STATE: TX ZIP: 75243 10-Q 1 f10q0322_zionoil.htm QUARTERLY REPORT
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

MARK ONE

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the Quarterly Period ended March 31, 2022; or

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the transition period from ________ to ________

 

ZION OIL & GAS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   20-0065053
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
12655 N Central Expressway, Suite 1000, Dallas, TX   75243
(Address of principal executive offices)   Zip Code

 

(214) 221-4610

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No

 

As of May 6, 2022, Zion Oil & Gas, Inc. had outstanding 469,022,602 shares of common stock, par value $0.01 per share.

 

 

 

 

 

 

INDEX PAGE

 

    Page
PART I — FINANCIAL INFORMATION
     
Item 1 – Financial Statements – Unaudited    
     
Consolidated Condensed Balance Sheets – March 31, 2022 and December 31, 2021   1
     
Consolidated Condensed Statements of Operations for the three months ended March 31, 2022 and 2021   2
     
Consolidated Condensed Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2022 and 2021   3
     
Consolidated Condensed Statements of Cash Flows for the three months ended March 31, 2022 and 2021   4
     
Notes to Consolidated Condensed Financial Statements   6
     
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations   33
     
Item 3 – Quantitative and Qualitative Disclosures About Market Risk   44
     
Item 4 – Controls and Procedures   45
     
PART II — OTHER INFORMATION
     
Item 1 – Legal Proceedings   46
     
Item 1A – Risk Factors   46
     
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds   46
     
Item 3 – Defaults upon Senior Securities   46
     
Item 4 – Mine Safety Disclosures   46
     
Item 5 – Other Information   46
     
Item 6 – Exhibits   46
     
Exhibit Index   47
     
SIGNATURES   48

 

i

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Balance Sheets as of

 

   March 31,
2022
   December 31,
2021
 
   US$
thousands
   US$
thousands
 
   (Unaudited)      
Current assets          
Cash and cash equivalents   8,221    4,683 
Fixed short term bank and escrow deposits – restricted   1,269    1,269 
Prepaid expenses and other   1,264    689 
Other deposits   605    617 
Governmental receivables   338    900 
Other receivables   2,376    483 
Total current assets   14,073    8,641 
           
Unproved oil and gas properties, full cost method (see Note 4)   48,099    46,950 
           
Property and equipment at cost          
Drilling rig and related equipment, net of accumulated depreciation of $887 and $704 (see note 2I)   6,759    6,834 
Property and equipment, net of accumulated depreciation of $615 and $604   139    138 
    6,898    6,972 
           
Right of Use Lease Assets (see Note 5)   263    327 
           
Other assets          
Assets held for severance benefits   553    541 
Total other assets   553    541 
           
Total assets   69,886    63,431 
           
Liabilities and Stockholders’ Equity          
           
Current liabilities          
Accounts payable   1,167    2,783 
Lease obligation – current (see Note 5)   169    203 
Asset retirement obligation   571    571 
Accrued liabilities   437    1,781 
Total current liabilities   2,344    5,338 
           
Long-term liabilities          
Lease obligation – non-current (see Note 5)   129    169 
Provision for severance pay   560    548 
Total long-term liabilities   689    717 
           
Total liabilities   3,033    6,055 
           
Commitments and contingencies (see Note 6)   
 
    
 
 
           
Stockholders’ equity          
Common stock, par value $.01; Authorized: 800,000,000 shares at March 31, 2022: Issued and outstanding: 466,593,391 and 364,322,883 shares at March 31, 2022 and December 31, 2021, respectively   4,666    3,643 
Additional paid-in capital   287,878    277,258 
Accumulated deficit   (225,691)   (223,525)
Total stockholders’ equity   66,853    57,376 
           
Total liabilities and stockholders’ equity   69,886    63,431 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

1

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statements of Operations (Unaudited)

 

   For the
three months ended
 
   March 31, 
   2022   2021 
   US$
thousands
   US$
thousands
 
   (Unaudited)   (Unaudited) 
General and administrative   1,435    1,971 
Other   711    792 
Loss from operations   (2,146)   (2,763)
           
Other expense, net          
Gain on derivative liability   
-
    426 
Foreign exchange (loss)   (9)   (63)
Financial (expenses), net   (11)   (160)
           
Loss, before income taxes   (2,166)   (2,560)
Income taxes   
-
    
-
 
           
Net loss   (2,166)   (2,560)
           
Net loss, per share of common stock          
Basic and diluted (in US$)   (0.01)   (0.01)
           
Weighted-average shares outstanding          
Basic and diluted (in thousands)   404,817    238,941 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

2

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited)

 

For the three months ended March 31, 2022

 

   Common Stock   Additional
paid-in
   Accumulated     
   Shares   Amounts   Capital   deficit   Total 
   thousands  

US$

thousands

  

US$

thousands

  

US$

thousands

  

US$

thousands

 
Balances as of December 31, 2021   364,324    3,643    277,258    (223,525)   57,376 
Funds received from sale of DSPP units and shares and exercise of warrants   102,219    1,022    10,405    
    11,427 
Funds received from option exercises   50    1    
    
    1 
Value of options granted to employees, directors and others as non-cash compensation       
    215    
    215 
Net loss       
    
    (2,166)   (2,166)
Balances as of March 31, 2022   466,593    4,666    287,878    (225,691)   66,853 

 

For the three months ended March 31, 2021

 

   Common Stock   Additional
paid-in
   Accumulated     
   Shares   Amounts   Capital   deficit   Total 
   thousands  

US$

thousands

  

US$

thousands

  

US$

thousands

  

US$

thousands

 
Balances as of December 31, 2020   237,382    2,374    245,539    (212,804)   35,109 
Funds received from sale of DSPP units and shares and exercise of warrants   3,848    39    2,810    
    2,849 
Value of bonds converted to shares   4    
*
    
    
    
 
Funds received from option exercises   117    1        
    1 
Value of options granted to employees, directors and others as non-cash compensation       
    821    
    821 
Net loss       
    
    (2,560)   (2,560)
Balances as of March 31, 2021   241,351    2,414    249,170    (215,364)   36,220 

 

 
*Less than one thousand.

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

3

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statements of Cash Flows (Unaudited)

 

   For the
three months ended
March 31,
 
   2022   2021 
   US$
thousands
   US$
thousands
 
   (Unaudited)   (Unaudited) 
Cash flows from operating activities        
Net loss   (2,166)   (2,560)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation   195    179 
Cost of options issued to employees, directors and others as non-cash compensation   208    821 
Amortization of debt discount related to convertible bonds   
-
    141 
Change in derivative liability   
-
    (426)
Change in assets and liabilities, net:          
Other deposits   12    21 
Prepaid expenses and other   (575)   530 
Governmental receivables   562    355 
Lease obligation – current   (34)   (35)
Lease obligation – non current   (40)   (45)
Right of use lease assets   64    56 
Other receivables   107   105 
Severance payable, net   
-
    (45)
Accounts payable   (331)   (150)
Accrued liabilities   (93)   (1,088)
Net cash used in operating activities   (2,091)   (2,141)
           
Cash flows from investing activities          
Acquisition of property and equipment   (12)   (20)
Acquisition of drilling rig and related equipment   (122)   (76)
Investment in unproved oil and gas properties   (3,665)   (7,028)
Net cash used in investing activities   (3,799)   (7,124)
           
Cash flows from financing activities          
Proceeds from exercise of stock options   1    1 
Proceeds from issuance of stock and exercise of warrants   9,427    2,849 
Net cash provided by financing activities   9,428    2,850 
           
Net (decrease)/increase in cash, cash equivalents and restricted cash   3,538   (6,415)
Cash, cash equivalents and restricted cash – beginning of period   5,952    14,662 
Cash, cash equivalents and restricted cash – end of period   9,490    8,247 
           
Supplemental schedule of cash flow information          
           
Non-cash investing and financing activities:          
Non-cash equity receivables   2,000    - 
Unpaid investments in oil & gas properties   1,130    2,363 
Capitalized convertible bond interest attributed to oil and gas properties   
-
    79 
Cost of options issued to employees attributed to oil and gas properties   7    
-
 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

4

 

 

Cash, cash equivalents and restricted cash, are comprised as follows:

 

   March 31,
2022
   December 31,
2021
 
   US$ thousands   US$ thousands 
Cash and cash equivalents   8,221    4,683 
Restricted cash included in fixed long-term bank deposits   1,269    1,269 
    9,490    5,952 

 

5

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 1 - Nature of Operations, Basis of Presentation and Going Concern

 

A. Nature of Operations

 

Zion Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 22 years of oil & gas exploration in Israel. As of March 31, 2022, the Company has no revenues from its oil and gas operations.

 

Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.

 

On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.

 

Exploration Rights/Exploration Activities

 

Megiddo-Jezreel Petroleum License, No. 401 (“MJL 401”) and New Megiddo License 428 (“NML 428”)

 

The Megiddo-Jezreel License 401 was awarded on December 3, 2013 for a three-year primary term through December 2, 2016 with the possibility of additional one-year extensions up to a maximum of seven years. The Megiddo-Jezreel License 401 lies onshore, south and west of the Sea of Galilee, and we continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential.

 

The NML 428 (covering the same area as MJ-01) was awarded on December 3, 2020 for a six-month term with the possibility of an additional six-month extension. On April 29, 2021, Zion submitted a request to the Ministry of Energy for a six-month extension to December 2, 2021. On May 30, 2021, the Ministry of Energy approved our request for extension to December 2, 2021. On November 29, 2021, the Ministry of Energy approved our request for extension to August 1, 2022, This license effectively replaced the Megiddo-Jezreel License 401 as it has the same area and coordinates.

 

The MJ-02 drilling plan was approved by the Ministry of Energy on July 29, 2020. On January 6, 2021, Zion spudded its MJ-02 exploratory well. On November 23, 2021, Zion announced via a press release that it completed drilling the MJ-02 well to a total depth of 5,531 meters (~18,141 feet) with a 6 inch open hole at that depth.

 

A full set of detailed and comprehensive tests including neutron-density, sonic, gamma, and resistivity logs were acquired in December 2021, as a result of which we identified an encouraging zone of interest. All of the well testing equipment and personnel are secured for the MJ-02 well. We have re-entered our MJ-02 wellbore and are progressing to production testing. This work is expected to take several weeks.

 

6

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 1 - Nature of Operations, Basis of Presentation and Going Concern (cont’d)

 

B. Basis of Presentation

 

The accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the operating results for the year ending December 31, 2022 or for any other subsequent interim period.

 

C. Going Concern

 

The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons. 

 

The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be impaired. The consolidated financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the three months ended March 31, 2022, the Company incurred a net loss of approximately $2.2 million and had an accumulated deficit of approximately $225.7 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty 

 

7

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies

 

A. Net Gain (Loss) per Share Data

 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share as the inclusion of 23,144,603 and 10,969,456 Common Stock equivalents in 2022, and 2021 respectively, would be anti-dilutive.

 

B. Use of Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.

 

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.

 

C. Oil and Gas Properties and Impairment

 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

8

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

During the three months ended March 31, 2022, and 2021, respectively, the Company did not record any post-impairment charges.

 

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $48,099,000 and $46,950,000 as of March 31, 2022 and December 31, 2021, respectively.

 

D. Fair Value Measurements

 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

 

  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2022, and December 31, 2021, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Binomial Model. 

 

9

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

E. Stock-Based Compensation

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

F. Warrants

 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

 

G. Related parties

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged. Zion did not have any related party transactions for the periods covered in this report, with the exception of recurring monthly consulting fees paid to certain management personnel.

 

10

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

H. Recently Adopted Accounting Pronouncements

 

ASU 2016-02 – Leases (Topic 842)

 

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 (including interim periods within those periods) using a modified retrospective approach and early adoption is permitted. Zion adopted ASU 2016-02 in the first quarter of 2019. Presently, Zion has operating leases for office space in Dallas, Texas and in Caesarea, Israel plus various leases for motor vehicles. These leases have been accounted for under ASU 2016-02 in 2020, 2021 and 2022 by establishing a right-of-use asset and a corresponding current lease liability and non-current lease liability. Zion is not subject to any loan covenants and therefore, the increase in assets and liabilities does not have a material impact on its business.

 

ASU 2020-03, “Codification Improvements to Financial Instruments”

 

In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. The Company is currently evaluating the impact the adoption of this guidance may have on its consolidated financial statements.

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods beginning after December 31, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company does not believe that this ASU will have any impact on its consolidated financial statements.

 

The Company does not believe that the adoption of any of the recently issued accounting pronouncements had a significant impact on our consolidated financial position, results of operations, or cash flow, except for ASC Update No. 2016-02—Leases, which requires organizations to recognize lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous GAAP. See Note 5 for more complete details on balances at March 31, 2022 and December 31, 2021.

 

11

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

I. Depreciation and Accounting for Drilling Rig and Related Equipment

 

On March 12, 2020, Zion entered into a Purchase and Sale Agreement with Central European Drilling kft (“CED”), a Hungarian corporation, to purchase an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, subject to acceptance testing and potential downward adjustment. We remitted to the Seller $250,000 on February 6, 2020 as earnest money towards the purchase price. The Closing anticipated by the Agreement took place on March 12, 2020 by the Seller’s execution and delivery of a Bill of Sale to us. On March 13, 2020, the Seller retained the earnest money deposit, and the Company remitted $4,350,000 to the seller towards the purchase price and $1,000,000 (the “Holdback Amount”) was deposited in escrow with American Stock Transfer and Trust Company LLC, as escrow agent, through November 30, 2020, or as extended by mutual agreement of the parties, pending a determination, if any, by us of any operating deficiency in the drilling rig. On January 6, 2021, Zion completed its acceptance testing of the I-35 drilling rig and the Holdback Amount was remitted to Central European Drilling on January 8, 2021.

 

Since the rig was purchased and closed during March 2020, this purchase was recorded on Zion’s books as a long-term fixed asset as a component of Property and Equipment. The full purchase price of the drilling rig was $5.6 million, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet.

 

In accordance with GAAP accounting rules, per the matching principle, monthly depreciation begins the month following when the asset is “placed in service.” The rig was placed in service in December 2020 with January 2021 representing the first month of depreciation. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion will depreciate the rig on a straight-line basis.

 

The $540,000 in spare parts was the original cost to CED. These items were received and counted by Zion upon receipt. All records and files are maintained by Zion. Zion plans to obtain a physical count of the equipment items at the end of each quarter, or as close to such date as practical, in accordance with our normal procedures.

 

Zion uses the First In First Out (“FIFO”) method of accounting for the inventory spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the inventory of spare parts gets consumed.

 

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

 

See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2022:

 

I-35 Drilling Rig & Associated Equipment:

 

   Three-month period ended March 31, 2022 
   I-35
Drilling Rig
   Rig
Spare Parts
   Other
Drilling Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2021   5,859    643    332    6,834 
Asset Additions   
-
    5    117    122 
Asset Depreciation   (159)   
-
    (25)   (184)
Asset Disposals for Self-Consumption   
-
    (13)   
-
    (13)
March 31, 2022   5,700    635    424    6,759 

 

12

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity

 

The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 400,000,000 shares to 800,000,000 shares, effective June 9, 2021.

 

A. 2011 Equity Incentive Stock Option Plan

 

During the three months ended March 31, 2022, the Company did not grant any options from the 2011 Equity Incentive Plan for employees, directors and consultants.

 

During the three months ended March 31, 2021, the Company granted the following options from the 2011 Equity Incentive Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 600,000 shares of Common Stock to six senior officers and three staff members at an exercise price of $0.915 per share. The options vested upon grant and are exercisable through January 4, 2031. The fair value of the options at the date of grant amounted to approximately $456,000.

 

  ii. Options to purchase 75,000 shares of Common Stock were granted to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 6, 2031. The fair value of the options at the date of grant amounted to approximately $68,000.

 

B. 2011 Non-Employee Directors Stock Option Plan 

 

During the three months ended March 31, 2022, the Company did not grant any qualified (market value) options from the 2011 Non-Employee Directors Stock Option Plan to its directors.

 

During the three months ended March 31, 2021, the Company granted the following qualified (market value) and non-qualified options from the 2011 Non-Employee Directors Stock Option Plan for directors to purchase shares of common stock as non-cash compensation:

 

  i.

Options to purchase 350,000 shares of Common Stock to seven board members at an exercise price of $0.915 per share. The options vested upon grant and are exercisable through January 4, 2027. The fair value of the options at the date of grant amounted to approximately $252,000.

 

  ii. Options to purchase 50,000 shares of Common Stock were granted to one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2027. The fair value of the options at the date of grant amounted to approximately $45,000.

 

C. 2021 Omnibus Incentive Stock Option Plan

 

Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares of common stock.

 

The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.

 

13

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed ten years from the date of grant.

 

During the three months ended March 31, 2022, the Company granted the following options from the 2021 Equity Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 175,000 shares of Common Stock to six senior officers and one staff member at an exercise price of $0.1529 per share. The options vested upon grant and are exercisable through January 4, 2032. The fair value of the options at the date of grant amounted to approximately $22,000.

 

  ii. Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $4,000.

 

  iii. Options to purchase 300,000 shares of Common Stock to one senior officer and one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,000

 

  iv. Options to purchase 200,000 shares of Common Stock one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $29,000

 

  v. Options to purchase 1,600,000 shares of Common Stock to five senior officers and four staff members at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $209,000, and will be recognized during the years 2022 and 2023.

 

  vi.

Options to purchase 1,400,000 shares of Common Stock to seven board members, at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $182,000, and will be recognized during the years 2022 and 2023.

     
  vii.

Options to purchase 160,000 shares of Common Stock to four staff members, at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 17, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $23,000.

     
  viii.

Options to purchase 200,000 shares of Common Stock to six staff members at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $26,000, and will be recognized during the years 2022 and 2023.

     
  ix.

Options to purchase 40,000 shares of Common Stock to two consultants at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $5,000, and will be recognized during the years 2022 and 2023.

 

During the three months ended March 31, 2021, the Company did not grant any options from the 2021 Equity Omnibus Plan for employees, directors and consultants (as the Plan was not in existence during that period).

 

14

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

D. Stock Options

 

The stock option transactions since January 1, 2022 are shown in the table below:

 

   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2021   9,741,750    0.64 
           
Changes during 2022 to:          
Granted to employees, officers, directors and others   4,100,000    0.13 
Expired/Cancelled/Forfeited   
-
    
-
 
Exercised   (50,000)   0.01 
Outstanding, March 31, 2022   13,791,750    0.49 
Exercisable, March 31, 2022   10,551,750    0.60 

 

15

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The following table summarizes information about stock options outstanding as of March 31, 2022:

 

Shares underlying outstanding options (non-vested)  Shares underlying outstanding options (fully vested) 
Range of
exercise
price
   Number
outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
   Range of
exercise
price
   Number
Outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
 
US$           US$   US$           US$ 
 0.14    240,000    9.81    0.14    0.01    10,000    1.62    0.01 
 0.15    3,000,000    9.77    0.15    0.01    5,000    2.20    0.01 
     
    
    
    0.01    20,000    4.17    0.01 
     
    
    
    0.01    130,000    4.75    0.01 
     
    
    
    0.01    50,000    4.76    0.01 
     
    
    
    0.01    60,000    5.04    0.01 
     
    
    
    0.01    200,000    5.13    0.01 
     
    
    
    0.01    40,000    5.50    0.01 
     
    
    
    0.01    85,000    5.75    0.01 
     
    
    
    0.01    25,000    5.76    0.01 
     
    
    
    0.01    30,000    5.91    0.01 
     
    
    
    0.01    4,000    6.01    0.01 
     
    
    
    0.01    25,000    6.77    0.01 
     
    
    
    0.01    85,000    7.46    0.01 
     
    
    
    0.01    205,000    7.63    0.01 
     
    
    
    0.01    35,000    7.76    0.01 
     
    
    
    0.01    75,000    8.76    0.01 
     
    
    
    0.01    200,000    9.14    0.01 
     
    
    
    0.01    355,000    9.29    0.01 
     
    
    
    0.01    10,000    9.42    0.01 
     
    
    
    0.01    500,000    9.76    0.01 
     
    
    
    0.01    110,000    9.80    0.01 
     
    
    
    0.15    200,000    9.76    0.15 
     
    
    
    0.16    340,000    7.69    0.16 
     
    
    
    0.16    75,000    3.69    0.16 
     
    
    
    0.18    25,000    3.67    0.18 
     
    
    
    0.25    50,000    9.42    0.25 
     
    
    
    0.25    363,000    9.42    0.25 
     
    
    
    0.28    25,000    3.42    0.28 
     
    
    
    0.28    25,000    7.42    0.28 
     
    
    
    0.29    25,000    5.20    0.29 
     
    
    
    0.39    1,510,000    9.27    0.39 
     
    
    
    0.59    1,400,000    5.13    0.59 
     
    
    
    0.59    1,800,000    9.14    0.59 
     
    
    
    0.92    350,000    4.76    0.92 
     
    
    
    0.92    600,000    8.76    0.92 
     
    
    
    1.33    25,000    1.07    1.33 
     
    
    
    1.38    105,307    2.76    1.38 
     
    
    
    1.55    200,000    0.18    1.55 
     
    
    
    1.67    405,943    2.51    1.67 
     
    
    
    1.70    218,500    0.72    1.70 
     
    
    
    1.75    250,000    1.27    1.75 
     
    
    
    1.78    25,000    2.43    1.78 
     
    
    
    2.31    250,000    1.76    2.31 
     
    
    
    4.15    25,000    2.26    4.15 
 0.14-0.15     3,240,000         0.15    0.01-4.15    10,551,750         0.60 

 

16

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Granted to employees

 

The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
three months ended
March 31,
 
   2022    2021  
Weighted-average fair value of underlying stock at grant date  $0.15    $0.92  
Dividend yields          
Expected volatility   127%-133 %   121%-143 %
Risk-free interest rates   1.37%-1.55 %   0.16%-0.38 %
Expected lives (in years)   5.00-5.50     3.00-5.00  
Weighted-average grant date fair value  $0.13    $0.77  

 

Granted to non-employees

 

The following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
three months ended
March 31,
 
   2022   2021 
Weighted-average fair value of underlying stock at grant date  $0.15   $ 
Dividend yields        
Expected volatility   103%    
Risk-free interest rates   1.78%    
Expected lives (in years)   10     
Weighted-average grant date fair value  $0.14   $ 

 

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the options.

 

The expected life represents the weighted average period of time that options granted are expected to be outstanding. The expected life of the options granted to employees and directors is calculated based on the Simplified Method as allowed under Staff Accounting Bulletin No. 110 (“SAB 110”), giving consideration to the contractual term of the options and their vesting schedules, as the Company does not have sufficient historical exercise data at this time. The expected life of the option granted to non-employees equals their contractual term. In the case of an extension of the option life, the calculation was made on the basis of the extended life.

 

17

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

E. Compensation Cost for Warrant and Option Issuances

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 214    821 

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 1    
 

 

The following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and capitalized to Unproved Oil & Gas properties:

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 7    
 

 

As of March 31, 2022, there was $325,000 of unrecognized compensation cost, related to non-vested stock options granted under the Company’s various stock option plans. That cost is expected to be recognized during the remaining periods of 2022 and 2023.

 

18

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

F. Dividend Reinvestment and Stock Purchase Plan (“DSPP”)

 

On March 13, 2014 Zion filed a registration statement on Form S-3 that is part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended.

 

The ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018, at a per share exercise price of $1.00.

 

As of May 2, 2017, any outstanding ZNWAB warrants expired.

 

As of May 2, 2018, any outstanding ZNWAC warrants expired.

 

On May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020 to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.”

 

The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00.

 

On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

19

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders.

 

On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.”

 

All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00.

 

On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders.

 

An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017.

 

Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.” 

 

The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders.

 

20

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”

 

The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.”

 

The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.”

 

21

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01.

 

On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering.

 

The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.”

 

The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00.

 

On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00.

 

On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021.

 

22

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.”

 

The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.

 

On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021.

 

The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.”

 

The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25.

 

On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25.

 

23

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program.

 

On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00.

 

During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP.

 

On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein.

 

On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein.

 

For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively.

 

The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program.

 

The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only.

 

24

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

G. Subscription Rights Offering

 

On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”

 

The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.

 

On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.

 

The 2018 Subscription Rights Offering terminated on May 31, 2018. The Company raised net proceeds of approximately $3,038,000, from the subscription of Rights, after deducting fees and expenses of $243,000 incurred in connection with the rights offering.

 

25

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

H. Warrant Table

 

The warrants balances at December 31, 2021 and transactions since January 1, 2022 are shown in the table below:

 

Warrants   Exercise
Price
    Warrant
Termination Date
  Outstanding Balance, 12/31/2021     Warrants
Issued
    Warrants
Exercised
    Warrants
Expired
    Outstanding Balance, 03/31/2022  
ZNWAA   $ 2.00     01/31/2023     1,498,804      
-
     
-
     
-
      1,498,804  
ZNWAD   $ 1.00     05/02/2023     243,853      
-
     
-
     
-
      243,853  
ZNWAE   $ 1.00     05/01/2023     2,144,099      
-
     
-
     
-
      2,144,099  
ZNWAF   $ 1.00     08/14/2023     359,435      
-
     
-
     
-
      359,435  
ZNWAG   $ 1.00     01/08/2023     240,068      
-
     
-
     
-
      240,068  
ZNWAH   $ 5.00     04/19/2023     372,400      
-
     
-
     
-
      372,400  
ZNWAI   $ 3.00     06/29/2023     640,730      
-
     
-
     
-
      640,730  
ZNWAJ   $ 1.00     10/29/2023     545,900      
-
     
-
     
-
      545,900  
ZNWAK   $ 0.01     02/25/2023     431,655      
-
      (1,750 )     -       429,905  
ZNWAL   $ 2.00     08/26/2023     517,875      
-
     
-
     
-
      517,875  
ZNWAM   $ 1.00     07/15/2023     4,376,000      
-
     
-
     
-
      4,376,000  
ZNWAN   $ 1.00     05/16/2023     267,660      
-
     
-
     
-
      267,660  
ZNWAO   $ 0.25     06/12/2023     174,970      
-
     
-
     
-
      174,970  
ZNWAP   $ 0.25    

06/02/2023

    439,916      
-
     
-
     
-
      439,916  
ZNWAR   $ 0.25     06/23/2023     1,020,000      
-
     
-
     
-
      1,020,000  
Outstanding warrants                 13,273,365       -       (1,750 )     -       13,271,615  

 

 

26

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

I. Warrant Descriptions

 

The price and the expiration dates for the series of warrants to investors are as follows *:

 

        Period of Grant     US$     Expiration Date  
ZNWAA Warrants   B,C   March 2013 – December 2014       2.00     January 31, 2023  
ZNWAD Warrants   A,B,C   January 2015 – March 2016       1.00     May 02, 2023  
ZNWAE Warrants   B,C   November 2016 – March 2017       1.00     May 01, 2023  
ZNWAF Warrants   A,B,C   May 2017 – July 2017       1.00     August 14, 2023  
ZNWAG Warrants   C   October 2017 – December 2017       1.00     January 08, 2023  
ZNWAH Warrants   A,B,C   February 2018       5.00     April 19, 2023  
ZNWAI Warrants   A,B,C   April 2018 – May 2018       3.00     June 29, 2023  
ZNWAJ Warrants   B,C   August 2018 – September 2018       1.00     October 29, 2023  
ZNWAK Warrants   B,C   December 2018 – January 2019       0.01     February 25, 2023  
ZNWAL Warrants   C   July 2019 – August 2019       2.00     August 26, 2023  
ZNWAM Warrants   D    January 2021 – March 2021       1.00     July 15, 2023  
ZNWAN Warrants       May – June 2021       1.00     May 16, 2023  
ZNWAO Warrants       June 2021       0.25     June 12, 2023  
ZNWAP Warrants   D   June 2021       0.25     June 03, 2023  
ZNWAQ Warrants   E    June 2021       0.25     July 6, 2022  
ZNWAR Warrants   D   June 2021       0.25     June 23, 2023  
ZNWAS Warrants   F   August 2021 – March 2022       1.00     December 31, 2023  

 

 
* Zion’s ZNWAB Warrants expired on May 2, 2017, and the ZNWAC Warrants expired on May 2, 2018

 

A On December 4, 2018, the Company extended the termination date of the Warrants by one (1) year.
B On May 29, 2019, the Company extended the termination date of the Warrants by one (1) year.
C On September 15, 2020, the Company extended the termination date of the Warrants by two (2) years.
D On March 21, 2022, the Company extended the termination date of the Warrants by one (1) year.
E These warrants were issued on May 5, 2022.
F These warrants will be exercisable beginning on November 15, 2023 and terminate on December 31, 2023. These warrants will be issued in November 2023.

 

27

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 4 - Unproved Oil and Gas Properties, Full Cost Method

 

Unproved oil and gas properties, under the full cost method, are comprised as follows:

 

   March 31,
2022
   December 31,
2021
 
   US$ thousands   US$ thousands 
Excluded from amortization base:          
Drilling costs, and other operational related costs   32,703    32,075 
Capitalized salary costs   2,210    2,158 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   11,729    11,260 
Other costs   39    39 
    48,099    46,950 

 

Changes in Unproved oil and gas properties during the three months ended March 31, 2022 and 2021 are as follows:

 

   March 31,
2022
   March 31,
2021
 
   US$ thousands   US$ thousands 
Excluded from amortization base:          
Drilling costs, and other operational related costs   628    7,002 
Capitalized salary costs   52    61 
Capitalized interest costs   
-
    79 
Legal and seismic costs, license fees and other preparation costs   469    1,034 
Other costs   
-
    
-
 
    *1,149    *8,176 

 

 
*Inclusive of non-cash amounts of approximately $1,137,000, and $2,442,000 during the three months ended March 31, 2022, and 2021, respectively

 

Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.

 

28

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 5 - Right of use leases assets and lease obligations

 

The Company is a lessee in several non-cancellable operating leases, primarily for transportation and office space.

 

The table below presents the operating lease assets and liabilities recognized on the balance sheets as of March 31, 2022 and December 31, 2021: 

 

   March 31,
2022
   December 31,
2021
 
   US$ thousands   US$ thousands 
Operating lease assets  $263   $327 
           
Operating lease liabilities:          
Current operating lease liabilities  $169   $203 
Non-current operating lease liabilities  $129   $169 
Total operating lease liabilities  $298   $372 

 

The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.

 

The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.

 

The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of March 31, 2022 are:

 

   March 31,
2022
 
Weighted average remaining lease term (years)   1.75 
Weighted average discount rate   5.9%

 

29

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 5 - Right of use leases assets and leases obligations (cont’d)

 

The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of March 31, 2022:

 

   US$ thousands 
2022   142 
2023   158 
2024   13 
2025   
-
 
2026   
-
 
Thereafter   
-
 
Total undiscounted future minimum lease payments   313 
Less: portion representing imputed interest   (15)
Total undiscounted future minimum lease payments   298 

 

Operating lease costs were $68,000 and $63,000 for the three months ended March 31, 2022, and 2021, respectively. Operating lease costs are included within general and administrative expenses on the statements of income.

 

Cash paid for amounts included in the measurement of operating lease liabilities was $72,000 and $71,000 for the three months ended March 31, 2022, and 2021, respectively, and this amount is included in operating activities in the statements of cash flows.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $nil and $nil for the three months ended March 31, 2022, and 2021, respectively.

 

30

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 6 - Commitments and Contingencies

 

A. Securities and Exchange Commission (“SEC”) Investigation

 

As previously disclosed by the Company, on June 21, 2018, the Fort Worth Regional Office of the SEC informed Zion that it was conducting a formal, non-public investigation and asked that we provide certain information and documents in connection with its investigation. Since that date, we have fully cooperated with the SEC on an on-going basis in connection with its investigation. Investigations of this nature are inherently uncertain and their results cannot be predicted with certainty. Regardless of the outcome, an SEC investigation could have an adverse impact on us because of legal costs, diversion of management resources, and other factors. The investigation could also result in reputational harm to Zion and may have a material adverse effect on Zion’s current and future business and exploratory activities and its ability to raise capital to continue our oil and gas exploratory activities.

 

B. Litigation

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

C. Recent Market Conditions – Coronavirus Pandemic

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic has significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments react to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. As of the date of this report, many of our employees are working from home. However, while there are various uncertainties to navigate, the Company’s business activities are continuing. The situation is rapidly changing and additional impacts to the business may arise that we are not aware of currently. We cannot predict whether, when or the manner in which the conditions surrounding COVID-19 will change including the timing of lifting any restrictions or work from home arrangements.

 

The full extent of COVID-19’s impact on our operations and financial performance depends on future developments that are uncertain and unpredictable, including the duration and spread of the pandemic, its impact on capital and financial markets and any new information that may emerge concerning the severity of the virus, its spread to other regions as well as the actions taken to contain it, among others.

 

D. Environmental and Onshore Licensing Regulatory Matters

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings.

 

The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.

 

As of March 31, 2022, and December 31, 2021, the Company accrued $nil and $nil for license regulatory matters.

 

E. Bank Guarantees

 

As of March 31, 2022, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $1,186,000) and others (approximately $82,000) with respect to its drilling operation in an aggregate amount of approximately $1,268,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits – restricted.

 

31

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 6 - Commitments and Contingencies (cont’d)

 

F. Risks

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2022 through March 31, 2022, the USD has fluctuated by approximately 2.1% against the NIS (the USD strengthened relative to the NIS). By contrast, during the period January 1, 2021 through December 31, 2021, the USD fluctuated by approximately 3.3% against the NIS (the USD weakened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2022, we had cash, cash equivalents and short-term bank deposits of approximately $9,490,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2022, exclusive of funds at US banks that earn no interest, was approximately 0.52%.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

 

Note 7 - Subsequent Events

 

  (i) Approximately $2,585,000 was collected through the Company’s DSPP program during the period April 1 through May 6, 2022.

 

(ii)On April 1, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one board member, to purchase 25,000 shares of Common Stock at an exercise price of $0.1128 per share. The options vested upon grant and are exercisable through April 1, 2032. The fair value of the options at the date of grant amounted to approximately $2,410.

 

(iii)On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to five senior officers and ten staff members to purchase 3,160,000 shares of Common Stock at an exercise price of $0.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2032. The fair value of the options at the date of grant amounted to approximately $387,660, and will be recognized during the years 2022 and 2023.

 

(iv)On April 15. 2022, the Company granted options under the 2021 Omnibus Incentive Plan to five staff members, to purchase 290,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,594.

 

(v)On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one senior officer member to purchase 400,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $54.612.

 

(vi)On April 15. 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one board member, to purchase 400,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $54,612.

 

(vii)   On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to eight board members to purchase 3,200,000 shares of Common Stock at an exercise price of $.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $392,567.

 

(viii)On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to two consultants to purchase 50,000 shares of Common Stock at an exercise price of $.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $6,377.

 

32

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

THE FOLLOWING DISCUSSION SHOULD BE READ IN CONJUNCTION WITH OUR UNAUDITED INTERIM FINANCIAL STATEMENTS AND THE RELATED NOTES TO THOSE STATEMENTS INCLUDED IN THIS FORM 10-Q. SOME OF OUR DISCUSSION IS FORWARD-LOOKING AND INVOLVES RISKS AND UNCERTAINTIES. FOR INFORMATION REGARDING RISK FACTORS THAT COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS, REFER TO THE DISCUSSION OF RISK FACTORS IN THE “DESCRIPTION OF BUSINESS” SECTION OF OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2021, FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.

 

Forward-Looking Statements

 

Certain statements made in this discussion are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may materially differ from actual results.

 

Forward-looking statements can be identified by terminology such as “may”, “should”, “expects”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, or “continue” or the negative of these terms or other comparable terminology and include, without limitation, statements regarding: 

 

  The going concern qualification in our consolidated financial statements;

 

  our liquidity and our ability to raise capital to finance our overall exploration and development activities within our license area;

 

  our ability to continue meeting the requisite continued listing requirements by OTCQX;

 

  the outcome of the current SEC investigation against us;

 

  business interruptions from COVID-19 pandemic;

 

  our ability to obtain new license areas to continue our petroleum exploration program;

 

  interruptions, increased consolidated financial costs and other adverse impacts of the coronavirus pandemic on the drilling and testing of our MJ#2 well and our capital raising efforts;

 

  our ability to explore for and develop natural gas and oil resources successfully and economically within our license area;

 

  our ability to maintain the exploration license rights to continue our petroleum exploration program;

 

  the availability of equipment, such as seismic equipment, drilling rigs, and production equipment as well as access to qualified personnel;

 

  the impact of governmental regulations, permitting and other legal requirements in Israel relating to onshore exploratory drilling;

 

  our estimates of the time frame within which future exploratory activities will be undertaken;

 

  changes in our exploration plans and related budgets;

 

33

 

 

  the quality of existing and future license areas with regard to, among other things, the existence of reserves in economic quantities;

 

  anticipated trends in our business;

 

  our future results of operations;

 

  our capital expenditure program;

 

  future market conditions in the oil and gas industry

 

  the demand for oil and natural gas, both locally in Israel and globally; and

 

  the impact of fluctuating oil and gas prices on our exploration efforts

 

Overview

 

Zion Oil and Gas, Inc., a Delaware corporation, is an oil and gas exploration company with a history of 22 years of oil and gas exploration in Israel. We were incorporated in Florida on April 6, 2000 and reincorporated in Delaware on July 9, 2003. We completed our initial public offering in January 2007. Our common stock, par value $0.01 per share (the “Common Stock”) currently trades on the OTCQX Market under the symbol “ZNOG” and our Common Stock warrant under the symbol “ZNOGW.”

 

The Company currently holds one active petroleum exploration license onshore Israel, the New Megiddo License 428 (“NML 428”), comprising approximately 99,000 acres. The NML 428 was awarded on December 3, 2020 for a six-month term with the possibility of an additional six-month extension. On April 29, 2021, Zion submitted a request to the Ministry of Energy for a six-month extension to December 2, 2021. On May 30, 2021, the Ministry of Energy approved our request for extension to December 2, 2021. On November 29, 2021, the Ministry of Energy approved our request for extension to August 1, 2022. The ML 428 lies onshore, south and west of the Sea of Galilee, and we continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential.

 

The Megiddo Jezreel #1 (“MJ #1”) site was completed in early March 2017, after which the drilling rig and associated equipment were mobilized to the site. Performance and endurance tests were completed, and the MJ #1 exploratory well was spud on June 5, 2017 and drilled to a total depth (“TD”) of 5,060 meters (approximately 16,600 feet). Thereafter, the Company obtained three open-hole wireline log suites (including a formation image log), and the well was successfully cased and cemented. The Ministry of Energy approved the well testing protocol on April 29, 2018.

 

During the fourth quarter of 2018, the Company testing protocol was concluded at the MJ #1 well. The test results confirmed that the MJ #1 well did not contain hydrocarbons in commercial quantities in the zones tested. As a result, in the year ended December 31, 2018, the Company recorded a non-cash impairment charge to its unproved oil and gas properties of $30,906,000. During the three months ended March 31, 2022 and 2021, respectively, the Company did not record any post-impairment charges.

 

While the well was not commercially viable, Zion learned a great deal from the drilling and testing of this well. We believe that the drilling and testing of this well carried out the testing objectives which would support further evaluation and potential further exploration efforts within our License area. Zion believed it was prudent and consistent with good industry practice to examine further these questions with a focused 3-D seismic imaging shoot of approximately 72 square kilometers surrounding the MJ#1 well. Zion completed all of the acquisition, processing and interpretation of the 3-D data and incorporated its expanded knowledge base into the drilling of our current MJ-02 exploratory well.

 

34

 

 

On March 12, 2020, Zion entered into a Purchase and Sale Agreement with Central European Drilling kft, a Hungarian corporation, to purchase an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, subject to acceptance testing and potential downward adjustment. We remitted to the Seller $250,000 on February 6, 2020 as earnest money towards the Purchase Price. The Closing anticipated by the Agreement took place on March 12, 2020 by the Seller’s execution and delivery of a Bill of Sale to us. On March 13, 2020, the Seller retained the earnest money deposit, and the Company remitted $4,350,000 to the seller towards the purchase price, and $1,000,000 (the “Holdback Amount”) was deposited in escrow with American Stock Transfer and Trust Company LLC. On January 6, 2021, Zion completed its acceptance testing of the I-35 drilling rig and the Holdback Amount was remitted to Central European Drilling.

 

The MJ-02 drilling plan was approved by the Ministry of Energy on July 29, 2020. On January 6, 2021, Zion officially spudded its MJ-02 exploratory well. On November 23, 2021, Zion announced via a press release that it completed drilling the MJ-02 well to a total depth of 5,531 meters (~18,141 feet) with a 6-inch open hole at that depth.

 

A full set of detailed and comprehensive tests including neutron-density, sonic, gamma, and resistivity logs were acquired in December 2021, as a result of which we identified an encouraging zone of interest. All of the well testing equipment and personnel are secured for the MJ-02 well. We have re-entered our MJ-02 wellbore and are progressing to production testing. This work is expected to take several weeks.

 

At present, we have no revenues or operating income. Our ability to generate future revenues and operating cash flow will depend on the successful exploration and exploitation of our current and any future petroleum rights or the acquisition of oil and/or gas producing properties, and the volume and timing of such production. In addition, even if we are successful in producing oil and gas in commercial quantities, our results will depend upon commodity prices for oil and gas, as well as operating expenses including taxes and royalties.

 

Our executive offices are located at 12655 North Central Expressway, Suite 1000, Dallas, Texas 75243, and our telephone number is (214) 221-4610. Our branch office’s address in Israel is 9 Halamish Street, North Industrial Park, Caesarea 3088900, and the telephone number is +972-4-623-8500. Our website address is: www.zionoil.com.

 

Current Exploration and Operation Efforts

 

Megiddo-Jezreel Petroleum License

 

The Company currently holds one active petroleum exploration license onshore Israel, the New Megiddo License 428 (“NML 428”), comprising approximately 99,000 acres – See Map 1. Under Israeli law, Zion has an exclusive right to oil and gas exploration in our license area in that no other company may drill there. In the event we drill an oil or gas discovery in our license area, current Israeli law entitles us to convert the relevant portions of our license to a 30-year production lease, extendable to 50 years, subject to compliance with a field development work program and production.

  

35

 

 

The New Megiddo License 428 was awarded on December 3, 2020 for a six-month term with the possibility of an additional six-month extension. On May 30, 2021, the Ministry of Energy approved our request for extension to December 2, 2021. On November 29, 2021, the Ministry of Energy approved our request for extension to August 1, 2022. The New Megiddo License 428 area is the same area as the Megiddo-Jezreel License 401 area and lies onshore, south and west of the Sea of Galilee and we continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential. 

 

The MJ-02 drilling plan was approved by the Ministry of Energy on July 29, 2020. On January 6, 2021, Zion officially spudded its MJ-02 exploratory well. On November 23, 2021, Zion announced via a press release that it completed drilling the MJ-02 well to a total depth of 5,531 meters (~18,141 feet) with a 6-inch open hole at that depth.

 

A full set of detailed and comprehensive tests including neutron-density, sonic, gamma, and resistivity logs were acquired in December 2021, as a result of which we identified an encouraging zone of interest. All of the well testing equipment and personnel are secured for the MJ-02 well. We have re-entered our MJ-02 wellbore and are progressing to production testing. This work is expected to take several weeks.

 

I-35 Drilling Rig & Associated Equipment

 

   Three-month period ended March 31, 2022 
   I-35
Drilling Rig
   Rig
Spare Parts
   Other
Drilling Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2021   5,859    643    332    6,834 
Asset Additions   -    5    117    122 
Asset Depreciation   (159)   -    (25)   (184)
Asset Disposals for Self-Consumption   -    (13)   -    (13)
March 31, 2022   5,700    635    424    6,759 

 

36

 

  

Zion’s ability to fully undertake all of these aforementioned activities is subject to its raising the needed capital from its continuing offerings, of which no assurance can be provided.

 

 

Map 1. Zion’s New Megiddo License 428 as of March 31, 2022.

 

Zion’s Former Joseph License

 

Zion has plugged all of its exploratory wells on its former Joseph License area, and the reserve pits have been evacuated, but acknowledges its obligation to complete the abandonment of these well sites in accordance with guidance from the Energy Ministry, Environmental Ministry and local officials.

 

37

 

 

Onshore Licensing, Oil and Gas Exploration and Environmental Guidelines

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental cleanup of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner, the Energy Ministry, and the Environmental Ministry in recent years as it pertains to oil and gas activities. Mention of these guidelines was included in previous Zion Oil & Gas filings.

 

We acknowledge that these new regulations are likely to increase the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that additional financial burdens could occur as a result of the Ministry requiring cash reserves that could otherwise be used for operational purposes. 

 

Capital Resources Highlights

 

We need to raise significant funds to finance the continued exploration efforts and maintain orderly operations. To date, we have funded our operations through the issuance of our securities and convertible debt. We will need to continue to raise funds through the issuance of equity and/or debt securities (or securities convertible into or exchangeable for equity securities). No assurance can be provided that we will be successful in raising the needed capital on terms favorable to us (or at all).

 

The Dividend Reinvestment and Stock Purchase Plan

 

On March 13, 2014 Zion filed a registration statement on Form S-3 that is part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended.

 

Please see Footnote 3F (“Dividend Reinvestment and Stock Purchase Plan (“DSPP”)), which is a part of this Form 10-Q filing, for details about specific unit programs, dates, and filings during the years 2016 through 2022.

 

For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively.

 

38

 

 

The warrants balances at December 31, 2021 and transactions since January 1, 2022 are shown in the table below:

 

Warrants  Exercise
Price
   Warrant
Termination Date
  Outstanding Balance, 12/31/2021   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding Balance, 03/31/2022 
ZNWAA  $2.00   01/31/2023   1,498,804    -    -    -    1,498,804 
ZNWAD  $1.00   05/02/2023   243,853    -    -    -    243,853 
ZNWAE  $1.00   05/01/2023   2,144,099    -    -    -    2,144,099 
ZNWAF  $1.00   08/14/2023   359,435    -    -    -    359,435 
ZNWAG  $1.00   01/08/2023   240,068    -    -    -    240,068 
ZNWAH  $5.00   04/19/2023   372,400    -    -    -    372,400 
ZNWAI  $3.00   06/29/2023   640,730    -    -    -    640,730 
ZNWAJ  $1.00   10/29/2023   545,900    -    -    -    545,900 
ZNWAK  $0.01   02/25/2023   431,655    -    (1,750)   -    429,905 
ZNWAL  $2.00   08/26/2023   517,875    -    -    -    517,875 
ZNWAM  $1.00   07/15/2023   4,376,000    -    -    -    4,376,000 
ZNWAN  $1.00  

05/16/2023

   267,660    -    -    -    267,660 
ZNWAO  $0.25   06/12/2023   174,970    -    -    -    174,970 
ZNWAP  $0.25   06/02/2022   439,916    -    -    -    439,916 
ZNWAR  $0.25   06/23/2023   1,020,000    -    -    -    1,020,000 
Outstanding warrants           13,273,365    -    (1,750)   -    13,271,615 

 

According to the warrant table, the Company could potentially raise up to approximately $16,408,000 if all outstanding warrants were exercised by its holders.

 

2018 Subscription Rights Offering

 

Please see Footnote 3G (“Subscription Rights Offering”), which is a part of this Form 10-Q filing, for a description of and details about the Subscription Rights Offering.

 

39

 

 

Principal Components of our Cost Structure 

 

Our operating and other expenses primarily consist of the following:

 

  Impairment of Unproved Oil and Gas Properties: Impairment expense is recognized if a determination is made that a well will not be commercially productive. The amounts include amounts paid in respect of the drilling operations as well as geological and geophysical costs and various amounts that were paid to Israeli regulatory authorities.

 

  General and Administrative Expenses: Overhead, including payroll and benefits for our corporate staff, costs of managing our exploratory operations, audit and other professional fees, and legal compliance is included in general and administrative expenses. General and administrative expenses also include non-cash stock-based compensation expense, investor relations related expenses, lease and insurance and related expenses.

 

  Depreciation, Depletion, Amortization and Accretion: The systematic expensing of the capital costs incurred to explore for natural gas and oil represents a principal component of our cost structure. As a full cost company, we capitalize all costs associated with our exploration, and apportion these costs to each unit of production, if any, through depreciation, depletion and amortization expense. As we have yet to have production, the costs of abandoned wells are written off immediately versus being included in this amortization pool.

 

Going Concern Basis

 

Since we have limited capital resources, no revenue to date and a loss from operations, our consolidated financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. The appropriateness of using the going concern basis is dependent upon our ability to obtain additional financing or equity capital and, ultimately, to achieve profitable operations. Therefore, there is substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

The Impact of COVID-19 

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic has significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments react to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. As of the date of this report, many of our employees are working from home. However, while there are various uncertainties to navigate, the Company’s business activities are continuing. The situation is rapidly changing and additional impacts to the business may arise that we are not aware of currently. We cannot predict whether, when or the manner in which the conditions surrounding COVID-19 will change including the timing of lifting any restrictions or work from home arrangements.

 

The full extent of COVID-19’s impact on our operations and financial performance depends on future developments that are uncertain and unpredictable, including the duration and spread of the pandemic, its impact on capital and financial markets and any new information that may emerge concerning the severity of the virus, its spread to other regions as well as the actions taken to contain it, among others.

 

Critical Accounting Policies 

 

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expense during the reporting period.

 

We have identified the accounting principles which we believe are most critical to the reported financial status by considering accounting policies that involve the most complex of subjective decisions or assessment.

 

40

 

 

Impairment of Oil and Gas Properties

 

We follow the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in income from continuing operations before income taxes, and the adjusted carrying amount of the unproved properties is amortized on the unit-of-production method.

 

Our oil and gas properties represent an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. A further impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

Abandonment of properties is accounted for as adjustments to capitalized costs. The net capitalized costs are subject to a “ceiling test” which limits such costs to the aggregate of the estimated present value of future net revenues from proved reserves discounted at ten percent based on current economic and operating conditions, plus the lower of cost or fair market value of unproved properties. The recoverability of amounts capitalized for oil and gas properties is dependent upon the identification of economically recoverable reserves, together with obtaining the necessary financing to exploit such reserves and the achievement of profitable operations.

 

During the three months ended March 31, 2022, and 2021, respectively, the Company did not record any post-impairment charges.

 

The total net book value of our unproved oil and gas properties under the full cost method is $48,099,000 and $46,950,000 at March 31, 2022 and at December 31, 2021, respectively.

 

Asset Retirement Obligation

 

We record a liability for asset retirement obligation at fair value in the period in which it is incurred and a corresponding increase in the carrying amount of the related long-lived assets.

 

Fair Value Considerations

 

We follow ASC 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

There are three levels of inputs to fair value measurements - Level 1, meaning the use of quoted prices for identical instruments in active markets; Level 2, meaning the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; and Level 3, meaning the use of unobservable inputs. We use Level 1 inputs for fair value measurements whenever there is an active market, with actual quotes, market prices, and observable inputs on the measurement date. We use Level 2 inputs for fair value measurements whenever there are quoted prices for similar securities in an active market or quoted prices for identical securities in an inactive market. We use observable market data whenever available. We use Level 3 inputs in the Binomial Model used for the valuation of the derivative liability.

 

41

 

 

RESULTS OF OPERATIONS 

 

   For the
three months ended
March 31,
 
   2022   2021 
   (US $ in thousands) 
Operating costs and expenses:          
General and administrative expenses   1,435    1,971 
Other   711    792 
Subtotal Operating costs and expenses   2,146    2,763 
Gain on derivative liability   -    (426)
Other expense, net   20    223 
Net loss   2,166    2,560 

 

Revenue. We currently have no revenue generating operations.

 

Operating costs and expenses. Operating costs and expenses for the three months ended March 31, 2022 were $2,146,000 compared to $2,763,000 for the three months ended March 31, 2021. The decrease in operating costs and expenses during the three months ended March 31, 2022 compared to the corresponding period in 2021 is primarily attributable to a decrease in general and administrative expenses driven by the non-cash expenses associated with stock option grants during the three months ended March 31, 2022 compared to the corresponding period in 2021.

 

General and administrative expenses. General and administrative expenses for the three months ended March 31, 2022 were $1,435,000, compared to $1,971,000 for the three months ended March 31, 2021. The decrease in General and administrative expenses during the three months ended March 31, 2022 is primarily attributable to lower non-cash expenses recorded in connection with stock option grants during 2022 compared to the corresponding period in 2021.

 

Other expense. Other expense during the three months ended March 31, 2022 was $711,000 compared to $792,000 for the three months ended March 31, 2021. Other general and administrative expenses are comprised of non-compensation and non-professional expenses incurred. The decrease in other expenses during the three months ended March 31, 2022 compared to the corresponding period in 2021 is primarily attributable to decreased marketing expenses associated with investor relations activities.

 

(Gain) on derivative liability. (Gain) on derivative liability during the three months ended March 31, 2022 was $nil, compared to a gain of ($426,000) for the three months ended March 31, 2021. An embedded derivative was contained within the valuation of Zion’s $100 convertible bond offering which closed in March 2016. The bonds were paid in full in May 2021.

 

Other expense, net. Other expense, net for the three months ended March 31, 2022 was $20,000, compared to $223,000 for the three months ended March 31, 2021. The decrease in other expense, net during the three months ended March 31, 2022 compared to the corresponding period in 2021 is primarily attributable to exchange rate differences associated with the fluctuating exchange rates of the New Israeli Shekels (“NIS”) with the U.S. Dollar (“USD”) and to financial expenses related to the Company’s convertible bonds.

 

Net Loss. Net loss for the three months ended March 31, 2022 was $2,166,000 compared to $2,560,000 for the three months ended March 31, 2021. The decrease in net loss for 2022 is primarily attributable to general and administrative expenses in the three months ended March 31, 2022 compared to the three months ended March 31, 2021.

 

42

 

 

Liquidity and Capital Resources

 

Liquidity is a measure of a company’s ability to meet potential cash requirements. As discussed above, we have historically met our capital requirements through the issuance of common stock as well as proceeds from the exercise of warrants and options to purchase common shares.

 

Our ability to continue as a going concern is dependent upon obtaining the necessary financing to complete further exploration and development activities and generate profitable operations from our oil and natural gas interests in the future. Our current operations are dependent upon the adequacy of our current assets to meet our current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, our ability to continue as a going concern will be impaired. Our financial statements for the three months ended March 31, 2022 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We have incurred a history of operating losses and negative cash flows from operations. Therefore, there is substantial doubt about our ability to continue as a going concern.

 

At March 31, 2022, we had approximately $8,221,000 in cash and cash equivalents compared to $4,683,000 at December 31, 2021, which does not include any restricted funds. Our working capital (current assets minus current liabilities) was $11,729,000 at March 31, 2022 and $3,303,000 at December 31, 2021.

 

As of March 31, 2022, we provided bank guarantees to various governmental bodies (approximately $1,186,000) and others (approximately $82,000) in respect of our drilling operation in the aggregate amount of approximately $1,268,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits restricted.

 

During the three months ended March 31, 2022, and 2021, cash used in operating activities totaled $2,091,000, and $2,141,000, respectively. Cash provided by financing activities during the three months ended March 31, 2022, and 2021, was $9,428,000, and $2,850,000, respectively, and is primarily attributable to proceeds received from the Dividend Reinvestment and Stock Purchase Plan (the “DSPP” or “Plan”). Net cash used in investing activities such as unproved oil and gas properties, equipment and spare parts was $3,799,000 and $7,124,000 for the three months ended March 31, 2022, and 2021, respectively.

 

Accounting standards require management to evaluate our ability to continue as a going concern for a period of one year subsequent to the date of the filing of this Form 10-Q. We expect to incur additional significant expenditures to further our exploration and development programs. While we raised approximately $2,585,000 during the period April 1, 2022 through May 6, 2022, we will need to raise additional funds in order to continue our exploration and development activities in our license area. Additionally, we estimate that, when we are not actively drilling a well, our expenditures are approximately $600,000 per month excluding exploratory operational activities. However, when we are actively drilling a well, we estimate an additional minimum expenditure of approximately $2,500,000 per month. The above estimates are subject to change. Subject to the qualifications specified below, management believes that our existing cash balance, coupled with anticipated proceeds under the DSPP, will be sufficient to finance our plan of operations through January 2023.

 

The recent outbreak of the coronavirus has to date significantly disrupted business operations and resulted in significantly increased unemployment in the general economy. The extent to which the coronavirus impacts our operations, specifically our capital raising efforts, as well as our ability to continue our exploratory efforts, will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others.

 

No assurance can be provided that we will be able to raise the needed operating capital.

 

43

 

 

Even if we raise the needed funds, there are factors that can nevertheless adversely impact our ability to fund our operating needs, including (without limitation), unexpected or unforeseen cost overruns in planned non-drilling exploratory work in existing license areas, the costs associated with extended delays in undertaking the required exploratory work, and plugging and abandonment activities which is typical of what we have experienced in the past. 

 

The financial information contained in these consolidated financial statements has been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. This financial information and these consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. 

 

Off-Balance Sheet Arrangements

 

We do not currently use any off-balance sheet arrangements to enhance our liquidity or capital resource position, or for any other purpose.

 

Recently Issued Accounting Pronouncements

 

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2022 had a significant impact on our financial position, results of operations, or cash flow.

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2022 through March 31, 2022, the USD has fluctuated by approximately 2.1% against the NIS (the USD strengthened relative to the NIS). By contrast, during the period January 1, 2021 through December 31, 2021, the USD fluctuated by approximately 3.3% against the NIS (the USD weakened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2022 we had cash, cash equivalents and short-term and long-term bank deposits of approximately $9,490,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2022, exclusive of funds at US banks that earn no interest, was approximately.52%.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

 

44

 

 

ITEM 4.CONTROLS AND PROCEDURES

 

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms. As of March 31, 2022, our chief executive officer and our chief financial officer conducted an evaluation of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and our chief financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2022.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in internal controls over financial reporting that occurred during the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

45

 

 

PART II—OTHER INFORMATION

 

ITEM 1.LEGAL PROCEEDINGS

 

Securities and Exchange Commission (“SEC”) Investigation

 

As previously disclosed by the Company, on June 21, 2018, the Fort Worth Regional Office of the SEC informed Zion that it was conducting a formal, non-public investigation and asked that we provide certain information and documents in connection with its investigation. Since that date, we have fully cooperated with the SEC on an on-going basis in connection with its investigation. Investigations of this nature are inherently uncertain and their results cannot be predicted with certainty. Regardless of the outcome, an SEC investigation could have an adverse impact on us because of legal costs, diversion of management resources, and other factors. The investigation could also result in reputational harm to Zion and may have a material adverse effect on Zion’s current and future business and exploratory activities and its ability to raise capital to continue our oil and gas exploratory activities.

 

Litigation

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

ITEM 1A.RISK FACTORS

 

During the quarter ended March 31, 2022, there were no material changes to the risk factors previously reported in our Annual Report on Form 10-K for the year ended December 31, 2021. 

 

ITEM 2.UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

None.

 

ITEM 5.OTHER INFORMATION:

 

None.

 

ITEM 6.EXHIBITS

 

46

 

 

Exhibit Index:

 

31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 under the Exchange Act
     
31.2   Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 under the Exchange Act
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished only)
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished only)
     
101.INS   XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

47

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

ZION OIL & GAS, INC.    
(Registrant)    
     
By: /s/ Robert W.A. Dunn   By: /s/ Michael B. Croswell Jr.
  Robert W. A. Dunn     Michael B. Croswell Jr.
  Chief Executive Officer     Chief Financial Officer
  (Principal Executive Officer)     (Principal Financial and Accounting Officer)
         
Date:

May 10, 2022

  Date:

May 10, 2022

 

48

ZNOG NONE These warrants will be exercisable beginning on November 15, 2023 and terminate on December 31, 2023. These warrants will be issued in November 2023. On May 29, 2019, the Company extended the termination date of the Warrants by one (1) year. These warrants were issued on May 5, 2022. On December 4, 2018, the Company extended the termination date of the Warrants by one (1) year. On March 21, 2022, the Company extended the termination date of the Warrants by one (1) year. On September 15, 2020, the Company extended the termination date of the Warrants by two (2) years. false --12-31 Q1 0001131312 001-33228 0001131312 2022-01-01 2022-03-31 0001131312 2022-05-06 0001131312 2022-03-31 0001131312 2021-12-31 0001131312 2021-01-01 2021-03-31 0001131312 us-gaap:CommonStockMember 2021-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001131312 us-gaap:RetainedEarningsMember 2021-12-31 0001131312 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001131312 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001131312 us-gaap:CommonStockMember 2022-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001131312 us-gaap:RetainedEarningsMember 2022-03-31 0001131312 us-gaap:CommonStockMember 2020-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001131312 us-gaap:RetainedEarningsMember 2020-12-31 0001131312 2020-12-31 0001131312 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001131312 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001131312 us-gaap:CommonStockMember 2021-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001131312 us-gaap:RetainedEarningsMember 2021-03-31 0001131312 2021-03-31 0001131312 zn:MegiddoJezreelLicenseMember 2022-01-01 2022-03-31 0001131312 2021-01-01 2021-12-31 0001131312 zn:PurchaseAndSaleAgreementMember 2020-03-12 0001131312 2020-01-06 2020-02-06 0001131312 2020-02-13 2020-03-13 0001131312 2020-03-13 0001131312 2020-02-20 2020-03-31 0001131312 2020-03-31 0001131312 zn:PurchaseAndSaleAgreementMember 2022-03-31 0001131312 zn:PurchaseAndSaleAgreementMember 2022-01-01 2022-03-31 0001131312 zn:I35DrillingRigMember 2021-12-31 0001131312 zn:RigSparePartsMember 2021-12-31 0001131312 zn:OtherDrillingAssetsMember 2021-12-31 0001131312 zn:I35DrillingRigMember 2022-01-01 2022-03-31 0001131312 zn:RigSparePartsMember 2022-01-01 2022-03-31 0001131312 zn:OtherDrillingAssetsMember 2022-01-01 2022-03-31 0001131312 zn:I35DrillingRigMember 2022-03-31 0001131312 zn:RigSparePartsMember 2022-03-31 0001131312 zn:OtherDrillingAssetsMember 2022-03-31 0001131312 pf0:MinimumMember zn:AmendedAndRestatedCertificateOfIncorporationMember 2022-03-31 0001131312 pf0:MaximumMember zn:AmendedAndRestatedCertificateOfIncorporationMember 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-03-31 0001131312 zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SevenStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember us-gaap:CommonStockMember 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:FiveSeniorOfficerMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:FiveSeniorOfficerMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:FourStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SixSeniorOfficersOneMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:FourStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SixStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SixStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:TwoConsultantsMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:TwoConsultantsMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:DividendReinvestmentAndStockPurchasePlanMember 2022-03-31 0001131312 zn:ZNWABWarrantsMember 2022-03-31 0001131312 zn:ZNWACWarrantsMember 2022-03-31 0001131312 zn:ZNWADWarrantOneMember 2022-03-31 0001131312 zn:ZNWADWarrantTwoMember 2022-03-31 0001131312 zn:ZNWAEWarrantsMember 2022-03-31 0001131312 zn:ZNWAEWarrantOneMember 2022-03-31 0001131312 zn:ZNWAEWarrantTwoMember 2022-03-31 0001131312 us-gaap:WarrantMember us-gaap:CommonStockMember 2022-03-31 0001131312 zn:UnitOptionProgramMember zn:ZnwafMember 2022-01-01 2022-03-31 0001131312 zn:NewUnitProgramMember zn:ZnwafMember 2022-03-31 0001131312 zn:ZNWAFWarrantTwoMember 2022-03-31 0001131312 zn:ZnwafMember 2022-03-31 0001131312 zn:ZNWAGMember 2022-01-01 2022-03-31 0001131312 us-gaap:WarrantMember 2022-03-31 0001131312 zn:ZnwahMember 2022-01-01 2022-03-31 0001131312 zn:ZnwajWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:WarrantsMember 2022-03-31 0001131312 zn:ZNWAHWarrantOneMember 2022-03-31 0001131312 zn:ZNWAHWarrantTwoMember 2022-03-31 0001131312 2020-10-29 0001131312 zn:ZNWAJWarrantMember 2022-03-31 0001131312 zn:ZNWAJWarrantTwoMember 2022-03-31 0001131312 zn:UnitOptionProgramMember zn:ZnwakWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:UnitOptionProgramMember zn:ZnwakWarrantsMember 2022-03-31 0001131312 zn:ZNWAKWarrantOneMember 2022-03-31 0001131312 zn:ZNWAKWarrantTwoMember 2022-03-31 0001131312 zn:ZnwalWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwalWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWALWarrantTwoMember 2022-03-31 0001131312 zn:ZNWAMWarrantOneMember 2022-03-31 0001131312 zn:ZnwanWarrantMember 2022-03-31 0001131312 zn:ZNWANWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:WarrantsMember zn:ZNWANWarrantsMember 2022-03-31 0001131312 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001131312 zn:ZnwapWarrantOneMember 2022-03-31 0001131312 zn:ZNWASMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAROneMember 2022-03-31 0001131312 2022-04-01 2022-05-06 0001131312 2018-04-02 0001131312 2018-04-01 2018-04-13 0001131312 2018-04-13 0001131312 2020-01-29 0001131312 zn:ZnwaiWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-03-31 0001131312 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001131312 zn:SubscriptionRightsOfferingMember 2021-01-01 2021-12-31 0001131312 us-gaap:EmployeeStockOptionMember 2021-12-31 0001131312 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001131312 us-gaap:EmployeeStockOptionMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesOneMember 2022-01-01 2022-03-31 0001131312 zn:NonvestedMember zn:RangesOneMember 2022-03-31 0001131312 zn:VestedMember zn:RangesOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwoMember 2022-01-01 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwoMember 2022-03-31 0001131312 zn:VestedMember zn:RangesTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesElevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesElevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesElevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesElevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwelveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwelveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwelveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwelveMember 2022-03-31 0001131312 zn:NonvestedMember zn:ScenarioThirteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:ScenarioThirteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:ScenarioThirteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:ScenarioThirteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFifteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFifteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFifteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFifteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSeventeenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSeventeenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSeventeenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSeventeenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEighteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEighteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEighteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEighteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFiveMember 2022-03-31 0001131312 pf0:MinimumMember zn:NonvestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 pf0:MaximumMember zn:NonvestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtySixMember 2022-03-31 0001131312 pf0:MinimumMember zn:VestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 pf0:MaximumMember zn:VestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtySixMember 2022-03-31 0001131312 zn:EmployeesMember 2022-01-01 2022-03-31 0001131312 zn:EmployeeMember 2022-01-01 2022-03-31 0001131312 zn:EmployeeMember 2021-01-01 2021-03-31 0001131312 pf0:MinimumMember zn:EmployeeMember 2022-01-01 2022-03-31 0001131312 pf0:MaximumMember zn:EmployeeMember 2022-01-01 2022-03-31 0001131312 pf0:MinimumMember zn:EmployeeMember 2021-01-01 2021-03-31 0001131312 pf0:MaximumMember zn:EmployeeMember 2021-01-01 2021-03-31 0001131312 zn:NonEmployeesMember 2022-01-01 2022-03-31 0001131312 zn:NonEmployeesMember 2021-01-01 2021-03-31 0001131312 zn:EmployeesAndDirectorsMember 2022-01-01 2022-03-31 0001131312 zn:EmployeesAndDirectorsMember 2021-01-01 2021-12-31 0001131312 zn:NonEmployeesMember 2022-01-01 2022-03-31 0001131312 zn:NonEmployeesMember 2021-01-01 2021-12-31 0001131312 zn:UnprovedOilGasPropertiesMember 2022-01-01 2022-03-31 0001131312 zn:UnprovedOilGasPropertiesMember 2021-01-01 2021-12-31 0001131312 zn:ZnwaaWarrantsMember zn:WarrantTransactionsMember 2021-12-31 0001131312 zn:ZnwaaWarrantsMember zn:WarrantTransactionsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWADWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWADWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAEWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAEWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAFWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAFWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAGWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAGWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAHWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAHWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAIWarrantMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAIWarrantMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZnwajWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZnwajWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZnwakWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZnwakWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZnwalWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZnwalWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAMWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAMWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWANWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWANWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAOWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAOWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAPWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAPWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWARWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWARWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember 2022-03-31 0001131312 zn:ZnwaaWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwaaWarrantsMember 2022-03-31 0001131312 zn:ZNWADWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWADWarrantsMember 2022-03-31 0001131312 zn:ZNWAEWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAFWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAFWarrantsMember 2022-03-31 0001131312 zn:ZNWAGWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAGWarrantsMember 2022-03-31 0001131312 zn:ZNWAHWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAHWarrantsMember 2022-03-31 0001131312 zn:ZnwaiWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwaiWarrantsMember 2022-03-31 0001131312 zn:ZnwajWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwajWarrantsMember 2022-03-31 0001131312 zn:ZnwakWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwakWarrantsMember 2022-03-31 0001131312 zn:ZnwalWarrantsMember 2022-03-31 0001131312 zn:ZNWAMWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAMWarrantsMember 2022-03-31 0001131312 zn:ZNWANWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWANWarrantsMember 2022-03-31 0001131312 zn:ZNWAOWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAOWarrantsMember 2022-03-31 0001131312 zn:ZNWAPWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAPWarrantsMember 2022-03-31 0001131312 zn:ZnwaqWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwaqWarrantsMember 2022-03-31 0001131312 zn:ZNWARWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWARWarrantsMember 2022-03-31 0001131312 zn:ZNWASWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWASWarrantsMember 2022-03-31 0001131312 zn:UnprovedOilAndGasPropertiesFullCostMethodMember 2022-01-01 2022-03-31 0001131312 zn:UnprovedOilAndGasPropertiesFullCostMethodMember 2021-01-01 2021-12-31 0001131312 zn:RightsUseOfAssetsMember 2022-03-31 0001131312 zn:RightsUseOfAssetsMember 2021-12-31 0001131312 us-gaap:SubsequentEventMember 2022-04-02 2022-05-06 0001131312 zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-01 2022-04-01 0001131312 zn:FiveSeniorOfficersAndTenStaffMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:FiveStaffMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:OneSeniorOfficerMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:OneBoardMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:OneBoardMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember 2022-04-02 2022-04-15 0001131312 zn:EightBoardMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:TwoConsultantsMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0322ex31-1_zionoil.htm CERTIFICATION

EXHIBIT 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Robert W. A. Dunn, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Zion Oil & Gas, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 10, 2022

 

/s/ Robert W. A. Dunn  
Robert W. A. Dunn, Chief Executive Officer  
(Principal Executive Officer)  

 

EX-31.2 3 f10q0322ex31-2_zionoil.htm CERTIFICATION

EXHIBIT 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Michael B. Croswell Jr, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Zion Oil & Gas, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have: 

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 10, 2022

 

/s/ Michael. B. Croswell Jr  
Michael B. Croswell Jr, Chief Financial Officer  
(Principal Financial and Accounting Officer)  

EX-32.1 4 f10q0322ex32-1_zionoil.htm CERTIFICATION

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Zion Oil and Gas, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2022 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Robert W.A. Dunn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the Report.

 

/s/ Robert W. A. Dunn  
Robert W. A. Dunn  
Chief Executive Officer  
(Principal Executive Officer)  
May 10, 2022  

 

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

EX-32.2 5 f10q0322ex32-2_zionoil.htm CERTIFICATION

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Zion Oil and Gas, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2022 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Michael B. Croswell Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the Report.

 

/s/ Michael B. Croswell Jr  
Michael B. Croswell Jr.  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  
May 10, 2022  

 

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

GRAPHIC 6 img_001.jpg GRAPHIC begin 644 img_001.jpg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end EX-101.SCH 7 zn-20220331.xsd XBRL SCHEMA FILE 001 - Statement - Consolidated Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Condensed Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Nature of Operations, Basis of Presentation and Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Right of Use Leases Assets and Lease Obligations link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Right of Use Leases Assets and Lease Obligations (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Nature of Operations, Basis of Presentation and Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Stockholders' Equity (Details) - Schedule of stock option transactions link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Stockholders' Equity (Details) - Schedule of stock options outstanding link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants transactions link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants to investors link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of changes in Unproved oil and gas properties link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of weighted average remaining lease term and weighted average discount rate for operating leases link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of future minimum lease payments under non-cancellable operating leases link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 zn-20220331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 zn-20220331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 zn-20220331_lab.xml XBRL LABEL FILE EX-101.PRE 11 zn-20220331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 06, 2022
Document Information Line Items    
Entity Registrant Name ZION OIL & GAS, INC.  
Trading Symbol ZNOG  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   469,022,602
Amendment Flag false  
Entity Central Index Key 0001131312  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Mar. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 20-0065053  
Entity Address, Address Line One 12655 N Central Expressway  
Entity Address, Address Line Two Suite 1000  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75243  
City Area Code (214)  
Local Phone Number 221-4610  
Title of 12(g) Security N/A  
Security Exchange Name NONE  
Entity Interactive Data Current Yes  
Entity File Number 001-33228  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 8,221 $ 4,683
Fixed short term bank and escrow deposits – restricted 1,269 1,269
Prepaid expenses and other 1,264 689
Other deposits 605 617
Governmental receivables 338 900
Other receivables 2,376 483
Total current assets 14,073 8,641
Unproved oil and gas properties, full cost method (see Note 4) 48,099 46,950
Property and equipment at cost    
Drilling rig and related equipment, net of accumulated depreciation of $887 and $704 (see note 2I) 6,759 6,834
Property and equipment, net of accumulated depreciation of $615 and $604 139 138
Property Plant and Equipment Net 6,898 6,972
Right of Use Lease Assets (see Note 5) 263 327
Other assets    
Assets held for severance benefits 553 541
Total other assets 553 541
Total assets 69,886 63,431
Current liabilities    
Accounts payable 1,167 2,783
Lease obligation – current (see Note 5) 169 203
Asset retirement obligation 571 571
Accrued liabilities 437 1,781
Total current liabilities 2,344 5,338
Long-term liabilities    
Lease obligation – non-current (see Note 5) 129 169
Provision for severance pay 560 548
Total long-term liabilities 689 717
Total liabilities 3,033 6,055
Commitments and contingencies (see Note 6)
Stockholders’ equity    
Common stock, par value $.01; Authorized: 800,000,000 shares at March 31, 2022: Issued and outstanding: 466,593,391 and 364,322,883 shares at March 31, 2022 and December 31, 2021, respectively 4,666 3,643
Additional paid-in capital 287,878 277,258
Accumulated deficit (225,691) (223,525)
Total stockholders’ equity 66,853 57,376
Total liabilities and stockholders’ equity $ 69,886 $ 63,431
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Condensed Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Drilling rig and related equipment, net of accumulated depreciation (in Dollars) $ 887 $ 704
Accumulated depreciation (in Dollars) $ 615 $ 604
Common stock, par value (in Dollars per share) $ 0.01 $ 0.01
Common stock, authorized 800,000,000 800,000,000
Common stock, issued 466,593,391 364,322,883
Common stock, outstanding 466,593,391 364,322,883
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Condensed Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
General and administrative $ 1,435 $ 1,971
Other 711 792
Loss from operations (2,146) (2,763)
Other expense, net    
Gain on derivative liability 426
Foreign exchange (loss) (9) (63)
Financial (expenses), net (11) (160)
Loss, before income taxes (2,166) (2,560)
Income taxes
Net loss $ (2,166) $ (2,560)
Net loss, per share of common stock Basic and diluted (in Dollars per share) $ (0.01) $ (0.01)
Weighted-average shares outstanding Basic and diluted (in Shares) 404,817 238,941
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional paid-in Capital
Accumulated deficit
Total
Balances at Dec. 31, 2020 $ 2,374 $ 245,539 $ (212,804) $ 35,109
Balances (in Shares) at Dec. 31, 2020 237,382      
Funds received from sale of DSPP units and shares and exercise of warrants $ 39 2,810 2,849
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 3,848      
Value of bonds converted to shares [1]
Value of bonds converted to shares (in Shares) 4      
Funds received from option exercises $ 1   1
Funds received from option exercises (in Shares) 117      
Value of options granted to employees, directors and others as non-cash compensation 821 821
Net loss (2,560) (2,560)
Balances at Mar. 31, 2021 $ 2,414 249,170 (215,364) 36,220
Balances (in Shares) at Mar. 31, 2021 241,351      
Balances at Dec. 31, 2021 $ 3,643 277,258 (223,525) 57,376
Balances (in Shares) at Dec. 31, 2021 364,324      
Funds received from sale of DSPP units and shares and exercise of warrants $ 1,022 10,405 11,427
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 102,219      
Funds received from option exercises $ 1 1
Funds received from option exercises (in Shares) 50      
Value of options granted to employees, directors and others as non-cash compensation 215 215
Net loss (2,166) (2,166)
Balances at Mar. 31, 2022 $ 4,666 $ 287,878 $ (225,691) $ 66,853
Balances (in Shares) at Mar. 31, 2022 466,593      
[1] Less than one thousand.
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Statement of Cash Flows [Abstract]    
Net loss $ (2,166) $ (2,560)
Adjustments required to reconcile net loss to net cash used in operating activities:    
Depreciation 195 179
Cost of options issued to employees, directors and others as non-cash compensation 208 821
Amortization of debt discount related to convertible bonds 141
Change in derivative liability (426)
Other deposits 12 21
Prepaid expenses and other (575) 530
Governmental receivables 562 355
Lease obligation – current (34) (35)
Lease obligation – non current (40) (45)
Right of use lease assets 64 56
Other receivables 107 105
Severance payable, net (45)
Accounts payable (331) (150)
Accrued liabilities (93) (1,088)
Net cash used in operating activities (2,091) (2,141)
Cash flows from investing activities    
Acquisition of property and equipment (12) (20)
Acquisition of drilling rig and related equipment (122) (76)
Investment in unproved oil and gas properties (3,665) (7,028)
Net cash used in investing activities (3,799) (7,124)
Cash flows from financing activities    
Proceeds from exercise of stock options 1 1
Proceeds from issuance of stock and exercise of warrants 9,427 2,849
Net cash provided by financing activities 9,428 2,850
Net (decrease)/increase in cash, cash equivalents and restricted cash 3,538 (6,415)
Cash, cash equivalents and restricted cash – beginning of period 5,952 14,662
Cash, cash equivalents and restricted cash – end of period 9,490 8,247
Non-cash investing and financing activities:    
Non-cash equity receivables 2,000  
Unpaid investments in oil & gas properties 1,130 2,363
Capitalized convertible bond interest attributed to oil and gas properties 79
Cost of options issued to employees attributed to oil and gas properties $ 7
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Cash and cash equivalents $ 8,221 $ 4,683
Restricted cash included in fixed short-term bank deposits 1,269 1,269
Total $ 9,490 $ 5,952
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Nature of Operations, Basis of Presentation and Going Concern
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Nature of Operations, Basis of Presentation and Going Concern

Note 1 - Nature of Operations, Basis of Presentation and Going Concern

 

A. Nature of Operations

 

Zion Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 22 years of oil & gas exploration in Israel. As of March 31, 2022, the Company has no revenues from its oil and gas operations.

 

Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.

 

On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.

 

Exploration Rights/Exploration Activities

 

Megiddo-Jezreel Petroleum License, No. 401 (“MJL 401”) and New Megiddo License 428 (“NML 428”)

 

The Megiddo-Jezreel License 401 was awarded on December 3, 2013 for a three-year primary term through December 2, 2016 with the possibility of additional one-year extensions up to a maximum of seven years. The Megiddo-Jezreel License 401 lies onshore, south and west of the Sea of Galilee, and we continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential.

 

The NML 428 (covering the same area as MJ-01) was awarded on December 3, 2020 for a six-month term with the possibility of an additional six-month extension. On April 29, 2021, Zion submitted a request to the Ministry of Energy for a six-month extension to December 2, 2021. On May 30, 2021, the Ministry of Energy approved our request for extension to December 2, 2021. On November 29, 2021, the Ministry of Energy approved our request for extension to August 1, 2022, This license effectively replaced the Megiddo-Jezreel License 401 as it has the same area and coordinates.

 

The MJ-02 drilling plan was approved by the Ministry of Energy on July 29, 2020. On January 6, 2021, Zion spudded its MJ-02 exploratory well. On November 23, 2021, Zion announced via a press release that it completed drilling the MJ-02 well to a total depth of 5,531 meters (~18,141 feet) with a 6 inch open hole at that depth.

 

A full set of detailed and comprehensive tests including neutron-density, sonic, gamma, and resistivity logs were acquired in December 2021, as a result of which we identified an encouraging zone of interest. All of the well testing equipment and personnel are secured for the MJ-02 well. We have re-entered our MJ-02 wellbore and are progressing to production testing. This work is expected to take several weeks.

 

B. Basis of Presentation

 

The accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the operating results for the year ending December 31, 2022 or for any other subsequent interim period.

C. Going Concern

 

The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons. 

 

The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be impaired. The consolidated financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the three months ended March 31, 2022, the Company incurred a net loss of approximately $2.2 million and had an accumulated deficit of approximately $225.7 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty 

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

 

A. Net Gain (Loss) per Share Data

 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share as the inclusion of 23,144,603 and 10,969,456 Common Stock equivalents in 2022, and 2021 respectively, would be anti-dilutive.

 

B. Use of Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.

 

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.

 

C. Oil and Gas Properties and Impairment

 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

During the three months ended March 31, 2022, and 2021, respectively, the Company did not record any post-impairment charges.

 

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $48,099,000 and $46,950,000 as of March 31, 2022 and December 31, 2021, respectively.

 

D. Fair Value Measurements

 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

 

  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2022, and December 31, 2021, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Binomial Model. 

 

E. Stock-Based Compensation

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

F. Warrants

 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

 

G. Related parties

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged. Zion did not have any related party transactions for the periods covered in this report, with the exception of recurring monthly consulting fees paid to certain management personnel.

 

H. Recently Adopted Accounting Pronouncements

 

ASU 2016-02 – Leases (Topic 842)

 

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 (including interim periods within those periods) using a modified retrospective approach and early adoption is permitted. Zion adopted ASU 2016-02 in the first quarter of 2019. Presently, Zion has operating leases for office space in Dallas, Texas and in Caesarea, Israel plus various leases for motor vehicles. These leases have been accounted for under ASU 2016-02 in 2020, 2021 and 2022 by establishing a right-of-use asset and a corresponding current lease liability and non-current lease liability. Zion is not subject to any loan covenants and therefore, the increase in assets and liabilities does not have a material impact on its business.

 

ASU 2020-03, “Codification Improvements to Financial Instruments”

 

In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. The Company is currently evaluating the impact the adoption of this guidance may have on its consolidated financial statements.

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods beginning after December 31, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company does not believe that this ASU will have any impact on its consolidated financial statements.

 

The Company does not believe that the adoption of any of the recently issued accounting pronouncements had a significant impact on our consolidated financial position, results of operations, or cash flow, except for ASC Update No. 2016-02—Leases, which requires organizations to recognize lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous GAAP. See Note 5 for more complete details on balances at March 31, 2022 and December 31, 2021.

 

I. Depreciation and Accounting for Drilling Rig and Related Equipment

 

On March 12, 2020, Zion entered into a Purchase and Sale Agreement with Central European Drilling kft (“CED”), a Hungarian corporation, to purchase an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, subject to acceptance testing and potential downward adjustment. We remitted to the Seller $250,000 on February 6, 2020 as earnest money towards the purchase price. The Closing anticipated by the Agreement took place on March 12, 2020 by the Seller’s execution and delivery of a Bill of Sale to us. On March 13, 2020, the Seller retained the earnest money deposit, and the Company remitted $4,350,000 to the seller towards the purchase price and $1,000,000 (the “Holdback Amount”) was deposited in escrow with American Stock Transfer and Trust Company LLC, as escrow agent, through November 30, 2020, or as extended by mutual agreement of the parties, pending a determination, if any, by us of any operating deficiency in the drilling rig. On January 6, 2021, Zion completed its acceptance testing of the I-35 drilling rig and the Holdback Amount was remitted to Central European Drilling on January 8, 2021.

 

Since the rig was purchased and closed during March 2020, this purchase was recorded on Zion’s books as a long-term fixed asset as a component of Property and Equipment. The full purchase price of the drilling rig was $5.6 million, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet.

 

In accordance with GAAP accounting rules, per the matching principle, monthly depreciation begins the month following when the asset is “placed in service.” The rig was placed in service in December 2020 with January 2021 representing the first month of depreciation. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion will depreciate the rig on a straight-line basis.

 

The $540,000 in spare parts was the original cost to CED. These items were received and counted by Zion upon receipt. All records and files are maintained by Zion. Zion plans to obtain a physical count of the equipment items at the end of each quarter, or as close to such date as practical, in accordance with our normal procedures.

 

Zion uses the First In First Out (“FIFO”) method of accounting for the inventory spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the inventory of spare parts gets consumed.

 

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

 

See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2022:

 

I-35 Drilling Rig & Associated Equipment:

 

   Three-month period ended March 31, 2022 
   I-35
Drilling Rig
   Rig
Spare Parts
   Other
Drilling Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2021   5,859    643    332    6,834 
Asset Additions   
-
    5    117    122 
Asset Depreciation   (159)   
-
    (25)   (184)
Asset Disposals for Self-Consumption   
-
    (13)   
-
    (13)
March 31, 2022   5,700    635    424    6,759 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 3 - Stockholders’ Equity

 

The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 400,000,000 shares to 800,000,000 shares, effective June 9, 2021.

 

A. 2011 Equity Incentive Stock Option Plan

 

During the three months ended March 31, 2022, the Company did not grant any options from the 2011 Equity Incentive Plan for employees, directors and consultants.

 

During the three months ended March 31, 2021, the Company granted the following options from the 2011 Equity Incentive Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 600,000 shares of Common Stock to six senior officers and three staff members at an exercise price of $0.915 per share. The options vested upon grant and are exercisable through January 4, 2031. The fair value of the options at the date of grant amounted to approximately $456,000.

 

  ii. Options to purchase 75,000 shares of Common Stock were granted to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 6, 2031. The fair value of the options at the date of grant amounted to approximately $68,000.

 

B. 2011 Non-Employee Directors Stock Option Plan 

 

During the three months ended March 31, 2022, the Company did not grant any qualified (market value) options from the 2011 Non-Employee Directors Stock Option Plan to its directors.

 

During the three months ended March 31, 2021, the Company granted the following qualified (market value) and non-qualified options from the 2011 Non-Employee Directors Stock Option Plan for directors to purchase shares of common stock as non-cash compensation:

 

  i.

Options to purchase 350,000 shares of Common Stock to seven board members at an exercise price of $0.915 per share. The options vested upon grant and are exercisable through January 4, 2027. The fair value of the options at the date of grant amounted to approximately $252,000.

 

  ii. Options to purchase 50,000 shares of Common Stock were granted to one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2027. The fair value of the options at the date of grant amounted to approximately $45,000.

 

C. 2021 Omnibus Incentive Stock Option Plan

 

Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares of common stock.

 

The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.

 

The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed ten years from the date of grant.

 

During the three months ended March 31, 2022, the Company granted the following options from the 2021 Equity Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 175,000 shares of Common Stock to six senior officers and one staff member at an exercise price of $0.1529 per share. The options vested upon grant and are exercisable through January 4, 2032. The fair value of the options at the date of grant amounted to approximately $22,000.

 

  ii. Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $4,000.

 

  iii. Options to purchase 300,000 shares of Common Stock to one senior officer and one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,000. 

 

  iv. Options to purchase 200,000 shares of Common Stock one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $29,000. 

 

  v. Options to purchase 1,600,000 shares of Common Stock to five senior officers and four staff members at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $209,000, and will be recognized during the years 2022 and 2023.

 

  vi.

Options to purchase 1,400,000 shares of Common Stock to seven board members, at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $182,000, and will be recognized during the years 2022 and 2023.

     
  vii.

Options to purchase 160,000 shares of Common Stock to four staff members, at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 17, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $23,000.

     
  viii.

Options to purchase 200,000 shares of Common Stock to six staff members at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $26,000, and will be recognized during the years 2022 and 2023.

     
  ix.

Options to purchase 40,000 shares of Common Stock to two consultants at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $5,000, and will be recognized during the years 2022 and 2023.

 

During the three months ended March 31, 2021, the Company did not grant any options from the 2021 Equity Omnibus Plan for employees, directors and consultants (as the Plan was not in existence during that period).

 

D. Stock Options

 

The stock option transactions since January 1, 2022 are shown in the table below:

 

   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2021   9,741,750    0.64 
           
Changes during 2022 to:          
Granted to employees, officers, directors and others   4,100,000    0.13 
Expired/Cancelled/Forfeited   
-
    
-
 
Exercised   (50,000)   0.01 
Outstanding, March 31, 2022   13,791,750    0.49 
Exercisable, March 31, 2022   10,551,750    0.60 

 

The following table summarizes information about stock options outstanding as of March 31, 2022:

 

Shares underlying outstanding options (non-vested)  Shares underlying outstanding options (fully vested) 
Range of
exercise
price
   Number
outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
   Range of
exercise
price
   Number
Outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
 
US$           US$   US$           US$ 
 0.14    240,000    9.81    0.14    0.01    10,000    1.62    0.01 
 0.15    3,000,000    9.77    0.15    0.01    5,000    2.20    0.01 
     
    
    
    0.01    20,000    4.17    0.01 
     
    
    
    0.01    130,000    4.75    0.01 
     
    
    
    0.01    50,000    4.76    0.01 
     
    
    
    0.01    60,000    5.04    0.01 
     
    
    
    0.01    200,000    5.13    0.01 
     
    
    
    0.01    40,000    5.50    0.01 
     
    
    
    0.01    85,000    5.75    0.01 
     
    
    
    0.01    25,000    5.76    0.01 
     
    
    
    0.01    30,000    5.91    0.01 
     
    
    
    0.01    4,000    6.01    0.01 
     
    
    
    0.01    25,000    6.77    0.01 
     
    
    
    0.01    85,000    7.46    0.01 
     
    
    
    0.01    205,000    7.63    0.01 
     
    
    
    0.01    35,000    7.76    0.01 
     
    
    
    0.01    75,000    8.76    0.01 
     
    
    
    0.01    200,000    9.14    0.01 
     
    
    
    0.01    355,000    9.29    0.01 
     
    
    
    0.01    10,000    9.42    0.01 
     
    
    
    0.01    500,000    9.76    0.01 
     
    
    
    0.01    110,000    9.80    0.01 
     
    
    
    0.15    200,000    9.76    0.15 
     
    
    
    0.16    340,000    7.69    0.16 
     
    
    
    0.16    75,000    3.69    0.16 
     
    
    
    0.18    25,000    3.67    0.18 
     
    
    
    0.25    50,000    9.42    0.25 
     
    
    
    0.25    363,000    9.42    0.25 
     
    
    
    0.28    25,000    3.42    0.28 
     
    
    
    0.28    25,000    7.42    0.28 
     
    
    
    0.29    25,000    5.20    0.29 
     
    
    
    0.39    1,510,000    9.27    0.39 
     
    
    
    0.59    1,400,000    5.13    0.59 
     
    
    
    0.59    1,800,000    9.14    0.59 
     
    
    
    0.92    350,000    4.76    0.92 
     
    
    
    0.92    600,000    8.76    0.92 
     
    
    
    1.33    25,000    1.07    1.33 
     
    
    
    1.38    105,307    2.76    1.38 
     
    
    
    1.55    200,000    0.18    1.55 
     
    
    
    1.67    405,943    2.51    1.67 
     
    
    
    1.70    218,500    0.72    1.70 
     
    
    
    1.75    250,000    1.27    1.75 
     
    
    
    1.78    25,000    2.43    1.78 
     
    
    
    2.31    250,000    1.76    2.31 
     
    
    
    4.15    25,000    2.26    4.15 
 0.14-0.15     3,240,000         0.15    0.01-4.15    10,551,750         0.60 

 

Granted to employees

 

The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
three months ended
March 31,
 
   2022    2021  
Weighted-average fair value of underlying stock at grant date  $0.15    $0.92  
Dividend yields          
Expected volatility   127%-133 %   121%-143 %
Risk-free interest rates   1.37%-1.55 %   0.16%-0.38 %
Expected lives (in years)   5.00-5.50     3.00-5.00  
Weighted-average grant date fair value  $0.13    $0.77  

 

Granted to non-employees

 

The following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
three months ended
March 31,
 
   2022   2021 
Weighted-average fair value of underlying stock at grant date  $0.15   $ 
Dividend yields        
Expected volatility   103%    
Risk-free interest rates   1.78%    
Expected lives (in years)   10     
Weighted-average grant date fair value  $0.14   $ 

 

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the options.

 

The expected life represents the weighted average period of time that options granted are expected to be outstanding. The expected life of the options granted to employees and directors is calculated based on the Simplified Method as allowed under Staff Accounting Bulletin No. 110 (“SAB 110”), giving consideration to the contractual term of the options and their vesting schedules, as the Company does not have sufficient historical exercise data at this time. The expected life of the option granted to non-employees equals their contractual term. In the case of an extension of the option life, the calculation was made on the basis of the extended life.

 

E. Compensation Cost for Warrant and Option Issuances

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 214    821 

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 1    
 

 

The following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and capitalized to Unproved Oil & Gas properties:

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 7    
 

 

As of March 31, 2022, there was $325,000 of unrecognized compensation cost, related to non-vested stock options granted under the Company’s various stock option plans. That cost is expected to be recognized during the remaining periods of 2022 and 2023.

 

F. Dividend Reinvestment and Stock Purchase Plan (“DSPP”)

 

On March 13, 2014 Zion filed a registration statement on Form S-3 that is part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended.

 

The ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018, at a per share exercise price of $1.00.

 

As of May 2, 2017, any outstanding ZNWAB warrants expired.

 

As of May 2, 2018, any outstanding ZNWAC warrants expired.

 

On May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020 to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.”

 

The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00.

 

On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders.

 

On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.”

 

All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00.

 

On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders.

 

An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017.

 

Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.” 

 

The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders.

 

On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”

 

The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.”

 

The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.”

 

The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01.

 

On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering.

 

The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.”

 

The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00.

 

On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00.

 

On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021.

 

The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.”

 

The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.

On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021.

 

The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.”

 

The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25.

 

On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25.

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program.

 

On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00.

 

During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP.

 

On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein.

 

On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein.

 

For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively.

 

The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program.

 

The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only.

 

G. Subscription Rights Offering

 

On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”

 

The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.

 

On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.

 

The 2018 Subscription Rights Offering terminated on May 31, 2018. The Company raised net proceeds of approximately $3,038,000, from the subscription of Rights, after deducting fees and expenses of $243,000 incurred in connection with the rights offering.

 

H. Warrant Table

 

The warrants balances at December 31, 2021 and transactions since January 1, 2022 are shown in the table below:

 

Warrants   Exercise
Price
    Warrant
Termination Date
  Outstanding Balance, 12/31/2021     Warrants
Issued
    Warrants
Exercised
    Warrants
Expired
    Outstanding Balance, 03/31/2022  
ZNWAA   $ 2.00     01/31/2023     1,498,804      
-
     
-
     
-
      1,498,804  
ZNWAD   $ 1.00     05/02/2023     243,853      
-
     
-
     
-
      243,853  
ZNWAE   $ 1.00     05/01/2023     2,144,099      
-
     
-
     
-
      2,144,099  
ZNWAF   $ 1.00     08/14/2023     359,435      
-
     
-
     
-
      359,435  
ZNWAG   $ 1.00     01/08/2023     240,068      
-
     
-
     
-
      240,068  
ZNWAH   $ 5.00     04/19/2023     372,400      
-
     
-
     
-
      372,400  
ZNWAI   $ 3.00     06/29/2023     640,730      
-
     
-
     
-
      640,730  
ZNWAJ   $ 1.00     10/29/2023     545,900      
-
     
-
     
-
      545,900  
ZNWAK   $ 0.01     02/25/2023     431,655      
-
      (1,750 )     -       429,905  
ZNWAL   $ 2.00     08/26/2023     517,875      
-
     
-
     
-
      517,875  
ZNWAM   $ 1.00     07/15/2023     4,376,000      
-
     
-
     
-
      4,376,000  
ZNWAN   $ 1.00     05/16/2023     267,660      
-
     
-
     
-
      267,660  
ZNWAO   $ 0.25     06/12/2023     174,970      
-
     
-
     
-
      174,970  
ZNWAP   $ 0.25    

06/02/2023

    439,916      
-
     
-
     
-
      439,916  
ZNWAR   $ 0.25     06/23/2023     1,020,000      
-
     
-
     
-
      1,020,000  
Outstanding warrants                 13,273,365       -       (1,750 )     -       13,271,615  

 

I. Warrant Descriptions

 

The price and the expiration dates for the series of warrants to investors are as follows *:

 

        Period of Grant     US$     Expiration Date  
ZNWAA Warrants   B,C   March 2013 – December 2014       2.00     January 31, 2023  
ZNWAD Warrants   A,B,C   January 2015 – March 2016       1.00     May 02, 2023  
ZNWAE Warrants   B,C   November 2016 – March 2017       1.00     May 01, 2023  
ZNWAF Warrants   A,B,C   May 2017 – July 2017       1.00     August 14, 2023  
ZNWAG Warrants   C   October 2017 – December 2017       1.00     January 08, 2023  
ZNWAH Warrants   A,B,C   February 2018       5.00     April 19, 2023  
ZNWAI Warrants   A,B,C   April 2018 – May 2018       3.00     June 29, 2023  
ZNWAJ Warrants   B,C   August 2018 – September 2018       1.00     October 29, 2023  
ZNWAK Warrants   B,C   December 2018 – January 2019       0.01     February 25, 2023  
ZNWAL Warrants   C   July 2019 – August 2019       2.00     August 26, 2023  
ZNWAM Warrants     January 2021 – March 2021       1.00     July 15, 2023  
ZNWAN Warrants       May – June 2021       1.00     May 16, 2023  
ZNWAO Warrants       June 2021       0.25     June 12, 2023  
ZNWAP Warrants   D   June 2021       0.25     June 03, 2023  
ZNWAQ Warrants     June 2021       0.25     July 6, 2022  
ZNWAR Warrants   D   June 2021       0.25     June 23, 2023  
ZNWAS Warrants   F   August 2021 – March 2022       1.00     December 31, 2023  

 

* Zion’s ZNWAB Warrants expired on May 2, 2017, and the ZNWAC Warrants expired on May 2, 2018

 

A On December 4, 2018, the Company extended the termination date of the Warrants by one (1) year.
B On May 29, 2019, the Company extended the termination date of the Warrants by one (1) year.
C On September 15, 2020, the Company extended the termination date of the Warrants by two (2) years.
D On March 21, 2022, the Company extended the termination date of the Warrants by one (1) year.
E These warrants were issued on May 5, 2022.
F These warrants will be exercisable beginning on November 15, 2023 and terminate on December 31, 2023. These warrants will be issued in November 2023.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Unproved Oil and Gas Properties, Full Cost Method
3 Months Ended
Mar. 31, 2022
Oil and Gas Property [Abstract]  
Unproved Oil and Gas Properties, Full Cost Method

Note 4 - Unproved Oil and Gas Properties, Full Cost Method

 

Unproved oil and gas properties, under the full cost method, are comprised as follows:

 

   March 31,
2022
   December 31,
2021
 
   US$ thousands   US$ thousands 
Excluded from amortization base:          
Drilling costs, and other operational related costs   32,703    32,075 
Capitalized salary costs   2,210    2,158 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   11,729    11,260 
Other costs   39    39 
    48,099    46,950 

 

Changes in Unproved oil and gas properties during the three months ended March 31, 2022 and 2021 are as follows:

 

   March 31,
2022
   March 31,
2021
 
   US$ thousands   US$ thousands 
Excluded from amortization base:          
Drilling costs, and other operational related costs   628    7,002 
Capitalized salary costs   52    61 
Capitalized interest costs   
-
    79 
Legal and seismic costs, license fees and other preparation costs   469    1,034 
Other costs   
-
    
-
 
    *1,149    *8,176 

 

*Inclusive of non-cash amounts of approximately $1,137,000, and $2,442,000 during the three months ended March 31, 2022, and 2021, respectively

 

Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Right of Use Leases Assets and Lease Obligations
3 Months Ended
Mar. 31, 2022
Disclosure Text Block [Abstract]  
Right of use leases assets and lease obligations

Note 5 - Right of use leases assets and lease obligations

 

The Company is a lessee in several non-cancellable operating leases, primarily for transportation and office space.

 

The table below presents the operating lease assets and liabilities recognized on the balance sheets as of March 31, 2022 and December 31, 2021: 

 

   March 31,
2022
   December 31,
2021
 
   US$ thousands   US$ thousands 
Operating lease assets  $263   $327 
           
Operating lease liabilities:          
Current operating lease liabilities  $169   $203 
Non-current operating lease liabilities  $129   $169 
Total operating lease liabilities  $298   $372 

 

The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.

 

The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.

 

The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of March 31, 2022 are:

 

   March 31,
2022
 
Weighted average remaining lease term (years)   1.75 
Weighted average discount rate   5.9%

 

The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of March 31, 2022:

 

   US$ thousands 
2022   142 
2023   158 
2024   13 
2025   
-
 
2026   
-
 
Thereafter   
-
 
Total undiscounted future minimum lease payments   313 
Less: portion representing imputed interest   (15)
Total undiscounted future minimum lease payments   298 

 

Operating lease costs were $68,000 and $63,000 for the three months ended March 31, 2022, and 2021, respectively. Operating lease costs are included within general and administrative expenses on the statements of income.

 

Cash paid for amounts included in the measurement of operating lease liabilities was $72,000 and $71,000 for the three months ended March 31, 2022, and 2021, respectively, and this amount is included in operating activities in the statements of cash flows.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $nil and $nil for the three months ended March 31, 2022, and 2021, respectively.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 - Commitments and Contingencies

 

A. Securities and Exchange Commission (“SEC”) Investigation

 

As previously disclosed by the Company, on June 21, 2018, the Fort Worth Regional Office of the SEC informed Zion that it was conducting a formal, non-public investigation and asked that we provide certain information and documents in connection with its investigation. Since that date, we have fully cooperated with the SEC on an on-going basis in connection with its investigation. Investigations of this nature are inherently uncertain and their results cannot be predicted with certainty. Regardless of the outcome, an SEC investigation could have an adverse impact on us because of legal costs, diversion of management resources, and other factors. The investigation could also result in reputational harm to Zion and may have a material adverse effect on Zion’s current and future business and exploratory activities and its ability to raise capital to continue our oil and gas exploratory activities.

 

B. Litigation

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

C. Recent Market Conditions – Coronavirus Pandemic

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic has significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments react to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. As of the date of this report, many of our employees are working from home. However, while there are various uncertainties to navigate, the Company’s business activities are continuing. The situation is rapidly changing and additional impacts to the business may arise that we are not aware of currently. We cannot predict whether, when or the manner in which the conditions surrounding COVID-19 will change including the timing of lifting any restrictions or work from home arrangements.

 

The full extent of COVID-19’s impact on our operations and financial performance depends on future developments that are uncertain and unpredictable, including the duration and spread of the pandemic, its impact on capital and financial markets and any new information that may emerge concerning the severity of the virus, its spread to other regions as well as the actions taken to contain it, among others.

 

D. Environmental and Onshore Licensing Regulatory Matters

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings.

 

The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.

 

As of March 31, 2022, and December 31, 2021, the Company accrued $nil and $nil for license regulatory matters.

 

E. Bank Guarantees

 

As of March 31, 2022, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $1,186,000) and others (approximately $82,000) with respect to its drilling operation in an aggregate amount of approximately $1,268,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits – restricted.

 

F. Risks

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2022 through March 31, 2022, the USD has fluctuated by approximately 2.1% against the NIS (the USD strengthened relative to the NIS). By contrast, during the period January 1, 2021 through December 31, 2021, the USD fluctuated by approximately 3.3% against the NIS (the USD weakened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2022, we had cash, cash equivalents and short-term bank deposits of approximately $9,490,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2022, exclusive of funds at US banks that earn no interest, was approximately 0.52%.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 7 - Subsequent Events

 

  (i) Approximately $2,585,000 was collected through the Company’s DSPP program during the period April 1 through May 6, 2022.

 

(ii)On April 1, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one board member, to purchase 25,000 shares of Common Stock at an exercise price of $0.1128 per share. The options vested upon grant and are exercisable through April 1, 2032. The fair value of the options at the date of grant amounted to approximately $2,410.

 

(iii)On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to five senior officers and ten staff members to purchase 3,160,000 shares of Common Stock at an exercise price of $0.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2032. The fair value of the options at the date of grant amounted to approximately $387,660, and will be recognized during the years 2022 and 2023.

 

(iv)On April 15. 2022, the Company granted options under the 2021 Omnibus Incentive Plan to five staff members, to purchase 290,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,594.

 

(v)On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one senior officer member to purchase 400,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $54.612.

 

(vi)On April 15. 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one board member, to purchase 400,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $54,612.

 

(vii)   On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to eight board members to purchase 3,200,000 shares of Common Stock at an exercise price of $.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $392,567.

 

(viii)On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to two consultants to purchase 50,000 shares of Common Stock at an exercise price of $.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $6,377.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Net Gain (Loss) per Share Data

A. Net Gain (Loss) per Share Data

 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share as the inclusion of 23,144,603 and 10,969,456 Common Stock equivalents in 2022, and 2021 respectively, would be anti-dilutive.

 

Use of Estimates

B. Use of Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.

 

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.

 

Oil and Gas Properties and Impairment

C. Oil and Gas Properties and Impairment

 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

During the three months ended March 31, 2022, and 2021, respectively, the Company did not record any post-impairment charges.

 

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $48,099,000 and $46,950,000 as of March 31, 2022 and December 31, 2021, respectively.

 

Fair Value Measurements

D. Fair Value Measurements

 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

 

  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2022, and December 31, 2021, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Binomial Model. 

 

Stock-Based Compensation

E. Stock-Based Compensation

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

Warrants

F. Warrants

 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

 

Related parties

G. Related parties

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged. Zion did not have any related party transactions for the periods covered in this report, with the exception of recurring monthly consulting fees paid to certain management personnel.

 

Recently Adopted Accounting Pronouncements

H. Recently Adopted Accounting Pronouncements

 

ASU 2016-02 – Leases (Topic 842)

 

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 (including interim periods within those periods) using a modified retrospective approach and early adoption is permitted. Zion adopted ASU 2016-02 in the first quarter of 2019. Presently, Zion has operating leases for office space in Dallas, Texas and in Caesarea, Israel plus various leases for motor vehicles. These leases have been accounted for under ASU 2016-02 in 2020, 2021 and 2022 by establishing a right-of-use asset and a corresponding current lease liability and non-current lease liability. Zion is not subject to any loan covenants and therefore, the increase in assets and liabilities does not have a material impact on its business.

 

ASU 2020-03, “Codification Improvements to Financial Instruments”

 

In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. The Company is currently evaluating the impact the adoption of this guidance may have on its consolidated financial statements.

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods beginning after December 31, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company does not believe that this ASU will have any impact on its consolidated financial statements.

 

The Company does not believe that the adoption of any of the recently issued accounting pronouncements had a significant impact on our consolidated financial position, results of operations, or cash flow, except for ASC Update No. 2016-02—Leases, which requires organizations to recognize lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous GAAP. See Note 5 for more complete details on balances at March 31, 2022 and December 31, 2021.

 

Depreciation and Accounting for Drilling Rig and Related Equipment

I. Depreciation and Accounting for Drilling Rig and Related Equipment

 

On March 12, 2020, Zion entered into a Purchase and Sale Agreement with Central European Drilling kft (“CED”), a Hungarian corporation, to purchase an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, subject to acceptance testing and potential downward adjustment. We remitted to the Seller $250,000 on February 6, 2020 as earnest money towards the purchase price. The Closing anticipated by the Agreement took place on March 12, 2020 by the Seller’s execution and delivery of a Bill of Sale to us. On March 13, 2020, the Seller retained the earnest money deposit, and the Company remitted $4,350,000 to the seller towards the purchase price and $1,000,000 (the “Holdback Amount”) was deposited in escrow with American Stock Transfer and Trust Company LLC, as escrow agent, through November 30, 2020, or as extended by mutual agreement of the parties, pending a determination, if any, by us of any operating deficiency in the drilling rig. On January 6, 2021, Zion completed its acceptance testing of the I-35 drilling rig and the Holdback Amount was remitted to Central European Drilling on January 8, 2021.

 

Since the rig was purchased and closed during March 2020, this purchase was recorded on Zion’s books as a long-term fixed asset as a component of Property and Equipment. The full purchase price of the drilling rig was $5.6 million, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet.

 

In accordance with GAAP accounting rules, per the matching principle, monthly depreciation begins the month following when the asset is “placed in service.” The rig was placed in service in December 2020 with January 2021 representing the first month of depreciation. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion will depreciate the rig on a straight-line basis.

 

The $540,000 in spare parts was the original cost to CED. These items were received and counted by Zion upon receipt. All records and files are maintained by Zion. Zion plans to obtain a physical count of the equipment items at the end of each quarter, or as close to such date as practical, in accordance with our normal procedures.

 

Zion uses the First In First Out (“FIFO”) method of accounting for the inventory spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the inventory of spare parts gets consumed.

 

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

 

See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2022:

 

I-35 Drilling Rig & Associated Equipment:
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization
   Three-month period ended March 31, 2022 
   I-35
Drilling Rig
   Rig
Spare Parts
   Other
Drilling Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2021   5,859    643    332    6,834 
Asset Additions   
-
    5    117    122 
Asset Depreciation   (159)   
-
    (25)   (184)
Asset Disposals for Self-Consumption   
-
    (13)   
-
    (13)
March 31, 2022   5,700    635    424    6,759 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity (Tables) [Line Items]  
Schedule of stock option transactions
   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2021   9,741,750    0.64 
           
Changes during 2022 to:          
Granted to employees, officers, directors and others   4,100,000    0.13 
Expired/Cancelled/Forfeited   
-
    
-
 
Exercised   (50,000)   0.01 
Outstanding, March 31, 2022   13,791,750    0.49 
Exercisable, March 31, 2022   10,551,750    0.60 

 

Schedule of stock options outstanding
Shares underlying outstanding options (non-vested)  Shares underlying outstanding options (fully vested) 
Range of
exercise
price
   Number
outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
   Range of
exercise
price
   Number
Outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
 
US$           US$   US$           US$ 
 0.14    240,000    9.81    0.14    0.01    10,000    1.62    0.01 
 0.15    3,000,000    9.77    0.15    0.01    5,000    2.20    0.01 
     
    
    
    0.01    20,000    4.17    0.01 
     
    
    
    0.01    130,000    4.75    0.01 
     
    
    
    0.01    50,000    4.76    0.01 
     
    
    
    0.01    60,000    5.04    0.01 
     
    
    
    0.01    200,000    5.13    0.01 
     
    
    
    0.01    40,000    5.50    0.01 
     
    
    
    0.01    85,000    5.75    0.01 
     
    
    
    0.01    25,000    5.76    0.01 
     
    
    
    0.01    30,000    5.91    0.01 
     
    
    
    0.01    4,000    6.01    0.01 
     
    
    
    0.01    25,000    6.77    0.01 
     
    
    
    0.01    85,000    7.46    0.01 
     
    
    
    0.01    205,000    7.63    0.01 
     
    
    
    0.01    35,000    7.76    0.01 
     
    
    
    0.01    75,000    8.76    0.01 
     
    
    
    0.01    200,000    9.14    0.01 
     
    
    
    0.01    355,000    9.29    0.01 
     
    
    
    0.01    10,000    9.42    0.01 
     
    
    
    0.01    500,000    9.76    0.01 
     
    
    
    0.01    110,000    9.80    0.01 
     
    
    
    0.15    200,000    9.76    0.15 
     
    
    
    0.16    340,000    7.69    0.16 
     
    
    
    0.16    75,000    3.69    0.16 
     
    
    
    0.18    25,000    3.67    0.18 
     
    
    
    0.25    50,000    9.42    0.25 
     
    
    
    0.25    363,000    9.42    0.25 
     
    
    
    0.28    25,000    3.42    0.28 
     
    
    
    0.28    25,000    7.42    0.28 
     
    
    
    0.29    25,000    5.20    0.29 
     
    
    
    0.39    1,510,000    9.27    0.39 
     
    
    
    0.59    1,400,000    5.13    0.59 
     
    
    
    0.59    1,800,000    9.14    0.59 
     
    
    
    0.92    350,000    4.76    0.92 
     
    
    
    0.92    600,000    8.76    0.92 
     
    
    
    1.33    25,000    1.07    1.33 
     
    
    
    1.38    105,307    2.76    1.38 
     
    
    
    1.55    200,000    0.18    1.55 
     
    
    
    1.67    405,943    2.51    1.67 
     
    
    
    1.70    218,500    0.72    1.70 
     
    
    
    1.75    250,000    1.27    1.75 
     
    
    
    1.78    25,000    2.43    1.78 
     
    
    
    2.31    250,000    1.76    2.31 
     
    
    
    4.15    25,000    2.26    4.15 
 0.14-0.15     3,240,000         0.15    0.01-4.15    10,551,750         0.60 

 

Schedule of compensation cost of warrant and option issuances
For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 214    821 

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 1    
 

 

For the three months ended March 31, 
2022   2021 
US$ thousands   US$ thousands 
 7    
 

 

Schedule of warrants transactions
Warrants   Exercise
Price
    Warrant
Termination Date
  Outstanding Balance, 12/31/2021     Warrants
Issued
    Warrants
Exercised
    Warrants
Expired
    Outstanding Balance, 03/31/2022  
ZNWAA   $ 2.00     01/31/2023     1,498,804      
-
     
-
     
-
      1,498,804  
ZNWAD   $ 1.00     05/02/2023     243,853      
-
     
-
     
-
      243,853  
ZNWAE   $ 1.00     05/01/2023     2,144,099      
-
     
-
     
-
      2,144,099  
ZNWAF   $ 1.00     08/14/2023     359,435      
-
     
-
     
-
      359,435  
ZNWAG   $ 1.00     01/08/2023     240,068      
-
     
-
     
-
      240,068  
ZNWAH   $ 5.00     04/19/2023     372,400      
-
     
-
     
-
      372,400  
ZNWAI   $ 3.00     06/29/2023     640,730      
-
     
-
     
-
      640,730  
ZNWAJ   $ 1.00     10/29/2023     545,900      
-
     
-
     
-
      545,900  
ZNWAK   $ 0.01     02/25/2023     431,655      
-
      (1,750 )     -       429,905  
ZNWAL   $ 2.00     08/26/2023     517,875      
-
     
-
     
-
      517,875  
ZNWAM   $ 1.00     07/15/2023     4,376,000      
-
     
-
     
-
      4,376,000  
ZNWAN   $ 1.00     05/16/2023     267,660      
-
     
-
     
-
      267,660  
ZNWAO   $ 0.25     06/12/2023     174,970      
-
     
-
     
-
      174,970  
ZNWAP   $ 0.25    

06/02/2023

    439,916      
-
     
-
     
-
      439,916  
ZNWAR   $ 0.25     06/23/2023     1,020,000      
-
     
-
     
-
      1,020,000  
Outstanding warrants                 13,273,365       -       (1,750 )     -       13,271,615  

 

Schedule of warrants to investors
        Period of Grant     US$     Expiration Date  
ZNWAA Warrants   B,C   March 2013 – December 2014       2.00     January 31, 2023  
ZNWAD Warrants   A,B,C   January 2015 – March 2016       1.00     May 02, 2023  
ZNWAE Warrants   B,C   November 2016 – March 2017       1.00     May 01, 2023  
ZNWAF Warrants   A,B,C   May 2017 – July 2017       1.00     August 14, 2023  
ZNWAG Warrants   C   October 2017 – December 2017       1.00     January 08, 2023  
ZNWAH Warrants   A,B,C   February 2018       5.00     April 19, 2023  
ZNWAI Warrants   A,B,C   April 2018 – May 2018       3.00     June 29, 2023  
ZNWAJ Warrants   B,C   August 2018 – September 2018       1.00     October 29, 2023  
ZNWAK Warrants   B,C   December 2018 – January 2019       0.01     February 25, 2023  
ZNWAL Warrants   C   July 2019 – August 2019       2.00     August 26, 2023  
ZNWAM Warrants     January 2021 – March 2021       1.00     July 15, 2023  
ZNWAN Warrants       May – June 2021       1.00     May 16, 2023  
ZNWAO Warrants       June 2021       0.25     June 12, 2023  
ZNWAP Warrants   D   June 2021       0.25     June 03, 2023  
ZNWAQ Warrants     June 2021       0.25     July 6, 2022  
ZNWAR Warrants   D   June 2021       0.25     June 23, 2023  
ZNWAS Warrants   F   August 2021 – March 2022       1.00     December 31, 2023  

 

Employees [Member]  
Stockholders' Equity (Tables) [Line Items]  
Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model
   For the
three months ended
March 31,
 
   2022    2021  
Weighted-average fair value of underlying stock at grant date  $0.15    $0.92  
Dividend yields          
Expected volatility   127%-133 %   121%-143 %
Risk-free interest rates   1.37%-1.55 %   0.16%-0.38 %
Expected lives (in years)   5.00-5.50     3.00-5.00  
Weighted-average grant date fair value  $0.13    $0.77  

 

   For the
three months ended
March 31,
 
   2022   2021 
Weighted-average fair value of underlying stock at grant date  $0.15   $ 
Dividend yields        
Expected volatility   103%    
Risk-free interest rates   1.78%    
Expected lives (in years)   10     
Weighted-average grant date fair value  $0.14   $ 

 

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Unproved Oil and Gas Properties, Full Cost Method (Tables)
3 Months Ended
Mar. 31, 2022
Oil and Gas Property [Abstract]  
Schedule of changes in Unproved oil and gas properties
   March 31,
2022
   December 31,
2021
 
   US$ thousands   US$ thousands 
Excluded from amortization base:          
Drilling costs, and other operational related costs   32,703    32,075 
Capitalized salary costs   2,210    2,158 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   11,729    11,260 
Other costs   39    39 
    48,099    46,950 

 

Schedule of changes in Unproved oil and gas properties
   March 31,
2022
   March 31,
2021
 
   US$ thousands   US$ thousands 
Excluded from amortization base:          
Drilling costs, and other operational related costs   628    7,002 
Capitalized salary costs   52    61 
Capitalized interest costs   
-
    79 
Legal and seismic costs, license fees and other preparation costs   469    1,034 
Other costs   
-
    
-
 
    *1,149    *8,176 

 

*Inclusive of non-cash amounts of approximately $1,137,000, and $2,442,000 during the three months ended March 31, 2022, and 2021, respectively

 

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Right of Use Leases Assets and Lease Obligations (Tables)
3 Months Ended
Mar. 31, 2022
Disclosure Text Block [Abstract]  
Schedule of operating lease assets and liabilities
   March 31,
2022
   December 31,
2021
 
   US$ thousands   US$ thousands 
Operating lease assets  $263   $327 
           
Operating lease liabilities:          
Current operating lease liabilities  $169   $203 
Non-current operating lease liabilities  $129   $169 
Total operating lease liabilities  $298   $372 

 

Schedule of weighted average remaining lease term and weighted average discount rate for operating leases
   March 31,
2022
 
Weighted average remaining lease term (years)   1.75 
Weighted average discount rate   5.9%

 

Schedule of future minimum lease payments under non-cancellable operating leases
   US$ thousands 
2022   142 
2023   158 
2024   13 
2025   
-
 
2026   
-
 
Thereafter   
-
 
Total undiscounted future minimum lease payments   313 
Less: portion representing imputed interest   (15)
Total undiscounted future minimum lease payments   298 

 

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Nature of Operations, Basis of Presentation and Going Concern (Details)
$ in Millions
3 Months Ended
Mar. 31, 2022
USD ($)
Nature of Operations, Basis of Presentation and Going Concern (Details) [Line Items]  
Net loss $ 2.2
Accumulated deficit $ 225.7
Megiddo Jezreel License [Member]  
Nature of Operations, Basis of Presentation and Going Concern (Details) [Line Items]  
Area of land depth, description On November 23, 2021, Zion announced via a press release that it completed drilling the MJ-02 well to a total depth of 5,531 meters (~18,141 feet) with a 6 inch open hole at that depth.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 13, 2020
Feb. 06, 2020
Mar. 31, 2022
Dec. 31, 2021
Mar. 12, 2020
Apr. 02, 2018
Summary of Significant Accounting Policies (Details) [Line Items]              
Common stock, par value (in Dollars per share)       $ 0.01 $ 0.01   $ 0.01
Common stock equivalents excluded from EPS as the inclusion would be anti-dilutive (in Shares)       23,144,603 10,969,456    
Capitalized exploration costs       $ 48,099,000 $ 46,950,000    
Remaining amount held in escrow deposit     $ 250,000        
Purchase price   $ 4,350,000          
Escrow deposit   $ 1,000,000          
Purchase price of drilling ring $ 5,600,000            
Consumable inventory included in the rig purchase 540,000            
Spare parts inventory $ 48,000            
Useful life of drilling rig       10 years      
Purchase and Sale Agreement [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Equipment and excess inventory           $ 5,600,000  
Spare parts inventory       $ 540,000      
Useful life of drilling rig       5 years      
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization
$ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization [Line Items]  
Balance beginning $ 6,834
Asset Additions 122
Asset Depreciation (184)
Asset Disposals for Self-Consumption (13)
Balance ending 6,759
I-35 Drilling Rig [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization [Line Items]  
Balance beginning 5,859
Asset Additions
Asset Depreciation (159)
Asset Disposals for Self-Consumption
Balance ending 5,700
Rig Spare Parts [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization [Line Items]  
Balance beginning 643
Asset Additions 5
Asset Depreciation
Asset Disposals for Self-Consumption (13)
Balance ending 635
Other Drilling Assets [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization [Line Items]  
Balance beginning 332
Asset Additions 117
Asset Depreciation (25)
Asset Disposals for Self-Consumption
Balance ending $ 424
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 13, 2018
May 06, 2022
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Oct. 29, 2020
Jan. 29, 2020
Apr. 02, 2018
Stockholders' Equity (Details) [Line Items]                
Common stock, par value     $ 0.01   $ 0.01     $ 0.01
Exercise price per unit     $ 1     $ 1    
Stock option plan, expiration date     The options vested upon grant and are exercisable through January 4, 2032.          
Unrecognized compensation cost     $ 325,000          
Warrants termination, description     An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017.          
Price per share $ 3   $ 1       $ 3  
Common stock shares, description     The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
Exercise price per share     $ 0.25          
Common stock and warrant, description     After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program.          
DSPP program raised amount   $ 2,585,000 $ 11,427,000 $ 2,849,000        
Subscription price per share $ 5              
Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Shares of common stock     38,000,000          
Exercisable period     10 years          
Dividend Reinvestment and Stock Purchase Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     The ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018, at a per share exercise price of $1.00.           
ZNWAB warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     As of May 2, 2017, any outstanding ZNWAB warrants expired.           
ZNWAC warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     As of May 2, 2018, any outstanding ZNWAC warrants expired.           
ZNWAD Warrant one [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020 to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.” The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAD Warrant Two [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.” The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAE Warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00.           
Price per share [1],[2]     $ 1          
ZNWAE Warrant One [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAE Warrant Two [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
Warrant [Member]                
Stockholders' Equity (Details) [Line Items]                
Exercise price per unit     $ 1          
Price per share     5          
Warrant exercise price     $ 0.25          
ZNWAF Warrant Two [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
Warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
Exercise price per unit     $ 5          
ZNWAH Warrant one [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAH Warrant Two [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAJ Warrant [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAJ Warrant Two [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAK [Member]                
Stockholders' Equity (Details) [Line Items]                
Price per share [1],[2]     $ 0.01          
ZNWAK Warrant One [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAK Warrant Two [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAL Warrant [Member]                
Stockholders' Equity (Details) [Line Items]                
Price per share [2]     $ 2          
Offering cost, description     The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
ZNWAL Warrant Two [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAM Warrant One [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
Znwap warrant one [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAS [Member]                
Stockholders' Equity (Details) [Line Items]                
Waiver program executed plan descripton     the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program.On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAR one [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2.          
ZNWAI Warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
Price per share [1],[2],[3]     $ 3          
Subscription Rights Offering [Member]                
Stockholders' Equity (Details) [Line Items]                
Proceeds from the sale of the rights         $ 3,038,000      
Expenses from offering         $ 243,000      
Common Stock [Member] | Warrant [Member]                
Stockholders' Equity (Details) [Line Items]                
Price per share     5          
Znwaf [Member]                
Stockholders' Equity (Details) [Line Items]                
Common stock, par value     $ 5          
ZNWAL Warrant [Member]                
Stockholders' Equity (Details) [Line Items]                
Expiration date, description     The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00.           
Warrant [Member]                
Stockholders' Equity (Details) [Line Items]                
Subscription rights offering, description     Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.           
Warrant [Member] | ZNWAI Warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
Expiration date, description     On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.           
Unit Option Program [Member] | Znwaf [Member]                
Stockholders' Equity (Details) [Line Items]                
New unit program, description     On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
Six Senior Officers [Member] | 2011 Equity Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Shares purchased under option plan     600,000          
Exercise price per unit     $ 0.915          
Stock option plan, expiration date     The options vested upon grant and are exercisable through January 4, 2031.          
Fair value of stock options granted     $ 456,000          
Six Senior Officers [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Fair value of stock options granted     $ 22,000          
Option to purchase shares of common stock     175,000          
Exercise price per share     $ 0.1529          
One senior officer [Member] | 2011 Equity Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Exercise price per unit     $ 0.01          
Fair value of stock options granted     $ 68,000          
Shares purchased under option plan     75,000          
One senior officer [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Fair value of stock options granted     $ 39,000          
Option to purchase shares of common stock     25,000          
Exercise price per share     $ 0.01          
One senior officer [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member] | Common Stock [Member]                
Stockholders' Equity (Details) [Line Items]                
Option to purchase shares of common stock     300,000          
Seven Board [Member] | 2011 Equity Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Stock option plan, expiration date     The options vested upon grant and are exercisable through January 4, 2027.          
Seven Board [Member] | 2011 Non-Employee Directors Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Shares purchased under option plan     350,000          
Exercise price per unit     $ 0.915          
Fair value of stock options granted     $ 252,000          
Seven Board [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Fair value of stock options granted     $ 182,000          
Option to purchase shares of common stock     1,400,000          
Exercise price per share     $ 0.1529          
One Board [Member] | 2011 Non-Employee Directors Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Shares purchased under option plan     50,000          
Exercise price per unit     $ 0.01          
Fair value of stock options granted     $ 45,000          
One Board [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Fair value of stock options granted     $ 29,000          
Option to purchase shares of common stock     200,000          
Exercise price per share     $ 0.01          
Seven Staff [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Stock option plan, expiration date     The fair value of the options at the date of grant amounted to approximately $4,000.          
Five senior officer [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Stock option plan, expiration date     The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032.          
Fair value of stock options granted     $ 209,000          
Option to purchase shares of common stock     1,600,000          
Exercise price per share     $ 0.1529          
Warrants and Options [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Fair value of stock options granted     $ 23,000          
Option to purchase shares of common stock     160,000          
Exercise price per share     $ 0.01          
Six Senior Officers One [Member] | 2011 Equity Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Stock option plan, expiration date     The options vested upon grant and are exercisable through January 17, 2032          
Six Staff [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Fair value of stock options granted     $ 26,000          
Option to purchase shares of common stock     200,000          
Exercise price per share     $ 0.14          
Two Consultants [Member] | Two Zero Two One Omnibus Incentive Stock Option Plan [Member]                
Stockholders' Equity (Details) [Line Items]                
Fair value of stock options granted     $ 5,000          
Option to purchase shares of common stock     40,000          
Exercise price per share     $ 0.14          
New Unit Program [Member] | Znwaf [Member]                
Stockholders' Equity (Details) [Line Items]                
Exercise price per unit     1          
Unit Option Program [Member] | ZNWAK [Member]                
Stockholders' Equity (Details) [Line Items]                
Exercise price per share     $ 0.01          
New unit program, description     The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.”The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
Amended and Restated Certificate of Incorporation [Member] | Minimum [Member]                
Stockholders' Equity (Details) [Line Items]                
Increase in shares authorized     400,000,000          
Amended and Restated Certificate of Incorporation [Member] | Maximum [Member]                
Stockholders' Equity (Details) [Line Items]                
Increase in shares authorized     800,000,000          
ZNWAG [Member]                
Stockholders' Equity (Details) [Line Items]                
New unit program, description     This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.” The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
ZNWAH [Member]                
Stockholders' Equity (Details) [Line Items]                
New unit program, description     The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
ZNWAJ Warrant [Member]                
Stockholders' Equity (Details) [Line Items]                
New unit program, description     the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
ZNWAN [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021.           
ZNWAN Warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
New unit program, description     The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”           
ZNWAN Warrants [Member] | Warrants [Member]                
Stockholders' Equity (Details) [Line Items]                
Warrants termination, description     On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021.           
[1] On May 29, 2019, the Company extended the termination date of the Warrants by one (1) year.
[2] On September 15, 2020, the Company extended the termination date of the Warrants by two (2) years.
[3] On December 4, 2018, the Company extended the termination date of the Warrants by one (1) year.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - Schedule of stock option transactions - Employee Stock Option [Member] - $ / shares
3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Stockholders' Equity (Details) - Schedule of stock option transactions [Line Items]    
Number of shares, Outstanding, Ending 13,791,750 9,741,750
Weighted Average exercise price, Outstanding, Ending $ 0.49 $ 0.64
Number of shares, Exercisable 10,551,750  
Weighted Average exercise price, Exercisable $ 0.6  
Number of shares, Granted to employees, officers, directors and others 4,100,000  
Weighted Average exercise price, Granted to employees, officers, directors and others $ 0.13  
Number of shares, Expired/Cancelled/Forfeited  
Weighted Average exercise price, Expired/Cancelled/Forfeited  
Number of shares, Exercised (50,000)  
Weighted Average exercise price, Exercised $ 0.01  
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - Schedule of stock options outstanding
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Non-vested [Member] | Ranges One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.14
Number outstanding (in Shares) | shares 240,000
Weighted average remaining contractual life (years) 9 years 9 months 21 days
Weighted Average Exercise price $ 0.14
Non-vested [Member] | Ranges Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.15
Number outstanding (in Shares) | shares 3,000,000
Weighted average remaining contractual life (years) 9 years 9 months 7 days
Weighted Average Exercise price $ 0.15
Non-vested [Member] | Ranges Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Seven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Eight [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Nine [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Ten [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Eleven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twelve [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Scenario Thirteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Fourteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Fifteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Sixteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Seventeen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Eighteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Nineteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Seven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Eight [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Twenty Nine [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Seven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Eight [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Thirty Nine [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Fourty [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Range Fourty One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Fourty Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Range Fourty Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Fourty Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Fourty Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Non-vested [Member] | Ranges Fourty Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares 3,240,000
Weighted Average Exercise price $ 0.15
Non-vested [Member] | Ranges Fourty Six [Member] | Minimum [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price 0.14
Non-vested [Member] | Ranges Fourty Six [Member] | Maximum [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price 0.15
Vested [Member] | Ranges One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 1 year 7 months 13 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 5,000
Weighted average remaining contractual life (years) 2 years 2 months 12 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 20,000
Weighted average remaining contractual life (years) 4 years 2 months 1 day
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 130,000
Weighted average remaining contractual life (years) 4 years 9 months
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 4 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 60,000
Weighted average remaining contractual life (years) 5 years 14 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Seven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 5 years 1 month 17 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Eight [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 40,000
Weighted average remaining contractual life (years) 5 years 6 months
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Nine [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 85,000
Weighted average remaining contractual life (years) 5 years 9 months
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Ten [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 5 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Eleven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 30,000
Weighted average remaining contractual life (years) 5 years 10 months 28 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Twelve [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 4,000
Weighted average remaining contractual life (years) 6 years 3 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Scenario Thirteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 6 years 9 months 7 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Fourteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 85,000
Weighted average remaining contractual life (years) 7 years 5 months 15 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Fifteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 205,000
Weighted average remaining contractual life (years) 7 years 7 months 17 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Sixteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 35,000
Weighted average remaining contractual life (years) 7 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Seventeen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 8 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Eighteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 9 years 1 month 20 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Nineteen [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 355,000
Weighted average remaining contractual life (years) 9 years 3 months 14 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Twenty [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 9 years 5 months 1 day
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Twenty One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 500,000
Weighted average remaining contractual life (years) 9 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Twenty Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 110,000
Weighted average remaining contractual life (years) 9 years 9 months 18 days
Weighted Average Exercise price $ 0.01
Vested [Member] | Ranges Twenty Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.15
Number outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 9 years 9 months 3 days
Weighted Average Exercise price $ 0.15
Vested [Member] | Ranges Twenty Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.16
Number outstanding (in Shares) | shares 340,000
Weighted average remaining contractual life (years) 7 years 8 months 8 days
Weighted Average Exercise price $ 0.16
Vested [Member] | Ranges Twenty Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.16
Number outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 3 years 8 months 8 days
Weighted Average Exercise price $ 0.16
Vested [Member] | Ranges Twenty Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.18
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 3 years 8 months 1 day
Weighted Average Exercise price $ 0.18
Vested [Member] | Ranges Twenty Seven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.25
Number outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 9 years 5 months 1 day
Weighted Average Exercise price $ 0.25
Vested [Member] | Ranges Twenty Eight [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.25
Number outstanding (in Shares) | shares 363,000
Weighted average remaining contractual life (years) 9 years 5 months 1 day
Weighted Average Exercise price $ 0.25
Vested [Member] | Ranges Twenty Nine [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.28
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 3 years 5 months 1 day
Weighted Average Exercise price $ 0.28
Vested [Member] | Ranges Thirty [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.28
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 7 years 5 months 1 day
Weighted Average Exercise price $ 0.28
Vested [Member] | Ranges Thirty One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.29
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 5 years 2 months 12 days
Weighted Average Exercise price $ 0.29
Vested [Member] | Ranges Thirty Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.39
Number outstanding (in Shares) | shares 1,510,000
Weighted average remaining contractual life (years) 9 years 3 months 7 days
Weighted Average Exercise price $ 0.39
Vested [Member] | Ranges Thirty Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.59
Number outstanding (in Shares) | shares 1,400,000
Weighted average remaining contractual life (years) 5 years 1 month 17 days
Weighted Average Exercise price $ 0.59
Vested [Member] | Ranges Thirty Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.59
Number outstanding (in Shares) | shares 1,800,000
Weighted average remaining contractual life (years) 9 years 1 month 20 days
Weighted Average Exercise price $ 0.59
Vested [Member] | Ranges Thirty Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.92
Number outstanding (in Shares) | shares 350,000
Weighted average remaining contractual life (years) 4 years 9 months 3 days
Weighted Average Exercise price $ 0.92
Vested [Member] | Ranges Thirty Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.92
Number outstanding (in Shares) | shares 600,000
Weighted average remaining contractual life (years) 8 years 9 months 3 days
Weighted Average Exercise price $ 0.92
Vested [Member] | Ranges Thirty Seven [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.33
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 1 year 25 days
Weighted Average Exercise price $ 1.33
Vested [Member] | Ranges Thirty Eight [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.38
Number outstanding (in Shares) | shares 105,307
Weighted average remaining contractual life (years) 2 years 9 months 3 days
Weighted Average Exercise price $ 1.38
Vested [Member] | Ranges Thirty Nine [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.55
Number outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 2 months 4 days
Weighted Average Exercise price $ 1.55
Vested [Member] | Ranges Fourty [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.67
Number outstanding (in Shares) | shares 405,943
Weighted average remaining contractual life (years) 2 years 6 months 3 days
Weighted Average Exercise price $ 1.67
Vested [Member] | Range Fourty One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.7
Number outstanding (in Shares) | shares 218,500
Weighted average remaining contractual life (years) 8 months 19 days
Weighted Average Exercise price $ 1.7
Vested [Member] | Ranges Fourty Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.75
Number outstanding (in Shares) | shares 250,000
Weighted average remaining contractual life (years) 1 year 3 months 7 days
Weighted Average Exercise price $ 1.75
Vested [Member] | Range Fourty Three [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.78
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 2 years 5 months 4 days
Weighted Average Exercise price $ 1.78
Vested [Member] | Ranges Fourty Four [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 2.31
Number outstanding (in Shares) | shares 250,000
Weighted average remaining contractual life (years) 1 year 9 months 3 days
Weighted Average Exercise price $ 2.31
Vested [Member] | Ranges Fourty Five [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 4.15
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 2 years 3 months 3 days
Weighted Average Exercise price $ 4.15
Vested [Member] | Ranges Fourty Six [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares 10,551,750
Weighted Average Exercise price $ 0.6
Vested [Member] | Ranges Fourty Six [Member] | Minimum [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price 0.01
Vested [Member] | Ranges Fourty Six [Member] | Maximum [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 4.15
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model - $ / shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Employee [Member]    
Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model [Line Items]    
Weighted-average fair value of underlying stock at grant date (in Dollars per share) $ 0.15 $ 0.92
Dividend yields
Weighted-average grant date fair value (in Dollars per share) $ 0.13 $ 0.77
Employee [Member] | Minimum [Member]    
Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model [Line Items]    
Expected volatility 127.00% 121.00%
Risk-free interest rates 1.37% 0.16%
Expected lives (in years) 5 years 3 years
Employee [Member] | Maximum [Member]    
Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model [Line Items]    
Expected volatility 133.00% 143.00%
Risk-free interest rates 1.55% 0.38%
Expected lives (in years) 5 years 6 months 5 years
Non-Employees [Member]    
Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model [Line Items]    
Weighted-average fair value of underlying stock at grant date (in Dollars per share) $ 0.15
Dividend yields
Expected volatility 103.00%
Risk-free interest rates 1.78%
Expected lives (in years) 10 years
Weighted-average grant date fair value (in Dollars per share) $ 0.14
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Employees And Directors [Member]    
Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances [Line Items]    
Compensation cost of warrant and option issuances $ 214 $ 821
Non-Employees [Member]    
Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances [Line Items]    
Compensation cost of warrant and option issuances 1
Unproved Oil & Gas properties [Member]    
Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances [Line Items]    
Compensation cost of warrant and option issuances $ 7
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - Schedule of warrants transactions - $ / shares
Mar. 31, 2022
Dec. 31, 2021
ZNWAA [Member] | Warrant Transactions [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 2
Warrant Termination Date   Jan. 31, 2023
Outstanding Beginning Balance   1,498,804
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 1,498,804  
Warrant Transactions [Member]    
Class of Warrant or Right [Line Items]    
Outstanding Beginning Balance   13,273,365
Warrants Exercised (1,750)  
Warrants Expired (1,750)  
Outstanding Ending Balance 13,271,615  
Warrant Transactions [Member] | ZNWAD Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 1
Warrant Termination Date   May 02, 2023
Outstanding Beginning Balance   243,853
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 243,853  
Warrant Transactions [Member] | ZNWAE Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 1
Warrant Termination Date   May 01, 2023
Outstanding Beginning Balance   2,144,099
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 2,144,099  
Warrant Transactions [Member] | ZNWAF Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 1
Warrant Termination Date   Aug. 14, 2023
Outstanding Beginning Balance   359,435
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 359,435  
Warrant Transactions [Member] | ZNWAG Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 1
Warrant Termination Date   Jan. 08, 2023
Outstanding Beginning Balance   240,068
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 240,068  
Warrant Transactions [Member] | ZNWAH Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 5
Warrant Termination Date   Apr. 19, 2023
Outstanding Beginning Balance   372,400
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 372,400  
Warrant Transactions [Member] | ZNWAI Warrant [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 3
Warrant Termination Date   Jun. 29, 2023
Outstanding Beginning Balance   640,730
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 640,730  
Warrant Transactions [Member] | ZNWAJ [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 1
Warrant Termination Date   Oct. 29, 2023
Outstanding Beginning Balance   545,900
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 545,900  
Warrant Transactions [Member] | ZNWAK [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 0.01
Warrant Termination Date   Feb. 25, 2023
Outstanding Beginning Balance   431,655
Warrants Issued  
Warrants Exercised (1,750)  
Warrants Expired (1,750)  
Outstanding Ending Balance 429,905  
Warrant Transactions [Member] | ZNWAL [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 2
Warrant Termination Date   Aug. 26, 2023
Outstanding Beginning Balance   517,875
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 517,875  
Warrant Transactions [Member] | ZNWAM Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 1
Warrant Termination Date   Jul. 15, 2023
Outstanding Beginning Balance   4,376,000
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 4,376,000  
Warrant Transactions [Member] | ZNWAN Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 1
Warrant Termination Date   May 16, 2023
Outstanding Beginning Balance   267,660
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 267,660  
Warrant Transactions [Member] | ZNWAO Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 0.25
Warrant Termination Date   Jun. 12, 2023
Outstanding Beginning Balance   174,970
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 174,970  
Warrant Transactions [Member] | ZNWAP Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 0.25
Warrant Termination Date   Jun. 02, 2023
Outstanding Beginning Balance   439,916
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 439,916  
Warrant Transactions [Member] | ZNWAR Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share)   $ 0.25
Warrant Termination Date   Jun. 23, 2023
Outstanding Beginning Balance   1,020,000
Warrants Issued  
Warrants Exercised  
Warrants Expired  
Outstanding Ending Balance 1,020,000  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - Schedule of warrants to investors
3 Months Ended
Mar. 31, 2022
$ / shares
ZNWAA Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name B,C [1],[2]
Period of Grant March 2013 – December 2014 [1],[2]
Exercise Price $ 2 [1],[2]
Expiration Date January 31, 2023 [1],[2]
ZNWAD Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name A,B,C [1],[2],[3]
Period of Grant January 2015 – March 2016 [1],[2],[3]
Exercise Price $ 1 [1],[2],[3]
Expiration Date May 02, 2023 [1],[2],[3]
ZNWAE Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name B,C [1],[2]
Period of Grant November 2016 – March 2017 [1],[2]
Exercise Price $ 1 [1],[2]
Expiration Date May 01, 2023 [1],[2]
ZNWAF Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name A,B,C [1],[2],[3]
Period of Grant May 2017 – July 2017 [1],[2],[3]
Exercise Price $ 1 [1],[2],[3]
Expiration Date August 14, 2023 [1],[2],[3]
ZNWAG Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name C [2]
Period of Grant October 2017 – December 2017 [2]
Exercise Price $ 1 [2]
Expiration Date January 08, 2023 [2]
ZNWAH Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name A,B,C [1],[2],[3]
Period of Grant February 2018 [1],[2],[3]
Exercise Price $ 5 [1],[2],[3]
Expiration Date April 19, 2023 [1],[2],[3]
ZNWAI Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name A,B,C [1],[2],[3]
Period of Grant April 2018 – May 2018 [1],[2],[3]
Exercise Price $ 3 [1],[2],[3]
Expiration Date June 29, 2023 [1],[2],[3]
ZNWAJ Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name B,C [1],[2]
Period of Grant August 2018 – September 2018 [1],[2]
Exercise Price $ 1 [1],[2]
Expiration Date October 29, 2023 [1],[2]
ZNWAK Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name B,C [1],[2]
Period of Grant December 2018 – January 2019 [1],[2]
Exercise Price $ 0.01 [1],[2]
Expiration Date February 25, 2023 [1],[2]
ZNWAL Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name C [2]
Period of Grant July 2019 – August 2019 [2]
Exercise Price $ 2 [2]
Expiration Date August 26, 2023 [2]
ZNWAM Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name D [4]
Period of Grant January 2021 – March 2021 [4]
Exercise Price $ 1 [4]
Expiration Date July 15, 2023 [4]
ZNWAN Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Period of Grant May – June 2021
Exercise Price $ 1
Expiration Date May 16, 2023
ZNWAO Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Period of Grant June 2021
Exercise Price $ 0.25
Expiration Date June 12, 2023
ZNWAP Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name D [4]
Period of Grant June 2021 [4]
Exercise Price $ 0.25 [4]
Expiration Date June 03, 2023 [4]
ZNWAQ Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name E [5]
Period of Grant June 2021 [5]
Exercise Price $ 0.25 [5]
Expiration Date July 6, 2022 [5]
ZNWAR Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name D [4]
Period of Grant June 2021 [4]
Exercise Price $ 0.25 [4]
Expiration Date June 23, 2023 [4]
ZNWAS Warrants [Member]  
Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]  
Name F [6]
Period of Grant August 2021 – March 2022 [6]
Exercise Price $ 1 [6]
Expiration Date December 31, 2023 [6]
[1] On May 29, 2019, the Company extended the termination date of the Warrants by one (1) year.
[2] On September 15, 2020, the Company extended the termination date of the Warrants by two (2) years.
[3] On December 4, 2018, the Company extended the termination date of the Warrants by one (1) year.
[4] On March 21, 2022, the Company extended the termination date of the Warrants by one (1) year.
[5] These warrants were issued on May 5, 2022.
[6] These warrants will be exercisable beginning on November 15, 2023 and terminate on December 31, 2023. These warrants will be issued in November 2023.
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Unproved Oil and Gas Properties, Full Cost Method (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Oil and Gas Property [Abstract]    
Inclusive of non-cash amounts $ 1,137,000 $ 2,442,000
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties - Unproved Oil and Gas Properties, Full Cost Method [Member] - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties [Line Items]    
Drilling costs, and other operational related costs $ 32,703 $ 32,075
Capitalized salary costs 2,210 2,158
Capitalized interest costs 1,418 1,418
Legal and seismic costs, license fees and other preparation costs 11,729 11,260
Other costs 39 39
Total unproved oil and gas properties $ 48,099 $ 46,950
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of changes in Unproved oil and gas properties - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Schedule of changes in Unproved oil and gas properties [Abstract]    
Drilling costs, and other operational related costs $ 628 $ 7,002
Capitalized salary costs 52 61
Capitalized interest costs 79
Legal and seismic costs, license fees and other preparation costs 469 1,034
Other costs
Total unproved oil and gas properties [1] $ 1,149 $ 8,176
[1] Inclusive of non-cash amounts of approximately $1,137,000, and $2,442,000 during the three months ended March 31, 2022, and 2021, respectively
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Right of Use Leases Assets and Lease Obligations (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Right of Use Leases Assets and Leases Obligations [Abstract]    
Operating lease costs $ 68,000 $ 63,000
Operating lease liabilities 72,000 71,000
Right-of-use assets obtained in exchange for new operating lease liabilities
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities - Rights use of assets [Member] - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities [Line Items]    
Operating lease assets $ 263 $ 327
Operating lease liabilities:    
Current operating lease liabilities 169 203
Non-current operating lease liabilities 129 169
Total operating lease liabilities $ 298 $ 372
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Right of Use Leases Assets and Lease Obligations (Details) - Schedule of weighted average remaining lease term and weighted average discount rate for operating leases
Mar. 31, 2022
Schedule of weighted average remaining lease term and weighted average discount rate for operating leases [Abstract]  
Weighted average remaining lease term (years) 1 year 9 months
Weighted average discount rate 5.90%
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Right of Use Leases Assets and Lease Obligations (Details) - Schedule of future minimum lease payments under non-cancellable operating leases
$ in Thousands
Mar. 31, 2022
USD ($)
Schedule of future minimum lease payments under non-cancellable operating leases [Abstract]  
2022 $ 142
2023 158
2024 13
2025
2026
Thereafter
Total undiscounted future minimum lease payments 313
Less: portion representing imputed interest (15)
Total undiscounted future minimum lease payments $ 298
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Accrued license costs
Bank guarantees to government 1,186,000  
Bank guarantees to others 82,000  
Aggregate guarantee amount $ 1,268,000  
Foreign currency exchange rate risks, description A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2022 through March 31, 2022, the USD has fluctuated by approximately 2.1% against the NIS (the USD strengthened relative to the NIS). By contrast, during the period January 1, 2021 through December 31, 2021, the USD fluctuated by approximately 3.3% against the NIS (the USD weakened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.  
Cash equivalents and short-term bank deposits $ 9,490,000  
Weighted average annual interest rate 0.52%  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Details) - USD ($)
1 Months Ended
Apr. 15, 2022
Apr. 01, 2022
May 06, 2022
Subsequent Event [Member]      
Subsequent Events (Details) [Line Items]      
Subsequent events description     (i)Approximately $2,585,000 was collected through the Company’s DSPP program during the period April 1 through May 6, 2022.
Subsequent Event [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Shares granted under stock option plan   25,000  
Exercise price of common stock   $ 0.1128  
Description of options vesting   The options vested upon grant and are exercisable through April 1, 2032.  
Fair value of the options value   $ 2,410,000  
Five Senior Officers and Ten Staff [Member] | Subsequent Event [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Shares granted under stock option plan 3,160,000    
Exercise price of common stock $ 0.1451    
Description of options vesting The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2032.    
Fair value of the options value $ 387,660,000    
Five Staff [Member] | Subsequent Event [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Shares granted under stock option plan 290,000    
Exercise price of common stock $ 0.01    
Description of options vesting The options vested upon grant and are exercisable through April 15, 2032.    
Fair value of the options value $ 39,594,000    
One Senior Officer [Member] | Subsequent Event [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Shares granted under stock option plan 400,000    
Exercise price of common stock $ 0.01    
Description of options vesting The options vested upon grant and are exercisable through April 15, 2032.    
Fair value of the options value $ 54,612    
One Board [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Fair value of the options value $ 54,612,000    
One Board [Member] | Subsequent Event [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Shares granted under stock option plan 400,000    
Exercise price of common stock $ 0.01    
Description of options vesting The options vested upon grant and are exercisable through April 15, 2032.    
Eight Board [Member] | Subsequent Event [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Shares granted under stock option plan 3,200,000    
Exercise price of common stock $ 0.1451    
Description of options vesting The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023.    
Fair value of the options value $ 392,567,000    
Two Consultants [Member] | Subsequent Event [Member] | Two Thousand and Twenty-First Omnibus Incentive Plan [Member]      
Subsequent Events (Details) [Line Items]      
Shares granted under stock option plan 50,000    
Exercise price of common stock $ 0.1451    
Description of options vesting The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023.    
Fair value of the options value $ 6,377,000    
XML 50 f10q0322_zionoil_htm.xml IDEA: XBRL DOCUMENT 0001131312 2022-01-01 2022-03-31 0001131312 2022-05-06 0001131312 2022-03-31 0001131312 2021-12-31 0001131312 2021-01-01 2021-03-31 0001131312 us-gaap:CommonStockMember 2021-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001131312 us-gaap:RetainedEarningsMember 2021-12-31 0001131312 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001131312 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001131312 us-gaap:CommonStockMember 2022-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001131312 us-gaap:RetainedEarningsMember 2022-03-31 0001131312 us-gaap:CommonStockMember 2020-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001131312 us-gaap:RetainedEarningsMember 2020-12-31 0001131312 2020-12-31 0001131312 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001131312 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001131312 us-gaap:CommonStockMember 2021-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001131312 us-gaap:RetainedEarningsMember 2021-03-31 0001131312 2021-03-31 0001131312 zn:MegiddoJezreelLicenseMember 2022-01-01 2022-03-31 0001131312 2021-01-01 2021-12-31 0001131312 zn:PurchaseAndSaleAgreementMember 2020-03-12 0001131312 2020-01-06 2020-02-06 0001131312 2020-02-13 2020-03-13 0001131312 2020-03-13 0001131312 2020-02-20 2020-03-31 0001131312 2020-03-31 0001131312 zn:PurchaseAndSaleAgreementMember 2022-03-31 0001131312 zn:PurchaseAndSaleAgreementMember 2022-01-01 2022-03-31 0001131312 zn:I35DrillingRigMember 2021-12-31 0001131312 zn:RigSparePartsMember 2021-12-31 0001131312 zn:OtherDrillingAssetsMember 2021-12-31 0001131312 zn:I35DrillingRigMember 2022-01-01 2022-03-31 0001131312 zn:RigSparePartsMember 2022-01-01 2022-03-31 0001131312 zn:OtherDrillingAssetsMember 2022-01-01 2022-03-31 0001131312 zn:I35DrillingRigMember 2022-03-31 0001131312 zn:RigSparePartsMember 2022-03-31 0001131312 zn:OtherDrillingAssetsMember 2022-03-31 0001131312 pf0:MinimumMember zn:AmendedAndRestatedCertificateOfIncorporationMember 2022-03-31 0001131312 pf0:MaximumMember zn:AmendedAndRestatedCertificateOfIncorporationMember 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember 2022-03-31 0001131312 zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SixSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SevenStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember us-gaap:CommonStockMember 2022-03-31 0001131312 zn:OneSeniorOfficersMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:OneBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:FiveSeniorOfficerMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:FiveSeniorOfficerMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SevenBoardMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:FourStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SixSeniorOfficersOneMember zn:TwoZeroOneOneEquityIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:FourStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:SixStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:SixStaffMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:TwoConsultantsMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-03-31 0001131312 zn:TwoConsultantsMember zn:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2022-01-01 2022-03-31 0001131312 zn:DividendReinvestmentAndStockPurchasePlanMember 2022-03-31 0001131312 zn:ZNWABWarrantsMember 2022-03-31 0001131312 zn:ZNWACWarrantsMember 2022-03-31 0001131312 zn:ZNWADWarrantOneMember 2022-03-31 0001131312 zn:ZNWADWarrantTwoMember 2022-03-31 0001131312 zn:ZNWAEWarrantsMember 2022-03-31 0001131312 zn:ZNWAEWarrantOneMember 2022-03-31 0001131312 zn:ZNWAEWarrantTwoMember 2022-03-31 0001131312 us-gaap:WarrantMember us-gaap:CommonStockMember 2022-03-31 0001131312 zn:UnitOptionProgramMember zn:ZnwafMember 2022-01-01 2022-03-31 0001131312 zn:NewUnitProgramMember zn:ZnwafMember 2022-03-31 0001131312 zn:ZNWAFWarrantTwoMember 2022-03-31 0001131312 zn:ZnwafMember 2022-03-31 0001131312 zn:ZNWAGMember 2022-01-01 2022-03-31 0001131312 us-gaap:WarrantMember 2022-03-31 0001131312 zn:ZnwahMember 2022-01-01 2022-03-31 0001131312 zn:ZnwajWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:WarrantsMember 2022-03-31 0001131312 zn:ZNWAHWarrantOneMember 2022-03-31 0001131312 zn:ZNWAHWarrantTwoMember 2022-03-31 0001131312 2020-10-29 0001131312 zn:ZNWAJWarrantMember 2022-03-31 0001131312 zn:ZNWAJWarrantTwoMember 2022-03-31 0001131312 zn:UnitOptionProgramMember zn:ZnwakWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:UnitOptionProgramMember zn:ZnwakWarrantsMember 2022-03-31 0001131312 zn:ZNWAKWarrantOneMember 2022-03-31 0001131312 zn:ZNWAKWarrantTwoMember 2022-03-31 0001131312 zn:ZnwalWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwalWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWALWarrantTwoMember 2022-03-31 0001131312 zn:ZNWAMWarrantOneMember 2022-03-31 0001131312 zn:ZnwanWarrantMember 2022-03-31 0001131312 zn:ZNWANWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:WarrantsMember zn:ZNWANWarrantsMember 2022-03-31 0001131312 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001131312 zn:ZnwapWarrantOneMember 2022-03-31 0001131312 zn:ZNWASMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAROneMember 2022-03-31 0001131312 2022-04-01 2022-05-06 0001131312 2018-04-02 0001131312 2018-04-01 2018-04-13 0001131312 2018-04-13 0001131312 2020-01-29 0001131312 zn:ZnwaiWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-03-31 0001131312 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001131312 zn:SubscriptionRightsOfferingMember 2021-01-01 2021-12-31 0001131312 us-gaap:EmployeeStockOptionMember 2021-12-31 0001131312 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001131312 us-gaap:EmployeeStockOptionMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesOneMember 2022-01-01 2022-03-31 0001131312 zn:NonvestedMember zn:RangesOneMember 2022-03-31 0001131312 zn:VestedMember zn:RangesOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwoMember 2022-01-01 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwoMember 2022-03-31 0001131312 zn:VestedMember zn:RangesTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesElevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesElevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesElevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesElevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwelveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwelveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwelveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwelveMember 2022-03-31 0001131312 zn:NonvestedMember zn:ScenarioThirteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:ScenarioThirteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:ScenarioThirteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:ScenarioThirteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFifteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFifteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFifteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFifteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSixteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSixteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSeventeenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesSeventeenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSeventeenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesSeventeenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEighteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesEighteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEighteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesEighteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesNineteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineteenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesNineteenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesTwentyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesTwentyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySixMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySevenMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtySevenMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyEightMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyEightMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesThirtyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyNineMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesThirtyNineMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyOneMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyOneMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyTwoMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyTwoMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangeFourtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyThreeMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangeFourtyThreeMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFourMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFourMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFiveMember 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFiveMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtyFiveMember 2022-03-31 0001131312 pf0:MinimumMember zn:NonvestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 pf0:MaximumMember zn:NonvestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 zn:NonvestedMember zn:RangesFourtySixMember 2022-03-31 0001131312 pf0:MinimumMember zn:VestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 pf0:MaximumMember zn:VestedMember zn:RangesFourtySixMember 2022-01-01 2022-03-31 0001131312 zn:VestedMember zn:RangesFourtySixMember 2022-03-31 0001131312 zn:EmployeesMember 2022-01-01 2022-03-31 0001131312 zn:EmployeeMember 2022-01-01 2022-03-31 0001131312 zn:EmployeeMember 2021-01-01 2021-03-31 0001131312 pf0:MinimumMember zn:EmployeeMember 2022-01-01 2022-03-31 0001131312 pf0:MaximumMember zn:EmployeeMember 2022-01-01 2022-03-31 0001131312 pf0:MinimumMember zn:EmployeeMember 2021-01-01 2021-03-31 0001131312 pf0:MaximumMember zn:EmployeeMember 2021-01-01 2021-03-31 0001131312 zn:NonEmployeesMember 2022-01-01 2022-03-31 0001131312 zn:NonEmployeesMember 2021-01-01 2021-03-31 0001131312 zn:EmployeesAndDirectorsMember 2022-01-01 2022-03-31 0001131312 zn:EmployeesAndDirectorsMember 2021-01-01 2021-12-31 0001131312 zn:NonEmployeesMember 2022-01-01 2022-03-31 0001131312 zn:NonEmployeesMember 2021-01-01 2021-12-31 0001131312 zn:UnprovedOilGasPropertiesMember 2022-01-01 2022-03-31 0001131312 zn:UnprovedOilGasPropertiesMember 2021-01-01 2021-12-31 0001131312 zn:ZnwaaWarrantsMember zn:WarrantTransactionsMember 2021-12-31 0001131312 zn:ZnwaaWarrantsMember zn:WarrantTransactionsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWADWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWADWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAEWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAEWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAFWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAFWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAGWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAGWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAHWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAHWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAIWarrantMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAIWarrantMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZnwajWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZnwajWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZnwakWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZnwakWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZnwalWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZnwalWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAMWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAMWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWANWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWANWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAOWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAOWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAPWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWAPWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember zn:ZNWARWarrantsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember zn:ZNWARWarrantsMember 2022-03-31 0001131312 zn:WarrantTransactionsMember 2021-12-31 0001131312 zn:WarrantTransactionsMember 2022-03-31 0001131312 zn:ZnwaaWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwaaWarrantsMember 2022-03-31 0001131312 zn:ZNWADWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWADWarrantsMember 2022-03-31 0001131312 zn:ZNWAEWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAFWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAFWarrantsMember 2022-03-31 0001131312 zn:ZNWAGWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAGWarrantsMember 2022-03-31 0001131312 zn:ZNWAHWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAHWarrantsMember 2022-03-31 0001131312 zn:ZnwaiWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwaiWarrantsMember 2022-03-31 0001131312 zn:ZnwajWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwajWarrantsMember 2022-03-31 0001131312 zn:ZnwakWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwakWarrantsMember 2022-03-31 0001131312 zn:ZnwalWarrantsMember 2022-03-31 0001131312 zn:ZNWAMWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAMWarrantsMember 2022-03-31 0001131312 zn:ZNWANWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWANWarrantsMember 2022-03-31 0001131312 zn:ZNWAOWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAOWarrantsMember 2022-03-31 0001131312 zn:ZNWAPWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWAPWarrantsMember 2022-03-31 0001131312 zn:ZnwaqWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZnwaqWarrantsMember 2022-03-31 0001131312 zn:ZNWARWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWARWarrantsMember 2022-03-31 0001131312 zn:ZNWASWarrantsMember 2022-01-01 2022-03-31 0001131312 zn:ZNWASWarrantsMember 2022-03-31 0001131312 zn:UnprovedOilAndGasPropertiesFullCostMethodMember 2022-01-01 2022-03-31 0001131312 zn:UnprovedOilAndGasPropertiesFullCostMethodMember 2021-01-01 2021-12-31 0001131312 zn:RightsUseOfAssetsMember 2022-03-31 0001131312 zn:RightsUseOfAssetsMember 2021-12-31 0001131312 us-gaap:SubsequentEventMember 2022-04-02 2022-05-06 0001131312 zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-01 2022-04-01 0001131312 zn:FiveSeniorOfficersAndTenStaffMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:FiveStaffMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:OneSeniorOfficerMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:OneBoardMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:OneBoardMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember 2022-04-02 2022-04-15 0001131312 zn:EightBoardMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 0001131312 zn:TwoConsultantsMember zn:TwoThousandAndTwentyFirstOmnibusIncentivePlanMember us-gaap:SubsequentEventMember 2022-04-02 2022-04-15 shares iso4217:USD iso4217:USD shares pure 10-Q true 2022-03-31 2022 false ZION OIL & GAS, INC. DE 20-0065053 12655 N Central Expressway Suite 1000 Dallas TX 75243 (214) 221-4610 N/A Yes Yes Non-accelerated Filer true false false 469022602 8221000 4683000 1269000 1269000 1264000 689000 605000 617000 338000 900000 2376000 483000 14073000 8641000 48099000 46950000 887000 704000 6759000 6834000 615000 604000 139000 138000 6898000 6972000 263000 327000 553000 541000 553000 541000 69886000 63431000 1167000 2783000 169000 203000 571000 571000 437000 1781000 2344000 5338000 129000 169000 560000 548000 689000 717000 3033000 6055000 0.01 0.01 800000000 800000000 466593391 466593391 364322883 364322883 4666000 3643000 287878000 277258000 -225691000 -223525000 66853000 57376000 69886000 63431000 1435000 1971000 711000 792000 -2146000 -2763000 426000 -9000 -63000 -11000 -160000 -2166000 -2560000 -2166000 -2560000 -0.01 -0.01 404817000 238941000 364324000 3643000 277258000 -223525000 57376000 102219000 1022000 10405000 11427000 50000 1000 1000 215000 215000 -2166000 -2166000 466593000 4666000 287878000 -225691000 66853000 237382000 2374000 245539000 -212804000 35109000 3848000 39000 2810000 2849000 4000 117000 1000 1000 821000 821000 -2560000 -2560000 241351000 2414000 249170000 -215364000 36220000 -2166000 -2560000 195000 179000 208000 821000 141000 426000 -12000 -21000 575000 -530000 -562000 -355000 -34000 -35000 -40000 -45000 -64000 -56000 -107000 -105000 -45000 -331000 -150000 -93000 -1088000 -2091000 -2141000 12000 20000 122000 76000 3665000 7028000 -3799000 -7124000 1000 1000 9427000 2849000 9428000 2850000 3538000 -6415000 5952000 14662000 9490000 8247000 2000000 1130000 2363000 79000 7000 8221000 4683000 1269000 1269000 9490000 5952000 <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 - Nature of Operations, Basis of Presentation and Going Concern</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. Nature of Operations</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zion Oil &amp; Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 22 years of oil &amp; gas exploration in Israel. As of March 31, 2022, the Company has no revenues from its oil and gas operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Exploration Rights/Exploration Activities</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Megiddo-Jezreel Petroleum License, No. 401 (“MJL 401”) and New Megiddo License 428 (“NML 428”)</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Megiddo-Jezreel License 401 was awarded on December 3, 2013 for a three-year primary term through December 2, 2016 with the possibility of additional one-year extensions up to a maximum of seven years. The Megiddo-Jezreel License 401 lies onshore, south and west of the Sea of Galilee, and we continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The NML 428 (covering the same area as MJ-01) was awarded on December 3, 2020 for a six-month term with the possibility of an additional six-month extension. On April 29, 2021, Zion submitted a request to the Ministry of Energy for a six-month extension to December 2, 2021. On May 30, 2021, the Ministry of Energy approved our request for extension to December 2, 2021. On November 29, 2021, the Ministry of Energy approved our request for extension to August 1, 2022, This license effectively replaced the Megiddo-Jezreel License 401 as it has the same area and coordinates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The MJ-02 drilling plan was approved by the Ministry of Energy on July 29, 2020. On January 6, 2021, Zion spudded its MJ-02 exploratory well. On November 23, 2021, Zion announced via a press release that it completed drilling the MJ-02 well to a total depth of 5,531 meters (~18,141 feet) with a 6 inch open hole at that depth.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A full set of detailed and comprehensive tests including neutron-density, sonic, gamma, and resistivity logs were acquired in December 2021, as a result of which we identified an encouraging zone of interest. All of the well testing equipment and personnel are secured for the MJ-02 well. We have re-entered our MJ-02 wellbore and are progressing to production testing. This work is expected to take several weeks.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. Basis of Presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited interim consolidated condensed financial statements of Zion Oil &amp; Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the operating results for the year ending December 31, 2022 or for any other subsequent interim period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C. Going Concern</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be impaired. The consolidated financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the three months ended March 31, 2022, the Company incurred a net loss of approximately $2.2 million and had an accumulated deficit of approximately $225.7 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty </span></p> On November 23, 2021, Zion announced via a press release that it completed drilling the MJ-02 well to a total depth of 5,531 meters (~18,141 feet) with a 6 inch open hole at that depth. 2200000 225700000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 - Summary of Significant Accounting Policies</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. Net Gain (Loss) per Share Data</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share as the inclusion of 23,144,603 and 10,969,456 Common Stock equivalents in 2022, and 2021 respectively, would be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C. Oil and Gas Properties and Impairment</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, and 2021, respectively, the Company did not record any post-impairment charges.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $48,099,000 and $46,950,000 as of March 31, 2022 and December 31, 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D. Fair Value Measurements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2022, and December 31, 2021, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Binomial Model. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E. Stock-Based Compensation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F. Warrants</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, <i>Stockholders’ Equity</i>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G. Related parties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged. Zion did not have any related party transactions for the periods covered in this report, with the exception of recurring monthly consulting fees paid to certain management personnel.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H. Recently Adopted Accounting Pronouncements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU 2016-02 – Leases (Topic 842)</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 (including interim periods within those periods) using a modified retrospective approach and early adoption is permitted. Zion adopted ASU 2016-02 in the first quarter of 2019. Presently, Zion has operating leases for office space in Dallas, Texas and in Caesarea, Israel plus various leases for motor vehicles. These leases have been accounted for under ASU 2016-02 in 2020, 2021 and 2022 by establishing a right-of-use asset and a corresponding current lease liability and non-current lease liability. Zion is not subject to any loan covenants and therefore, the increase in assets and liabilities does not have a material impact on its business.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU 2020-03, “Codification Improvements to Financial Instruments”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. The Company is currently evaluating the impact the adoption of this guidance may have on its consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods beginning after December 31, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company does not believe that this ASU will have any impact on its consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company does not believe that the adoption of any of the recently issued accounting pronouncements had a significant impact on our consolidated financial position, results of operations, or cash flow, except for ASC Update No. 2016-02—Leases, which requires organizations to recognize lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous GAAP. See Note 5 for more complete details on balances at March 31, 2022 and December 31, 2021. </p><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I. Depreciation and Accounting for Drilling Rig and Related Equipment</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 12, 2020, Zion entered into a Purchase and Sale Agreement with Central European Drilling kft (“CED”), a Hungarian corporation, to purchase an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, subject to acceptance testing and potential downward adjustment. We remitted to the Seller $250,000 on February 6, 2020 as earnest money towards the purchase price. The Closing anticipated by the Agreement took place on March 12, 2020 by the Seller’s execution and delivery of a Bill of Sale to us. On March 13, 2020, the Seller retained the earnest money deposit, and the Company remitted $4,350,000 to the seller towards the purchase price and $1,000,000 (the “Holdback Amount”) was deposited in escrow with American Stock Transfer and Trust Company LLC, as escrow agent, through November 30, 2020, or as extended by mutual agreement of the parties, pending a determination, if any, by us of any operating deficiency in the drilling rig. On January 6, 2021, Zion completed its acceptance testing of the I-35 drilling rig and the Holdback Amount was remitted to Central European Drilling on January 8, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the rig was purchased and closed during March 2020, this purchase was recorded on Zion’s books as a long-term fixed asset as a component of Property and Equipment. The full purchase price of the drilling rig was $5.6 million, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with GAAP accounting rules, per the matching principle, monthly depreciation begins the month following when the asset is “placed in service.” The rig was placed in service in December 2020 with January 2021 representing the first month of depreciation. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion will depreciate the rig on a straight-line basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The $540,000 in spare parts was the original cost to CED. These items were received and counted by Zion upon receipt. All records and files are maintained by Zion. Zion plans to obtain a physical count of the equipment items at the end of each quarter, or as close to such date as practical, in accordance with our normal procedures.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zion uses the First In First Out (“FIFO”) method of accounting for the inventory spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the inventory of spare parts gets consumed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I-35 Drilling Rig &amp; Associated Equipment: </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="14" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Three-month period ended March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">I-35<br/> Drilling Rig</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Rig<br/> Spare Parts</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Other<br/> Drilling Assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,859</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">643</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">332</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,834</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Asset Additions</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">117</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">122</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Asset Depreciation</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(159</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(184</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Asset Disposals for Self-Consumption</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,700</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">635</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">424</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,759</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. Net Gain (Loss) per Share Data</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share as the inclusion of 23,144,603 and 10,969,456 Common Stock equivalents in 2022, and 2021 respectively, would be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.01 23144603 10969456 <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C. Oil and Gas Properties and Impairment</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, and 2021, respectively, the Company did not record any post-impairment charges.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $48,099,000 and $46,950,000 as of March 31, 2022 and December 31, 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 48099000 46950000 <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D. Fair Value Measurements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2022, and December 31, 2021, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Binomial Model. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E. Stock-Based Compensation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F. Warrants</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, <i>Stockholders’ Equity</i>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G. Related parties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged. Zion did not have any related party transactions for the periods covered in this report, with the exception of recurring monthly consulting fees paid to certain management personnel.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H. Recently Adopted Accounting Pronouncements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU 2016-02 – Leases (Topic 842)</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 (including interim periods within those periods) using a modified retrospective approach and early adoption is permitted. Zion adopted ASU 2016-02 in the first quarter of 2019. Presently, Zion has operating leases for office space in Dallas, Texas and in Caesarea, Israel plus various leases for motor vehicles. These leases have been accounted for under ASU 2016-02 in 2020, 2021 and 2022 by establishing a right-of-use asset and a corresponding current lease liability and non-current lease liability. Zion is not subject to any loan covenants and therefore, the increase in assets and liabilities does not have a material impact on its business.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU 2020-03, “Codification Improvements to Financial Instruments”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. The Company is currently evaluating the impact the adoption of this guidance may have on its consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods beginning after December 31, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company does not believe that this ASU will have any impact on its consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company does not believe that the adoption of any of the recently issued accounting pronouncements had a significant impact on our consolidated financial position, results of operations, or cash flow, except for ASC Update No. 2016-02—Leases, which requires organizations to recognize lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous GAAP. See Note 5 for more complete details on balances at March 31, 2022 and December 31, 2021. </p><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I. Depreciation and Accounting for Drilling Rig and Related Equipment</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 12, 2020, Zion entered into a Purchase and Sale Agreement with Central European Drilling kft (“CED”), a Hungarian corporation, to purchase an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, subject to acceptance testing and potential downward adjustment. We remitted to the Seller $250,000 on February 6, 2020 as earnest money towards the purchase price. The Closing anticipated by the Agreement took place on March 12, 2020 by the Seller’s execution and delivery of a Bill of Sale to us. On March 13, 2020, the Seller retained the earnest money deposit, and the Company remitted $4,350,000 to the seller towards the purchase price and $1,000,000 (the “Holdback Amount”) was deposited in escrow with American Stock Transfer and Trust Company LLC, as escrow agent, through November 30, 2020, or as extended by mutual agreement of the parties, pending a determination, if any, by us of any operating deficiency in the drilling rig. On January 6, 2021, Zion completed its acceptance testing of the I-35 drilling rig and the Holdback Amount was remitted to Central European Drilling on January 8, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the rig was purchased and closed during March 2020, this purchase was recorded on Zion’s books as a long-term fixed asset as a component of Property and Equipment. The full purchase price of the drilling rig was $5.6 million, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with GAAP accounting rules, per the matching principle, monthly depreciation begins the month following when the asset is “placed in service.” The rig was placed in service in December 2020 with January 2021 representing the first month of depreciation. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion will depreciate the rig on a straight-line basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The $540,000 in spare parts was the original cost to CED. These items were received and counted by Zion upon receipt. All records and files are maintained by Zion. Zion plans to obtain a physical count of the equipment items at the end of each quarter, or as close to such date as practical, in accordance with our normal procedures.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zion uses the First In First Out (“FIFO”) method of accounting for the inventory spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the inventory of spare parts gets consumed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>I-35 Drilling Rig &amp; Associated Equipment: 5600000 250000 4350000 1000000 5600000 540000 48000 P10Y 540000 P5Y <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="14" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Three-month period ended March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">I-35<br/> Drilling Rig</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Rig<br/> Spare Parts</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Other<br/> Drilling Assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,859</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">643</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">332</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,834</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Asset Additions</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">117</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">122</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Asset Depreciation</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(159</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(184</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Asset Disposals for Self-Consumption</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,700</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">635</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">424</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,759</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 5859000 643000 332000 6834000 5000 117000 122000 -159000 -25000 -184000 -13000 -13000 5700000 635000 424000 6759000 <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 - Stockholders’ Equity</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 400,000,000 shares to 800,000,000 shares, effective June 9, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. 2011 Equity Incentive Stock Option Plan</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company did not grant any options from the 2011 Equity Incentive Plan for employees, directors and consultants.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2021, the Company granted the following options from the 2011 Equity Incentive Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 600,000 shares of Common Stock to six senior officers and three staff members at an exercise price of $0.915 per share. The options vested upon grant and are exercisable through January 4, 2031. The fair value of the options at the date of grant amounted to approximately $456,000.</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 75,000 shares of Common Stock were granted to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 6, 2031. The fair value of the options at the date of grant amounted to approximately $68,000.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. 2011 Non-Employee Directors Stock Option Plan</b> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company did not grant any qualified (market value) options from the 2011 Non-Employee Directors Stock Option Plan to its directors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2021, the Company granted the following qualified (market value) and non-qualified options from the 2011 Non-Employee Directors Stock Option Plan for directors to purchase shares of common stock as non-cash compensation:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 350,000 shares of Common Stock to seven board members at an exercise price of $0.915 per share. The options vested upon grant and are exercisable through January 4, 2027. The fair value of the options at the date of grant amounted to approximately $252,000.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 50,000 shares of Common Stock were granted to one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2027. The fair value of the options at the date of grant amounted to approximately $45,000.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C. 2021 Omnibus Incentive Stock Option Plan</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil &amp; Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares of common stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed ten years from the date of grant.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company granted the following options from the 2021 Equity Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 175,000 shares of Common Stock to six senior officers and one staff member at an exercise price of $0.1529 per share. The options vested upon grant and are exercisable through January 4, 2032. The fair value of the options at the date of grant amounted to approximately $22,000.</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $4,000.</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 300,000 shares of Common Stock to one senior officer and one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,000. </span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 200,000 shares of Common Stock one board member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 5, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $29,000. </span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 1,600,000 shares of Common Stock to five senior officers and four staff members at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $209,000, and will be recognized during the years 2022 and 2023.</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 1,400,000 shares of Common Stock to seven board members, at an exercise price of $0.1529 per share. The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. The fair value of the options at the date of grant amounted to approximately $182,000, and will be recognized during the years 2022 and 2023.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 160,000 shares of Common Stock to four staff members, at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 17, 2032. These options were granted per the provisions under the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $23,000.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 200,000 shares of Common Stock to six staff members at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $26,000, and will be recognized during the years 2022 and 2023.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ix.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options to purchase 40,000 shares of Common Stock to two consultants at an exercise price of $0.14 per share. The options vest on January 17, 2023 (one year from the date of grant) and are exercisable through January 17, 2032. The fair value of the options at the date of grant amounted to approximately $5,000, and will be recognized during the years 2022 and 2023.</span></p></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2021, the Company did not grant any options from the 2021 Equity Omnibus Plan for employees, directors and consultants (as the Plan was not in existence during that period).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D. Stock Options</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The stock option transactions since January 1, 2022 are shown in the table below:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number of<br/> shares</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,741,750</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.64</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Changes during 2022 to:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted to employees, officers, directors and others</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,100,000</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expired/Cancelled/Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-33"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-34"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(50,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,791,750</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.49</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercisable, March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,551,750</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.60</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about stock options outstanding as of March 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="15" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares underlying outstanding options (non-vested)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="14" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares underlying outstanding options (fully vested)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Range of<br/> exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number<br/> outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> remaining<br/> contractual<br/> life (years)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Range of<br/> exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number<br/> Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> remaining<br/> contractual<br/> life (years)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.81</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.62</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.77</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.17</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">130,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-44"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-45"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.04</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-51"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-52"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.50</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-55"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-60"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-61"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.91</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-63"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.77</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.46</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">205,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.63</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-79"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.14</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">355,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.80</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-100"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">340,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.69</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-101"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.69</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-104"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.18</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.67</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.18</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,510,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.27</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-127"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,400,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-128"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-129"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,800,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.14</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-131"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-132"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-133"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">350,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">600,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-139"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.33</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.07</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.33</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-140"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-142"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.38</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">105,307</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.38</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-143"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-144"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-145"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.55</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.18</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.55</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-146"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-147"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-148"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">405,943</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.51</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-149"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-150"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-151"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">218,500</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.72</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-152"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-153"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-154"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.27</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-155"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-156"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.43</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-160"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.31</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.31</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.26</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14-0.15 </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,240,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01-4.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,551,750</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.60</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted to employees</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the<br/> three months ended<br/> March 31,</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average fair value of underlying stock at grant date</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yields</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-164">—</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-165">—</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>127%-133</b></span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121%-143</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rates</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.37%-1.55</b></span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16%-0.38</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected lives (in years)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.00-5.50</b></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.00-5.00</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average grant date fair value</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.13</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.77</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted to non-employees</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the<br/> three months ended<br/> March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average fair value of underlying stock at grant date</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-166">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yields</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-167">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-168">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">103</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-169">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rates</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-170">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected lives (in years)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average grant date fair value</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-171">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the options.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expected life represents the weighted average period of time that options granted are expected to be outstanding. The expected life of the options granted to employees and directors is calculated based on the Simplified Method as allowed under Staff Accounting Bulletin No. 110 (“SAB 110”), giving consideration to the contractual term of the options and their vesting schedules, as the Company does not have sufficient historical exercise data at this time. The expected life of the option granted to non-employees equals their contractual term. In the case of an extension of the option life, the calculation was made on the basis of the extended life.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E. Compensation Cost for Warrant and Option Issuances</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the three months ended March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 48%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">214</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 47%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">821</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the three months ended March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 48%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 47%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-172"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and capitalized to Unproved Oil &amp; Gas properties:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the three months ended March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 48%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 47%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-173"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, there was $325,000 of unrecognized compensation cost, related to non-vested stock options granted under the Company’s various stock option plans. That cost is expected to be recognized during the remaining periods of 2022 and 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F. Dividend Reinvestment and Stock Purchase Plan (“DSPP”)</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 13, 2014 Zion filed a registration statement on Form S-3 that is part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018, at a per share exercise price of $1.00.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May 2, 2017, any outstanding ZNWAB warrants expired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May 2, 2018, any outstanding ZNWAC warrants expired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020 to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.” </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020.</span></p><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"/><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. </p><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"/><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program.</p><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G. Subscription Rights Offering</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer &amp; Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2018 Subscription Rights Offering terminated on May 31, 2018. The Company raised net proceeds of approximately $3,038,000, from the subscription of Rights, after deducting fees and expenses of $243,000 incurred in connection with the rights offering.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H. Warrant Table</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants balances at December 31, 2021 and transactions since January 1, 2022 are shown in the table below:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Warrants</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Exercise<br/> Price</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrant<br/> Termination Date</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Outstanding Balance, 12/31/2021</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrants<br/> Issued</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrants<br/> Exercised</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrants<br/> Expired</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Outstanding Balance, 03/31/2022</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 12%"><span style="font-size: 10pt">ZNWAA</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 10%; text-align: right"><span style="font-size: 10pt">2.00</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span style="font-size: 10pt">01/31/2023</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right"><span style="font-size: 10pt">1,498,804</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-174"><span style="font-size: 10pt">-</span></div></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175"><span style="font-size: 10pt">-</span></div></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176"><span style="font-size: 10pt">-</span></div></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">1,498,804</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAD</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">05/02/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">243,853</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">243,853</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAE</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">05/01/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">2,144,099</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">2,144,099</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAF</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">08/14/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">359,435</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">359,435</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAG</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">01/08/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">240,068</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">240,068</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAH</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">5.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">04/19/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">372,400</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-190"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">372,400</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAI</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">3.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">06/29/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">640,730</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-192"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-193"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">640,730</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAJ</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">10/29/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">545,900</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-195"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-197"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">545,900</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAK</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.01</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">02/25/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">431,655</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-198"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">(1,750</span></td> <td><span style="font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">429,905</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAL</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">2.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">08/26/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">517,875</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-199"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-200"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">517,875</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAM</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">07/15/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">4,376,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-202"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-204"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">4,376,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAN</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">05/16/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">267,660</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-205"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-207"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">267,660</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAO</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.25</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">06/12/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">174,970</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-209"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-210"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">174,970</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAP</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.25</span></td> <td> </td> <td> </td> <td style="text-align: center"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">06/02/2023</p></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">439,916</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-211"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-212"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-213"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">439,916</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">ZNWAR</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">$</span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 10pt">0.25</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt">06/23/2023</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,020,000</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-214"><span style="font-size: 10pt">-</span></div></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-215"><span style="font-size: 10pt">-</span></div></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-216"><span style="font-size: 10pt">-</span></div></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,020,000</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Outstanding warrants</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">13,273,365</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">(1,750</span></td> <td style="padding-bottom: 4pt"><span style="font-size: 10pt">)</span></td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">13,271,615</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I. Warrant Descriptions</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The price and the expiration dates for the series of warrants to investors are as follows *:</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Period of Grant</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration Date</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAA Warrants</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2013 – December 2014</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2023</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAD Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2015 – March 2016</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 02, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAE Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2016 – March 2017</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 01, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAF Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2017 – July 2017</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 14, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAG Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2017 – December 2017</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 08, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAH Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2018</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 19, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAI Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2018 – May 2018</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 29, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAJ Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2018 – September 2018</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 29, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAK Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 2018 – January 2019</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 25, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAL Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2019 – August 2019</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 26, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAM Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2021 – March 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 15, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAN Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May – June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 16, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAO Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 12, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAP Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 03, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAQ Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 6, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAR Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 23, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ZNWAS Warrants</td> <td> </td> <td style="text-align: center">F</td> <td> </td> <td style="text-align: center">August 2021 – March 2022</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td style="text-align: center">December 31, 2023</td> <td> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zion’s ZNWAB Warrants expired on May 2, 2017, and the ZNWAC Warrants expired on May 2, 2018</span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">A</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On December 4, 2018, the Company extended the termination date of the Warrants by one (1) year.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-size: 10pt">B</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On May 29, 2019, the Company extended the termination date of the Warrants by one (1) year.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-size: 10pt">C</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On September 15, 2020, the Company extended the termination date of the Warrants by two (2) years.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-size: 10pt">D</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On March 21, 2022, the Company extended the termination date of the Warrants by one (1) year.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-size: 10pt">E</span></td> <td style="text-align: justify"><span style="font-size: 10pt">These warrants were issued on May 5, 2022.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">F</td> <td style="text-align: justify">These warrants will be exercisable beginning on November 15, 2023 and terminate on December 31, 2023. These warrants will be issued in November 2023.</td></tr> </table> 0.01 400000000 800000000 600000 0.915 The options vested upon grant and are exercisable through January 4, 2031. 456000 75000 0.01 68000 350000 0.915 The options vested upon grant and are exercisable through January 4, 2027. 252000 50000 0.01 45000 38000000 P10Y 175000 0.1529 The options vested upon grant and are exercisable through January 4, 2032. 22000 25000 The fair value of the options at the date of grant amounted to approximately $4,000. 300000 0.01 39000 200000 0.01 29000 1600000 0.1529 The options vest on January 5, 2023 (one year from the date of grant) and are exercisable through January 5, 2032. 209000 1400000 0.1529 182000 160000 0.01 The options vested upon grant and are exercisable through January 17, 2032 23000 200000 0.14 26000 40000 0.14 5000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number of<br/> shares</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,741,750</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.64</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Changes during 2022 to:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted to employees, officers, directors and others</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,100,000</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expired/Cancelled/Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-33"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-34"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(50,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,791,750</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.49</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercisable, March 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,551,750</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.60</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 9741750 0.64 4100000 0.13 50000 0.01 13791750 0.49 10551750 0.6 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="15" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares underlying outstanding options (non-vested)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="14" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares underlying outstanding options (fully vested)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Range of<br/> exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number<br/> outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> remaining<br/> contractual<br/> life (years)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Range of<br/> exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number<br/> Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> remaining<br/> contractual<br/> life (years)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise<br/> price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.81</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.62</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.77</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.17</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">130,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-44"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-45"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.04</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-51"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-52"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.50</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-55"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-60"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-61"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.91</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-63"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.77</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.46</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">205,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.63</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-79"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.14</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">355,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.80</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-100"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">340,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.69</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-101"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.69</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.16</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-104"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.18</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.67</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.18</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.25</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.42</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.28</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.29</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,510,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.27</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-127"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,400,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-128"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-129"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,800,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.14</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-131"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-132"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-133"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">350,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">600,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-139"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.33</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.07</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.33</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-140"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-142"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.38</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">105,307</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.38</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-143"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-144"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-145"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.55</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.18</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.55</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-146"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-147"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-148"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">405,943</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.51</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-149"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-150"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-151"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">218,500</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.72</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-152"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-153"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-154"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.27</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-155"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-156"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.43</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-160"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.31</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.76</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.31</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.26</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14-0.15 </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,240,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01-4.15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,551,750</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.60</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.14 240000 P9Y9M21D 0.14 0.01 10000 P1Y7M13D 0.01 0.15 3000000 P9Y9M7D 0.15 0.01 5000 P2Y2M12D 0.01 0.01 20000 P4Y2M1D 0.01 0.01 130000 P4Y9M 0.01 0.01 50000 P4Y9M3D 0.01 0.01 60000 P5Y14D 0.01 0.01 200000 P5Y1M17D 0.01 0.01 40000 P5Y6M 0.01 0.01 85000 P5Y9M 0.01 0.01 25000 P5Y9M3D 0.01 0.01 30000 P5Y10M28D 0.01 0.01 4000 P6Y3D 0.01 0.01 25000 P6Y9M7D 0.01 0.01 85000 P7Y5M15D 0.01 0.01 205000 P7Y7M17D 0.01 0.01 35000 P7Y9M3D 0.01 0.01 75000 P8Y9M3D 0.01 0.01 200000 P9Y1M20D 0.01 0.01 355000 P9Y3M14D 0.01 0.01 10000 P9Y5M1D 0.01 0.01 500000 P9Y9M3D 0.01 0.01 110000 P9Y9M18D 0.01 0.15 200000 P9Y9M3D 0.15 0.16 340000 P7Y8M8D 0.16 0.16 75000 P3Y8M8D 0.16 0.18 25000 P3Y8M1D 0.18 0.25 50000 P9Y5M1D 0.25 0.25 363000 P9Y5M1D 0.25 0.28 25000 P3Y5M1D 0.28 0.28 25000 P7Y5M1D 0.28 0.29 25000 P5Y2M12D 0.29 0.39 1510000 P9Y3M7D 0.39 0.59 1400000 P5Y1M17D 0.59 0.59 1800000 P9Y1M20D 0.59 0.92 350000 P4Y9M3D 0.92 0.92 600000 P8Y9M3D 0.92 1.33 25000 P1Y25D 1.33 1.38 105307 P2Y9M3D 1.38 1.55 200000 P0Y2M4D 1.55 1.67 405943 P2Y6M3D 1.67 1.7 218500 P0Y8M19D 1.7 1.75 250000 P1Y3M7D 1.75 1.78 25000 P2Y5M4D 1.78 2.31 250000 P1Y9M3D 2.31 4.15 25000 P2Y3M3D 4.15 0.14 0.15 3240000 0.15 0.01 4.15 10551750 0.6 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the<br/> three months ended<br/> March 31,</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average fair value of underlying stock at grant date</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.92</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yields</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-164">—</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-165">—</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>127%-133</b></span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121%-143</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rates</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.37%-1.55</b></span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16%-0.38</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected lives (in years)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.00-5.50</b></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.00-5.00</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average grant date fair value</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.13</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.77</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the<br/> three months ended<br/> March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average fair value of underlying stock at grant date</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-166">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yields</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-167">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-168">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">103</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-169">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rates</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-170">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected lives (in years)</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average grant date fair value</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-171">—</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 0.15 0.92 1.27 1.33 1.21 1.43 0.0137 0.0155 0.0016 0.0038 P5Y P5Y6M P3Y P5Y 0.13 0.77 0.15 1.03 0.0178 P10Y 0.14 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the three months ended March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 48%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">214</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 47%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">821</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the three months ended March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 48%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 47%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-172"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For the three months ended March 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 48%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 47%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-173"><span style="font-family: Times New Roman, Times, Serif">—</span></div></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 214000 821000 1000 7000 325000 The ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018, at a per share exercise price of $1.00.  As of May 2, 2017, any outstanding ZNWAB warrants expired.  As of May 2, 2018, any outstanding ZNWAC warrants expired.  On May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020 to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.” The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $10. The warrant is referred to as “ZNWAE.” The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. The ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of $1.00.  On May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one (1) year from the expiration date of May 1, 2020 to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share at the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company may, in its sole discretion, accelerate the termination of the warrant upon providing 60 days advanced notice to the warrant holders. On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. 5 On May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAF.” All ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise price of $1.00. On May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  1 On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.”  The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. 5 An Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants to purchase Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $1.00 per share. The warrant is referred to as “ZNWAG.” The warrants became exercisable on January 8, 2018 and continue to be exercisable through January 8, 2023 at a per share exercise price of $1.00. The warrant terms provide that if the Company’s Common Stock trades above $5.00 per share as the closing price for 15 consecutive trading days at any time prior to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing 60 days advanced notice to the warrant holders. On February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.” The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  1 5 The unit offering consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $5.00. The warrant is referred to as “ZNWAH.”The warrants became exercisable on April 19, 2018 and continued to be exercisable through April 19, 2020 at a per share exercise price of $5.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of April 19, 2019 to April 19, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  5 On May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one (1) year from the expiration date of April 19, 2020 to April 19, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 19, 2021 to April 19, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.On August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAJ.” The warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price of $1.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of October 29, 2019 to October 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. 1 On May 29, 2019, the Company extended the termination date of the ZNWAJ Warrant by one (1) year from the expiration date of October 29, 2020 to October 29, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On December 10, 2018, the Company initiated another unit offering, and it terminated on January 23, 2019. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.” The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. The offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) is comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional two hundred and fifty (250) shares of Common Stock at a per share exercise price of $0.01. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that are acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.01. The warrant is referred to as “ZNWAK.”The warrants became exercisable on February 25, 2019 and continued to be exercisable through February 25, 2020 at a per share exercise price of $0.01. On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  0.01 On May 29, 2019, the Company extended the termination date of the ZNWAK Warrant by one (1) year from the expiration date of February 25, 2020 to February 25, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. On September 15, 2020, the Company extended the termination date of the ZNWAK Warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On April 24, 2019, the Company initiated another unit offering and it terminated on June 26, 2019, after the Company, on June 5, 2019, extended the termination date of the unit offering. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) two hundred and fifty (250) shares of Common Stock and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $2.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional twenty-five (25) warrants at an exercise price of $2.00 during this Unit Option Program. The twenty-five (25) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were entitled to the additional twenty-five (25) warrants once, if they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $2.00. The warrant is referred to as “ZNWAL.” The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00. On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  The warrants became exercisable on August 26, 2019 and continued to be exercisable through August 26, 2021 at a per share exercise price of $2.00.  On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022 at a per share exercise price of $1.00. On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. 1 1 On March 21, 2022, the Company extended the termination date of the ZNWAM Warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. On February 1, 2021, the Company initiated a unit offering and it terminated on March 17, 2021.  The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional twenty-five (25) shares of Common Stock at a per share exercise price of $1.00. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional ten (10) warrants at an exercise price of $1.00 during this Unit Option Program. The ten (10) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional ten (10) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant is referred to as “ZNWAN.” The warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021. The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  On April 12, 2021, the Company initiated a unit offering and it terminated on May 12, 2021.  The unit offering consisted of Units of the Company’s securities where each Unit (priced at $250.00 each) was comprised of (i) the number of Common Stock shares represented by the high-low average on the purchase date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $.25. The investor’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants acquired under the Units purchased. For Plan participants who enrolled into the unit offering with the purchase of at least one Unit or who enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, received an additional fifty (50) warrants at an exercise price of $.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program. Existing subscribers to the AMI were also entitled to the additional fifty (50) warrants once, provided that they purchased at least one (1) unit during the Unit program. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant is referred to as “ZNWAO.” The warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of units of shares and warrants to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25. On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”  0.25 0.25 the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued on May 5, 2022 and are exercisable through July 6, 2022 at a per share exercise price of $.25. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program.On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 in equity issuance costs to an outside party related to this waiver program. the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet to a participant. After conclusion of the program on September 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting ofunits of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQX or any other stock market or trading market. The warrants will be exercisable on November 15, 2023 and continue to be exercisable through December 31, 2023 at a per share exercise price of $1.00. During 2021, two participants who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 67% of the cash raised through the DSPP. During the three months ended March 31, 2022, one participant in the “Request for Waiver” aspect of the DSPP contributed approximately 85% of the cash raised through the DSPP. On December 9, 2019 Zion filed an Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235299) solely for the purpose of re-filing a revised Exhibit 5.1 to the Registration Statement. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly, such prospectus has not been included herein. On December 10, 2021 Zion filed an Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-235299) for the purpose of converting the existing Form S-1 to the Registration Statement on Form S-3. This Amendment No. 1 does not modify any provision of the prospectus that forms a part of the Registration Statement and accordingly such prospectus has not been included herein. For the three months ended March 31, 2022, and 2021, approximately $11,427,000, and $2,849,000 were raised under the DSPP program, respectively. The company raised approximately $2,585,000 from the period April 1, 2022 through May 6, 2022, under the DSPP program. The warrants represented by the company notation ZNWAA are tradeable on the OTCQX market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-K, are not tradeable and are used internally for classification and accounting purposes only. G. Subscription Rights Offering On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.” The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020. On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021. On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. 11427000 2849000 2585000 0.01 5 3 3 On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.  Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.  3038000 243000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Warrants</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Exercise<br/> Price</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrant<br/> Termination Date</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Outstanding Balance, 12/31/2021</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrants<br/> Issued</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrants<br/> Exercised</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Warrants<br/> Expired</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Outstanding Balance, 03/31/2022</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 12%"><span style="font-size: 10pt">ZNWAA</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 10%; text-align: right"><span style="font-size: 10pt">2.00</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span style="font-size: 10pt">01/31/2023</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right"><span style="font-size: 10pt">1,498,804</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-174"><span style="font-size: 10pt">-</span></div></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175"><span style="font-size: 10pt">-</span></div></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176"><span style="font-size: 10pt">-</span></div></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">1,498,804</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAD</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">05/02/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">243,853</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">243,853</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAE</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">05/01/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">2,144,099</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">2,144,099</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAF</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">08/14/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">359,435</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">359,435</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAG</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">01/08/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">240,068</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">240,068</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAH</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">5.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">04/19/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">372,400</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-190"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">372,400</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAI</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">3.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">06/29/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">640,730</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-192"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-193"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">640,730</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAJ</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">10/29/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">545,900</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-195"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-197"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">545,900</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAK</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.01</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">02/25/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">431,655</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-198"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">(1,750</span></td> <td><span style="font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">429,905</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAL</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">2.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">08/26/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">517,875</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-199"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-200"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">517,875</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAM</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">07/15/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">4,376,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-202"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-204"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">4,376,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAN</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">1.00</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">05/16/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">267,660</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-205"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-207"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">267,660</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">ZNWAO</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.25</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">06/12/2023</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">174,970</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-209"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-210"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">174,970</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">ZNWAP</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.25</span></td> <td> </td> <td> </td> <td style="text-align: center"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">06/02/2023</p></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">439,916</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-211"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-212"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-213"><span style="font-size: 10pt">-</span></div></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">439,916</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">ZNWAR</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">$</span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 10pt">0.25</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt">06/23/2023</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,020,000</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-214"><span style="font-size: 10pt">-</span></div></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-215"><span style="font-size: 10pt">-</span></div></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-216"><span style="font-size: 10pt">-</span></div></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt">1,020,000</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 9pt; text-indent: -9pt"><span style="font-size: 10pt">Outstanding warrants</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">13,273,365</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">(1,750</span></td> <td style="padding-bottom: 4pt"><span style="font-size: 10pt">)</span></td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">-</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">13,271,615</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 2 2023-01-31 1498804 1498804 1 2023-05-02 243853 243853 1 2023-05-01 2144099 2144099 1 2023-08-14 359435 359435 1 2023-01-08 240068 240068 5 2023-04-19 372400 372400 3 2023-06-29 640730 640730 1 2023-10-29 545900 545900 0.01 2023-02-25 431655 -1750 429905 2 2023-08-26 517875 517875 1 2023-07-15 4376000 4376000 1 2023-05-16 267660 267660 0.25 2023-06-12 174970 174970 0.25 2023-06-02 439916 439916 0.25 2023-06-23 1020000 1020000 13273365 -1750 13271615 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Period of Grant</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration Date</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAA Warrants</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2013 – December 2014</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2023</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAD Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2015 – March 2016</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 02, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAE Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2016 – March 2017</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 01, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAF Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2017 – July 2017</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 14, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAG Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2017 – December 2017</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 08, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAH Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2018</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 19, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAI Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A,B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2018 – May 2018</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 29, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAJ Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2018 – September 2018</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 29, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAK Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B,C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 2018 – January 2019</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 25, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAL Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2019 – August 2019</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 26, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAM Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2021 – March 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 15, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAN Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May – June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 16, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAO Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 12, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAP Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 03, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAQ Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 6, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZNWAR Warrants</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 23, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>ZNWAS Warrants</td> <td> </td> <td style="text-align: center">F</td> <td> </td> <td style="text-align: center">August 2021 – March 2022</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td style="text-align: center">December 31, 2023</td> <td> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> B,C March 2013 – December 2014 2 January 31, 2023 A,B,C January 2015 – March 2016 1 May 02, 2023 B,C November 2016 – March 2017 1 May 01, 2023 A,B,C May 2017 – July 2017 1 August 14, 2023 C October 2017 – December 2017 1 January 08, 2023 A,B,C February 2018 5 April 19, 2023 A,B,C April 2018 – May 2018 3 June 29, 2023 B,C August 2018 – September 2018 1 October 29, 2023 B,C December 2018 – January 2019 0.01 February 25, 2023 C July 2019 – August 2019 2 August 26, 2023 D January 2021 – March 2021 1 July 15, 2023 May – June 2021 1 May 16, 2023 June 2021 0.25 June 12, 2023 D June 2021 0.25 June 03, 2023 E June 2021 0.25 July 6, 2022 D June 2021 0.25 June 23, 2023 F August 2021 – March 2022 1 December 31, 2023 <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 - Unproved Oil and Gas Properties, Full Cost Method</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unproved oil and gas properties, under the full cost method, are comprised as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,<br/> 2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Excluded from amortization base:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Drilling costs, and other operational related costs</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,703</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,075</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized salary costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,210</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,158</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized interest costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,418</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,418</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Legal and seismic costs, license fees and other preparation costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,729</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,260</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,099</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,950</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in Unproved oil and gas properties during the three months ended March 31, 2022 and 2021 are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Excluded from amortization base:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Drilling costs, and other operational related costs</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">628</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,002</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized salary costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized interest costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Legal and seismic costs, license fees and other preparation costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">469</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,034</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-219"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*1,149</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*8,176</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif; width: 0in"/><td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inclusive of non-cash amounts of approximately $1,137,000, and $2,442,000 during the three months ended March 31, 2022, and 2021, respectively</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,<br/> 2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Excluded from amortization base:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Drilling costs, and other operational related costs</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,703</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,075</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized salary costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,210</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,158</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized interest costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,418</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,418</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Legal and seismic costs, license fees and other preparation costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,729</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,260</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,099</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,950</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 32703000 32075000 2210000 2158000 1418000 1418000 11729000 11260000 39000 39000 48099000 46950000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Excluded from amortization base:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Drilling costs, and other operational related costs</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">628</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,002</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized salary costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized interest costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Legal and seismic costs, license fees and other preparation costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">469</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,034</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other costs</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-219"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*1,149</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*8,176</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif; width: 0in"/><td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inclusive of non-cash amounts of approximately $1,137,000, and $2,442,000 during the three months ended March 31, 2022, and 2021, respectively</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 628000 7002000 52000 61000 79000 469000 1034000 1149000 8176000 1137000 2442000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 - Right of use leases assets and lease obligations</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a lessee in several non-cancellable operating leases, primarily for transportation and office space.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below presents the operating lease assets and liabilities recognized on the balance sheets as of March 31, 2022 and December 31, 2021: </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December 31,<br/> 2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease assets</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">263</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">327</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liabilities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current operating lease liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">203</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current operating lease liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">129</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">372</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of March 31, 2022 are:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining lease term (years)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.75</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.9</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of March 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">142</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">158</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-220"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-221"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-222"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total undiscounted future minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">313</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: portion representing imputed interest</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total undiscounted future minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease costs were $68,000 and $63,000 for the three months ended March 31, 2022, and 2021, respectively. Operating lease costs are included within general and administrative expenses on the statements of income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash paid for amounts included in the measurement of operating lease liabilities was $72,000 and $71,000 for the three months ended March 31, 2022, and 2021, respectively, and this amount is included in operating activities in the statements of cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets obtained in exchange for new operating lease liabilities were $<span style="-sec-ix-hidden: hidden-fact-223">nil</span> and $<span style="-sec-ix-hidden: hidden-fact-224">nil</span> for the three months ended March 31, 2022, and 2021, respectively.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December 31,<br/> 2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease assets</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">263</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">327</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liabilities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current operating lease liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">203</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current operating lease liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">129</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">372</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 263000 327000 169000 203000 129000 169000 298000 372000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">March 31,<br/> 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining lease term (years)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.75</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.9</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> P1Y9M 0.059 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">US$ thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">142</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">158</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-220"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-221"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-222"><span style="font-family: Times New Roman, Times, Serif">-</span></div></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total undiscounted future minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">313</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: portion representing imputed interest</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total undiscounted future minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 142000 158000 13000 313000 15000 298000 68000 63000 72000 71000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 - Commitments and Contingencies</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. Securities and Exchange Commission (“SEC”) Investigation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As previously disclosed by the Company, on June 21, 2018, the Fort Worth Regional Office of the SEC informed Zion that it was conducting a formal, non-public investigation and asked that we provide certain information and documents in connection with its investigation. Since that date, we have fully cooperated with the SEC on an on-going basis in connection with its investigation. Investigations of this nature are inherently uncertain and their results cannot be predicted with certainty. Regardless of the outcome, an SEC investigation could have an adverse impact on us because of legal costs, diversion of management resources, and other factors. The investigation could also result in reputational harm to Zion and may have a material adverse effect on Zion’s current and future business and exploratory activities and its ability to raise capital to continue our oil and gas exploratory activities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. Litigation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is not subject to any litigation at the present time. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C. Recent Market Conditions – Coronavirus Pandemic</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic has significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments react to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. As of the date of this report, many of our employees are working from home. However, while there are various uncertainties to navigate, the Company’s business activities are continuing. The situation is rapidly changing and additional impacts to the business may arise that we are not aware of currently. We cannot predict whether, when or the manner in which the conditions surrounding COVID-19 will change including the timing of lifting any restrictions or work from home arrangements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The full extent of COVID-19’s impact on our operations and financial performance depends on future developments that are uncertain and unpredictable, including the duration and spread of the pandemic, its impact on capital and financial markets and any new information that may emerge concerning the severity of the virus, its spread to other regions as well as the actions taken to contain it, among others.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D. Environmental and Onshore Licensing Regulatory Matters</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, and December 31, 2021, the Company accrued $<span style="-sec-ix-hidden: hidden-fact-225">nil</span> and $<span style="-sec-ix-hidden: hidden-fact-226">nil</span> for license regulatory matters.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E. Bank Guarantees</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $1,186,000) and others (approximately $82,000) with respect to its drilling operation in an aggregate amount of approximately $1,268,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits – restricted.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F. Risks</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign Currency Exchange Rate Risks.</i> A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2022 through March 31, 2022, the USD has fluctuated by approximately 2.1% against the NIS (the USD strengthened relative to the NIS). By contrast, during the period January 1, 2021 through December 31, 2021, the USD fluctuated by approximately 3.3% against the NIS (the USD weakened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest Rate Risk. </i>Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2022, we had cash, cash equivalents and short-term bank deposits of approximately $9,490,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2022, exclusive of funds at US banks that earn no interest, was approximately 0.52%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.</span></p> 1186000 82000 1268000 A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2022 through March 31, 2022, the USD has fluctuated by approximately 2.1% against the NIS (the USD strengthened relative to the NIS). By contrast, during the period January 1, 2021 through December 31, 2021, the USD fluctuated by approximately 3.3% against the NIS (the USD weakened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future. 9490000 0.0052 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 - Subsequent Events</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 29px; font-size: 10pt"><span style="font-size: 10pt">(i)</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Approximately $2,585,000 was collected through the Company’s DSPP program during the period April 1 through May 6, 2022.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.3in; text-align: left">(ii)</td><td style="text-align: justify">On April 1, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one board member, to purchase 25,000 shares of Common Stock at an exercise price of $0.1128 per share. The options vested upon grant and are exercisable through April 1, 2032. The fair value of the options at the date of grant amounted to approximately $2,410.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.3in; text-align: left">(iii)</td><td style="text-align: justify">On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to five senior officers and ten staff members to purchase 3,160,000 shares of Common Stock at an exercise price of $0.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2032. The fair value of the options at the date of grant amounted to approximately $387,660, and will be recognized during the years 2022 and 2023.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.3in; text-align: left">(iv)</td><td style="text-align: justify">On April 15. 2022, the Company granted options under the 2021 Omnibus Incentive Plan to five staff members, to purchase 290,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $39,594.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.3in; text-align: left">(v)</td><td style="text-align: justify">On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one senior officer member to purchase 400,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $54.612.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.3in; text-align: left">(vi)</td><td style="text-align: justify">On April 15. 2022, the Company granted options under the 2021 Omnibus Incentive Plan to one board member, to purchase 400,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through April 15, 2032. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $54,612.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.3in; text-align: left">(vii)   </td><td style="text-align: justify">On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to eight board members to purchase 3,200,000 shares of Common Stock at an exercise price of $.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $392,567.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.3in; text-align: left">(viii)</td><td style="text-align: justify">On April 15, 2022, the Company granted options under the 2021 Omnibus Incentive Plan to two consultants to purchase 50,000 shares of Common Stock at an exercise price of $.1451 per share. The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. The fair value of the options at the date of grant amounted to approximately $6,377.</td> </tr></table> (i)Approximately $2,585,000 was collected through the Company’s DSPP program during the period April 1 through May 6, 2022. 25000 0.1128 The options vested upon grant and are exercisable through April 1, 2032. 2410000 3160000 0.1451 The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2032. 387660000 290000 0.01 39594000 400000 0.01 54612 400000 0.01 The options vested upon grant and are exercisable through April 15, 2032. The options vested upon grant and are exercisable through April 15, 2032. The options vested upon grant and are exercisable through April 15, 2032. 54612000 3200000 0.1451 The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. 392567000 50000 0.1451 The options vest on April 15, 2023 (in one year) and are exercisable through April 15, 2023. 6377000 ZNOG NONE false --12-31 Q1 0001131312 001-33228 Less than one thousand. These warrants will be exercisable beginning on November 15, 2023 and terminate on December 31, 2023. These warrants will be issued in November 2023. On May 29, 2019, the Company extended the termination date of the Warrants by one (1) year. These warrants were issued on May 5, 2022. On December 4, 2018, the Company extended the termination date of the Warrants by one (1) year. On March 21, 2022, the Company extended the termination date of the Warrants by one (1) year. On September 15, 2020, the Company extended the termination date of the Warrants by two (2) years. Inclusive of non-cash amounts of approximately $1,137,000, and $2,442,000 during the three months ended March 31, 2022, and 2021, respectively EXCEL 51 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

M2H0?C;._YFR>J67"UA/Q%L,0F7/'=0/'#02S3&2[_Z[^._IFC_WLV:NM\Q@?NZ+$#M 5()EY M:%J8F88_>U8/=0+BG!R_A ^F<'RL[6(YW#$L>-T/X"?LQ^#O;Q5^JR)!"@ G M846:A$2>?P8C_14*QX 1#L\8!=;"6$-10-JL?#4AVI);K=53]MK"[Q9MLYS8 M21JBS=NH.+'%:'-G[''0AZ$O/-ZVC#-V"ZJ?!,"MBWMMC$C$Z"V" G4ECO8_ M"1YM3_ ?E;8 ?1/&[1-@DXMMI8,H"0#YJ]I#=(P3YTXN=TQV%PB!9W(Q^@\G M6<+_7:UBO?,#?EYH%O>Q??XO,!9*=Y;-_L9[H(]\X?#XC6/LCS?#W@&&OI-2 M"H[P,B%C2I>QC'F()0N*ITM,@/YLNR\^>_\]$E,?MG[*&Q0[6]G5J^D7LF*4 MT#):V_*@&DB=[8,_^QZJ(A];'L'Y_"')P3KP=A=GPD@"U-^3[$. M<:OW\K=?7 ZR"[+:F46-.8'U_^"TB.6GL M^F\'4;+:>W9HLUX8[9V/Z!.+S%V,12Y^$%,&)C6L0VJ8JN\J/!Z@=P']]L]6 M8(D8?^:%0,J=QBB0IWQCYY_HBSLG&L[Q8IK;-!WU$]V,9XRB#F'Z)>XJ\?H (;#]W)Z8.]2XUFJE M7#W-#]\T,+TBT$2#[/E.8PG0+PSG5>[W%H=S>DCW1#A/!.K\5/J:!I>ENPL3 M[2%IB7KBK]#R9.DN3P! #0O,(4=1)GZ+?U.UKM G/VHJBSR=RLLFK'<2%LSD M<_,.F*/%9,N-YSOW*]&'([:X++>VE+R?3\9/@^=\+#4SCIJ$P93:AB>',ZE[ M"1ADA(^9L<4Y@764UD@O&^)8'Q.\=/T@6<+0HD(BJU4P?%LD]^FP01R9WD\=]U MKN#PK]39WWNB9X6]*<*HN3F*6*,PZG+G2:!R;0K/>H:-/PMF6[QMV58PV!6< M/BP 3F=G8U[%)_N%6PX:FG?.\#NP0" M2UA=..8$%!K%G,.C-?E[/NP."2X*T0E$>=B8[2C/GY#[XL(<#MKEW%8=(#%. M2(N[&#T("RY#0 TGF!\96EK>K0^:CH"HG%_MC!D2 M0#DGPO6+O5]."LH0E.YB("GDF0=MTM)[#FO:%LO!6@$A)?O$94"XW>MP:HT\,BC7P(Q3/.79OTLT>@>9>0F8>*[DQ^U9F1PVB M=8*Q=KB,&WU+QM"TPN3S4!\RGF0PP!SXLD#RF1ID=BWZ%2AWY<&W0]L(^*]# MN,^!ER>-F6@Y;[K=7*DG69SS^@YU^VQE\1.LE:O'L\-PY^XUD(G<7HFAW,Z3 MP*)93";9:YA>>>^YSY8IS-\'W^$ P)J*P'\10W^NE*OJR6Q-0O.:S!+DUGF4 M\T3I9L=QLLNPRFV@8*X6LXILF(.2YPY!'4O]MIQGX2^2^JV/,J=.J@OCK]#R MK2A[I.^AQ \&%#B'^:[]WEN\ZHR;5_$!Y?X^N@0G3]PK^&![[.#",:\C$$U) MLUA3'$]QC?IU0#&U3'2N'6,C=&5ZEFTCOP1@$VU%B5EOE\8PI6\(I+O.E0+1 M-^L)4.*;A,]<]/5F"6Q=(#PJ4,[,2O;M#>DM" PT;D,'Q-TS$*%KV4243]R/ M)*"V<]=-[$,I,#R%&^>[.H,[RP:4_<+]^QC^4_H&E%NMV1 ME:OUM^5+FV8T:1Z3N2_M)@+_0@Z81OGH9';-#LUJ-NI+6^XHC\JU^NSP-^U+ MTPZ8C?K25#\%[4LKO"\-V)0AA*G.5?P4GF%A&D$'!G:!CZKZ23FW]+-SIBGP M? ;H4)I3(L!09A5C&1$:.ZP3IO7 / MJT2]84U[(P1]HP[BKO,/!?#)V'A2;M9G!TZOHE.G [1PBO5&6,DB)U7 MMH;R)=+78]OWE67"VH.IBISF.EF;]Y\CZ*?;A*\YT-+.)\V!LK/L%SI%X$9S MA/IFS(VTS?[V##UD_^]-%4OZX M-QZ(ZTY'&%,N/1OEP\:::NH6[N)X^V+(.?U@:T?Y.]E:L]R: MHR)7(4W?9O9<36 =QA7X67,9=(:7F.F&;5NLGYDM,/8\*%_/'\:#C7RRN'75 M7#,G6_G@UW;*"Q_IUA2S*4T0RO7FXI[7IK:7M;V\BKW\$/;[ME E0GVC*\S0 MILL9([H+!]-94D>B.4R.P)JKQ6A:R\=BLJ6U-4:!K)4_\:5ED_NY0A7XKCA_WJ)WXFZ\BJE;AJ>U\JU M.2K+YP?/L[MT7"=4Z^5&:W9%E_Q)DTO>MT /MWZACV:L)QR08B#0A\-X +9E M.U2]XY9,D-HR<R)#F(YJ# (T# MFN^\!/]38_63(#EEM6H_8(]6#W#V5KRP;VZ/.V7Y19D]",_JG+$>]YXLIQ*X M_5-61:)07T2NP>JX:Q![M%J= 6S6[W-GY PZO&?9@]/I4PXWA._#EOK1-C:X M"4,@_UMZ#\H![@-CE0O<.W_LBA(WL 4R=P9H=P&EN,1 M?P%%!/"$ ^&!BEZ'8CD?76@ _D4Z]OU7XK8H$*0"< MA!7QOOZC4F&?+6&;I^R>/XDS&.FO4#@&C- Z8__#[1#'8I6*>I/(6KZ:(,OD M5FOUE+VV\+M95YY[8V!.["0-T>:"\-[(%J/-G;''01^&OO!XVS+.V"VP6PF M6Q?WVDR^=!"]15! &,;[GP2/MB?XCTI; (^'Y [K[+,)3N4EQP3J&5>3J_NU^J'EC*O*\=&J-:XW/ M 2P4_/;37GUO38M/$R=SR*=E]_8']XRNW&"C5O[8]@[DYNI5+,.S\NG,&QJE M,:GPF'0E#-%K"R\=F6J%1:;7G@O-R37]Y8_^OC_\1IL)NF[H@_[F%Y;B-/IH M],D9PUXAYF-S3%T9'T>M=VME\&@GTL[0*!PW%]> )9'-]"X;REQE1?D4E&IY M)^_2G?W+KB^S@.97D:Z+Q+?6TVI=K _GNO2=,]]P!5@.D8:VJD) ,3U3%J3L6#^Q>90+4X*VV .5Q?D!*-IW M?6LM@GJ#ZO02JULF V[[C&NY;+OOR6EGR6FM+H6YR&E2 MA9,BDE-ZN&R!PLQ6"XL\>KMAD8O&Z]RBO"SY83"O #UY=^W M/ @]@?E"U#49@%TQJO_&9_Y=VV,"M),^K#;P0O$JQ_/5F^-B9^78ZED":9UX MA@A5 OG,Y+XP.62XLS+[G?N6CU_>>\+'^BJD(^+%^Q<7TTP ,PWA.>/85E!X MO$:P@Q&D2A$>2>Q3*,9C/7HN? .3%<7/=)1<'J21!Z>Z+QTU>2!DP+N+_5(: MQJT!D?*PP71$2N)')JC4F(U*]>50*0] G:35E!EG5\+F+S(?Q.N[N1QERZI=+F56G?OS ++_$G9'$6_&S;T>3 MJAP\]F(%75A8U_(#UQL@EM?K;""X1^QTM!Y%\GW+83>^QX6]SR[H48J(9XU: MF6+@R[0RM:12%UYV7.:)9P'X$?4L 4T@N3HWQH)]35K+DE9S-FDU"DY:/6Z! M@+A_C(N.V[#)&R[8%V MV@7T[5B&H+I,8>;7,_B79?4QH M)B#:2]>U;9 6+PY\],.V;YD6O*4>COIO3Y=[Y1@M$X@.(\*+)3[2*;[\NDT\ M$0GL&X;$9'%?4@W,':U?":+T]3LNEKB9*,".%A MP;JQ-;-HS8!%@W@I4MC+O4NFX7H)SH,;4(U\7J^1\0 Q\H<(2@A$VB-I 8)J MVFN6LC1+:W[.K;S=>O-[=?(K6V8]E MCX2K^-)WAZH_D/_(9_?P7T7^C_%H=R2_]R4-O)Z,!BS% _[#]6R386T?VP;4 M#;G-5(F5 ;OSGKAC_8IUW!3)7T9^A;W" B08'/ /#N1BLHLG3XB8.<&0@6NX MH!_? *&:)I76*I>F+7&X9TF0UJLM)M1N37#+$MS1;()K%9?@/K9'!Z/I3&$H MF7$:.B;@L>6(O?/KH2@I?K MQK?:EFT%@Q(8-Y$6 J'ZZ@1 0"P''(!A'TR(0!0/ZT>4 WV\D6/F73'20_& MM-W8P*EA8+_K>D!JOANB9P\(ZD7X434ML&4X_OD%8&X+45:_Q_C"W- ;L3 Z MKA'Z# P&P=KP3M.X!,LE/4"0(K9A#_P ]&3X,/&6!:H/*AF)1?4=U'_L[A6@)8G^EIU M-M6?%)OJE9!@[PWW&1Y3MK3/>P++,7'$VS_^JU*M?9C. ^I5Q0-\ZV>E!Q-U M)>FG43A36!T3>6GX4DSE^^P.%"M@(S:KG] ,-66Z^V&[9P72O>)A)(X_M"\L MQ_(#Z9V_=H3W-'BUJG@"?&>4(=5K^R68] \^8(UJ-.6$88&0/0"8230>K0+G MFCX^;NH6WI-?GDR8I+30)!?A$Z &B^\3'KN6#RQ.LCOI= #N86,9^+[-#2%] MIM/X(_&JV!9-X +F9[NN9UH.FIB:L2S/6&IS7!)7B\U9D&W4A_XQP#U'\I ( MJ]N#2=2%[LD0,%912)7H)G)8MD:Y03\T*3TQD(RJ'@M!O*5[$;:]7YH625(_ M' \(^0IH?A]Z!N"_4.5GKX1O>!;]C;[?! DW1A;#'<<-'22Q9PO(!;0@E/"> ML*G;:]#E 2H!>*-H"V1@,7 (#K1Z7+'4;@(7N]^8HH^NR X[+!\V:JPGZ-;F M_?^K'9=KS5JI(T3P(;J;;*'WMHL>2X=U05- 5R1-2H/LOPI^T.2[+/G.$^.Q M9)!''L!Z4>J$@(:^('78% $GKYOD_SW ZBZ*'U!)00I0/P;5PI4Y(@0=U:E@ M=!M(>E2N'Z_%RU-48R!W])0,&"J\/&(]%;57]?+J/5%*S)"D+60:^ M%=JTFI>N!3@.JKB%<3"@^=+"F' ,D)+\"5?Q"XP&?#0J3K_/+F WZG90$IAJ M:S-Z30*'".MU\"X3EN0+ \[6+$67+T/ZW&?_$*S+8?^>J-#%H9+1PT?:+E7J M-6DDX'=/R F(TNGJP QE<+Y:Q[X4VB^N]P/O-8"#"4/5 P_X#T'6C0=ZTHL0 M/]ZRV)TG2OWX[4:IMW24>F[Q>S>BF'4@>K$WI0/1-W36>8A^7FLT.#J(G$ % M9"$6[!:L9J"_[Y=2D4M?0FV<2ZX1F><(FJVM%#6K MRO)/V K>ZXPT19G>\J0TO>4)HB9Y;5+T&6G=M85PT(>#T7-DF>+DGLE1J98N M%_@<.F1)]CVP@JV^#7M\$@Y::_8 ?Q=]7 F\^SI"!^:_($\,CZ]LOUQ2N%"+K NARW8<:7:P'&_B:?0IF%FL/ MRB58SH"9+L70J1I?C ^MY/%99/L9]$&3E=X>,%PJ+3%R9Z7WE<&@'AS0[5L. M#@;CP^F#KH\_ETLX)3?QA.GQ,AV@)8USU[')*>C@2FSL8AIZGFP_:W@AMWWF M" /,:G0*2C=_AUO><')\=[@F*EI#X8?2ER##]F,$+L7%1[&]-"QDB %1"31Y ML9B$3+(X6H 6_'_+L&I8]S=!P*QI"-K%.N*-T1W(!^G"++MR['\ZWISQ+S7E@QZS[.N=[E?>CO)HVDZWKIO%^8(=*X5 M.-(9+P>C!"/@[:'G2\'KA@')7BD@W(2=2HYTX/[I(?TRH^%9>)C81,YSQY>^ M#)/2G6)!+F6-%!@OG"*-5(=T8,FF: ?#%O>1+*&H"#Z,6Y )"^K2 ]01Z:2G M>4#\X]V?ARE7M"13] 51+ O[M."N)9XI52 1L@/2$G1 %("EQ+T S-0=F)YK M<*^->7ZO<;&@9[^M"[LY0IEK!8YE3I!4K/9%6 OX&4>MT5W:$S%K0S)K1-LQ M1'7;B,+1M71"QXZ( X>DZ&BZG.J$'FDR">(L2?1_%K:K;M=&B144)@M4: Q* MD<:2,J'/$/1%3(6-;OC\2/?MA'B^1+VO $+TBF;!<'!4 M]L9V3TJV"7R!&T3QE#NIWN34ZQNWWT/E-_D3L1U0:='+IA13TF5+"<4=EBW' M'%I \>+P(K 7F85!%[.\DL/LLP=I/,B?AD^#,8%_>!89G)2]!5PK**=9 J4Y M40)3H6!<"UY&_5KRPI%FHJDF2HK-C&QO;/ VNH7*)7F-2Z$88#YR:5UB;VD> M,4 %;(2?;0$DS/@7VY(;L41\[C(H"1,Y79 GY.AL8VH8H.X^NPKCP+;7^G]I M2C[VD,ESH(. @>5!YT,A+#\C%/YM@?;'A_/68[T5P5>8+>ISC%3QZ-YSQ+6X MV%KK58OY_=>EUE@/8TR4&=_EI@PH-<)>*#,%30&2R H6W59]B6U%$387P^DO M>F"3JD._$AV!P)8W$ (;0/M3]EH_W'_=S+FD=DLX"WC0H<1"P"UNP2P\HN@U:1ZK5/!^MO.'+^ DR>::8+7#NQJ-; HT,0]4 :3"@#?-ADXIJ MDG?T,"I3XETBGKT#@M./(^(3/RA-%*CT(-)&L5L\4H(O"UC(5X92LI0H!('H MCFFVL-$V^B^0>X8>.6HH HR\4P;O6QA3AIFVY U[3DA:E5"D*> MO-U0FZ,="K79510N>J2&#K8I]J9TL$W651\?AHZTB_@J]AX ;H#Z\ CO_6Z[ MQH]Y*T'.-UIQM=X)&'BQ,$S.&V;W++*QC*0(0MI;#WJ,'Y@/>QS+: M/+OB 7\S]+ ^Q_R"J-Y8CD+J>Q.<$?.30F%/$V/M#.EUM^P0+>7878G8ZQ/V M J_'VR9,F@M@WV4L",:>T8!;Q-=77\C5=TD3/N!\]]R[\TC-,SL_;"R)VZ/IDN4]TP$J,B8&]P .ELHY.;BX9+5 M6]5*K1H56XH0AMU'E+\?E5RZF@Q>*YDNZY.?VTA[3J75DKO"5Q[M^3W(U<4\ MK4 +A!'6LWC ^"ERK%S_E %#GSVWATZ;4,9FWG7&*>6BAU27>D#1T=0;Y5JS M66Y57_<,)7R"MNY*W)E.9R,J6QH-;UW1> :M'EW+Q*UNA;NZ=3_;Y? M^B[OY.)-:BTJ:XP_7 [CFRE:U%PX'MDU$TF@L(>,L03R1CN^@7X5B3O[EN*U MYC%W^+BZY"Y-#!]7D0)^(K" @A0P/&,8*D!15+X?]OHJ^('N/F7$!,/Z28$? M79N.OH2[E=7P!E1S-CD&U1>1\"")ZK^ZNA_>U7L4@2S,\D@8KUR&Q+&G1)3% MV-M1]K@*",9HL$3ZN8QI-T5<*@$43A=% MT,#&W1Z(6.$\6Y[K4(* 2O=/X'5;V!8@*[E/922][SIT2TDH*H>T/"/LX54_ M%@TNC50TIYM!7Q88GKS+%RS:BPN6/XT,"-AK( GNLQM;1J8P RMV175_88?/ M+F9?P)KDK6XY*CA>DILUU!VJD.5.U&LR@ :82MMRY,4I ,I3I4-$\G(2?L#K M7HH9G[$3ZCHP0N/X!.896)ZJ#H07PPZ&O++=#5)D30N&\)(1C<"WHOO5)-[NL\LN!ZQ6$3LC04PE.28B!+VJY WQU>1+ M(A5'XOMJ3W1L63=!/3T74U:PD4'W;Z:XPM;4DM9R:LGA).?.1&VDL,>'Z@:5 M7Z$J7R3()1.D&(N[_[FYJM1.&,QF"J0$C+8P+8SYLRF.&7-5U"<,X /AC)5) MHF"X"=E/Q#6&%(*)+T6U7WK<%.-AFR(> MO#-YIIK)Z1@7=1/R2 M(G9&(T5?\SHL7)QDZ1*5B*&GLG#-&[/EC4?+\<;6@DZ*.\N^<,POW+^/-5[I M$E_RCFC>\7;/L7&Y3_$95# !N,QP__35#<5/(UEK;T?6I'.\'.D9=!P5 M0PN;-[4\S)BH3Y8CZN/U$W5C6:(NL!UR8=NE!+8K ARCHZ33;-2M$ZF-9J1U MRO12FB.&BI2F1L-0P9X?*Q?>DTX?*$E [-?X-U,!>+>V=XP&^S MZ&4VUES<3&=A*W#MYEQS67.NP"W!TRIBI%ARU"9&ALNB:03:?F1 3;"?H@@% MY9_!:V85@SG,LQWJ^?A4J>^ZMK)^7EE1'B8.AT[20 IDC9+8=%()SI";1EH-^LRZYO:+VS1YUMD3 RWB- MQ#6=-K\R=G7%#8$69ZIKYXZ'RW+' C=TER5B2G.5B!S&=I?'@KN351!,BZJF M4@TQSR1NT0>^5$FP#$G2^EXU<^):-N>N-BGJ9 F:*NS17D:A!U0T.,9O*<3B MJ H*6(WKY=DB(=*I?'"D T@@HAB4\G1<)9D1FAG5!\;:?4GG=+*B2.RH7J P MTV*Y)U2:Z$;5ADIT@AXM650=+UG4/"Y73T[*U6KU=4();G5&%M8*R3+++KA5 M/CFL3E@P@7B\>*YCOBIZ.\8E-;?+FMLMF3]9JR\81_(9Y!BYF/\ A3J4,=$K M!9+,/>#N19)<[9=P]])ESQ+[UYDRV1/,DLEAM<9,W7MQ$HE4E66(J[#(D18_ MDG#)/00@5[AG^J MF'1 !.KW%P^7']AQO5J.$G'^ [MU]UGM\$BEK,AH MDBD8I/=@9";J.99L:"X?&2NS%E?M',:)3LBKP2M72_HVJ ."S.F.,G<2 M7XU6SY?+@DEG3;#/ -(E #05BW3@Y>&8%'7#L:9=-.!PDI$*IM)J0CT >S9B M4'#7 E41U ?RQ@Y=%H$PNHZ%S8Z'G=2I$"W5%(P*\%M./PPP\T158%8Q!6,; M[DDL@!U\'GY)WJ0.N9)4:' ?&) JE/[ M,WK<\3%>EL?P&E"C$(?1;2EZE_ 1I<^U1?""_AX92XSY]P'P%@ ?PESZM'I# MO*6RTF69S!'7+QV.5I+A E&R@\H@D^7]>AASQQ%L9 MKELK9EG+F253,FNS5,@4.:DG(FI 0\Z>VI )?SDGQCR)HPR\ & M8H&5R%*5DKO);B03^+&BX7&&3,60XRXV)5D(.9FEL,1PH$!5AHUQU)# $52( M?[*]B)0N%OIU+:J FV U,D=NN.LXH31I\6/5;TSC;J-A3S:^8L*4+!=7"U4Q M02X#IF7U /HRLDY2.@FD2PX/*2K9';-OI2Z<:N:5 M,?-:,G&KEI:YM2KS:B[-O%!EER7F#2"Z/M;?=9[(\X&? ?)&]'EA%'JQS*"+ MCU;?[6%TS\? 6WR09W1S&=R.T P0O.#*I>"H?EOT5NJB71THGZKH^>Q\Z4%.S<4=_[^VILP9+I^V)>UHM"W#XPQP+YBGJR?0)HP]JZ- M"@PIA\>XOR-R*U/_L1=GI+#._ PV6Q?$&=M5SKMD_F#(?=BP?M\P!5:FJN*\OUL8+L7M MTA^N*>RWU=ASSOZYN.)3F_,+=)OH:.23G#,6]);#C:E$QQU@N,Z M$AQ7AU/I.EOF2.8^UDP=A;ZF'P.X9'H8(/E$V+OR/3],(Q@56C MM_!9W-O<4:D)<[?!6GSHW8O'O=XO46^'"@&")2&A W(S;Y&U9#)*_P/L6WY<%D#R0I1TA.\B[]+60J_++)5?Z LN)*N>J MCW/264 5NKF?6"%!R7UQL,61U:=6TO(61_Z"K@R!Q:00M#(M=U\V(AJ%!.EQ MT:BPG*$7Y\GC477\L4GC%5-\KN$"A?V2H51&\D"C)..Y2VG'->A?N5XPAHL' MPQ']Y+R8+R;C5REBC9F4B*F.%# W7CZ])L\2=TW1TV;BL"UB'Y+:A=@'HN\&^#/3;!QT;FS7+7S)%LSXQ M17,U3E_84TZ&N,;^6F2F1/Z*?8Q0.G$THBD,)HVYB?0! ]F'=L!5^3Q.13FI MJWRRQEV4QH =21XNV6'UL')8+9>B;FJ2(4820BI4]PD&=@O37D?3QIW6$BYZ M'#A%#K 1.4 +&MV!I;A22640)(-G.Y+%"&0_\%S/)7:(0@ X@(R,11?W*7O/ M/]#+3R[&TR(@(XX390B7(!W14SSPKBW %'.-!EU.'"2?]TO17M=@P.5A4WDVX);,J*RG95320+,QO+ L[,8I MP18<(=E]+%>O+-1O009_$XD:3"B4I8UU'WJ@[8(^C0I,W 'UZN'^/NY\JO1T MM+(0>D]1(MYX&0C2TN'VEE1TY]A_UB9FN&& 1EMI+1' U#X M!7X+8'.=T9O3.#X#BZ/TPT &)6'.&II^>$UL#TJ@Y O1HU_:4B'ONC9V=Z(; M9[Q[E3DYEK1 G[V?QWJ_R8,!\PE?V'47XX0,] MO+-5E0_2DO7V682GD58EN[[]&3ICIXL_DTP>:\HKJUG)!!U54,,SL=V9O&E' M"I);YI0]&"T$CSU9J@L?,&4+%[#2,%NQ@BN1!3.BET;F54H*U<^2ANS(:0X7 M\BK'5-EU"5-NHHF%-KU48,RH1YJ"0QD+;\7=3JC>\MC+"=B2<0MKD< =H9RH M+UD2X6D#I.!A/?H!J%/2#T&G@XYSUBBSC]8YT97$,U^YQ)E47H&3GFMM*6NA ML61Z9+VYH+;T328JW_-$W9Y%=*:I[^^>YO1EOZ1V+!.6U]*\-0][R[,"M62V M77UBG[1YD;ZPO$WMK$3:@6JX*=T:E,P?%SM(*C^6JDW/H[:?J5'YY;BP(NHR ME%U/0AJ-:Y-CM:0^V!1\2NYDV1\-51@E=M4C0Y5 +6J?C5$; MX[;OQ@[K1)H_N8\C8:[>+I.:UHO;999+/8JH2_0GHS4'J P!H"VA^B9,'56V M0QL9..'QCM9).TFTJHLT,#XHF0(##CL$0'Q\$&V?/"K8'6&T@Z3E=&P9U233 M(>)9T1LO.Q*@>,'"9@1*5+CR=R="4ZFR*<- M^@_&Y,1E!:D%'8(W.P 65M2/MSQ$09A,]*.ZH<.T MU,ZM%&'-NK>#1N-:ERR0$%]T_&,?T5R8TJ\EX\_![?1ZL[42 VIHBMG$)E M\;N)YZ(A\,J/O!D4BNL8'KXMG5Y][@G'&*BPM1[ZZ%0]5MYS*8[WB3NJ_X"/ MM\I1$"H%_](XR6HJ]$6R_I6*(6MS&^\K2WY7Q.54L1RD+?B\]=%6JGZ4' M&/V,%A9E_7)Q<;^?A$>R\")>D\-[L";*5L:RM''<;++>; E++?(?:@G#T.#W MN-S1?0P^R MT&5.,C5;#:-O#MD^1KY.>B8H^RN:L5-&6KE?IE8$5X[9N^' M0<[D@+5ZL7\3_9CDVZ3RRO++#^ING^/EO3P83P2>&S4DD&GCW) Y[QA7!PAC MJGM_6&L?(^^"(/:_\DAY2FY)A1=:GH_5UJBO%.:9P^\G^Z!;$5CQ'H%&Z*8A M1D>&F>-U-]9BH;CK*V[;Z)P GL(E5L*7EUSX@.F\S&Y\CPN;]6U I&?N$4(E M1NNY@>N5GD77,NQAER[U 'F/J?74,*B@0QVW$#_']E:O8HEM3,>/&M_4D7[B MIE42O"DH)7'-<#WL_^!2C$C)D-U$QA%3=0EQ*A-^5]!7L0%^V,:^RM+5/V"V MRQUR;CL\JO9-H03H!2RK:M&*55BJB+-?&J^R:KK"3WC6&2;N>U0G 7B)@9<( M1!5M1"<@2NW7SE@9:"R92E>?W2]P:5G>7%49*'#_0*DBUZN5:B.1 I0HQW_3 MH\X]<5CW4$^X&89_*4&NB2=CXEDR@ZXQ.X-N:=P_7)5X"MQ>#C1I6>]&RE)2 MHT$S'M6(UT1;IZI/I7!,E7^ Z@E(SK"/#G,*D)!5S6&M@[*4SR#@A.>YU$Z@ M+*,Q0:/L60Y&0HQ-SDG=$,$@2O@(4'=7<9?RMIHF3>PJ#OC$8$$#O?8PCA*T MB9M_I1FBK(WT@$2J8)]Z3QE*F:'AU=*&"E!:>2.UODA-2P*VE#0C0)_Y(:(X MTQDF.E(U1Q)*XRJW MWP/5$J89)EZ2Q>1@_,RB*CDH@Q0_H%1G6'6TR83JG(S(Q4:I44NYN%6I I+2 MM>#/4JR$TP' 2U'_% PHD;BC5+*9N8E:5\M:W"R9O==(R]Y;D[AIK2IN"MRR M$<3-1?@$XTZ2-VF.F^\D'I+>E]AQ<^ON*]VO50;Z;P>2Y"]=YQF8%YG%P(CN M*/Q*9ECZ[/U#V";&RYI'U4J]^D%5>(O*J4GF]7=A G">*I<8#@:D3USZ&I86 M#$O6W;TX*@Z[-!STN'98:58_E)-[0=8EUQ18F#IPDRS8YF 5A\0D?,H\0];I M T>R5<.B>"+BD49BHF1^ WF6>L"2,7"*_TFQ7!0PAF"B!()$(K.*"%2R3KJ# M\');MNQ EP'%&B;G,A'\B0E++Y9MRQA'5>Z2L@/0Z6&+D:Y$L3Q4J9+#2#8^ M"D-D[Z9)>:+Q 7<$5/(5Y/*&CW@>)!8LJ6[BDTKM]]2E>4E)SA%S)+EI MP'USS)@9$H$;>I.TU+YJ'$A-)U>OGQ;R\L(BY0H<;;SATN*9#AW,L M"W"O1;VNPZ],!XAL7%)/:C$\2.^".9:TA_Y! :Z&8WN64_EX:>^U1?E.*U8 M1,0LRY-BE"6E&JL*K<-)J L>2MC?%./^[*D*=B.<&W-)3,"('K?]3WL5P%\J M3P<89_T,3IVP5S'=H**>&&?)-P[F9P-:75#K4E+.]AAZ+.&AUAX+'4M.$_I@ MFA[NMR)*C=9RSGJX2]#BJ1R.WRV/Q)(9Z%RA.\9 U?^D"U874\E1)33=%P<+ M!C$>S[_/_H%>(N635?4%'@1=K\Z Q'$2$M6Y $'51WJ>-< M^X;GO@"QH3ZPCLAR6+ M)5%*^V"(HVR.0& M30F_, X(H9QCS">?*K-4I(#XEO(% M>9J<0]9V$C2MY*T7)*J!$U*5IQ(5@^ZH@F*/'EZ51H?]]>MEF9!?OLV?L(Q& M7 +D%J,\R-%8C9 +^: O"TZ8$N5[84 7/S'6NV.%1OI"1L/RN+:G9-M8(X.J M>, @H1_[HF-/*C:^!XF.<>XJFB7)Q GU_XL["3*N*5$4N51E&8_7C"YJBW53 M:1R.C!G3PAC4"=I)OC=9>+G#11TKY^S.:H5YN>]9LGY0(ZU^T.IZ86,%O;# M^3,/%EZ3T#62]40$$W%=4Z:I@, 4<=)MK3K6#_I$H:B\.&G$M(_R#C)BNZ10CT5=!];:U*(8]&;%*5NG-70 MFF8(C-H2FAXH."-2[ZX3L9%O\/_E=#W5W=#':WGDJ,,^@?9@UA[J2^EHZ&0, MJ7QEK+%.EGJ'S0G"F]M FUS)LJ3F/8>P7F+=D;"F,)YHW< E'G!FK*[E3U%! MCM/%]L@6$A4IAY$G=-\H46^T+/;8?L?>4 T8^QB30H4@X]]M83ZA7%>UST&4 MAL%(; Q6@P*$$B )16]8^V@$NU/3F+30REAH+5EFH-'*1&@U5Q!:!<[SN $S M:ZS,/][4)R,?O-"62JRGRK,%1E=&1% 5.5N4XY)A9M*)2 %*TOR@WV%RX \O MLM^'D"0G99;E1]T#R%24'%"61(L;!#PFY>KX4Y0_%\4$D&U).XGT4$IF&\EX M'";PR:4!&TJN?;\DJZ\-*_''D2.VU8FYUFOU^7TD_NG]6/Y_*&,PUPP7=X)I M5WQAG(*B@(%9XPS[,]8+%E^Q%<$-F(_.$\8)7B UM8:['.Y9![8H3RV*4T1Z1JUK%L57<5/9/*NZ9>5=Q%-KB" MR=VVC)QE_>[ 5PW!PZ .AMEDN+VIU@K=$.$YBFK?*K([<+V5 X,C;9HK8F M^*U*%>)V.:UM#8;C.7A*MLS5,2FP63.TC!G:DM4]&K.K>RS#E%HK,+0"IX90 M"%/HJZCWSZ3QW#CJC[MP>,WT^>;S7>Q:[8F@ZQ(-CJ4*R.1Z9>,F^4\9FR,X M4K,::5KD*]HN#7TA40;#4 ]R14U#EH M.J8F[(P)N[EDIGYC=J;^,L1YM )A;SPX?8UV6U"R5*UPQPW$"^RQ.Y#$%R7' MQDY Y5(9^"1DE;.#;"E%B8E+44QV&2:51E=TL**P S(6)"=EJPH'&Z'0=+'# M$]NJ#14"K,/=#U +8K9X%C88'O>88*/RS^+L7B3QL \6A^"]Y'5U68K_D>5$ MWF1[E6@!*K-7\KJ0C*$1WF"6$R8CUAM608NQ/C(88 MJ?(;/+R:L@>:;V;--YV:TI>2&K) M1/3FDM%G>3B0C^V)+5^680+GZ,,LC01WRFP'$&,N^083=X:GKX^:[71WH&6Q M>BFDG-T&=$*'J@>C*\S0%G<=4"+1A>>& M%ZU/:G6 *G>A]Z#4!]0>DICSB PS63)9F36X;R;KP=_Z*&EU[HO4&21'@+ODJHJW%(\]8 MK6/),S?FBP,DT6HW M2&>#90+]V)MF-OD2 M_Z0MPD\D=C%YK3DM^=T'7VRZ6*?I1(T^4S:9 X@ZUGP?QJ&0E]G_?>9TGB&- M?E,F8HG41MW)?;F+?+\A_4AR5FGWPX)%D$P_,PL0MFSC_FQ8"USQ>K&(2",O M2"-=2Q52F#0_C*(7R92*MHVUJD=R5($<"8')Q4@ZZYCTUI$4D125GYOT^FXX MCB1/2+)$L@0Q-<.%-[569,A^)"VS0K[47Z-P.9LT^%Z'T4L6?1U=N:U.W6T/ZFZW^[QRDS)U@73= M[_<*U($69UXS5DPXJZ6((#"9$^?[XRCI(2,RTV)/AS=<&Y[LLG3 ^':'LG=7 M,C;;9=,=BY[#W$G,3YK<39Q'L[>?1+/7!]WADUAV3($S>GM)'XS6A][)]:'7 M:9,VD#88J0W]DVM#N^V2-I V&*D-I[\:ZH-VQVIU. Y^JPZ=H?/]T@,H9W.= MULK .O'1>6'+/YQL>PQ":A-YTRAF+Q($VD$?S;N@@D7HIQ3A/4YF!^!.]B#8UR'MNXK*88]BM%I M'5;GY.*6*,B)3F)=HLX"1)>TX3W..?[0=@+>+Z[ M%C(4=+Q?NH:<4$&?8P1.!&K*.$89LV?AH,S>-U,5Z=3D2-7*(/R\_Y=^' MD3CC"T=\&4/A*'&1E>CI40QL4E';5+3LC>;2C4;J0NIB(-2E"^UT>-ADSV3Z M\7$76=:-*Z;E892-(Y[.;)YN-Y'M5)"NU]_0>L9XPHX\/\8NX"GUQ3U]SD;; M0@<0:8NQ"WA*;3E]AE/'M= 91-IB[ *>4%LJN%KJ?1N#QW:$LKZ0!>1?K_?$ MV5=WW]+^ C^,\K48J6V;5SJY)Z__2Z/!W@?^=/*2??*^^J_X._ZS]&=C,8O. M*_9/T;&;_R=K--(?RE,F[X>0#;[X=L?=\/J>^*Q$#:25Y2@LY^:B2N4F79AC M-KM7[,OCG#_Z.O)&P?@5^\CU-5F!CZ&8J^,6?_4B^YEGD_,@VAM;;KHFB:_B:\ MYX][3 4L9O&=%_GI C!O/H]"T6Q<-,SCNCB;R)[?:8>]]9]>WR>="%;D*E65K*;)[\2PV@>1LFN\4,UZ_TI>_MQ #;R(]DE6 Q#]M8S MYTCV0[K>'V9R)O%U_O*-D\JFTVG);O:;.]JGF\4'OWO$W5..>+!CQ+7D2W7F MW][ZHC>DSWY>SGPV3.IH7DI'U=,=KVWMX]4]X#+//,)9K+0)^\)O^.MFS6TY M3GJ9BR.1CU+(H%P==B,C$]BGJ3=#N.A-F+-9LMC1EL6VO5?]6]GX-FF@*[K> M,=GU+M[8_;:^$D3 6@3C3!7]N3$CJ&J->%H31?\J%PHV:+H M]+3UI/OL-+UTUT/TRCUB0Z"I(=9\?C9#=AZ<,"V0M9]$%AVDAS*'!L'X22!<._28S(!V>E8Q"$:[X1T MO3T E!^B"7A/+6D^T3CXD\7^+ @%JW ;C"6K,9NDMT.\\&YOV;WLI, _%^8- M\__THW' EV8>\:^+9^YF&CHKY9;+>93S11+C_B3>4XI1&#I/HY1$T^)D_DVV MBYX5>[GAY3_RA9^\*5PPUQ&_"+]*/;*.N(_; G6O MTG],//K6"S+&)Z6=LI>E1,HD99;2]]V+AN@)DR+9JS_YNB_\Z>.^7=00==' MO>0:CM;7,-7%G\2@XP^S1#GD7V_Y<-_S24O":9M8/'O=Z?8VZD+SB.>SG M.L?(BL7PU%Y ]3:4L0..9 ;TM E_X&-T+QSC_\^NVEU^])KUM-B:KLNNT- M#KMM#47G@$OX%%A\H'T)]\_/3?!CZB;X&,X:V6G)WF:LTF9GP=/=M$$*C>>( MAMIR.;@(+G6OR^ _2S[.VX#_[HK/Y ]_D=PQS[<0K)M%OO9$Y*6_?!$KKI7< M"-BB[[2T97]X$;)?RH^P5?Z%@2:(?O6%C1I1*WL)2"]$K@[D:3!*E1S](+/6 MI9 ,IX7KEI(,1^,8+-5S,*/1;9GEV6AWX9X-_YL_8Z.0H]L#/1A=QPH/1M^R%*9:,86IOC%#;S6YKY!V)M+[)LG= MD=TD(J&=;4AH9R6$O":IR"OQ7K?U*ONN^%!^Y+QZOC5:FCV)E@[XT1YX4WY+ M\3O6C[X)/E7\6B3*>:*: Q]MY"_YH1#M,8[T\L\2 ^CFMI 7N!O+#[;FG24* MDWRQMD;$DNL"_4#0S_1Q+$[U$5F]195C(H 241V+MWU*WP5SUCTE*-O%_XF*]X*;R(OM1O38*9WP8:?*N)XR[F+^5 M30-_*3T1PNL0COA:>.G30Z'-R0\:TC#,?B7.!6Y)2YT56B_T+D[,X+F8)5?J M4'SA7C@$Y7/GB4D9UY*S8B>LW_7SR_-P68L_VHEOQ^HG,CL69 MS,**+X;C2*P8+!9^3O7^*(EQ_H<*![H2OX@"<0))ZW[BSWU)EBE\_5Q4G.%V M^IP?7($@F&7 D+\0AO-,0&L9\\1M(_$$:7K7:P]W_BS)F@O9PUUXGYODBJU/ M^(8G]7N25#O^0.%PS09>,.A7F?QXE2!?H\)K8J2>,/&#,(DOY,/Q_QS[?+8[ M_<;=%:0O>OB\G"RC!VZ+QOZL /3?J7 \Q7W%&P0*8N%LH5Z(9"K"Q$I^Q"I*91$@@!JH+H=-VG MU>_+AORUS([X:[O51OSU+0O+=3.@"XLNK#4A76. M-U9/+X/GT!NK#:^JM^G*0L2H WBX_D$8]>A!^]TC7K(G!)P]QS+ V1YN!IQ; MFMO1+5ZJ(K]^10AG2++Y+?[M'"]QMQK8";S$D3+K>AI]=L[RJDY"C,VZ MK6W+VG,O^K8^7@2%JU]WQJ6Z,W1AYZ,^R_M:KXW:P9[AND8Q^UN9J;/!.7P; M+B.&45JYKJYKKQ@7SG9ZT^&DIH)M(6?. M8'/,V<&FPME6=#.S@)L]HR*)J S\?SMB6,#%&!+5A,UQ^0*S(4](#VTKPK" M@YVGHTV!)#8"&@>2F1RG-0;T0GPJ- 8VMPHF#L2N M&\.>49%$5&9#!'^2!7&H!:$7.'>H!=$!&Q"+A[!8D$77?&B3^7!2\T$OXJ@Z M\V%S1BNR]4!]&/3C,/0+W[L6%[[7[]'YM#\M?G4L=N7%.5?)'F0=K(4H?>W_ M&<0+64LX5Q1^O"15[9Y?Q=I5!KE=[7?2:7Y;7[I=%J.LD-DZY) M8^K?RGO'>9H3(OX)UX&D-RWYW0=?=",3ZS2=J-%GRBFQ/>I8\WT8AT)>9I)# MQQG\)H*A!&.A.[>/LGV#G$]X^\,H>I$Y'Q"V9N,^;)@TB9'U8O0O^7)_(B5( M3NN:GS?>5S\1J"T)^C<+E;-+@NQM&+UGT=73EMCIUMSVHN]WN\\J/X!0Z]'O? MHQ['-\M%O/!FXHUU.<.W_C@I_Y4Y2A%$)8,]WQ]'(0\9D9EW6SJ\X=KP9%/E M \:W,PC%<37"I _..$J!>$$,$\BQ,RYJ6.]WG'J_^S0$!5-8C18-TB6+=*E< M!-T1="G#72G:6@G0*Q68UWL:F&>3BAW'6JC<%C!/S8PYC,Q;&MQCYRB#,F.A M2(9(A@CJX1[O;^Z$T1#+":7!I=(9N@A?DKZ2OE8^)I(ADB$RV"&+]E-2)45. M2'2[5XD'6?W?0@I"TH-G<>='& [;XU*[AVS1'D[=%(7>,\PC4Q(:.>I8E,1J MIMGNG,>ZLZ5NPO$WP PY,4:KS%N:ZO0%F<*+00IS,(WGM(^A33:: I<%_][] M.>>FP.3%&V\F8A?Y?[T/HUM?9'60/5#]85;2'BAD[#5B?]P(_FS-%H]T^8$Z-?#HR')CN6+ICM62P8X0,VG@S&7?OX =598;+42Z?D\: M'24*T(J3$V$BA]KM5P8"W8_A+#'=DQR7#[-X$2VEI9\+_4[8VST:YBT;IX^ 79+'/CM^K=+MWX1FB6>4MS*3=^06<.SZ,YBB:=YL8_ASK,A=YC M6\LBZ52?[5]P]=DN59\UMO37>10NI=JS=D^*:L^:NM=FUYZU>R%.77:VKU]I ML7= V=G5!2QK:*"MLB@!>AM.I^&#[)@@ZS7&RWO^4OZEF 6S!"F(%?9&X9*; M3X5ZH3$+%9W'/-E*9Y6M.;0BJ E+9%A%T(&^G/:/6Q%4PK3KY>(N%,(S^4UT M&RZ4"17].N(?'U=0WZ\"1)Y1Q="\J)73/5*-LSVTS\%ESY)=E!.2[:*GCT*W MBWJ>Z?X5EZ-&TM :(TZEVD@TM7&=\]^XV^5T^LCPMNX$%>Z.7 _2^F)T\B!= M*3![3M5 K3Y1;!6IQ,.A:LT6CA(2)!*D\G-[6K;8*Y8MCOQ[+Y@)J9)_"I-4 MD/M+;YI\, UN?78E.QX>[;(BP;L,P5NIE_V.;DB2+S*Z2*0,$JEUH^N&C"X2 M)#*Z2/ L%KRS-;K,)J6JIR1Q.B08>$B<3/5WR;5&=)LI35'.; 2T@V9 MR'0,DPB0"%AQ#M$Y;OL(: ?I&*9CV#Q4>_RR%7:T3W):I^V?U('G??UWMB7E MJU1\GT915;M[(U'[L7/6GVY1?SY\?(^0.0E7(^EF3!Q#-[<%AU":8+DS!]GM M'*TBFB420RJ&I&([(L?E15/0#%';].5D&0G_T4:M&"%IQ5-M6,LQ_C7S<[U1 M'JXO?G3O'K#BP^9 M7-=SXHE?2)],N?*LK>X#YF%I&/&ZEC/?%AUG#J:EH@# MZ0]L>"?NZMRW'54Y!*I(P3 4;">FZET0IG*:/95O9#*?M.*F&&2CBV@Y0N M 132&0V TFY=$$!QFVZ+ JI2#77BKT Q49KS,ZDG7/7%UFE1DK18Q([';+W8]$CL2N].+ M79_$CL2N>DMM#[*Q((_:1M1"*F&O2MB?&DU1+J0T6B3R)24[=YH.1;F0BE1T MKQ");#^)3!0Q4<1TI**2)@,B34CL3B]V0Q([$KN3BUVG16)'8E>]I;8'MUB0 M"VDC)B&5L%(I4EB1V*G*79M$CL2N^HMM=W(AA^.Q"(;LN^D$F:H M1-MV%KE+)#(IC0Z)W'$OBT3N$8E,*E+-O4(DLOTD,E'$1!'3D8I*FG2(-"&Q M.[W840D4$KL*Q(Y*H)#8&6"I[<$M%]M\TKQ])Y4P0R6L;RC9(XJ8E$:+(KZD M)I'=9JM#%#&I2#7W"E'$]E/$%&=,)#(=NB>F5:C$)XE=!6)'15)(["H0.RJ2 M0F)G@*6V&]ETJ2F>,?M.*F&&2EC?%,^EOMVD-5HL2VN)UFTZ;6&12D6HN M%F*1[6>1B2,FCIB.5$S6I$LU/DGL*A [*H%"8E>!V%$)%!([ RRU/;B%FMX9 ML^^D$F:HA/5-[SI$$9/2:%'$E]3TKMOLMH@B)A6IYEXABMA^BI@"C8E$ID/W MQ+0*E?@DL:M [*A("HE=!6)'15)([ RPU/8@&VJ+9\R^DTJ8H1+6M\4;=(E$ M)J71(9$OJ2M>E[KBD8I4=J\0B6P_B4P4,5'$=*2BDB94XI/$K@*QHQ(H)'85 MB!V50"&Q,\!2VXU;>M3SSIA])Y4P0R6L[WGG$D5,2J-#$?==EWK>D8I4 M=J\016P_14QQQD0BTZ%[8EJ%2GR2V)U>['I4(X7$K@*QHQHI)'8&6&I[D UU MQ3-FWTDES% )Z[OBM:E8!2F-%HE\65WQA@Z1R*0BU=PK1"+;3R(314P4,1VI MJ*0)5?@DL:M [*@""HE=!6)'%5!([ RPU';CEC[UO#-FWTDES% )ZWO>=8@A M)IW18(C[E]3QKB?O%6*(246JN%:((;:?(:8P8^*0Z= ],:M"!3Y)["H0.RJ1 M0F)7@=A1B102.P,LM3W(AGKB&;/OI!)FJ(3U/?&H5@4IC1Z)?$D]\7K-?I]( M9%*1:NX5(I'M)Y&)(B:*F(Y45-*$"GR2V%4@=E0 A<3N]&+7IP(H)'8&6&I[ M< MUO#-FWTDES% )ZGAGD620TF!2Q)?4\:[?[% Y8U*1BNX5HHCMIX@ISIA( M9#IT3TRK4(%/$KL*Q(Y*I)#852!V5"*%Q,X 2VTWLAE03SQC]IU4P@R5L+\G M7HM89-(:'19Y<$E-\?K-7IM89%*1:BX68I'M9Y&)(R:.F(Y45-:$*GR2V%4@ M=E0"A<2N K&C$B@D=@98:GMP"[6\,V;?227,4 G[6]X114Q*HT417U++NWZS M3X'&I"(5W2M$$=M/$5.@,9'(=.B>F%:A$I\D=A6('15)(;&K0.RH2 J)G0&6 MVFYD,Z2F>,;L.ZF$&2IA?5.\/I'(I#0Z)/+PDKKB#8A$)A6I[%XA$ME^$IDH M8J*(Z4C%)$T&5.*3Q*X"L:,2*"1V%8@=E4 AL3/ 4MN#6ZCGG3'[3BIAADK8 MW_.NU2*.F+1&AR.^I*9WPZ;3(8Z85*2:BX4X8OLY8@HT)A:9#MT3\RI4XY/$ MK@*QHR(I)'85B!T522&Q,\!2VX-LJ"V>,?M.*F&&2EC?%J_=I4ACTAHM%OF2 M^N(-F^Z06&12D6HN%F*1[6>1B2,FCIB.5%36A&I\DMA5('94 X7$K@*QHQHH M)'8&6&H[<8O;HJYWQNP[J809*F%]USN' HU):30H8GD;7!!%W'&)(B85J>9> M(8K8?HJ8 HV)1*9#]\2T"M7X)+$[O=@-J4H*B5T%8D=54DCL#+#4]B ;:HMG MS+Z32IBA$M:WQ>M2N0K2&CT6^9+ZX@VII#&I2&47"['(]K/(Q!$31TQ'*BIK M0D4^2>PJ$#NJ@4)B5X'840T4$CL#++7=N,6AKG?&[#NIA!DJ87W7.X9&-!8SRG:Q]J(96P5R6H,9Y-HD%:@\DB7U9C/(HT)A6I MZF*QET6VT1ZC2&/BB.E(M8 UH2*?)'85B!T502&Q.[W8.2VJ@D)R9X"IM@>X M6-#WSNG9!TI()>Q5"?O[WG6()":MT2*)+ZGO7;_9H[YWI"(572P6D\06VF,4 M:FRBOA"-3(&12D*1[>>1B24FEIB.5%S6A"I] MDMQ5(7=4"87DK@JYHU(H)'<&&&M[H(L%W>^<@7VPA%3"7I6POON=2RPQ*8T6 M2WQ)S>_:S5Z?6&)2D6KN%8M98@O-,8HV-E%?B$>F0Q?.JU"M3Y*[*N2.JJ60 MW%4A=U0NA>3. &-M-[AI6] AS[6PEAZIA+TJ87V'O"Y5K2"ET>&1VY?5(*_C M$H],*E+-O6(OCVRC.4;1QL02TY%J 6OB4+%/DKLJY(YJH9#<52%W5 N%Y,X M8VT/=+&@ YZ-L(14PEZ5L+X#7KO7)IJ8M$:')KZL#GA$$Y.*5'6Q$$UL/TU, MX<9$)-.A>VIBA8I]DMQ5(7=4+H7DK@JYHW(I)'<&&&M[P(T%7?)<"_,D227L M50GKN^11V0I2&CT>^9*:Y+6)1R85J>Q>L9A'MM L<2D-%HL<>>2 M6N#UB24F%:GL7B&6V'Z6F**-B4>F0_?4O H5^R2YJT#N7"J70G)7A=Q1N122 M.P.,M3W@QH(F>>[0/N!"*F&O2E"3/(LD@Y0&DT>^I"9YW:;;(AZ95*2:>\5B M'ME"2N"KFC6B@D=P88:[NA2]>"%GAM M"V$)J82]*F%]"SRGWG6H"Q[IC0Y1W+VL+GANGXAB4I%JKA9[B6(;+3(*.#91 M7XA*ID,73JU0N4^2NRKDC@JFD-Q5(7=4,(7DS@!C;0^XL:!/7M="X$(J8:]* M6-\GSZEW6D0ED]YH4 L;8'NEC0!\]&6$(J8:]*6-\'SZD/B"@F MO=$CBB^I%=ZPZ72(*"85J>9J(:+8?J*88HZ)2J9#]]34"A7])+FK0NZH; K) M715R1V532.X,,-9V@YN>!^'U*-Z8M$:/)KZD9G@#HHE)12J[6(@FMI\F MIGAC(I+IT#TUL4(U/TGNJI [*IE"%W%')%)([ XRUW>"F;WR[/*?9;ML' M7$@E[%4)Z]OEN5WBD4EI-'CD_B7URG.:+>J51RI2T;UB*X]LISE&X<;$$M.1 M:@%KTJ&"GR1W5<@=54,AN:M"[J@:"LF= <;:'NAB?"<\#DL&]L$24@E[5<+^ M3GBM;KTM*##2&M(:&$U\27WP7 HW)A6I[&*QF":VT!ZC<&,3]86(9#ITX<0* ME?LDN:M"[JA>"LE=%7)']5)([@PPUO: &^,[Y3G-;M<^X$(J8:]*6-\ISZ6Z M%:0U>D3R)?7):S6= 1')I"+57"SV$LDVVF,4;TPT,1VI-M F5.Z3Y*X*N:-J M*"1W5<@=54,AN3/ 6-L-70;&=\%SFCV*G"25.*%*6-\%K]/JUH<="Y.'26LJ MIHD'E]0%SVUV':*)246JN5CLI8EMM,<&-\GSRGV:?(25*)$ZJ$]7WR7&=0[U*\,6D-G$B^ MI#YYK6;?)2*95*2:B\5>(ME&>XSBC8DFIB/5!MJ$ZGV2W%4A=U0.A>2N"KFC MJ4A% M%XO%-+&%]AC%&YNH+T0DTZ$+)U:HWB?)715R1P532.ZJD#LJF$)R9X"QM@?< M6- HKV]A8Q92"7M5POI&>6Z7>&12&AT>^;+ZY(G:+L0CDXI4<:]8S"-;:(Y1 MN#&QQ'2DVL":4+E/DKLJY(ZJH9#<52!W/:J&0G)G@+&V![H8WP7/;;8=^V ) MJ82]*F%_%SP*-R:MT:.)+ZD+GM/L]X@F)A6IYF*QE2:VTQZS,]QX%$;\^&PD MKWO)?ISR]S&GV9TO6!Q.@XF9&@4;M3ED]-R;"/W(!RZ';.82;QRJ,3=)/JRI"DDZ0?3])-JF1#DDZ2?C*C>R?0;;>,[YG8:3I' MR9DE)20E-$4)K>_2>+Q@=U)34E.PFN[PF\@;[V+\)F[3/8;?A)22E-+(N]-6 M3\U9&;DFQOEO%-D.%]A)N!Q-?8OT;-N@#U.S5TQ^-^87&I>2UGRQ5^^,SUEN M-9W.$YUJ[)F51GK0R6?U]*0XVFW9L>5:[YA^J=-94_Y*[]D.A]MUMW.TN#[2 M4=+1$^@HW2DDKS;)*^1.L14F;C3^2$5)16U043C$U&@-=VHPUGH:8+L/8AJ? MQG4J,HI.&3IE3F\(6)\RYK3JW:Y3[W<)79*2VJJDA"Y)7FV25\BE8B^Z[)W+ ME9*Y(%\L/"X*KW^8%Y^;H(]]H[[WHJ_!K+$(YR]92XPX_2";16M]%O^[C!?! M[2,F/EJ;V7Q#$ ?_6\AB,%MZR7Z)X.1:K99&*:=_97_^I=%@[P-_.GG)/G$) M><7?_)^E/QN+-PY>L7]ZTZ7X3]9HI#^5ATK^J&Q2Q;5QW V+TQ.?[0L3>+:V M+X6IKZ[LF(N\'Y7:DF9SS1U]'WB@8OV(?N08F*_ Q%'-U>L5? MO:L>RK3X;D5\3X5/,*Q$X5*9C]/K?7#UK-\&4_=6[G[]B/WG\ZQ]FX^8/ M+T:OG\[7ZMENVT2K)\6W\ V_;\7)Y?%+ML;_F/#KVI^PC^&"/VD1;-Q MX$W9YP7_CKBJ8W;UV\Q;3@+^D^>5;_4)%59_5AL&7/;LQ]QLL:NU-FLPB>3O MPBF_S&*9"M1_Q=[]9QDL'IG8T"MQ_Z:?BRT^KX78L[UKY@=+_^ V*+=^?R^N M7+)B8E'?!O%X&L;+R/_")_CCE'^G,6[]+G[ZN\LMZ6"B]]/!ND%ASRIS6SFZS&;O);%VQ6H\D8NV6OH@-]43,A'/ZRYU? MNPVGT_"!8S$F<1&+?7X_<9MU<<>"68)9Q0I[HW"Y8(L[GSVDB++A)9"2W7I! MQ+X)F,#"6Q8F$)1]3627%667<4S*)D'DCQ=A%+/),I+OY:,0H?9UMHS3OU-@ M\'G,MX+_+'EF8\[AC?C"?3CQI_)9&\?CQ?'R/AW%4MS%?!8L7H[ODC'%+P]4 M'Q-VSC#U<;35I]W:DYOA<-5<&]_XSI\LI_[-[682I,"RQP*])N2)$HHO0LX+ M(^&O2,;"9^''8V_.-V<1+?TGK SJ>_FT$X4;^]-I2H=()D;\S;=UG/T-EL^' M8+*X$U]M??\,/>CZL)#K]6=R'4I5)1"&,Y]@H]5TW&XP4Q218(*X4F4?FT@[ MRN\FYY!8I^GDI#DFXU#(R^S_/NL]0QK\)J*E!'.C.[?W891,CQ_G/XRB%\G4 M%G>1[R>?W_.'W<7)?_M<4";R6^P7+QK?)9^VG;H=5(H%>3+"D",J;6;C?;U %8QSHNP:)NB/?X:WH+"SX-O@6\+=.Y(P>161#? S+WYBCZKAFPC&A$^KY5?SA[@*. MG:=U&&V )-0$ %DB*Q*_KIWB=[&(&'%9W_TY]\?"-2]F]"V<Z7JJ M_C XZO6T.4YCC\E=13FJ]UX027NZX(#,A/:?N;S^RLWOW.!NN 6+>[Z,_&>O M';?_Q-#^?D\RHZ-1!'3\:'N<8'.!O:J:)S M/=;)\C1+>N_)4D7!!J3I=C:=+(8IQ0;Y^YXH"]"I\FL0_]&XC?S$+1((/YP? M+UC$Q8.X"P,.:\.-PTYU9YJ0W/=<<#^D,KOW1&NV#[4-K9IM=Y-/ATQ#8PX@ M$T\;8TQ#BS2-W\J] RU#JV;;'I!A2)3B.J4X#;[Q[UX%,R8R(^+G9#M6?YI7 M9SMNR8QH']BUXND9-X*@7]&(PGGVNMM4-6VS&@2-W0/O&#+P[I.!8YITYLFP M,1IOWM*4PF4J71 MC!0V+*,:U^IMY4&.^3%6+H#8 F\!625'UJA+# K&49_^4V;:0!DY3HVZDQ?W M.*0DW4F*$[CZQ0F<C025DCBIF;7TQGH*TW[V=/Q),\Z7GV82ZS90J4@D'+]+2[/DA9D0:K.@MNX]KBDC8$% M6T@AD132XN(;KK7Z1!)C0+D6JR3&SN 2*M:R9MI2L9:S*]:BT8S/O%H2QVEL M=S*!HM(MU6I@1;GGO5VYYT:MMR5A#U3EY"Q"&>R(]@2I>O\(JF[%)A@CLN8M M367".#B",-IXV9@%'ZFR"5U)YPCVD)+O6[O#Z8R4FN_I^CS#ZW-(UZ?-6(W* M.] -6?*&M"@)V6GV=RX079;]$%>4'XDM+?N-41;SE@97#=8ON_I"WO7;F'/ M!(U)08O\.9=&;O#$*^F[+$O?3:16RJ.0Z,4=E^_U5&)NT^3B*_**1UQPEXMX MX4D1YQI3$&^6BG>M(-[%G&25CRPRBB=!Q'\51K%016Y4C9=33WQQ12L_!_PW MP6W /_G%7]SQT7K\UR)[FG\B(_'9YX5W>\NNQ^-P*>3F*_MQ.9WZ_+]J'\-F M(IF.TV)7XB)T6Z\^7_^8?R@_?? V^B=]S28@#_N1$&OFXQ4"$> AC M;NE-^49&]VM:G.5("SC#CQB9')!FU<;UFI=L@+!0O=DCFX1\"6;A@MWQG6#Q M\O8V& =\F_CE'?,%$?B/KZD?C8/8%SC)2PX>ODQBGS:O>6$P6]/ :_Y_^/#C M=)SK,VJR#\F:C_D&B"=RN>02RTUJ\7PG M^9C37\I'3=(S\((/O?S/OS0:[+VX9EZR3UP;7_$7_6?IS\;B!<-73,(-_I^L MT4A_*JWA_%'9'(I+X;@;UJ(G/BN1*K6R#869;LZ]*E>ZHC#';':OV)?'.7_T M=>2-@O$K]I'#N60%/H9BKDZ_^*L7V<_D,LA%5FNY>4%&_ [_HS'R^;W,'SR7 M2UL<;6_S&A57(/G7=!+9/F]]=W&X8AYJQ[*MMD'"-PGTFL2>8AJ)?"'7=?DW M5\;:33!E?_7NYZ_83Q[_^H?9N+E>U^7DFX8_VVV;:/6D^!:^X9>L.*B$B5#C M?W"0*\P$8=#%XJ)['\R\V3C@=QFW!Q:2^8G9U6\S;SD)^$^>5[[5)[F!SF%6 M?+/%KM;:K,&*%KPD,OJO6&+),[&A5^*V33^?/#^WA=AZ'A\+-_7U<5/O@+I? MF6.BU4S\#R:L/1?"=\U:D5+FUGN<@/U_>9$$_L+D3UAD]B&.E_SX0:D49L+T M#0/T WW![-L-Z,&5PL9%D1T+D>7XZZ$@L2F""S*)91R%AU]G_+U)^:XM()U* M>:%+]5!?J@>[PT)$@:W5T>45OHI'FCC1;F[3X^QZEKK$LK-LO:I77M.+^?'8 MF_/-6$3"(9;XX_X[>WGX2^PO%W9.M:N2DE4LJ5;%)'F3U*AB5)YJOP!87/F& M:B51K228Q%"MI',]#G[[_%UZ'X3+F%N$&%D[=#9/=A>C1[D=^AQ8@:MW?ZS+ZJ%KB]][-):.Y7#;9U0.0;" MOCRJ)!*X:M1$)?.&L#Y' 1/00"4S'P=FQ>'0VD/@8=E"$>_%W1'LQ>T"70@'JL* M"[==[=K+/ZF-O7FPX!/];Y+/^=ML'H7?^'^O9#,Q_N%<&!=$QAY!!?3[5'?< M#60L-F'J$F%:.<(APO3"&1(B3(D4(<*4CH.S8[SH;"#Q,>R@H*A9@Z-FW?8) M:=4^Q&)3SGE.HO\I$YB6MU/E!OTA=[S77Q2=#&ID%BH/9@6RXEKW[PH MX,;ERN_8?.K-8E%?T%LD!'80KQ=_+(QMLHPD.WXG/KWW@IGX*ZN$RB?N+61'1DS!HNK 6%I,/WIF&Q9\A('C%1& OXO4S" MPSXOY_.I'!,W>]2_R06N9:.KRPG;7K:Z8XDR2GVP<1;+7%TQJ'.N4UZ]!W-&L06S")N2GO-M/SK@Z M>_#9U%O.1)P@"Y<1 YHE0GXWF"9LOHQ$-.%"0*CDC(H+*RU5-^N3Y(O_%&\2 M/5K&_*'S[!5)J[M,W]:H1?'W/1>%9%AEC[38*[XM?3DZ,#;H>^?EY(,:\XZ0*HX#OK3>=9E?$D]ME9>ENTJ_7-CXM M7U1UN:A9B)5\]R=?K]E7.8'[():-5/(^-._>Y+_?2M,6SL_B_5G[O.FFE\>8 M9+N]6[Y(V8E&A]2.2KG];H'+3P-O14]CONGBJ:+WXULI69(@WU]: 7YJZ=>V M[EA>V_K?'_]U_6-6=D38#E&\R.V&I/V1#&N6*LH-/:F?/:%8]4S)LU9%XE%O M5K_89\E9]N1[;U>_-ZC7N/'B"=LL.==4ZR5^_X_ES[YSFJW6I>C1>E$?/;WJ M5:U7^M6U.P-[]2IS@>9:(!# 8[%E&UM3.__/.;]O+^:6P)'N?L72W=4O=M6Q MN-C5NG0/-DOW&Y+N,M*-*Y'Z):NZK=W=#/J#]78&>U6NP7^4MRL ::JEPB$! M)%>+H=2+X2H9EK5>S*F2=/:BMV3>.S(QC;+>-B.N53.?73G/$^8JAV)2H59_ MG>NCVZIQ5*G^=)H)69DUU(R3)I9YH;E8&%U\=@+'^(F31UAAUY_?L('3;71: MC7:WX3;9-8>'R_%=%LH3B.:9[)N(EN#/B/F2)M$I\N%YQ\KS57E3*BYV]7.# MN\[>2Q&@X]DX0,?"[B-GJ'/D#"_MR/GLSQ?^_8CKK---#@",@V?Q$+(K-SEX MXA(G3TT<-6SEY&F?_N2I7?S)4^E9I)^DW=V4I*U]%K7A9Q'.^X?PLW"HSD)+ MQ?1&>-^^I4=0P@^MGD YA>Y)^ID?&K>^C%K=3KE*2ODI32[?\0?MX.U7EKJ=!GM/D[Q7!L)\R= @^>KV\:QE_\^N(N"I=? M[]1OW!;;1XG7+HX2+_-)1=2+?@A?MX-Y%G3A9P'.^X?PLVBX<=#1PX M<"X-!R)03^^TJ2=GE7IRB'HR!P!6"@GU T:[7/X0?RT/$8SD[ M!P&05!V=NX]E5^=8=B_M6$:CY][ITW/.*CWG$#UG\NF,E\_J7' ^Z_",\EDM M2BW;GCME?S8D);3:/2E*:#5UK\U.:+5[(8S:7O%Z=(RIGZ[2[6%BS#X<8^*\ M?PC'N$-$C)L!1H ;0,%2C/>[<(SK*HQKJ5X7'(YI.HZH2L^17)IL6B(O:!%Y M$Y$E,PJ_^7L*,PU62@JZH(J";Z8<".8EU6^B7T5ILW>I-^.3<&;D_QBG_QH[ MV^HV?>+*+1VZSUYWFYNJ-RF'B9>V!.#:+ZLB2;>)R MUNA+U^N.ES.H1RR"^ M,/$>8^ETX;!\P1<_S3V4X'4CMEZH+5@%]??>HTR/$+E6W-[PV80?0I$O?EQG MWGCL3_U(/&,=\Z\^DRWG20(OWU4QOEXK'>+DFRA%+SH5+,24T@%FOTI/P/.% MV!B0NAS(/A8KJI]OU.UCWE@#^(V%\_XA_,8<(MZ8V?4#<%:I2P[QQH+VLL[*?/='A0DI:X8$WMU_X&^/DT.1/[ZSQLGDUV/V_MO<*S;QF[J;J M!86H)9&WOQ*Y),)]@G@MFDD2J3)C5Q9X$#\:A_>CPMD^3B[?.(\_RF.,:LGW MDULG*5# KX^T?D%8#')2>?'AU\B[3XH+%(8H;[DZ&RWYR 0C^R B!L0/8A&A MD'Y%_I3=^MZ"'S)\@?C0.;[EHTR2CQ-S8F<.K\?_*_ G2=S3ZCID%UJ2V/OS M5&PCB? #^3,0^3%;#N@K3K?U6,EOY05+/OL=72_R$7/ MOTIK%2018<)W*@;R/*NAX7WC%_[7W&BXXS:.W+AI^, W9IK^=$\V=RW/YH[\ M>1BE"RR^__'Z\]OK_\G^6@U3D\:*>-=5P.>Z.]9M1=:XDHERY4(LO"ESN^G* MU)X$THDPE2Z6G MGV?='6)>*DX+?JO@#& (O]6&B+=:=D4 "&9U$2'>*I!;S2U[JX$NB+;.K6)Q MK#M.7.E[K;C2M0M'Q):N?E1!?.DE1#"=X0VB7Q>AUT*]01SX#>+@C&"H<8<- M$>^P[$( 4+[JVD&\0R!WF%OV#@-=!QV=.V1?CD1/)QBW1\&X&#=:^6#W*EG3 HMT8I$^=TQ>G7 >FAU@%Q= J!X(Q@J'')#C$OV>S" K!_ZEI$ MO.,@=ZQ;]HX%75==G3L.AX'LP8.!\GO0VF-/Y"2?,!BH?T PD'RG?.4G+[J) M9)SM1*8I?/(CR>QAA/[$H-"?&E[HSUWZZK6P'^G=VA[X(QY;H^@?D^!II;>Y M?B6='FHE'4>CE(Z#6DL'9$\,,>V)[&H&L*[* $"\S2'6A%O6F@!=S#V=VQR' M^>W! Z5R V G8M;)7KVLY-7K6>U:5*^7\3ZBYX:;W36;0X*N9!>9K / R)^& M#\\+[6OX]M^,%Z$$WUDXT-E>4E4!SDHO+?UR2#W4 MFWGR/H#G51<=XJT%N37=LKN/$]:WE]\[Z^8O"PL-PRPUF#M>+W0+/ MVA.XX&[8%F;\LS>3K6$'29.8E3#C'5'&*S]SVR5JH.[V5 PKC3)>N;5/X)X_&,NF7[>ZAENUV-.IV.ZB%NT$\UQ"3Y\H9(YW: MW3@1,*X&S^66YKE C-%0AV;"BNS=S&KO_5$D M"2$G:S:\N49/:5]@_D W9:::.UU_PY:6ZV_8.LSUMUY39URL+22]?"):-%Q& M>%Z];FM7I[3M;K!:"3?8UF>-^:4JW'BJL%/BP\T6Q[(9]I T5\-J M=4M;K;!R/BT=HQ$G#*X'3\7*[4Q4HQ&6;ERZ/23(# +Y1Y7MA#,&1V<,A1Y( MEMY-)7RTU_R2GS)GN,%%N[,25.%GI=I4[G1:#MT3N6@W>B+KW*):K#8AKJ^$ M#'8RW%$J-QQ:YT18K2N[,)0YX2L+O-E!6/",L%:R_65D\[*L'\,L)/VRSSW4 MLL^.1MUG![7P,\A&&V+::+FUHU'[&2EZS-6PT=S2-AK,0G)T+"2D&+8>/+\M MMZI03218MGKIKKD@:P?$[2F["M5$@HUAM87'5MZEK9%H-VR?.-,NO4?-*YWV M-[W2:2L&1&W=I#"P,:^QYHPYF7S&FS?ZQ9][J,6?'8WJSPYJ^6>0@37$-+!R M4T6C C22V]+5,+#^7[GX-LE1 +)2R MB5#-&]@8,/N]9/8,@!-5)M!N\^I)OY856S>]OFM7\A$U5RVRJ M)\2-@;7\]*VLO8=:GMW5*,_NH-9G!QF>0TS# M,S?A-$JT(WD>70W#TRUM>,(,.*TR[4C^SZR8("0S,S<54>T^6 &,TAUI028< MB%I3QB*JW0<; V8[G,R( S"]RE3$>'\';G?:WPJ'FX9I565W8]3@GA(B24N] M8+$6.*BL3;>710Z*H*@],7JGKL1A9/^Z^7(T#<;31YG%Z0LO<[$1XK[*'')A M/F61A6]1*G/4%@_<[GYLW(HJH%=N]_G1 Q3+52DY=CP@VQ$/F/47+%&9!! / M^//9=_$S"/YK#2/IH&A$^N[80, MH%Q?9*JQ8M,GFVJU',OXU&^;TT=MF^-JM,UQ4=OF@,S?(:;YFQN2&GUSD*(F M7 WSURUM_L+,2*W>.4BQ&YDAJ=,]!RMY9ZV%.]!B134^00RZLEA1C4_8&#!; M)F:6),"CH^Q51.,38OR6:YU%QS(]!YBFMZ9$0L)*R@8 MRYB&KT8WN!*F-\R$U>H'AQ3]PM:WO@>_OPRWOOK*\+36%N,6; M^^6=%EYD=-:SQVTG5/&>BJIZS12'!S93/%F@=K A3EM @KOE;!+)E9VPV^"6 M&^I7_'>%N.,:H.AJF=Z#I5ZZ7@JTMK.4%_N.3]0Y=4PT'_N_\NF*MDFR;] A MD=*%!IKEBZ>*:KN@PJEJK4H%2O]]>^'4,T5A)F&CJ@-D]0]R'J/F1T1QKJ/F1&Q0%+9W69W8=*'/CH9+%^3^L^:D]K5Z.GM8O: MTQI$5P\QZ>J<+-;H:8T4!NQJT-5N:;H:1OMJ=;5&"D;.B%^-OM9HE30RMD6O MLS56Z?963CYKL,58L1J.UB"VB\1 MUS:'C<(I/0J I0T(<5+V/*)Q#@$''4QPD/>Z!1OG.%'4?3@XZ)<%!R [&]8^ M8[ "$+9%2SBM)PUH2TR0_^K28KD1;+B.K2@;$4*XZX:(AP/ M).AW?NVC=GYU-3J_NJB=7T$P10$+3)"@T?D5*=S1 !#"0&*L<\B & J!RS(,* M8&#ME$IW2X> $< 170 ]*"/(NYX#1I"#'&OM6=%22?:V=#N;7"Q[\H:WI TO M9W[62VFXK9"X_%(W^TX&CFJ[P-'*J\\73)ADK)O_R0GAA'X;]#YJ&W17HPVZ MB]H&'01H% 3!A!,:;="1@K;<_&EP.('40!!%/ M0/!,#D%0\02LNU(.0C#Q!.",+F 03#P!0C0Y!MGCDG'773(WJ57\)HP7:\_, M$ND*CI@MW[87Q8ALDE5@,GY2"FA;"U.TGJV+A[ &+-5QXG?Q;[_(T"A%XON3ASQ1VS7[CX MW4T?V0>Y6FDA@+3>S_4O'])B/\_Y"LLA),67N-8']\M[N>")*(D]N1>/8J'X MC\BOL\@?^\$W*3^K!9_66MKF@B$V=[9M3]ED*75!>N'$+&LW4L^SM4GV_,G# M"R_.W_,@%..6CS-9'O'4?+GYE+.I-MF[/[G6B7^.ER-QL(RDCU%]43RHQE\8 M+*9)"I=L0EQFJN%LS%Q ?I<'%SR-S\ F508M?5(% MA?[/")(VI$6O(F(P214(K:.(&$Q2!9+]I(@83%(%0NLH(@:75('E7RDJ!I%4 M 97*4$0,+JD"JZNLJ!A<4@7FE5)4#"ZI AN%4WH4$(($4J5 $3&8I J$UE%$ M#"*I HERS7D81%(%0NKD/ PJJ0+K&I@S,9BD"N",+A QF*0*B-;)B9A](]A/ MHF3R7X9NL=9.+U&:XWKYE;\W]_&6+LRQ\CO7*5&60^*ELP4_)D$)6S\I LC3 M.8,'CC9N&:"X&7+< NGNK+ .(FX!(2>%=3!Q"R0A2V$=3-P"04X*Z^#B%EA* MF$([F+@%4D=$81UWW-'*QTPTRI*!X2F _Y#+QTP@5JU'&IQ4+:*OB@5D/Q9%GQR0DCG MZD,Z%)(SAV>0CNH*!F)".@BH5# 0$])!DM04#,2$=!!0J6 @+J2#IDG E!745P2L>JQ7T7;.HZM1)CJO[S@&_\P M#;(43JWQ4D3,II^+Y6*?[WP_"4GVTK3&)#(S"QD=)^'+(H11?B<)1TX";(5? M+,ZC:#-/W7/Q11$T6XAG%O\NXC!E3[W%]%'$BNY\D8K@35X@XA&+@9%)Y&+A M@[RQ)UZ/T!V!PK)'J Q%S4*&*X_GW-DVP(5W#GT]J=]\V7ZS9.17T6+I*#@T^[ M$*'Z2Q:A6GQ&S'=].A4_$9[@R/\J0O%%@*L((5Y$WD3*6Q)@??/ES?_\/Q$" M+5Z2Y!@GPL=5_0]_42O\(OFDN?JFS1[JK'6QDQ5#*KJH=WBH?UY.\Q^YN7^Z MMC5V_EC[+UM%R'W6WM2SI5A,HB?.XY,3DBQM?9(%Q2.3$R8 GU"!F,$D62 T MCR)F,$D62.JN(F8P218(S:.(&5R2!98\K*@93)(%4IM*$3.H) NPM*ZB9G!) M%IB?4%$SN"0+;!1.Z5% "!-(12!%S&"2+!":1Q$SF"0+).)8$3.8) N$YE'$ M#"K+ NQ0F',SF#0+X* N4#.8- N(Z,FIF<-IEFYIF@4IR+FSZK.'43-[O/== M+>]]]]*\][]XT?B.N4Z" S4]][]HM1U90:#"T9.>R.PV7E\HIFH MV@.>..APM:,/5U%(]QQZ0OJ'*XB+"5^LAB/ ,"[*"+H:@0DYIK46RW"E0F&$7Y\6^/,[YHZ\C;Q2,7[&/'-*O7F0_D\L@15FMY>8%&46^]T=CY-^&$7_P7"YM<;2]S6M47('D7]-)9-JT M]=W%X8IYJ!W+MMK68V--8D\[C5.=MXE$8UY(/XQ>"W:R=A-,V5^]^_DK]I/' MO_YA-N:7R>CUTQ4^X?KBSW:;V%@]*;Z%;\*9/!J%65#C?TS\F:BS*/@N6^U2>AC<]A5GRSQ:[6VJS!B@1G&HK) M$J*3B0V]$O=]^KG88HL78N]NHI/(77T2&<6EF!/" ']^@7C&))$A-+8BGC%) M9$B%"D4\(Y+((!I;$<^X)#*L1H:BGC%)9$BM1T4\XY+(L 8:BGI&)9%AD5<% MZAF51 :.PBD]"@@A#"FPIXAG3!(90F,KXAF31(:DMBGB&9-$AM#8BGC&)9%A M3=T5]8Q)(D,R[ K,,R:+#.*Q<^;YP(9^NMQ5Z7$FO]N+?(JSP_9_W-[B6TSVGGP0:B4M96DL#1_+?+G_'\$!)_( MVBQ\-'?!U[O&-'Q@WC<_$I18FN249YO)*"^-MA^U/1TAMC48V=O\P]%H_E%# MS.G3;OY1V]_\@Y5L_L$?O_8P0.N/VN[6'^S UA_^C%TYK?TM/VIR)Y^T_& ; M6WYD#T5O]5%;:_61]539WN_CR?R2/A_\+=^"),C26T!;?M2VM_Q@)TT1K:UJ M6/:E0)P=VUI^?$1M^2$/;-;:&@M7U4>05)@T%*=VKJ"M<&@K6 M8 M-!2$"%/4%2X-!=+, GF%2D,!CNHB=X7)0\&HL)R\.IR(&I0FHI#2#3NK890P M\@J3B (%5.;D%8KXY\03B(4MT%5'@RPE:K_\XCTR)ZU[6RM9]Z7PFW99UJ2" MR$B*::P80YC MA7EQT2ML%$[I40"0**1Y: 'Q8J)7"'Y6B!<3O4)R 17BQ42O$/RL$"\N>@5I M9@'SHJ)74%J6@KRHZ!6$H!7D/1R^#DO#5Z3LP\YJ_ 8,\F+"5U D1PYY<>$K MB+TI@%X[3/K-.8'7'*9.F>.B9 0^Y@^R+A^0ZHD:_TE%O3L'^E 2A6/,82& MY"_ 3TPH"0&S"GYB0DE(*1$%/S&A) 3,*OB)"R5AQ4P4 ,6$DI!:K I^XD)) M6,,;!4!QH23,Z:, *"Z4A(W"*3T*")2$5+]4\!,12H+ K(*?F% 2DA&@X"? MF%@2Y(S-\2 MEDL"*#RU^C2 35,\NT2 7,U*Y0'<4![ 97]R0D)LJ$^(H7@MJ L6B8 MC!@HOB-GT7 9,1 E7.#1]HVB' >6G<1E&;,J4Q)^7G+DF$52E,U)*/ZH3%)" MRC-N[D7KM(9KW6C7P[E7N@N7Z#K+X6R&%HM-9RDGXL(_L3I+ E[[$QN,#UOZ M8!S%[9,!ZP[ \UH \)A@'$('* "/"<8AR>$*P&."<0@=H \+AB'I:%PP#AN%4WH4$& -J5.H #PF&(?0 0K M8X)Q2*J% O"88!Q"!R@ CPO&09I9@/"H8!P4\:X0/"H8!Q$""L$C@'&W/!A' M2N[(PKU I0ER!(^)QD$1,CF"QT7C(#ZJ@.%QT'@;A,8MSK#X300IU(3S5\0C MK*97) $,'OM5-&^)%S)JX5]>P%G M*1[NH)@K4GC":>- I(<_"1=((T+*N^QKZ"[[_91*:QNA\EDN J?LA(OP""!D;A%Y$REA M2=#+S9$DH6D1SS1'+Q=7M#U_&RF2_2#Y9&68:.Q+$\5*&LDQJ M.SBQE!)C$$HL^8U;,K")TI;HDS.)TQ@ZVM30$,7_D5-# !]D@4Y"I(9 Y)2B MDS"I(4CE!44G85)#$')*T4FXU!"L]H,BE#"I(4@E2T4GX5)#L(8JBE#"I89@ M/FE%*.%20[!1.*5' :%Y(+4#%9V$20U!R"E%)R%20Z#4*44G85)#$')*T4FX MU!!(,PN$$BHU!$I@47P2*C4$HJ<4GX1 #;7+4T-(R5H9-02J^Z'X)$QN"!0K MDO-)N-P0B!XM,$HXW% 'Q VU[>6&;F:UI(FVF_3CYDAU9U4]YTGZ5QDA<=:3 MP,J5Y"L257P(_BS)JO#SFA]B>V564LK<2"XAHV=$7E.69?'H>Q&[C<)[^37_ MSWD0K?ZZ"--%+DCA[W:3_3N5HS@0^"5)4\DIGE@@>K[6OB!DDOZ3 N)??W[# M!DZWT6DUVMV&VV37,8N7XSM)64FV@J8B%P^038*)S2HX!P M Y#ZG(J#P.03((R&XB P^01()HSB(##Y! BCH3@(5#[!!6EF@85 Y1- V0B* MA$#E$T" AX4"8%+*(!8M0(-@4,H M]$"$ DZ0C;.6!@,C(4X,'R4-P ZF 6J;: !17!.2P2+^*T\%T4]EJ>4$@7XN MRP:" )C+4D/)94$H/UG;5>4U&P)_U'3*[KQO?IFLDO_)LDH8,*ND=H2LDC1Q MJ9ME@G#9*:2 K*6,3!]9KUX#I(P(3%VD=-:*P)154:I-8L$GUE4HV=''-9O& M7QH-]C[PIY.7[)/WU7_%?\@/\]G8?\G<[BOV3Q$EQ6?'&HWTIXS_G^*45L4^ MF9KC;IA;3WPVXL>8'^6?_3CUN$H[S2Y?NCBBS ME3EFL^,GT^.$GO"2232A4F= M_S!Z+?P:M9M@RO[JW<]?L9\\_O4/LW'SAQ>CUVLAJ0 _9KB5L%5*%"])]/9ND\K8RV]+!N*5\;;7C^-K*UXVKG;35VT9? M6PWF:_M5U]>VO8);[9 *;KNZ&KCE2KC55DNXP6JXL>N\5>#TL9Z$DP>S\5)V MSOO.<;KU5JLE6C:F&>-BY)Z@]L?\#D]T9<8/FX7(.)<2\,C7;RHHOSQ'_"'1 MTZQ7X--$\?6_[0K]IDAOVS[9$.E]-,JNJT_9H810Y?0;((RQ0/-A4G80TE#1 M?)B4':2:F:+Y$"D[$&FH:#Y!81^@Q2[5S0?)F4'(0T5S8=)V4&2UQ7-ATG904A#1?/A M4G8@S2P0?9B4'22'OLCSH5)V(-I0\7P(E%V_/&6'E"Z?L6^@6GJ*YT.E[$#A MYHKG0Z;L0,QUD>G#X>P&(,X.)\G!6+V8'A,6HM^=J MU=O+SI 3U-O[]8!Z>T\*[E'%//H+= PFM0(A M=Q0=@TFM0&K!*3H&DUJ!D#N*CL&E5F#5Z!0A@TFM0%H7*#H&EUJ!=;54A PN MM0*+_%"$#"ZU AN%4WH4$)H$4BQ>T3&8U J$W%%T#":U LGC5W0,)K4"(7<4 M'8-+K8 TLT#(H%(KH$QJQ<=@4BLP>D?Q,0C4RJ \M8)4.2!C24"5"!4?@TJM M@"*R%!^#3*V &,8B(X-#K0Q!U I.'*"SEL,/HV..0:VT#Z!6<$ZDC'\ %2O, M.0MK8?8QBQ5JU1?X[,\7O@Q6!I-C@; \BI?!Y%@@]?$4+X/)L4!8'L7+H'(L'5B%/L7,8'(LD X0BI?! MY5A@[2$5,X/+L588*-P2H\"P)>T(37W%2^#R;% 6![%RV!R+)"< M-\7+8'(L$)9'\3*X' M(,PO,#"K' LHZ4L0,*L<"XGD4,8/ L0S+"M+R6"2+! I<$IGO>D0)9T# M2!:<(RDC3$ %''-BQEKD?4R294^BVUHER!I2)4B1F/0Q_*9#U-1D@M7(/V*6 M6OH"8Q+5G&:K=4BFVN?*,]72%5U+35N7@/:>]+2L7&3MK3].?MAVLA_N35&3 MBT@T''UBX"8=)PD,8IBKK#I>%@C5@5>8=+P\'".A1YATO#P4;AE!X% MA(:#M*I0U!TB#0'2<"#-+)!WJ#0<*)-( M<7>H-!R("E3$T7!YD58JQ0Z7A0,6N%'>'2L.!PJT4=X=,PX'8Z")[AT3# M.2 :KD3V&H13@XB!4SJ338=+ZQ[ PR%U9LU,00T>[N3UL-XNQ7F1,4P/8:U MVL3LX2Y4+(Y@DX*$\DCIDXQ6N\UIM8Q*\>*Y/UYD%-/;SY\^R86,@E'"M72"5BI24"7'7@.-?=!=&3O;-G8B5>@3DSZ1/,I).)6A/J>"XC+, M^1& V[[ PV!R*A!61_$PF)P*I!Z,XF$P.14(JZ-X&%Q.!5:11C$QF)P*I*BX MXF%P.158,UK%Q.!R*K P#L7$X'(JL%$XI4 54C4D0,*J<""J]21 PRIP*B%HM4#!*GXL(X%9RP/F0W&PQR#4^D= MP*D@-:=U5]D=& ]C+?*^F:EHCJ'@-9QA4@GG-IC*NL;L^MZ?341++_8Q;#(G M*5_CLU]EQ$I:8R=O^R7"2MZ'(KJIX;"K]_P9\E?M=KOAMKON[/NV 4+%BWN>?-(N0EB)^,=A+Z ML0RRN0\G?.ED!,T\"OG#@Y6H*,G(+.,D=XR/[3Y.0ZJR[VR9K^RJ.AZ'D8B^ M$7671?F?P@/9G1>G03Z^K,<\70HF250'"F84#T.?F/C)Z>)AN%6G3]Z@.)HR M(J8+4#RYY QN%4WH4$"(&4M!7$3Z8Y V$/E*$#R9Y M \F,4X0/)GD#H8\4X8-+WH TLT#YH)(WH-PDQ?B@DC<@ DDQ/@CDC5N>O$'* MQ@()R%..#3-Z .,PBYX-$WK1AY U2I9OUK#@8XW,,]J9_ M 'N#U"'.7>618(R/M>"[R-XXK;3'% Y]T]Y"WZSQ-H(>&4N9YSOVM9;47D[3 MUW(BJ/0[S2!QB,,QCI&@3TSF5Q %EMBCF!Y7$ 1%)BOE!('':Y4D53X(Q/];"[_=A5"N9 M<228BB23:C5)Z#NQ^C,NKU&B*7+QBYWM)_Z8?W<:_]]G_ ]!C7A\4X(_%R]G MR_O&)%PTTB]D[;N6<>.KY\U?WD3!UW3M;V[_$7JS+^&GM*I.06&>L7CLB77@ M#Q?5=^1KE_'DV6O'J7?P!.[ *OA,D1 M05@JQ2MABN*5\+DB" LE>*5<#DB6,47Q2QA MGN87[Y'U,O9J,U>R5KDF65RYJJR5$!%EMHFX#OK$%*ZC?0#7@>)GRGD+@*^W MP(]@)'4+D. M8-,QQ9#@)' M,+D."-NB^!%4KJ,-TLP"0X+*=8 26Q1!@LIU@/@619 @OHP;@.I.HKZRE50(+D&%Q'GF"E1Y1@ MDAV@0CTY06)MK,&7.[_VD$PU9I$_YP+GST1EW-'CYGY+HLO2-1.=AT0?)#]K M<*1Z)Z6-DA0!$3_>C\(I_^'-3_]JLK^%#SZ7\#H3;9W27*&DSU(^C/&=)_@/ M/N+_"A9G%'[SZUG!WX5\X!/YV\9)^\K_XK+AC_6?JS,1<(M_>*_=.;+H5LL$8C_2GC M_Z<>M4H9)J+KN!MDMR<^&X41U_[\LQ^GWO@/YC2[7#7B2-@O$K]M&[]Y,5^!B*N;J=XJ]>9#^3RR"5 M0JWEY@491;[W1V/D\R.$/W@NE[8XVM[F-7JVF895>KGUW<7ABGFH'__F$VYM?(Z/73^5H]VVV; M:/6D^!9RNUR>7-P&G-3X'Q-_)FP(03++IJ#ON9$X&P?>5.4ZQ^SJMYFWE)T[ MGU>^U2=46+MGQ3=;[&JMS1JLZ%5(>ZJRQ+O Q(9>B>LW_5QL\7DMQ-[S&-^; MTSG FX,2$9)[9@!1604/$*8W!^)/4AX@1&\.)+^ZX '"].9 _$G* X3KS8&5 M9E,^($QO#J3/@O( X7IS8+TKE0\(UYL#B])3/B!<;PYL%$[I44 \,Y#*]LH# MA.G-@?B3E <(TYL#R:]6'B!,;P[$GZ0\0+C>')!F%GQ J-X<4(:K<@&A>G- M'B7E D+PYO3*>W.0,KHSQPRH+)]R :%Z'.P>EFZ^>/@_IRAGC]'XK% 4 /\!ZVFVPUF9B Y M#FE_:M8^+T?Y9-FOP=>[1 L,/D'" .B. M,_@%2TTMQ%HC\ X@!49S%TQ%H$ @X*< 9&0"I]:]( MAX,FHGB#0QY3 /X'/<;9\1A]# XI4*YP.R8&A[ "K=C8G!(_JK"[9@8',(" M*-Q^D#@IZ(T)HB%YL$7DC0JB04!>(>\MRUD*.Z,"8E"),X6B40$Q*,12H>A# M1+*(@[<\IS2.106FH"YOY=,ZM;"E>P@P16H(Z.:/@P-3"8XMQ68WLYK,6V2N M['TWD.%\;]+P0F\V"Y>S<5)'/4S/#'8E?*MNZY7\^B[X*K_GO'J>YT)>W_// MQ]XL\> RJ2G\JTD 1NU+Q*>7O;O._O&/-^Q*C"9]W_34NOQG1?Y*5:HBXC&&=^R1?I"&76X:>17OC>^JZ4OE)^E[Y QBN-P M.LTJ6M5986C)K]5T0Q&8*!--&1=<%OOC911PT98Q"7,^HG 6LX>[D(4/,[ZX M8N2K8S(9G9RYOLTS**EUQTLY78 MNTUU)F;-DL42H\C'4QO+L7!!2\?RY*4"V$?^V.=K,BFUQ'7V$"SNDC?*3V0L M:R0S@\4"S-*MRX)04W&H):N2"$Y=E+1GWT1L7#*"?4G$*T747% 2<>%T_N1% M-Y&,(YG(N+Q/?O19#'5;!C'_]V0EG[UN-5O.EBQB+@[IC(O"7IQN+E="!L4" M%?^192G-+#VQBM)7XZKF32:!>)TW75WRM<61>N3>"E@-[K-#3G= MS9I<@VP5O5L^F$DL93#@MS)7@21N.IS/PV@AGORXHNC;)'=UM^3:I2'5^0(# M5ZUW@#2+:.J;VW22-Y%L?FJF0$]M)GQCXR:80[J/1G;T#Z$X4-V9.70)""0H4*2;= M"2%<%46*27="RM,IBA23[H00KHHBQ>0I(>TL%+>)2>E!RM4K&A"3TH.0BHH& MQ*3T(&G:B@;$I/0@I**B 5&Y.%"*JB+P,+DX&!^H"#Q4/@U4#DZ1<*A\&BC( M19%PJ#P6J-]=^91=+2JJ?0B/A=0;T?2]B>0TU M_\]Y$*W^3JQ\+=VOH=BAE:V@;%_Z9&\@"I?HCTM).J_KX:! *'V0_(Y(#LO4 MYUTNC6NGY?[H2 W0UC\ \*&XZ7+P!O!;%T B)N"#0$X%$C$!'Z1&EP*)F( / M CD52,0$?)#:] HD(@*^#J3VM *)F( / CD52,0$?)!,#@42,0$?!'(JD(@* M^$!1[ HEH@(^$.A4*!$5\(%J8BF4B KX0$$<"B6B CY0:ZSR4?U:F*US".!# M L)N_C@-P.?:"_AN9C516CG#!_45GULI3"(=3]K() $(>,:5?L'_PBWF0:PDV*P\;B[##0 MX&;>UMA,F(U[P$.4J7[ 0SH[\ L4!&U,[0=CN4,VN0!C#WB(0N/Z#RF0"@<\ M1'$CPN;X[,\7"0'J=)/['\/R6#R$[,I-+(^X+"GJ.NND:+O)_IW>'W$@CORD M^&(6@N/%@KKFYZ@O@H^2@CF"R[[^_(8-G&ZCTVJTNPVW:<"]:?0G[#IF\7)\ M)W<^\D5HTRQ,XA&9J%;Y=28]"C6Y^%(@1$CWI9B%FH3LL$#(%H/[$C]&%JMZ M%/YU>("Q9'&161'O6"O$2;,\D+?IM-B50$-<=!=WS\6YXVT(YF570=-O2MBT MX1]%]589YLL?ED44BW#GY^I?LGC)6N$$30MWQ:MQDTF@]-,(Y$M1J@JQ1)ZK MKZ=:UFZ+\"COC9W/K_A$.@4CD?0J=P9-]J5@%Z3-KV;^0G1]&OO^1 ;\@YIA MN0>T,?^4OO0]MRT^Q")!8.Q_F 6+P)M^6HZFP3@_8;?VPVK76^W!ED;FNZ\R?WR;OTC>(J:_= M)MM[?W7:FSN?![/Q4L8P!W)T,S\9J$QJ$/./$OG(DF4NY7S2K7'8$9^@!'7ZS5(=M7# 'XS['Y7.^+HMHZ:\S&9_'=_YDF==>>?+N]1#X M? 3\K8E8C?WI="[RXF=?)?07?_,-'&=_@S?E(9@L[L176]\_$XCIAT64/>2; M'RV"L3?--BFQ)YZEN&HQR<'<*FX=;<"M3V1T[73/)KYRJB\F3UZ53CU_EWR+ M$N7B+\:A6)B9S%0H.="R%O':X+,\AA]&T8O7-9G-@#@/[5\<:;;I5B63+7@? M):=MY?[=+!?Q@I_V@MO[,;D2ZLQQ7[2=%^(BJ'0O3[<*N0K*C14\JS^YR*EG MZGRILY\'T<7,?:/JM]JIZKN'KP+_?U&I:_45MT;'?WR-PN5LTN +$$8OV?]Y M\^;=N_?OG]ZXV:7M?K]OCK*YYJXI9(_Z?N?F%;ZU^WW?E7E7Z_O5[9*.A[V[ MM2_^7H=KQH./W.OFUJY!.7,-*H MZ0\/G7WWHF??.\?9'W+F]%#.G/CIH7.R,P=@)RESJ(3M\W;34#;MTB%V#?9V M:A1:.)XMXY2U93:NZ@Y]@-LF_1/8)MT7+;>T;7+(E-$%Y62VA@@P&G3;J$(! M7;72=T7_@+NB\L$/;![\T,#!'Z)L@THN65UEPR4>2MRT[VR\:8=TTVZ\:8>G MN6G+LP!5*_^PFINV[G0Z]=9P:,5=.V@9>.*7'KQC\^!= P=_@+JU6]7FE*M;EZ)?JX(73L>527164DUVJ[>ZPWFEW[;A2VP8> M[*4'?PA'7_G@#Z'83;Q2W4JN5%UE.SE\_ M;]5("NN\<(;67*C51'FU^VZ]@RP41SO63?3_E1W\T&8J>V@BE7V(LE43 MWJ2K;">'KA]LO&F-BG':V$:FFIOV%#%.O1>N/3=M-3%./6Y-]]MVW+1#$[U_ MI0=O,\,]-)'A/D39JHEQTE6V8T'7GVV\4"F4:?.%>H)0)J=ETX5:32A3M].M M#RV!KD,3?7^E!V\SD3TTD<@^0-DZU00RZ2K;R:'KWRV\:3M&Q3>UFBW'C)NV M%V[7EINU4$]_4:3OU7M>.^*:A=;Z_JSU[CA1FDY;A*&ZT:,[ EW-C M(F:_6_*PWSVYY]@'1ZDE;9Q2,@_1YVI"J#KND%_F1PVA MW9_[#QSC8J4JIT M>9#CW]FGB)0:O'![UMS9U41*=9U^?="WY,ZVV+'KMBQV[+JM,W/L=JJ)E-)5 MMI.CXU]LO&F-"J$RAX?NG"*$JO_"L0<=5Q-"U:FW^[V-_7$,O&OY5AIXXI<> MO,6N7;=U9J[=3C5!5/KJ=BSX^M'&2]6H:"F#+M735(1R[(&O%56$ZO7KO9XE M5ZK%SEVW9;%SUVV=FW.WHHI0FLIVXJ*4+T7CC6U M%SO5A%$Y_4Y]V+?DIC71N5MZ\#:SW(Z)+/J>*IA?>CT MK+AR'1,]A*4';S/9[9A(=A^B;!4%.VDJ&RZXS1ZQI;_3_IOZUY/TSCK@EM_X M1/3&%%VCPJY*7_[H&P7]A4;CINXI(KEZ+]PVN'$3?N=*Q+:7Z$)^PHY/+;=5 MVK-V2I&N8/M*W]*'>'5I#9,UQ&@^=>EKB-'"ZDS7\)"CN)J PF,=Q5H\TK;' M=X19D7TX]6\7+]DPMS2"&9=-_DECN-^N+/9,??9P#[[2F(..;,K:CPJSFRGWG-PS^SXWO^[C!?![>.F%;_U[H/IX\M]WJ!LK.D4YQOX%_ZWV*)@ MMO22]1#HH9:""/G?V1_F3RX9;C[@OS0:['W@3RX9W4! M"TJSR;++7R)?V]KPUD3;"G/,9O>*?7F<\T=?1]XH&+]B'[D.)2OP,11S=7O% M7[W(?B:708J(VOK-"S**?.^/QLCGFLL?/)=+6QQM;_,:;?%OJHW<^N[B<,4\ MU(X=+IP[%W@+K:HGL8D;=^6PW";"5D_JA]'K?_.3I'833-E?O?OY*_:3Q[_^ M839N_O!B]/K,9GNN6_@FG,ESRUOXDQK_@\/]V)^PC^&"/VD1;-QX$W9 MYP7_SCT?0\RN?IMYRTG ?_*\\JT^]((YR5YO&'#9DQ]SL\6NUMJLP?<:"B>9OV^L&!6"= M,_).^#>#F1FZQ:7P0[.6VO?LK1^/HV NUCE>/TG.YO#88GMO-+[QA:][@/!U M#A"^BI7\RYU?FXN( ,9Q(UO<^6S!-?GT[#AYC]?R\/E%(3EN^VOK^62G_TE/OTDFM\$,BHHXW!%H"H(/W*,#F$_^G<"(' MQD_VGX0FK5@89BY<>DUV1:W)-XT1'CP-?M7B<")[)I&??U^ M 4M?._Q>)PJUGUA8P9^_=WX7H4[[_/1?@H6TC/SQ,N+VT'I4;\$CM#&S07<5 M?JR_@82P5KL3KGO@5G1W;X6\-(42%V ZYD1_\:+Q'7-;3IM)LLEYQ=[Z8_]^ MY$?BTXX].W%9KUT_ ;8ZC+6ODMW.Y0$D>2 5]=Z*J"_CQE?/FVLE%#B8A5S- MV%!;SZ]^J:M$6B6/XAS;LM.>#*# 6X"?O=G2BQZ3=6@[]>0_H.D1)]H;K)SD M0\R>MSO-GNK!^TYQ'.;B.##9LKFNE[1MK%GN8;762ZKEPE+IYO9+;M+TC%GJ M\WG))J$YL>W1:VG8'D[KI,9'^3)\9RT9T./$<9KO!59+7,]EN.!-*HKC>>QC)XWM4 M)!_1SXV&GY?31[(9SM5F:/= =90R(1V0T6#!4;*'WJS*:+A>?EW&"^9T+#49 M*B0C?K+9J.BHJ &CR8AS,"@*:UTQ%7$S7H0I$]'?&*1!AL5Y&A:@;GV9L!(; M8<.18B@;L1(UT1I8:EX#6/;4"\]T=1 M%B8Q,&9ES^>^!'923$/ JFS!G6F6WV087T MPP>;+8B!DDFC$TC.Q8(HK'?%62*)K@OSH1 *0?;$&=L3H%:+F92>-L&C3?:$ MUEEB:L;&"+(:SM!CZH%Z2J;"V*2O#@B.E;6A61NX8M=!HJ)"#^+O-9H4*SFD;'0)Q M'F9%8;4K#H(HQCLHPZ*0_SDT9KG/YR4FF!4ZT97MTP9!M)HMA\P*^)%B:!"$ MJ\%I*:'K&IV-8;_-L++6%6=B9(D7P]Q>4.0$F0OG:2YT M=&(F3YN,4;HPU7E+!O@T,3L9P^W99RQ42$+\8K@Y@7U>;;&&NZHDYQ&",M^N M2Z&EQ\#*.E4<3*DH!]=Y4A?"=2I7__-[B0EF14_#K.B<-KR2G!MZYXFAX942 MO#C$0"B3X>.EF S6:E6_TJ(+JMZ"""2BN_A<[V)0Z6FZ>RTZ)2HLPL0WK4?FPSF;#SJ1>>W31N:1 M^:!WV..-!&M"/,\M6Q36+@+GD?9SW:=X;M/7E 8559B[X&L\8BG+]D M_!GY!\GQ(S\[8ES-?,,9S/\6NQ',EEZR]9/@V^O:#R_$_R3_G?WQET:#O0_\ MZ>0E^W4Y]1N?O*\^:S3DMW1&6UR+]H:UD)\]!)/%'9].]_MG3U[$/]Z_#:,P MFOA1\I8?I_QT9TZSRW\6A]-@HKW63Y96KM"3=7KQ9*'X#P-XV7D?^'B]>.4?ZQ<9Z?3N3<1MX,\.,3??);C[&^P)F1[V&I]_VSM&B[_D/4+ MFV_HLR='#WA,PNS\_]G[UNZV<231[_P5N-GT'&CE5Y+).6[;2;LGL3.V MT]F=+W,H$I(XH4@U2-I1?[B__585 )*294>V*)N4,&Q@0DZC>_9OH-X\AVN<< 5ZDPK4U]<6P& MF@1+AIP>/_K)X_MS];*Y;/8Q?*1YFZ.61^/C.]GE7'ZYHL4@&%/SS/*11[. MO2=A 1E+!OTZ<,8QH)_^:Y8[+$3S:NAV=_QC80J9NEJ\J&VVX'CG8=XWJBMQ MWB;R.(I&\-X$Z"+AH<7 >*#0LZM/W&17U)D! G&VU7K$)=T3C M@7;-W"U[Q*I^+7^7B"E053FL;U_['3HJ?X?RDI[JCEISR7U*;B*VU9;[%#_7 M1AVO I7(!I1J?GL-D.FDY#VZ&O*8LQN]RALN.//C.,W%LT2P]NH6_&'QMMTGC:E[*$Y!B::3%C2^,^4ARY@SB=TH)T=_-,PW'=Y#3].Y)%\>BFU=8HU[=6W8U&Y;=N:,N-R!LPC7VMZ;,BGU:[0-I)/FJN?\#>D)[GS?[O%^)&#@,6UM M$=K=^7M4W 'YJUJ$/L@[YRZ".V/\K@7&/GX1"\ [#[M*C17UR-"SSOV _MZA$=12&P*Q)MGP0>/AS$(.55W8]Z 7%RC\L93=HI;QL0PV'H 2%\$=$851P> MS[&07S >N\X8U1:1\ED/_7UCS$J3BK*\^;B&2&5UV3;[&HX%Z$0>0]Z!*A8L MEN6KM=F'%'2HHRA.V&>>#"-O%LMJN@<_=Z/?[06ZW\N[$-ZI\FR+(FEMMUFC MEQ4I]!H >HT+Z)4"FQ-DK_41T5Q$M!$AFLT.61<_><(S>XCX%7@Z] M)BJ6H0N;[D CLM^UU/O):+F\K'??SI MS#V*.:LRF%1[3-(NLOG(U*HM,MUV8AI.;NBO>O3W]?(E+0;TV30&]3>N+<49 M]#'H8QCVRACVR0\W2#VPDW%%?1&-F#.* ,"_I'W7*+=9+^L6AE8YN#N [*:/$%!?/!SB)?E&#^Y MMW)0O+>RW7E0^<$+'B\B0)*/QX&'JGH['C"_SP1437?@P3Q]D5 ME<[T%947[SMM>Z_9N?=2X*8A1NN7*A)7A3?LX)>G))N#9C7(IKEW_UW:JA_Y M:O2$9]<"2MRT(V?L)S#47\H*C)T ^^64)=ZK*]-KPJ_K)[WQKF6.5)>$3YC) M$=\.R-[->]IVNW5_C?YU/O;*$$GUMJ;R4K@D]&_M[*\"_>LH;FM@EJ]0(/OH MS0>-SHCDJC"@^HED;1F<*EPB?E1 M+L947E< 5Q MOH["=YU$ZR<^< ):#OJV8^['(\HI)7=WX+MX\X'U.0R1^[['@H\=Z?TV$K@J MK*>^$OB"7_,PY1]$-#J"47&&;WXR/$ICH#8N9$ >J. PCCG\GW?E_+B'4;7L MO?:!D<[/3375VYK:2.>RZ:&]NQ*O41TE=PW-YO+S],Y1B.=1[=HG%SY'0F%5 M6-K2"ZF@7O!7^(90]&OB!WY"CL)[ G(KD?6+IF96$RGJ3GM5W-.'05U![:*Z M5%5'1:(&:D*W9)I?G6Y0-J2EML2I1*U*MXH8^".@*JA$K)L)=^V!G M)=Z*N43X-)K'$F7.'USX9]G"Q4M4-5]5>8SN0\IC=.I;H.5HZ(0#'F-MQ*P4 MT/Q:+G?(O11;C2C4. TU8LR9[V>%M,#^>]B I@S,LP=GS>WO!0)OND3H M C5''[LV4P;&8-+*,2:JKVVIC^>N 5.%4A:[[95CF&X%*&;/ M;C;;IO9+]9/A3.V7-;W>5#^I74KIBYV5<)U:G'AEZ*-Z6U-QZ5L*YN^VS-6U MVACAIN*+$<2S[*C0*74[YNZV_V-[Z'N 4&^8_"_,YR;;[=;>$HO:SM9#B5U& M)AJ96$V9^/@"+'LKN9I01T&X3F+.5%]9"X9[?Y;V1G3U-!H66WNJ:* MR<]AKP_A5G%#G[2*R?TD^3"37Y-DZPE)UN0DV31>&>JA)QNT9$98J7 M_)_M;?;!YX'WAEVD =_^X@PXV]Z>TE\?N^[.G.H8])W.!=SYY<6MB>#KGU=7 M4+1)LY1Y_6UF;Z52/;M/KV]M%&QGF14W=A]2<6/GQ>TYZ>U'E]9864V,A2K] M3!7.*,DRR'7XV1)"UG+9K$T_?%%&5FRS47+8;4XAF?\NV3.;EV$"].M'41)& M"=?"9^_?^IL7[,!,XB#1@]'Z]+'--IR$(JMB_YBSJ,V"!VZX3#_$B8QHF M,7[GC 'C?X!<3'@P82\75WR;B^9_92"<1>$1S'Y(DV>2LCE'>>U@DO7M"F#R MVLW],':?!,:VW>VVY\+XH+),=E:7R6:"QV,.8US#.62(6$ N]1WYD 6=G M?W-&H* "=[<9B&K@0;WW:[;:=3U"D#K$M_!>M 4?/,QF\]@9B*Z8Y)@?.J'K M.P&[3. 9O(47LZVOH9-Z/KSRZMF/>MEBJ@\_ZX>4A_R$62AFWEJUD84VN[U5=##AQN!,--F ]8!3B%2P8] MF\7\&M8=* L\1$<1>9 BO1T*(VTV%F":"IB?]/1$.&$\CD2BU'#,_^WW?="R MT,_$&VN+H.64[UT0YSH/0]%VO5%4^BY[/(AN,(T\)HF+[HH99)SBCC[8 $9 M@$QP-QJ$&!YAL.'X8L\)$*=9/.3T CF6YA2@/N8N'_7 ?H5O+?1ZO+E]^#7= MV I@514O. M,7ZY/D5%.P>M1_8%GC+FR5M^WO^JS?J[$UO;NQU30723*HB63"Q/2!GMIZ6, M3GO/U FM_N6SY^<=E6$8U=N:C2S@;W#(X% UF7<-K+$56V"%2*CI_F.(]OEA M,CAD<,AH[0_9M*-4")B4%C2;\U)@[Z:BXK.Z".KG1-/9M-/^ IT-,U%H=T_5 M!E,Y\?D)HV)44''OV+(HWVZNQ'E<1PE;0].J_$CO&>9'/Y]XKG]YN.K+]=+* M)M9'\@-6NS\5_NTG*=ADBC76M%CCTY!>O=6-A>AL-4JVJ0[YE&K&/676PDJZ^IOKC,U%>W2_IM5*]]8T2N795=U+.7&Y<[#;EQVZWUOV.-C 71$%S@#_YK3+=_[[@SC M%T,0",P?455%6=O#$?CZ"(M[L-Z$[@_S'UCYC.LB# D7(W.SO10,W7T8AN[4 M&T-5\86L@IFJ\C'@(19?""8@GU@8)0RQT?< 64-$SAL.W> M/5NBBPW\[@"9B FC:@.M ZJ=D>VTI? @&3I)MFP/*VU$0JX/OL<"18;IE,)T M]A[&=!Y9E+$*FSV/Z4A3"/#+P9(O Z3:D>.'.<4C81"CN?7D-..8PN&\8M&\ MVAJ"OS&H6P;J[C\,=?>6KZ'Q32'!H<0!FND*,.0P](X5.EP -IA"&DLX$9 ME*UB /+9THKG,J,IE=YD%#\_GWG.".!4K&*9C(<9/E4T%+YPX183(+;;A4#& M.!7\Q?N=1@WSC'\Q(8P'-29H;7!C@@/3F* J"#Z#L;4M8V\Z$=1[4:83P1.= M=17:H3RT[']!AKO3]>D>!BD75L4 Z M,)* R[+J::B-0. V_91Z=(W\T!^EH]FPZA8\.0ZM6M ACKN3_HJC12,:T8=51R.7H*KJ;8$;L?:'I.47?W8R# M3I=_MPHAJLQ52QY:$Z,JA;!:S8=1UL'R0:H/A+6?)=+2/%\4RGY%1,2\^QP- M9P$RD:MJ77^OX^VN3)G7VM]^75$,JZ38Y5-5!311J>=V'#_PKMP\+2%+ M=]=B_#CE9S#;U0T/KOGG"!L6WW.%KKN23'@3R*JRU@!LJE/UR@PF?%5[+O2_ M8)5>W43W,)^=E5QM6Q..4P,UJER>U#4\R?"DI^!)0\'Y/5QI)66,UH0IK1G+ MV3$LIRXLIQ#3QR3 ;?_']M#W &O>,/E?F,]-MMOMYA*+VL[60SY>0^\;IX3L M&HZP=AQAF4Q?PQ&JI@&LNCS3_*BPX$X_X:*FY:7J7*BP-+926K7"A1E/NQ*, MIRIU XV&L@K6E!5 6SPWQ:@XS\Z+UMW/-?,=K5% M#G'I#RQY'@M U M*XZ""6S^:)PF5#E$UD0Q*IA1P1Z]DJWGX8Q?"[+YY(<+CQY289[[8F-K4T+Z ME=$"YW'6[NV\UF\Q;E MTJ69^P'L/A& G?D 8FTWNGB#:05L%&'")>.@%7@SM=UD24KX"SZ#(8-U4OUK M'DP:['SFMHX\($=PRP_=(,6A5,E%5?^21G(\E.%Q@J]>R\JK(5V DY=ZXOSF M8]3'NHO1R%1%+(EYM!_(/%KU91Y'3CRTQH[O$:++>J)4.57BI;K/)HNBR@*D M^TZNLPAO+(WU+ !I:RZD$LJ[>9"U& _2 MY7+]6)>,]:$VL]SF04RC75^F03>UMZ/^ M=AIS2UW1CGJ)XX<2F_@/=^B$ UD8-81A[V48!46E".']L;?.B_>A'ZB#DZ\7 MB'KQ<;JWQ_F9Q+=^*O$?@$]UP( %JH7<5]^FO;GU;3I-4]^F(CQK76NEF'(W M]5Z4*7?SF+.^OTK"M-5W%(U&?D*[=AAZ1_0;&-HN*!]8CB^(T+29HZ#-K[:@ M%?R'C5I?74]7Z-EEVZRP9E)]IE8]BX4U7>_/G9F/]3X\$@^U,^+1:+S,4>@@ MEXQQ5>%\ !\/&]8E=U,A[0=$Q!-M<- FQ3%N_A86A6HWWUZ>'-%?K;>O0#!> M8R\663]JK1&V'(?9(W&NLQS*UM@R/HRML>#7?I3&V,1(+C)OGZ4ZD-CHQ/T] M#3EKRS8X^S;]_"$2"?L&_PS9!1_ <8#(/^_W?3?K' 3(# 8V^J%@4%3]9$L< M/R&_&Q9Z2ET*!3C261785'IJG/8"D)-^$?VEDSG^SCTYQ@W/NBVY7* QKV;* MG_8B-Y78P/QIJ!>JFDGY M NWX-(!Q72?$_E,]W!3N^6X&I'HEF33PC!SA!3R.]?%$:8)^>'0,J*,J@&.Y MU-R)-@![-WG77,0<$Z <-\%%IS',YSI8_@[&"V#T0,8*;, D?!A7CM7!G! L M,W+& KA1*EQ$25Q#A!VQ&+HV(I$UJ2J>.8%@.4$_]*&/G(F"F6$/*X%ZJ(:=]_MEWE(_32V ]QI_ [_F,< M1'#PD9A8!7\C%5!#U4+&@!$*X?@8,''&?B([7&G^!%LM6.3+4,D <+\P9L&' M:7R4*V'PW>48?&?]=))?&]8GWV@6JT:\G>40K\9]/3^(:&0E\ Q5@O11R!0; M!R*7!F$5I[W_($=&U@G""%@N"S*TM)D;.#Y6F!2HFF#>;1;DB83GA]B7#R2$ MD )(L^SI-G\>[_/0BRU@U#SHLVM_$ FI[: <#0( P1VBI !1 :_^%MUPD!4D M^I5,50*U*# 1(BU+^@RG40)U#*8GG"WP_KG+L/0R&K=QM:;G7$&BVUV.Z-:C M52E&3!%["Q2&W^9HB?TZ"65E;CO1J$'+%:+EWG)HN5PSRTHJ(4<-ZX*CBQH# ME=]Y@@XZSY>F$"GGK;?PE0 ]_]H78&U\ >69CWS7Z"NKPM']Y7!TK[ZL\YB: M**O\E':SW00+E0V"J >R?*SPCIP6'@=Q+G(?R;=(@)7\&W<"L+;/Q< )_;\< M=6\H(&>!*H4MP"KT0.\8J"[#H$M0N)14".#5UQR4D00LR!";&[L%O->NP:/S M/TZ/MUL'VC\H-9T,NB% %\/^^'T?5!?T&$A;G3PF8/S"$44C&7[05*:TJ:\A M-4VG<(VT:T]CX?# QI+;?>YADI\M$VMD;?O(A6T98$?F4#I88"%2R)!(D>Z; MH=P35_BQ#SOOPC.44U& ,?=I%#-XIL"Q%2P6-;:ES58KP;[6I^%TAVK8N>G9 M\:W8Z?-D8@/: "BHR]':M^BE4#D2;);_-;/05]AI6W#M#=+%T&$,RJ-(A'2W MP-'A$>)K@O^9^H@C ._W?H0.#]P;_,3ZH!BS(68_LL/,$>-EW;9]W$N\>6:C MWX042W0=\-$XB":;LK,H,51B&V",Q,=8XTDV M!UH# &;,,]<>3H7JBW.#?R$]2!\-YJ=^NZ6:P_G@@FUJB6ZI?!C8OI +Q"G8 M$G>8E997J \4+]8"Q!-%8,GHB4*3)C)\08TY#18MX$<2> MH1TO%;E3/H8''2\SF)7PLJ5W/ -7NU"GX1R1FBBA1_+#7+V"T]\BX)"9 ,F) M 9$[ !EJ.&+DD.BI59.3=)4S*ZB ,4F?M*!X!G5%O^&PQX[LN.$H4D^<[SS4 M_ET*/0"_=D81<@A\WU#[$R\:H5L)?\EZ8CR:/ZV=V7;Z"#]) 1CD^2Q^;,=Y6)0JS2V2/1_7:'L>,YXN' V>@ MK@K,";II6306$06@"Z'#'B<';\%MIH.NQ21P*0XFRL3#IWB1(BPWX$ZXG8Y1 MTI#\ #69DX8HQ#P%1VF'R\V$3L]M0D8@5HKDI!52NV!DIX MT;SDO=;R7YH'4;_!_E#6P2#U/1Z@-BZ#IST.\HTLJ7@H]U%:8=KJ)=L,)Y-? M9PK'%YZ(*.#IJ)#:P@6I""?PQV B\U^FEO]9WAM3^^HGJ([@CI.=4#R^0IR4 M?48_NXPO SP8 0BP<55A'6BL%^^,Z$0'BT+%?1^WR\CI%;&B9;/ :GQ%KH"+H'0JM5DBJI BD8B9[,T\L\'!'!;TDV">A?1LT#U*L%DE1XCC"!3A++E# M7F)!LD=-N,C=Z )]3'27L09\AOC!=(0,9W SS3XLVNNYYMU+A<=5/@:+7+#& MD58=#3M0H?1YX#QTY0JC"D*O7*62$#.[03._Q[%KHKS$EW$E-$12,8YBY=C1 M@-AS-@XMD,#_SH/)5)8%_)UMH++:.:R;>^2&L^1^4=A/F0 AQ_(G&$ATT@1T M%^6[4R;&&#.,G( 8$6WCK-1(T.=4W'>YOX:IK(2I+)FG5^QI5L?SMR> M/ 8,'O5 ]*FO6].!=L=U!>P[>\@ELYWB)3-UY7WQMW>GWD8*#\@HB@@PQ!4>_0\9L\VH;J6.2AN;1%&LH/'Q-=01.ZOSI M^^'5 ?X*WR#)9!1S%7W,H+B[-D#+;NWOSBT/\,K*;-JG!SZ^BLYQYKL!WY]? M?N&55+;5E6G2,4%=SBWNS*J6&GS63%G7+L#X[FJ7FE5QP/7E)'??$;7OJ'!# MMH&UA3K\*]9/,1* U>R4"QV$> $[40D?\L"32=E9(%0'8[=[W!&R1H.KZW1H M-P*IUX*K6&?6^]FZ%8:2,Y/!NL M8SR;*[X"JL/MYO-/OPVZZL B90BS)E!Y[H MK.< O"CG?_H[_ S/= O5(*4P>J_6;2\J=<*KR[)8\LY&:[E+&Y7T5WUH6!=^ M_-UXJ5;GI5KR2D9KN3L9SWH<\L:%)0##,&'"83T180(<6M2ZHAS]&/7SS''8 MB)AY,LZF[U3+;-DL=[OO^()=HR$C\]KS$*(?@D5.]_')QY"_:JG+@#1E%D_4 M?B]U.[R84YAE>PN9((YJ/^Q37L=/?>_"L48>)OR-A>_*C(K7>'7OSS3_4N>0 M6R$5("A<*/3D=7Z5I&SKM&3^8TPU$G1:/]+HKXENRQ6X$!8*0]:\LI-J\9W;M[Y[S](.K&.-)UDI7$NT(-* M A#(P7_/?E)#:]H1JH;5HUX))XQ5[NXQCUWAC_'O%^\/LR8_^IZ%*EMM(W> M+8%UL<#I1?DODG153EB!SP6!@RY4+&Q!*=/(,$,R5> QW!+EZV>70_Z= M!_FEGK/3R_P^SV&>4Y%7'RG>ER'F@TG9!>Z#L/>#U*6+&,"Q9E@-\B.+KM4T M+AOL. H"1V2S?[T\UK/;M %RV1/EF*5T#K6)\"[=D9)YVW (D<=^=X 8X&D5 MYL :I%$Z&,Z-?L!4%EY1TJ#**U33GO%VH_4+"T5*L_@O2.(CI/>!VZGT;D'W!N. M6>)W@GJDV8>5KTME\,D10 #16GOZ-1$8_"OP(J60F$&5E@2A**(Y"/M%34S!-79K+R\'Y M\FK.W.'U);@ [ZU@/K.MXV:VUL)E%2CX>5* 1-6/LHM9S-1@B;3P@NY,VR$O MU.GK=4C)."?Q@IFG]7X"F\WK/M'%FGP31C@U+:7 M[O1V32OY[*90C&I*(H88:T7FFE\>HKL]R@2Q[MQ=8&DX1,"N *[3_+#NCAX?V-V#YMW18R9;$*$DD7@+6 LL[Q;NY=>CIZCPULX] MH*4)G&D ]MHU8::,7@-V@2C%[58IKMP1(6!@!HU-F>+3V[]X0XCNHKD(W]2F M',H].:0MT=P+F5>VW]OMPH:/@=Y>O&\V=MJW-OL7$]F>V]'@\8*TMKN(.1M: MD?;:N[F.5\ MR+R7%)Q0\;JU/5AM5>K+M!=37#XYN<;=>W ! MZCL'J"_5Z3C5'MMF^?*87-]:N^T7JR_]7 DW"YE;/T=H?8=I$=1__XYNOC.7 M!X'JS4B*$WZ&K7/UYP=OR(WO)4-\M/E+EM+CHE]@',,9Z;]>O"^VL)W3'I8> MR#I-JD';W?&/_(03;^XS!^,?!&\+3\/!,\Z(6;6>6_J4XY=AR#= ]8JN.0:7469EKMU3&MA3:DP-D0DONXUQV[9]UF5S+N\^)6;]WLYPY&A8JCR:ZX M6SYRC.EWYLYY'FIJFI?9/Z#4:(]%8WF+$!13+HU7="I;YZ/0[Z4Q9I[A]670 MB+\$#M41 746N+LC0+,E1[1-RGD*UBU>9;S7'.T<+-'W[W+H"/XKS.'A$G@8 M$]8=YG6+?IWDCZBV@(Y7.%'7'!\&GXA1O-11/%\OT&,@\0OWK=WYG MY0F!1>MU-1NM5OMVIV=DP')MC7L#6 1Q22=#__R!1=3# 76^BZ5]J'$2C2- MT70,VT;XFB7CJWTFGJ!%10'9.^U;+GUR]TR'_&6A 76)-IFJ;J9F&ZG6[YA$ M4!1]UH-.=<'&W7"L'P ^2JT^[P.X"G'IBWO:=MO=UASWEFSP3D)Q>9E(?) U M[V!NQ1SDTF(,/Y<*W87E1\?(CRGY\6 !LO,@"6)1P/)N"=+'#S$/?;Q23TTX MA'25)!R5**??5Z(E?HAHV:F/:.G80#!+2!=K8>FR\PS2I;O36D*Z[*Q:NK"B M=,$8S!2.=[#8)NDX$^Z(5XL(G)W%)(ZUE,1YV$FO5N)T]O?LW=W;R"MC?A3S M[V'0Q(T&(1B/7M',PUV-90:&:O':V0!1M;.PJ.H:45445=+(FA4)#S8X-/]7J<)Z+.R^G6'>6-G6 M=)\^]K,.6EPGVUF'8ZJ>]$-G7B$*-DHU6AYV-BL6(0?VSD%W$ZV6W85%P8X1 M!051\'!)4*K-@AKAM,FB),)#Y,%>?>1!M_DT\F"O,O+ 4N;)\\H#2R=?5T > M/ )='RD.=KJ-W=;MM*$-$ =["XN#72,.BN+@X3ZL4BV#I:(@^T8.W+LEE; + M[G=3[:_4377_W'O/./?ND[KG'BU[;^=2W/^Y]K;;P=/9;CM=>T.%]?["PGK/ M".LI8>V_DD=6_/=9[3E*<9^2X \(-H%0K(\$[]CM)Y'A,YO2+4=,_S2<=*^< M)ICJ&$ZBJ,AC$QBLI>7)S%FNVA?8MG=V]]9!H"PH'?:-=)B6#L^]_JEJ+TSB&5R/EWLXGNZ]>.WJ35 M7T%Z@8=0T&T6'V3NG21YHM-W<98H<94I17M29RKSHM_IU71U\O+T_,S=GAV#/]_^.E_+T\OV?D' M]N'T[/#LZ/3P$SLZ/SL^O=+/7)QW@D0*HHB6*NLC M0Y8LN.ECO5HJ3%:9&I-7OYU8'\X_?3K_=GKVL8@2E[^=?_UTS'X]@4,_/&:G M9X@*OW\].R)D^'9Z]1L[_WK!OIX=?@4$.<$GKDXN3C\7<.?RZO"*T.Z2D >F M@K$^'>+#9^=7)Y?LZAR^/+\\*3QIG9X=??IZ3./!CX".'\XO/@.PV_]LL,OS MSR>$>S!Q 53YT+?#B^/M3^?G_\"%X'RG9W^5($&18Q-04M M]H2I@ES')Y='%Z=?$"8+GM3#J2)=[/)$'H+:B<.SLZ\ RL7)E_,+ D'OV#]H M@3CN_YX<7K"3,]S6XY.CD\^_ E!YE:L/IY_@!SI2?!B&_WIQBCM$>W;R/T>_ M'9Y]/+&.SC]_/B7P&Z:$\J-DT].74/X0"32KMC]%$;;OL/*JV&57PJ["@C>' M;1^IMNMQ7N5\Y'BJ8:0?,\^/W90:KY(YK/A*7V%#(+&!Y6]KUH+E/%0!MQ%W MBJ7HO@C_&FW?R[QLU2?XC^Q(:UV@UC]BARZ5;6T='.SH))TI"*GG&RS)";#( ME-_OJH>GLUUCO*?2RKRWUM0.S8^&; MA-]Z0W=OO34!;--HW@MCP3V_.'4D]$\Z*JJI3=:TLK+J95D?8]R!0J=H%]VP M0CJS"GLCR]51B'4\ ^<'NWD%)H#]!92^$;1#)VJZART4H:UIAR2T9(),U)-U" M@Y1"W?6<$[Q]G*F^*.Q3O. V)UB=36XHW%!X?2D<2)=@"_P_4Y^Z%5"33.RP MWO.I%@N-!UQCZV_Z1+="$U1L3GL"+;RGU+T M\4W=F1D,!<=P!\,=#'>H*G=^RYA"I MT>X-01N"KAQ!Z_9A!""5G!>I2BLC[_?1^1^GQ]NM P83>GSDNX:,#1D;,JX: M&<]1PZ,>]88)88RB&1U/J>C44HLG(@IX.IHRT%6U7D/NAMP-N5>-W*<$M:UD M-_6U +/Z#C^[[+M&OCN*W.D&J;(O47:]U8U$%#K7ODCC3.;KID6>\(, +799 MMU%:[ZJ+Q^??_ZM-@-P #4DLT'Y"[19$)R$U .SW(V'<_8:U&-92/=8R1Y.0 M:@&G5F0%OST+L9<:T/7 47S%IS09& &;&<>IB_UR^BDFU.#/NDTS9=@8)[_A M"88GU)N'3_0+ "T?HS:4?#> MSE(A8^[':"\4?LIL!F (L2P6#=3NI?+J:?8@OHV6 _[7(<4!68?*(Y+U>.(H M#'E@>(3A$89'5)5'Z";'?3; K!]J1DS)\X,T<*2W DEYY">)]B-(;T3 !_1< M(1, E M9:TLUJ,=, JS!AXTW8'B#X0U5XPW:>LBN)6A7(WSD MK"^PA:]R!]P,?5 D^BFVAY^B\*GTP(!:35"AE\3YSD-#]H;L#=E7C>S=(9;5 MT8D%JH-VP>0/G%"Z#4FZX_6JU!OP-0P++%3=96>#J[MT3'67Y[BJM@#&&@ED M)%!])9 V2LF+I'Q6/U3..0H>I6=.9\>@)JJNI )*V5A'#8/<9*2BCHI.+.GS MAI&(3\&P@L=<7'.R6768"Z<-$])9'RG2#-\P?,/PC:?G&_F5>X]@3 1>S-=* MK,Z873L]U="NH=W:TZYV-BG9KJJV4)+:F$O3TU"NH5Q#N96E7)TMBF5R0L\G M,C;Y(89P#>%6E'"EJ"7P@&2^\P0SOH!PZ1*9RA##U% TN3%5U \] $),##$; M8C;$7#%BUCXSCX_(18:%WA3M%M*];0:$-&1!)).Y\TP-HO$@ZN'7;_&3(7)# MY(;(*TKD>;96/TBQS*F\T%60U=0 )L;[7[/Q6W6):ZT\VP\HWECSN_/ M@4]<^_S&5%M>>%45+&#[+RQQ?*XH]B-*YM/0;=C,8<<\<&ZPPK(;B;&B6IOY MF',Q1>)%HG954RT*@CELZ,>4?04,HMVF-D;2DS;_;2M3 QKL&Y?M5/U0S\ZQ M("S[ _[GI,W2]K%2N_-IDH$F7T\6P,\_WL*FL8!/=[!">09(\0!IP9@P*#\ M$,P.)[#&:2_ :ZM8Q1E9&@SUNQ.F#JP%7M]KL'.J1TF-KV+L366SL:.[*[W$ M+L%YFRFVA0:,*I-;;):E2N6^TM5O +Q$.)YDE\ABJ8X5^RQMHJPO&8LGHUX4 MZ!'_=7;^41?=U1=FIUIRP?JIH=-] WQKJ"$V >4WA[BQN*KNEF8@<'V%].W?=V!8]E"V0U " O\!NLL(T$BO3L4MM5UJ$&#TUYI93% M_H]M0'C@.5A#6G(?:KX*TASGG (5#2>;8L$WU;?X,3 /=$Q,6*>II[QC6-JY:\6J-!0X5W%\-G?\,WA/?JG792TUR6$Z '1ELL]&6YZ9 M.K+ )PY&2&.S.$I1% !CNJ$F=S)S]Y([^.='0/V <]N2OT_?]"OB8C]RTY@- M42+TG%CB CX3)ZF'TZ%7*$'02<1@)T8X>;H#!)-]YQ,VX%A7'%@Z8" 6,:<+ M @ !HL0,$5CQ)$ZXPJ(82),*$0,#G4HD4/E2@3F[S@"^!I(;7<(Q-': UVJ#VQ)Y:9/E<$0 MODPD$?RHQGN[,X1KB<>I)-0D$ S62;.WA>Q9!J_I PC\86O'X M&&A#;\K5<;8C0%$[=G.WR48P+U#BUC2S;^W:NZ"K]3E/7A'/$)SV9KHCJRP\ MA#,.8?\Q[AIN@\SBUHTO..P;9T#*P)%]O JP);L$D&!1C2:I9/@(TRKAN5?Y MXO.E%BL+N,1/\!F7[@UQ3W&SNUFCE8VF:YC ]Z!K@4X53QJ5;^&'Y!:RL86G&Z]*JD2$DJB';V69!_!T MWQ[[$PHH@)W:8?3CP1N8[HJ=@)VBC8+A:(-D\GU$&5OT 'C&DV M1/K#F'0;G-763Z#)ALP%9L]5KY9]>Z66X&Y$6IH#\(3;0%5#<@\AZ" [7;"$ M@""!A_@)]EC6.L:4JP@S+ @^;!@,VM!!5PP:3NR[O_!!/(+4J5I!)5@M@ M8D>3*;/16^;A)KA5Z Q ,;-0FSZ]:S72K\-0>&TIJ2! M)!]-)B 1KGWT/BK%/P *" FM06\$^O,XD!)5MKROH!4UJI($_0U45MEG)R=@ M_9IUUVL@E83P20F7;V0/]?XC,3I6^L0-=@@"B38>1P+T=&1)0*,Y.MO'64T %.G4V6L8161( M3.L6>VT6(R\&?=\/(J5_Q&#T1FGH:>[Q^?>,T?Y+^ZNDX@8GKXT3QY6EQM'? M9<$4J"OH,Z;":6/!91LB_0:"Z3F)H]L6%7Q0";FX'&)4W\/H!C2I@31B<*QH M&HM4*31=#?GS[]O-=E%;LPCT3:#3I>Y"[6[P7:BNN0M5%;3>)+EZ'EI2#6M) MKU-3B4_"=[*+R7S\DL(SR/N045XZ 6>'(%;)[I*2XPC^PAR!DQ2U00#N6//& M[_T$HQ*_I>' $;X33H2))?) M7G03HHN3.1Z>#,Y.:H/@RN6HQ,0E,'\0F2_;.TU4B]'6_,![@J(2N\H?BA$5 M5%C @ =F6.I+1PZ)I4GV_TO"+RT-8Z"2 FW[,X"]2D<%H\FB:+O>.'6I4#* M]$'KIR5TJ@LW"CWNIH5./0'H+"# 4&RS7WTI; D!8'%IK'R@-&Y'(U!AS2AP ME4N SRS0XZ"Y^TENYFL=/]N^EUV[H[9,[J05RU'5WDA7\=3!RM%>MO E>K$8 MP_DM"KP>2H##$>@62>;\0*U(0:,\0;$KHAN)V(>@7Z(;405EKH03QGTN2 .\ M$NA+U7!_^G1$VZ$#3KM3CNB"JRF)Y^&64DE.MSL[MQU-^,L,^ BV542U.TEP MHQ6/]5LIN3I)P\QY80!C4\A%!P$4<<]QANF(J@HH-._!V:C?]Y5MA5Y&3R'O M'>KM=+BB,S62$X: LRX, $8:LF.!3GY@WEBY6-I7?E*@D6QE4OG'^:3?;M:7 M28[+G4Y+.2ZMK?_7VK=;W9;T5>IX]BZ<([ H]$AB%(U+!PY9A3"(H8^U6NFA MA0YB,#_)V/10 @7:4XS13#[$<-BU=KGG?NB0IXF(PFT/?T\F& ,+?=<&)60T M"CS<*K<((,.N:ARF7[:+E]3M*QL'643('IU!1=L!# M?(+G5_?4RY05D[U-GNE^0'I90.R?AY[.N,DC0[>:3=)G/_?[%!TUA..@NJF9 M\WP*5<16$4_!L51(@WH-ORK_-U $>@5S3WBNU5Y'03J2U)3X(Z7H4=G,G)(: M[#3/<+ 9KI_Y?=Q0(N5\;7Z8SS9SM:+@"K7RB(&ML@%D2**X<>E8*J6CB%I[ MJGS/8MHWI7L7JG/F1T$WM&)>Y)V)\T.=F(@F3H!S&U)?JY4"U5K*.*2V\'U" M&$10O V0R*A8J[V[LP-:H"BZ!'Z0MG?C@$2]Q. OIKF#F7@,BB6BV!7_ =BU MM]/N=NPL$RX!U7 \1%$8IJ10@F39:K>ZKQC8;-O=W5:S82$?Z6'T?*C R8Q8 MH"52,//["?#Z ?O-"6#QP$8N$["0@65)0$^EPQM-^B^.^&ZS(X?'Z$%GG>;^ M_@'"JJEY#EC6_SW8:V]WMW?;G>W]'8QZ(5PWO$=9!ADD\1LV=19T6AZ&L8@S MO:$L/PR2OWA_=/L#Z2TL4ZF9%$Y_HB M.CO1.?0F [L>N/K.?Z^RB[95=I'U)5,65-#MW6N_U-.LPKHW1[S5,>66')NM M%L;0P,)SQJS58%\I6UP"X+/ N5$>F"'U:@&H06,CZY=47"JL?'=6_VR7%IE> M G(>='Q9&4M?'!@YJAHSKEEPTFC)YWM-(0(5*]57$)3F[/FQB]6B)VS.7+8^ M!JNP&(Q+^$D 2T]UBPF\]:8Z30?\&O,],:).=Y"5MJ]')>=1I[E-R3$%.Y:< M4+;,D_7H?A\\N=.4]QZF0@+DH/+);:L#WA@!FVIH3W:PJELP4_5^@S3BI>+ M>QL"J('?UQ1\*K;OD2YDW,-C/;V!8SW(98G82:^G+$'=MIQ1_,N88 M8^5R^L*17\SJAMF+S99Z#N3 P^]7L"6O5UAE7J]@#[M>4> ;U:*9S5&.KS*_ M_S*!0BL/%)::=K)N\Q]\G* M$@#KW&+').E IK M=@YNA/@2_OU%J_NB).CGN4@6\+D\=G%7>)=,6J"T*I!#?N05;Y7)Y7>495?" MDN*U7%)1@M>6] P>/0,>(<)D:'1) MESB^.+/%Y@P6&2RZ=VWG&(*,/$H+?5 M;G;M=F??;N_LO'IVE5*%0';:O_P4H9;4.+-8+2Y8^:=;)2",#N+\LAHB70:B M:FKL"KR#&? H*WH)^';L_9V#,L^STKMGT.V9T6VWVS'(9I#M:9"MTRDCDEJ/ MO3/(]MRY+?:I7BI5[M9KXRB+CVB&C,0X.*%4'%K7;U#43#$C< M#UO[93B^GQ(1-\/W77Y:5$'_]N-Q%#N!+,%[R8/^]E$4QNEHO"J-_$F3O!X! M\,\RMFK#+I9>2!5TK$43TJIY! ;Y-Q;YMUIE9,@\"_JO1-DSF+\IF&_8OD'^ MC47^M6'[FQ?E4%^O=I.I2DPQ"7\E(;#*,)::L(T5,X4=>Z_9K+QKQ3B<*[N! M):>X=JKO<#;(6-D-+!<9N^WJ.YT-,E9V \M._M^K07["/3E)KZE69PW+S=Y= MA'2ASAW[&]RY8]=T[GA6C+WU^CVE=6>1>_U*DF,-?-T/T2IT6\5"Y1-&W0:I M5+83Z$K?V'<)<0^K*\/+6";=8>M5U MQC[6R>^+:$3/J,85LNMI'R -![%M947)PX@Y<9P*:JCDPL)[5/O[VH?!3-7N M\E> 2E/;.'PT 8Y*_OWC!8N'^_05\_G>SV6K\9SS(JG<,E;S=V6F.?V07 M\+K-O?&/%Z]+I3USK&4S\.W]:6GR(Q(@+]GL4\_%P5=TMJ[#PS6E0@N=K80O(<9 .!BC:I=A' M(3W;50>;5-$/_7EXH'HSZH;(V/Q=8)LH?(%:?/0X#QF_=MP4&S;8K)=%0=]'*][%!M70! MH"DO>U9.L!6>DU"O8UY$*\L-N!.F8^H=EHO=2*B.SU,/H_Q/LN:/(G*YEV)C M:H1(/IY+^GDSHZS.&N]AN^9\P9;2160SL6C,U2S47SKJ-T N"3]*8Y+^D@P* M"L@XA7GCH=Q&V4!:MSJ\3'!RF$Q^G5DW>4-W.(R1'V.74"YL:ZX^H?6?^7H% M3BHX2BC91)K)1IQC>1KQ;-?MW,_2 /N*O"^YZI,OS\+&C;)WG%S76/!KV@)J M>(B,XV_4+PM91]_'/2U7FZDJ 6T.J_C&K8(N+1M*2C0)80S!!VF@:4UPH/KO MV#<>'7:A*U3?2T[M\D+/3R2EYKW52)>.>HBBLC?AS133H:".)&U-LA8^0W0J MF^=J+B8;\L42OD+CX+X?@IX.6C98!0)['H+JGP; *EPW%;.-"Z?:DF(/7Q_] MA\QUXJ$V.^0,EAH$.<.-'R,'8"EVP\6K%!GC@$G'J1B#,1,WUE.?6%/O1._] MD?0K6Q<\CE+APNN_ 2X&A(\;V =PO?@9Q@Z016$\@4\UENZGH4>R4K(-R;QT M+VQOBC?Q/M"Z8DXCX%^D])"E"?PO8P'(I2+F ;.SL2$J:0LX"?D-\$>F5Y:U[\Y6 MJ58V9Q(,CB"K2R8X^&M@8#AF<NY'#%_ M[56#G=T3?+&(<=^H=?10I72![.)^&I!JU3N?+)-C'U$"$/V"^X!J<9*U_[U,(O<[^P(<>8BJQ9? "U M58_9V!&DP^%+X\!QY9-W#""9C;19E!I*1M?ER1%P#F0T#D,KK=U\"Q9=T*>_ M6V^GAR/C,U9ZZ!T3X1P>=P,'^T^#R.!H=_',+H3IX/%B&*O5;5CGL#S>$RGV MJIM5UKGS?=(=\_. M!IMZW]+OMP[@W]U7-CTOH^GX5H*=4""+8U@[-']"NB&-7V M5,JURW0\#K@R;//?:(,M#9WL-CZB27*C&*V"V2%[W(7G"KN>;76K>0=4A;=S M8&:PA3SX/Q];HL7\ 2D7@MUS2H SL2O\'ID;7,DW9: <7W[Y@NNVU!G*1\:P M]6+^=-,[)N?.7YD+A3QK8\FOU4HS7MO>DYR&5-+ 24,7O5:H:#Y(\K(MQ"+% M)A$K%9=\A58OZI;D#Y2<(L;7AU$ N!<3 ?D82H$)R*UT32Z]F'3"L9XB'CKH M+5!8KSA?YCI#AQD@K 0+\)O\AO#?-*1@W_R7"DJLYPN@DV!B90$\];"DVSD4 M)WA&E>0*NYM?1,*'LW4PZTDRZEL\?FKKSM7CUMS1LDW-6?RT-7"B5.^"#Y%M MJ:%!&F3OYX0_NRTY%RM*,>MRGKRUE4M5<*E8)P"F:#-3N2.BMA ."-8#QK:L=0*E#>:>:G0AJ-TC /][6:&L,H;6O\3 MW1SX!?@9! X* ?"I>@:62B%!X:*.O>"PY:C#9:.Q:).&CV]S@A(]]D_!1 M0[1>OY6BA7WC" %*.QC.3H NVAB]I[I[7-8Y3IK<\&#LN-)S'?N(LK\[(3DL M%',E?3D>1C>AUI7I?A(8SD%T\V;#''9RZ2Z8**KRP-]?-%_09WC!U9\?O'+= M:*;9_.5%Q9IN/W=9D6\*EVM?TJ7VO4I/?G#A@K;TKB=>RV5]$;[+:]NQM(Y( M]!P$O/3-'T7".=Y<<3'R0^FH/ 9%O?;'4GO:/D^3. %] /-R<%&_2L7!!MW\ M=:?UNJ1&LX;.-P:A,K&=$?UI'*?<,UADL&@9+-)*B$$D@TA+(M+8%P:-#!J5 MHB8U.TI-*J,4X/,@5#V+13ZL+J3VL^R7V]'W7V??#@_+[#=<&>-Q-1V07Y:W M5V6WCFXW2JGR6(^^V]5#M-GC7-KWT&PIQEQ&2=_*;EO%\:QL(FW9W8-]>[]9 MJQ[O!N7JC')E%,2OQ\X95#.H9E"MFAMF4,V@6DU1K98Z6Q5[$S[,XU&RE^-X MZ=.K#!E6S)]1*JV5X\2H'G>J)/(L[Z/8>=ULE^.CJ.0&50-W2O83=COV_DX9 M3J7J[91!HB="HC+4[^KMD4$?@SX&?0SZ&/2IV-9LI@:T"7D-)5OY)X8*C95O M6'CY5GY)F0B5W*!JX$[),LYN=;MV\Z",?G+5VRN#1D;3-NACT,>@3\6VQJ"/ M09_*H$]]=" 3K9^QXS\8*C-VO&'1)=OQ^Z];76/'UTJ&=78.[&YGQU"902*C M1QOT,>ACT,>@3Q7VR*"/T8!,M'XY*_^CH4)CY1L67GK= ##TC95?)QG7[C;M MYNZ^H3*#1$;/-NACT,>@CT&?*NR101^C 9E(_7TV_&^&QFI@P^\8&[Y6-GSW M=>O V/"UDF"=O;;=-51FD,AHT09]#/H8]#'H4XT],NAC-" 3J5_.RC\U5%@# M*[]CK/Q:6?F[K]O&RJ^7C-OM-NV]CJ$R@T1&SS;H8]#'H(]!GTKLD4$?HP&9 M2/U]-OSOAL9J8,.;;/M:V?"MIK'AZR;!=KH[]H&A,H-$1HLVZ&/0QZ"/09]J M[)%!'Z,!F4C]V^G8FKV*X,^=4$?PWT,^BRC ;4/P,JOO@9D M(O4S-OPG0V,UL.';)E)?*QM^_W5[U]CPM9)@.ZT]>W^O^A+,(%&%D]TRD?IZR;BNW=G; MM9N&S@P:&4W;H(]!'X,^!GVJL4<&?8P.9*+U]]OQ9X;*C!UO6/1\.WZL1QHY M8N##+\UQPIIO&0[\AK7PT\\L^IW7+1VW'Z_;/E4#A4K.B]G=LW=W#;$9)#+J MM$$?@SX&?0SZ5&*/#/H8#<@$[9A3._2IBP9D O8S-OP70V/& MAC<,NG0;ODDV?'L]-Z@:N%-VB;P#^Z"U:ZC,()'1H@WZ&/0QZ&/0IPI[9-#' M:$ ;'ZG/'Y3POF&MQLYX6>/_HH2S+ANN+N*P M*AO>-=S&N6(2 &1>E/8"7DV\?!#02XOVCMW>Z]B=W57XJPWI&YQ= N"[B-?K$D8LF0:]<8H\.SZ:NC M: 3339@;I8''QE$"B_"=()@PX?@Q9^F8P"RB'_[(23C\\K*U:W>;^^A6 ME9OI]QF\PJ+<$Y=YX=@-%YSQ'URX,)QG]2;,AV^'40!$%S?*/(8J;'GYR%6% M5;WSW[>;K7WK,NW%KO#'B1^%[ )98^V_7[=U;PZK^!)P)^96 MS#G[$$5)"'R =3ZRK;_]UWZ[W7Q[W\'3(ZVWKVQV,_3=(?-CYH!H$@F+^L!B MX..'2(Q@GNU_LKX?P!LVS"_@(8_G@\*SP#G@J\3Q@]AR>L!,B$'=-_7&L(]L M7?]G>YM]\'G@O6%?G $H)Y?\SY2'+HS0;;UE?SA!BH.Q[6WU*FES\EWX1P-9 M7&NK/6>QN_C=ST)U+V;VN;"4^7[@!;;XQ=0:]>K>LJO)&(8^%$[/=]^R,V?$ MY0Z<1;C6SD'QK=?Z-=H&*H"L-^"N#>D)[GS?[G% 3!AX3%M;A'9W_AZ]F%^L M.3_(.^P.N]_P(,QO7'3F"ABA2%')49X%)1 M*D!IBA-VF8C435+!W[WNK>DV;([\.T^%%8VYG/"Q!BPI00N(5;OL=+ID';29>ZIA- MQ5@)PASL[AV4!/J*83T%L]<7(^!#!"(0\]<0;-QK[K%S/R .\-&)V1>!7"'Q M>?R&Y:]HMH"ZKN!N- AA9(^A&8P:+!D ^T6B$IC%:W 0(P."!6/&O>8-= 7MQ1E&*D@>$49!Z^6< !28,8?IX MS-V,&WG HE#%9HJ9 :]B3BSGA?\.>!1$ Z0,6B%\' \G,7UV0:;%^"V!<0V\ M+DKC;#J"GTQYFCB)V&DL'![X , @#9PD$A/FI,DP$C[N5N/G7J-YS''1XYQB MC[>9X^KT&C!0'_UX:,BC1NQ&8AS!,!S@=/I]6[$3X$H ES,@CI22 M.A7@8\ M)-O-N)0-W,/SDX+J!9RPS^,8?@3NU.>X+OPQX /B5J-QX#MHX_D9 M=Z?5I9:[!/N8/R&,\[[ 6^7#GE]&.YQ,IVP0E?!-P^L@.1Q'@SU^2!1!;=5U! MO[TA%2Z>Q D?P<^N(F?BAE)?+S_320\]+S3CBQ0<'3 M ,':*:2CM,(XCG#U -F-GPRG6'FV(\1PQV/<"]@'6%S,U>NX&L<=LC3T"22M MX^+FHC%C5:QR/K2AIR+<] M!=,XBH)':KX5=0NL;42K]_YCA)'1HPC$K@C9KT[LQ^C)6[>5;HX/[])'#4KQ M A;X(Q\9EN:PP"B!;;DX0!C!IVL>IAPYA8=:*[$7%D0QJ+0B&DTIII*#AA3R M(![8!^L^1)L=E5U@[<2 :=(>!P8"#&P,#,6SD&VQ :(9OD]HUD,TTY$R^!+> M'J.FA_HA! 3,A%_B RF)(7Q[#H2H5 /OY73(+!WCS+ +YKM. MS@]!X1ABW8+T_#CM88(!)BA0=@Z8"Q0GG($-]]7'TT5Q.;T\V@Y)$C\_4B\B M-TWF>@DGL%Y$7/DS^41&&)%$Y(+52=2A TD3$*H\BX"F.#EN6#+9F)CETZ\* M[[65*B( 5RST^DG_VM'Y'Z?'VZV#U<1[JK'HS9$6QREF$%B?'0& #,X?$1Z.LW#O)!-T!VSGH3HNUOD0@\]ANP:]"$S\7 "37;UD:[RK82 MP/P\4" '@N)#R!0HS$SL'3C+-4=N(X K6/"-&PE@H]>^ %U3IUUHC-,I%M(E MG$$W!.ABV!^_#]9KF,!4/B$K@@#/<>!P$3X'_Y5<.A,87T.2C9<)B1X4,M*= M:ULP9)][Z!RQ)2N4(BA"%_$ 0!:A9'ZP$#?1*QVGO0#AD7OB"I^$'!A!,IQ6 M@+' "0OR:PH<6\%BX<0WM-EJ)>BY.95O^)A0P&44;GIV?"MV^CP!*?,?../8 M\UVY]BUZ23KF<7GY7S,+?07R&26.-BN*R@!.*GRYQ\+!(Y3N&I!WB", [W<0 M6J!FX-[@)RD4AB -R%31?GJ<4$L'T!? B+#153;1)AOJ!=&$6=03W#H@@3Q8?)K M.SE.*F]ZP&,=400U!W[GXT1[?V?5: #V$!@A8+?2TVFFS&^C/>(YQ-94;#6JN5?N,6.5%]A SL167&SB=*2=8WZ'(-R(V(2M*(HEE*PF1F MN,:T:7S$D(Y*YO3H,D%A(FNL))(D*S^\CH)K+HT,'3 +^ _$^CCM_8=3OA8Z M"OQ8&P9(,W&,.%]OW63).PGMS;V3T&V:.PE&FUZE-NT7LUB!%\U/7"W[8EX5 MEKY10E'>,)"7#=(@V*:!,?QV=VJ' MXX+V&?LR9Z*0XV')VWF9:X)4\\)4F(T=HQ'*JU0SFU+ M_V*6<&+TN?5:Z6$06(73S;-OYJ/HK!M+VSJ>=HQER40*#9G*U\]1#_%))>0@ MMDDC#;..MJ/^=IX,9"GBD2'PW*:2J4G%(3'>@)F* A)]+[;JF)LN5@K)W&Y)X,%4@33=MXA?EF4F_A M;W2"4Y B#QL4+7BIS.@'$^>'SNJ%@2T96Z>4#2$FI)%/33QO[_,,K/L.7'%+ MPU_6:J5T9V\N*\D3(Q'Q_8R$[Z!@2.A/.&1CX@.#7/K_!#PFECB?LS]0! MPU8$$\D4U>B6WR_2* :)B2_0V%=3Y(Q._6ER=H=PCED"*CE@8DRK8HYF5.2" MHU&1J6&V);G58(>=7N#'0UH!L&R!CGFK,+KT:Q%9JVF*LV 8H<?E?J#,&4>4N)+LQH$.G#5:I&] M\-""G4 _AW*;8Z!/1M7SW!!*)\\N/N?A1U!#E)70SWJ#7)*L7Z5D#7E 0 MDVA B0.63&.G'$:M;X;BZ+O.3_%\&;&4^_@ MC*!D'&"9-GKY97?7/MAIRL_)#*:2?P>^/08N..K! MJ.J'&<2M=S"CTMG+);N&#S%H:UWP!(P*8B'GH)X/2"*MQ".[,O2U.9SD M&[>T],AB]!.E\\:D.&9X$&5X@/1.NIQD.BJI0<;6\S1*7_MYY-5$>5,&ID*V M$,ET2OA1T&5F/[3DK<:Y#ASM!@XB[!+C(V.3J06&J]1B5U% MALZEDFO*/]:L M:0ZIK;["5WG25%[B 2;]V00-O=%@VO8Q)[XP)L7='$P*5@-:ALD*MM+WJD8IP!I&LLE MZ"B+7K E%SR26 K^% 0';%:AZ=3=\?"=W5V/Y46[I$G@!/7S[RJL1/P0GB" MO NZP% BG##N$)6Z6P= MY0A,66NVS*#+,OX+H\E(2B82LZOU !]F %F.=PTC.P..-RW4E'VZA^ D^5(R MN(W=ME8KI;NI%KH#I0<@0%*A.)NB(>0 .76,BHQSFWW"IQD85O!]YGU*Y;7= M/]-(^@!]O$*$&"7]7)C/YH=8PB$+1=(]'6ZI)/VW:MCV@L/&/BS=$?,'S3+_ MX<'[(,K'L6;&T0-D]QVR/I&^]EO..1*\1(1W%?*+QL[,3M@Z.2))8=FT);&=L1K: M&LF,_]Q3B\.KT_.QR8Z\O/4]MM^5Z("_7 7E.Q;AEVR)7H142/7O#,74"]RGP MGK0%NALAOH1_?['[HB3@Y\F=!0398]?V(1)R>:"CO.N)UW)I9"+([XN1POR! M+!"SNA[EM_:F^DW*#8%6ET#;-250#'36EL@,QCP/QK1JBS&&+6\6D=55;]KZ M>DF+>2F=05$:8_1C%7U]#=U5@>[.=;XI+2EK/)$5.W^S],E7IB-N%;E5F?UL M5P)4-3;*X)#!H55S=1"K($8'5)=N&^1X)& [![VM=K-KMSO[=GMGY]6S1?YJ#N [*:/$!!?/!SB)?NFFYW.V4T M3*_M'K=^J2*>5GC##GXI&P,/]LIP!#S9[JU&6CV[+)K=M/(-[7-,KJB]3^ 1 M /_,P*\-SUQZ(&HL/5A@KJ:/PJX&I5N*V M7J8]NII(*SHOW!"?]=:M0E96AE'4A-NN6*"U[59W=_5@5F,W*X-[U=N:LK%J M;[>SH6Z_=9(4'[$K 77S#>=F9AL!\?QTNV(!L6V$@Q$.I6+45K==AL91XC:] M,B;&$WK@:)59/_60)\8E9UQRR^3Q&8]T0FQ,_30"<#EXGX G (#4^QGOA]>$\RZ[CA+<=[ME*--S<*4V9U!K M/*_BACX(Z.4Q>&=W%1I<]^DDWVNZ);L1]X%+JO12A96^\]]?R)K+#0M+G&$K M8MV8F)H*LC#259E5H\!DNN=!^:5_-N+PJU"^ X_OZIP._#98(@1]X5&LPHF M/RT4S&ZPHLM+"K11@59L,4=M*I,(O][;[>#7UJ(#MF3M;8]GA1FGJGS? K30 M9?&GL%I%V&03@V(QR+Q^),*!U73&PH?3\[&!9I((OY?*@@%40KT(H6JT>5\V M,!;X!V)CO0D5F@RC<-MUXF'^^VP7E3B)0"Y%U"63#025 WO(8MF]B[6F%VO* M?*W52H'^=9+Z/2@IV<#'!7#WH=R TIZ1[.T,"RUD!Y2,2EQB"7:P",!W$(HU M%^9["5WV$+A-KK)HK6P?Y$9AR&7YO9^1[H/9D*',M5HI2F:*$BA$4J*8>LG/ M:1R\ ,$Y,7NYUVK=EKU[!^V?D)HU2VH2CD6D&37 @]F$3U4Y^Y)"X OXV.7V%F"4Q-M&#)[7U=E)O*VIJ1]<2_*%'D+RW>+:HA*B#Q5'([ZK=TEJF6? M)MAF*GM*55RIYIPLF+H):+U1!+R%>2.OK#N31OSW#2:?N2NQY!$D'OJ!/87? M#AM@^@J0WM;+;IMT[U [5Q$7T5G4.IVH9_@O^ MF]4D?MD"_1[>(;A 4E^WU.BY3%V+$,L)26$I!VL[4K93L^'4O%@2KH MPB/4%((>G90O!*N 11M%+U,"CT+B??\011.)HMV<5C*ES=GNW"GWYBF M\RS.VY"5+H>LA>Q,_L,=.N& ,X%%P3T?B0J+0L[ONMD/4BSTJJ15XQ-:6JIA^=GJIBJ&_RH?\VKALL.,HP,JL^L&OE\?9@U19 MO%@VO* A9T7%YU4RGV481E"NUTJ!\#$(^"F*E:$)GR@<^& BQR#0/-?2SFYS M85O2FD_H81&FGQN#BVC&2ES>!8QU)Y/XN"UU=NJ ML*IWO?>?_#]3W\,VE\C;CF1_2W;!XR@5+EZ5ZIDF.;45Q?GA8H< 79J?VI=( M*510R[2%"D)IQ+%'0)1@:7U !O)_%KNX@ TI6[>F,9IV3B^Z!F7YALOPXM!' MEXAJ:CK"POVIT(U3K>(P6<-D:N42QRDVQI%=6T<@#94WU4$3,<"N--@LQ^7< MB_-N+/P'%ZXO6RO<.$)Z7&6#6.F.@=6, 9&'#C7+EL,.'6&\,VNV4NRL7L!@ M=&3X&.#&YDYL$*E.P2X7X9SFO MUU45Z"7C"=:-PV697Y#Y/U7V(NCKG7D#9 M!%.&V?G\;KL2G9%*=-/,$+L< >5A\TP?E0P>YWTG9'/E!CM'LE+-D0N#4:,2 MO3XK:S[L>$!YCCO1C3KUFZK9DZ;ZXD^DV0+WF&WB5&@E#(^J,>&00-[C[QE' MT0VB8XML4&QW-<5%)'9>#JG9DOP]>P6;+^$?PB-(W/O"- M7J%1O9P1<24W6^,$II'K6MP^(49'7>3'@DME'K%@9OZ>$_N L\H/!L-Q0"%: MG>PMB(VDZ=2HQ73>=8OZ3/$D";(NS<5&7_@$LC(_R7K7R,"R&"&SAOV1_+"7 MQMBF2^_S-\6>\[:(BE-+E,BR!M J4K.$V.\;;1R2 /T@NM&XFN>*R,&IO1!J MF7;>D29.>["W4H1@AE6"@B)-'G" ];9[-IH?'R;3,::VT@\ [<; !'\0E0-A MO]RWVVT9P\)X*N(9X3>%7(%77#L!(?F4!Z!K[^YW=%/@.>U_)<%Y$7 >;.($ M&!^D'J#;)!]/HB.DFW.;A.G1VIJ:03?F>#U$'EE',2M=>. M\+$-WP 49Q$B&P>DZT4>LO>M&0)IV:U]%>0AQ1;YZ^Q3ULO]MGP$B$@UO]:" MWA,@!:<2_+3$< 8#@1R>%YK>WIJ\O;N/(TL/VA;2Y2M).73S3^E,,;<*"T0- M9,@#3P&CZ4TK,ML][I!+W9$--DF"2=>T]*^1NC&.1)*W?9SU(?><@(R%>,A) M:,8@T'_ X_$07MN&>49RVT$1PIZ<<0$.H_BOU4J/*3QC+:2VR89W4D:0A$E5 M9#)/-"PH[E1+!GY_":1UT)+Q)FI*CRF/ZO-4HWGK",?,Z;YH0!3&?4A J0@Q M29H#N]O>GX)E?Z=Y&Q:;O#GWNK0S8_IVC]-C'U< UQPF>% :BB.>$DF^1=M M47\!*F1;^(H*$!U??OFB^^I&PE+?XF,Z;M1@& Z8VGTYQ\PNQ2EL ZPX#7%# MD1,HVV@@'0%C#"$A8J"6,,X C%%+H%:JL=RPCKUW0)*9=N3EGMUJ=Q^4B#9U M!E/G;83VTS*-0D/F.&O(K"S*@OU)T5.9M,!GC WK/FN16L_K7"$4GB%G$XY] M*<&0(==[HB,V'@TM ZM]7TI7_ 0$]P',,-B;[7]2OTDTH5UZCQFK5%A9##/^V*_13?8270: MMKOA*JX)NY[FVXJ!QE$Z*D)MW5;2X' EU'BBDI-)=8T7K)PXO%+3 M,$\C'0HLFA+7*_-$Q?0ZL*AI-),G ;BA4DTZ$64#1E>ABCV3TUF9PV)I*9-"C M$/ @5DE\HP_R)8EM'<^PG/A.3UB192*?R=XEHI#.7;2,I">XR$TS;R/98/Y@ M"-"D*-[0P:T\*R%RR1X:J-PCB\@BJH39^ZCU(;E*CXF6$R RG&(O8WV0F!]U M \_VT?,HD^!I[A&(#N /8L"U;-4CQ<@6<;6W4<#*G>*4GUSRT_'YFCA4Y$UE*.DJ& M4KH/TBL22H5&AA>BD(3? ]1U' \^Q*CF2SDWJS/@<$5E!#@>3A079+BUA?(= M(V^!/P)>B.+UE8TJ$1FGR"T%?$($CS&BB7=M&3JF11J238>*-MX)P$L]F?%2 MU$\P?((/9LI_T8*3B]67D6=RETG=DA<1 F="LY$AD#C:M:P-?._6C-(O,P[2 MP8"L*70=]^#?*)RQ*Y5:XH-],!FCBD;9(DJ44$P4=T+XR!@\[1P?.W'2V!R4 MW9R5HD621_^+VFM^^T7B *4,A230"&/GY@R@Y3(G$8!"_Y*F49T9:1M9*R]: MU[=N.Z(621A@X+[7GQZ0,6,64 ;"% /SYVZ0F7&AWO(C-1F =#P]5 M)X#!EJ"Y(&TX\D!;RL0 >'GF5]>@>4+^__:MT!5F7 M&+$#=4V@[XFP *\(F#33.K/4;]Q2A)Y7FDEC2>X1G/U4M)8YA;,G7WTXS'QZ M@4Y819TD-4P*^\WF;>AK&%"_(+!A/K%"0D M2)!"?.>+B,((F;[A$&O!(5#I4CD I!U-7^MDPP*WJ!,[-)AI8R)<7*>8G4/>+I4((M&9!*>]PTMD+_ M.,SW_O["^7>SN0=3OW:TPT)F$+@\"%1MNK^_:+Z@SS":JS^O9EMT,\)F$]M+ MEE.:-2^B.KO?UG(M$YM^^**,UHO-QEZY#3#F<^33JY//Y(BZZW^=QA03+J?$ M_6JDRS^_'IY=G5X=7IW^<7+OFF;_=WAVS.#E3^I==GQZ>?3I_/+KQOF/V>VPJ'2BJ9M82Q'UFHX$2D*,(H]YJ]: M:!+WN#+ZR3*&5W72J'(8%J-T.K527OFW$5X.^S13"L"6-Z!(O1X+WY6.@=>P M-G2Q95\VV"E!;MVZ4>"1FT(["6R=VG3($D+P9W,EBD@ M%T6^AP@3D %XA##=3[V2'#5&"E%68I M/#&.GR\X'8]!SQ3D3Q,8O+?5'2DDX1 Q%#,"YM3'8'/J M8]#51T=197[G<2:9*Z)KE@5Z0-COJ=&!%&(M4'1#YC#)94]4DC1Y#M4NPKNS MZ5U9+LSM!*_I)$>:_O+80H>F!E5FL4ZG&[4;K5^8@R6(8JFUP^[('%!X&] # M !G )W2CRJI8U]E.P).P@;].U%'$L(&WTM$TO):Z&I'!.^>>AY[T/G [CO*DOUP!&")=%:S$Y"/5[%N0"Y92W"VG"GEV^+3!50L MU&B\DODP.9*!S60-N3= 2RB&A0NXC95:2#E;0G&@[:*FY'U,Y-HGN9I[6 M^PDLC;M.&F-#%W%#^*P[=Q?8!Q_+0ER">ZD,A5(0!D\<6=CL\L-K7\A@Z_]O M[_N;TT:6M?_WI]#-6^?>W3IQ@B1^^IQU%;9QEL0Q7F-O-KEUZY0, V@C)"() MV^33OS,C@809&X$EI&ZF[JT]L<&:GNEGNGOZZ6E1K[AR[2V\[L?0]';E/A^O M]HHM$_O1Q!6 7+OA?8-QI8&+U1:&WHJ OYN#T*A LC M;=8)(=@A+))^[G*=V+9'[&[P2!9ELY+4H,"<]<(D=W[L$+P_59N)BO:J>URT M5Y9%>P6'L)@HJ$NB0!(%BE*&0Q2<=BYOKCL7W8U)@JOKSFGKC/$"D@5 %+=] M(0>+8R[K<&8%)V:>L'*L(-3A=];Z_ 9AG[!8*SA5$#LX7+.H)UXOMRA@I=^Y M(_.G1I6F01HOJ@\F'[L8UXV.R8ML:3-H]* V]/);%D'.WT[Q M-I"2]6=CY]XQRY/^Y(FC?M1<(=;DFT>4809N<>-O?E.JVSI==%YPIU:88&4S M#%K!"1I@\",6C3$'K$5;;QI&OS0F)6[0QF+Q><2'S#^GBTW/G_Q 9\]O\H9- MDGC/M\$@"%>#RV!AEXNUNJ*G='X5C!^(Z4I%#]Y*VH.8M+RXL1]=@DP '-[U M?#$3=BEL91'W)AR&;1N9$PEI.];'A(7&[.KN::!X7DA/0\,YQJ_G.?NTZYF* ML!3[XR9XO[,#OHEM9X6WM TKVO@< )&1BTB;P%STPFYL,2*$GH^I>7;%G>?X M7_&\7]0>[\#@AH29>E84R?OG&)YCTP!DIECF=Y8TXSG?13^]X _>AMF(I"+O MC45*=$"O[?$!O2(/Z 6'L/B WE@ZH.]BR@$64W:X5\WKFX-VFP>EVK\Z-[^W MKI7VY7GG^G/SIMVYW,-:X64]JR69B)&)&$51X21B+EH?FA<;96%X!J9UUK[\ M(%,P*<366F&":XJ&*-7!.=I%NN.476+D[Q1%R0G^3J)VT$ENR(_U>^@% M$)VPFM[!Q"7WK.(UZ (4)LWN9O&&H&]9.N?CU":*Q@](:CVH"CNG!Q;E"_W/ MB)ZXAT$SK0Y/V,QK-"ALPBP=?2A[JUV8N//G+\)C*2AV>][@B2[#>AN\U')Z M9YF]>'?0-5EX MS9^^7!/&7IC'ZNF"VK+X*\'8!/EH]+^'P07CX%)RHA&7MY(WOX@;EM+P,Z9I MLT-P<-EOJ<504(0SOU8C:#@4#!K=Z&4Z,MR^%>;S8A> 685/J*J8. >]6/6+ MO2B\CBI>INQ.]J(DQZ)/MX*:N[<42>S+83EIK&G@_)*A]S9JLSLOM0[*3)9U MSD4X,"S/B=7YT9/R-&BP0 <<&>Z8';N_S97.J/"P8F=^%%_('J0"F>Q+;UA< M]*%F^=:@V].B#5;X-O1Y3X2G[QS@Q'S4*")H1#&_4OFTVU2\N6:\ST)&;S,M M@H'9+X=Z84JWB,$MGO,."8RL8=6.YCAXX<+<'2KAQ9%8H:-++2FU%XJU ,!; MI6<9YIBW4:-^E5JLZ+**X]+C(:M9$KQ&@AO!Q25.,B!VWSN@5H98 ^7>'#IN MX*J9$["LH'\O-7,^:\<6ZXA)Y@XA] 9Q:\\DFAO"P;S&F9>&+]Y%))S&P7P: MLF$+PIG&[PZ;P!4=Z^-('[V?#4.>)(14F1"2"2%%49MP M,D+LANU&":'SYNE-YUHF@_(V_O]2,GK!PTO$Z+REWIR379RPYN1L_#;>O.=> M+,.P*(H);Z T@SL$ 5_/SF6LL?N!6CK\M+@@P)O#![*LOM&G.$XG775LYG8T MZ7:DVU$4#8[7N;V\;GUH=V]:UZVSC;Q/MWG1ZBJ=N8@9?&7!IS3,:\+(VY-.:@[F]];E]NUN"MVSQOW7R-]W631EP:<4Q& MO"*-N#3BBE*!8\1Y ?=&5OQ)L?>1M-\IV.\BS#1U^UV$26UFOZO2?DO[K2A5 M./:[]=?O[9/V#;I(^I47!.M[?$&P*B\(@G0^RZW^@4Z9F:3'D7EG^@=M&N(\ M+H>(^Q%49!0W+(4$=/\\B0J2/408$]Q18S9TG:G=/^PYEN,>*>[P[A>M5'ZK MZ?6W6J7RZYMPPRZ[P5=H+)Q,_1]IZD57WZE+3C 3F=5497Z"I5=)'0K84/_Q M7.AA*".7#.@SU=*/DJYIY%%7#]7__#0=VS&M=R-_G.;<3AG8YJ^SY]-R!LHI M;^;26C1[Z83-7"93UYL:P0O N^$-&;VD+2X-&>Z=81/OL/-HD=F\^8Y6HM^( MVO3$>_,LEM0(0S@6$*6Z;5+>%$5%E13U>5'3!]7.;7'*!E@#JLFT115:6FVG MEI99Q*M%*]NH$9*TN" 1)465%G?5XFH9AKRP0">PN%J!8]M&J9K TOXRF+JV MZ8UX]T1K]JNTL5 -%R!1I8U]:F-E5/N"C=UM5!O8V&31;)HV]J# )G:N^/0U MOI,G!PL<6]_4;$C"#1<'G5I2W[4ONZ)=)%J--4_[Z^3Z0FG;GL_?LWX6]IY9 M8VP3@B:IPM;]+JD$FR@@P2)W3W]/:9';ML7Z+/"UOC$>V0M"V5L-?6+S;C/= MWHB,C906OR@+_$J$GS8O=K/XIX;5FUK<@BL7IOW]SO#V:1^\4DUGK?/=J.F, M#$S;E%K:2DL7S9/=:.G"N".65-#&"KJZ;NU&05=!\Q-I[K;14SDE'9WR)NJ\ MDH2_$\ (7O1P9O@&/3=8A ;\O",@?\V%I\15RM]*Z/!WD 3]",)B!OID]5>A M^I8JK #5NF=1V5J@222J$FOL<95835:)@;QBLOR>-[!MY+OM#Y?-FY4[8!"- MT%Y?^KH*LVX'\QX_P1NW@@:[\]3;NI=G!7\X-#W?90D\WCVV'[PJ*N@-%+Z_ M*WSA%PVM6(?5.S(RK,&\*S&GI(,O'/!V1%.;_E%_RMZX,O5'#G\'U[Y=3P-6 MB1B+(VFDR>;TVQMM"_DROC_PK=VYY()VVA?*?QMC&B-_:';?*NW+TY6+ ^DD M3=.>Q M$06$7/GN:"@+\?KE>V,E?)SH)70].4G?/3U)!T]\Y8ST=*?TWGO/IW'MW!'V#HQWS7?*V=2VL]E%BUEH MI<)>2)!8>BV6/IOTP$0LY>2=,VGAY&1=MI8RW^,)#660HK MQ!059"BEY%D1>M8Q9O1[P=M@@A(.0" JIIP@58ZX*BY)05F%KF!GPM_:>Z1< M&)Z_=U5E]6VJREZH[(I70 _F?T^ ML><_T6]=3L=4N3U>V4F7XYK=8.N5WO":JN#+A^RU5(?T5S:=$1V"F$&TE:'TN9#3;W#H6%,COC[VWU>F-.T^Z<.CW>I=DSBO5&FMAD\:NKU MWRB/GGEDF]9O;WQWRE;X_?+8QVNDT5>ET?.31J"&\ER:G_;1!\.T+M[@YT3+\SP[&(^MQPFQ/7)";#(P_5F4 M\JHHU9Q$407+4HOIZ'QJ][UKTB-4-WWV&MZN89'.X,R;3&ZI( Q!W9'AI@Z= MQJI8]:=+U/6=WO>VYTU)/WA=WA6%D=/G=<7\L] AM!Z)VS,]TD\=4Z+5:^0A MYAHYZP)[6-I$SM9X8CDS$LK[8!/7&YF3*\NPTQ=6M*BJFI^T6ZSMB@>X2^HL45>L?J82:"*5E7=B1M:!2:2>%;O_$I@ZK*0U Y2+M+;B!7(0 M3*C+6@$$$WA-=2.?L*U<6ZQ7/DY@B[V@Y>@&MEA8K;A^0+BZ:3J"S>V)EJ87 MV#BZULI/1V^.'=GQ_/^52\;F=+R+H%];L?[1Z8.=2"Z> MG$@NR19!]Q9B56/ND@;_+C$\D;%KOB08^2/+%[9Y$3Q^[S"Z#$\YN^[YIW4Y_T;YR.:5%7 M_\'P*! G[+O;>/QM/(56C\OL>'3I0HL;V(X;9VXLO+3E77-B%YF-1DS8IN<1 MO]GO\PX!6:R6+K <>NFI!&=DXI*>R?=NZB 3+8*NKHA@>A/',RSOW'&[Q!I0 MO'G3\203B!Y&GU";0;?CF&4.N,::KLOR7"SIP3._"LL8EY8TC2N>;IS.KXC+K6 4Y]U1V*YUG")ME+NR[E851-Y$G:O'IU=".3;! M;$"[WAPQ%:Y,=/4\!ABW-<$$5P]V6' K4&=Y]7 ('[/5;"Q2V;S,H$ M5PZB6' K5&?J45$1<"LXU903QD@P<%L13% <"&' K4B=XJ@(.&X%9[MRPH ( M!FX%Y^>R.!#"@%N1.L51$6S<5@2!?"5A0 0"MQ7!N:PB#H00X%:H3G%4!!RW M@D"^DC @@H%;P;FL(@Z$,.!6I,Z$Z2%0N*V*"K02!D0@<%L5G,LJXD ( 6Z% MZDR8'H*%6T$@7TD8$,' K>!<5A4'0AAP*RK.3)@>@H5;02!?31@0P<"MX%Q6 M%0="&' K4F?J%%H!<%L3!/)53'Q937 NJZ+ERX3JQ,B7U02!?!437U83G,NJ M:/DRD3IK&/FRNNB&"":^K"XXE]70\F5"=6+DR^J"0+Z&B2^K"\YE-;1\F5"= M&/FRNB"0KV'BR^J"@5G-E6%2Z9MIU*0=-JZJ8H:2:B"CJR T2OJ#*(*>KMB0:]8 MI2!)M;53%87X@C:TD-$K.K4)^M>B0:](I8(&N!C0*VRB#HM<6X=>T:EMM4$O M'O0*50J28%LW55%K"76US3!D](IZA:@:7))M.Y6"I-G63E44XFNPB+9UZ!6= MVC2X5-M6*M51,)-6G':QCH%74249_I M=8T!O6*5HN3:1.TGU*1]KX&@5W1J>Z;C-0KT"E6*DFL3-:%0DW:_AH%>45<1 M]9F^UQC0*U8I2JY-U(I"3=H#&PAZ1:>V9[I?HT"O2*7/-,.&CE[A&W%1<6VB M#B/J,SVP4:!7J%*47)NH+86:M!\V#/2*^HRHSW3"QH!>L4I1BS92Q/[T['H8RS3GVTWM?5P%$TNQ<[6HLE=F][WP M/4?HKO)WI[6DG:RW-2=/W-W"NBQ6(4/#(GJKNOI,9^N5"6_Q_OKU HFR;$F; M3VRN\A]VH[%I!8C%RBFS%PN1D;\LBA]BH[UQ!(K/?V+FE M%8FAE7*RM&)A_-57=N8*$8N240Q +DY.]K8@680]_>T.%N>V^.;X9 M$8\H#^'@RH-I6D7SDCO> KNAI\Y9WRS"@FAX%BQA[+O\^G-A?Z^-__=7AX0U=4 MH3\I V=J\[]8S-(C?/J>0I?1'-KT>;ZC='LCTI]2X9U!-"S]O6G?$\]W7._P M\%B\6MI+J]6QE<_&3-$:;&(J_:\_(@JC0@Q[1M?,)W:?C4]_.5\1AH@^7Y@! M__U=G,*)O@A'B+E3G! L28$';W23$LRBOT=T" MF66NOSI$_0DG7ED+6K.7O_P5%^T8+9 M>SN?_K..1ABHK52JS%G\4\?SO5-C8OJ&Q>KA,F!PA0+%H^D.75GW-BB88/)L M+L/+ @@=;V.' HA"L]6F>!?$\PCI3(A+<6F[C:JVD+.E>*+C>0T[\F.Y%RIF4@J9W- MT)VPHK@O]I3[IJ5H'0&MQXK MN2%^Y\XW3&H7VG;KL3=B52WGCOO,5#+8LJ(=L]H7KE@RBVHB-"T>[%^8/6)[ M9+L=OHV6JVD-_F)!],*0](EYU*2H[C-DGUO&\,WQP+ \LEIQO,$#3Z>NRQYG M>CW#8KND9?=9<=2;X\-#53O4U96G)W_VF=.;CAZKJFU04+ MO:Z8_9E.MRMUZZNU;7>;5"2R4G1U;2DZBUK.76>\'(J$U7&'1E >IPSH.,H] M&XA][ 0#*4,6KP2!#!E/+&=&B,=/A'UZB.VQ\$7I3UUV=F1Q%(N9WBI3;_[S MG67TOBM>;^18],^"9QY.J$SL"V.G3RQZ5/1'"ELYY7_^^__5-57[U_]$ 1&; M2+#W%NAVR8!&.':/>,?_MDS[^Q%].AD;=-V51_[SR&4J^&FS[+A6TG7UW2/? MC?Q#?S:A.O%,.A6^4,M/"%8N-H(2C>I1UTQ_Q6)0VZ,6P?'T$8VF1Z/IE54E::_"A!X)K4=" MZY'0>F-U2'TM+M:,NH&ZC5:+1*M%H M%<'^K;X6Q]5([JH 6;6UR&)NT3P*PR(>1=. *QA94<)/"0^ZCOFO%K]DET=\ MF2QY6X_TW@V=^_>G[4_+D=_3/UX,]?[)6+'Q)SPV?3(^]=\NORAP MS"*(0QH%EM3Y0Z+/E/#QL;GT8W^D\Q!Z^9.X-(N1692SM%3'HI53WRP&+/+2 M!<&/'ZY!Y;!473P\_.05:Z!!7(,X#E)8 QW<&JCSXV1J:U"&L09+9D3=QHRH MJ9N12BY+%RT)&;)C;6S2X4=]*LCCQ*+G0O]SD,SOF_2;'O4GL1.T3V?/_K[U M8\HSNN.)8[-D7_/1]-X*6X;)B @_-[JOO@?)RLII%C+4; M>Z#NO(UM$?6NLN,I9J7G:: +J7 5N<+S#X73/P&K&G*EY6V:L]6>CEQ[!0F" M,]!<&;GF\C>6I=1/+FH%N=(*9"PST%X5N?8*8BPST%QMYYHKV +4D4.W"/F2 M@I *:@.YKO-V,D54NB:3)?NURS69+,F>N4C[T*;)9,D.23)5#WW>Z3 M)05; '")AY_VT97KT&GZ,_:R +]I]QEX)^Q1-[,)"9!+O_69#,U^W_E(?KJ$ M6.']G[7(S2@X* B3HNT^4Y%+4+5T3$YCW7:?)WC]-F&[P>L,FD.*?WY+:;XS MKJ9N;V1XA&Z=KF&1Q1=VN#F6DAH4Y;&52,&H[3ZI\3J4ESC*JYNAG/Z1%ONC M-%"^^P3!J]=-.U3UC==-C_U1"NNF[_Z,_?H-IZ>XX?3=GSE3 (Y6V@(XJ;H5 M???'OE<#)]TR>7 G)SA^-8-+#>"HY8)KJXA'!!WI7CV6'@R6SH8MO7* MF6M:EFD/K\UA/ILS_>)G'2P)G51O5%G=B>&2*[HQUJ:@H&@-W,%R4ZWQYD[S M_<8;U:Q/'T)1'ECRO/"FLI">$2Q_7G +6T1EE\'RYC ,K-7"Y'U@6-EOE@4L%30:E(_XN^4 ][,?/IFV.I^-$^VD3?%RS M%CNL.2#%R(UKV%[02-([F<4_6<"$]XPD?0JD:^*Q@HS^*447G7N/_KLS:-L] MQYTX+N_:L[[R @R"P.691 @R'B6"0RN%2=A%LAS!2X+.'+N*&:D[@IL)D"EZ64<"N"F:J 2WBN<6_D MGM@GCN'VDUPR2 \NEX[="ANPG\U;KTL3M0PU<'E6";7$J"L?2#IH*9ID)B#60*76(M7S<(+FN^3H?T?Y@:Q[9Y-_6V]TO8 MC87,=>,%7+860Z:M\2*GD*9*YKOQ BY;4X4L=>0Z:J>$#+UD3)/#H^Q!32-"%+ MHI\S'<>=X3[[PFQ-%+A,ND0.;%.%+86_\PJ&XN$L6PN%+7,O 5-,PX0L87_N M3-TD6=>-AH0'M6QM$[94_5-6D2I3%N85QT;5D*7LI8TJ+M20I=>9:4N&-,1 MR]09UI#EQR5BBFJ:D*75J=9/'=N;6FP')GBK"&:\96NAD*7))7 *;JC )=>? MU?L9PQYAG55,^YYX/GLV:QG--#YO(9U YU ,!;@D]:+2QS(\KS/X8K@N78.. M>VT.1U&S[V^77YHGX6=8&JC5P.6'D^OJ%)NNP.58D^OJ;/[9VI09H( )7'YS M_U&[YUC;], ?C.D/76-N6-7V+ M8C\82;/F:',_=7"YGY=SC9?D@2$K,:; @RI;@X,XP72.,9@ FV1ZP:7CVU5@ MTTL;=CIGV^S#SE+MA72O&#-36T3WQ=^4#; YJ4TW);6EH[W>E VP*:TM5/UW MTGPD]I-. VEB#%F^N8$Q'Q;&0K\CS#SR1*)8=* M+H-5\GK;>X'2]E80:^PSROBF"E9C6Y!-=K+\$R#UU?9&?70'7DJN<*[W.EB] MGYNV8?=,PVI3_+M3?@-V4ZX0,]XR-A@-L, I8,5/(6V#BC;)1#WX!&,0IF). M,G7WWEFK:#-25+W7"78BF'V80U;IU1 O;P/QRF&IFBK$'+(?;P*/.$B; :>X(]4/57PY)"#>#5XHB5(!3PYG.-?8WQ+S+6F6O:DJG"/ MM.O#5G.CE'XJQ^G-SD1[$(7!/?E*'2?4L8;UZ-N=WGD]U^0%.?P3^M4!71Q[ MN-/N 4M*5[=1NGJH:FDK'>[I^4G;@?FO6^.)Y*3/7@Q,/S48 M!/AOO>;4'SFN^9/T;^T^<9^T[O5.9JU'XO9,CURY9H]<&_8P$IC_E/3=((@- M!MRB$0G"XIDTN 4MJVCZ,PF4MA@)#YB*:='@5N5(#!;.H,'-BZ)QC^N+=+%; M-+C)4PG"PIDT'6Z:%HM_W'N+IJ/)&DL,YF_0T*2U ;O'D4O6UX2"012:++I$ M%&P_B8DB .HG)0XI#C&Q!!*'!?"PF(@"H!Z6O;@>R^4!'5/27^()K)_$1!? M]),2A:J.B2^0*,S;MY8Q$090?:MYC^:B9QE3\E_B":J7+&.B#8!Z28G",B:J M0:(P=]^*B3 ZEN[YB,29KV,*>TOT0340V*B"F!Z2(E!3/2"Q&#.7A4320#5 MJY)[LNX>,:"H'U/"7R(*KI^L8*(*@/I)B4.*0TP4@\1A_AZV@HDL .IA6ZSU M%AY$84K\2T0!]I68* .8OE+BD.$0$]D@<5@ #XN). #J82]-/"\HJ& B 22> MP/I)3/0!3#\I4:A6,%$.$H5Y^]8J)N( J&^]69NO!8,F3.E_B2:8'K**B3* MZ2$E!C&1#!*#.7M53$0!4*_:LA+1ZG PA2GI+S$%VE=BH@M@^DJ)Q ")F(@& MB<1"^%E,I %0/WOS0*SU-XT!80H3!2 Q!=ECUC#1!S ]ID1B@$1,U(-$8A'\ M; T3D0#.SW9[Q#:HPFY&INL31%=::IBX 0DKZ'X3$[D S6]*,#X!(R960H*Q M* X7$\$ SN%&?9D3@ H,I# Q!1)2D%TF)H(!FLN40(P!$1,K(8%8 "=;QT0N M0'6RYB#160#.::".B2B0J(+M-.N8* :@3E-B,<0B)EY"8K$@WA83O0#4VW;- M1VRHPL032%0!]YN8Z 68?E-B<8Y%3+R$Q&)!O"TFB@&JMV778I+@"@RH,-$% M$E2@O68#$]$ U&M** 90Q,1.2"@6PM4V,)$,0%TM[_",AYIO8.(*)*0@.TQ, M! -,ARF!R(&X*C\[Y?/?U;^[W__ZDVFCU_M2J/_LW8__#JS;\^F M#Q]J;J/V2?O[]F;F6;7[WL^2]=%_[W?)QY\U_?NCVKOP2]_.S[7NI_?WCR>G M7TOW_:[[[:MIW_W\=M.S:E_'?U3)],,7UX=FL]4_-_/XW&?ZX_[TVF_ZS]_5\ M6&F79C^&CU\>?M1_?IL9W9._+GONE]&G^^_?OY++RM6X33Y?_[@8GI5+XR]= M]Y];W4?VW^J)_]4O[MGWQNS[I?I8^ON8V5Z<:;?5]R9]JG5 M&'XZ^ZLYK/X]_%M__*A]UG3;^EC[]/#;;_^GG':O#P^/Y;;-?]MF'))@HF& MAB2L,S8F2&%B4R2D( <7F"@8F.Y2 I$#$1-M(X&8OY/52IC(%Z!.]N:!+L)L M?7#0@ H312!!!=IIJIC( M!)B6@ [3PE'!D< M,5$4$H[%<;N8Z ;0;I>UTDZV)2# "A-U(&$%W7EB(AT@.T\)1@I&3&2%!&-! M'*Z&B7: [7#-!&\D!@,K3!2"A!5PUZEA(A] NTX)1DW#1%A(,!;%X6*B'4 [ MW*[YB(6TUS"1!Q)4L-TF)L(!LMN44-0PD102BL5PM9BH!MBNEC75QD/4:YAH M PDL\,Y3QT0X@':>$HX,CIB("@G'PKA='1/E -KM\N;1B("%B3Z0P(+O0#$1 M#Y =J(0CAR,FRD+"L3AN%Q/] -KMLJ;2:&A['1.5(&$%W7EB(B$@.T\)1@I& M3,2%!&-!'&X9$_T U>&.3!=3;^DR)@Y!8@JRTRQCHAV .DV)1(Y$3#R%1&(A M_"PFJ@&TGT746+J,B3"0H(+M,S&1#)!]IH1B&1,Q(:%8#%>+B5X [6H1-98N M8Z())*A .\T*)G(!LM.44*Q@XB0D% OA:BN8R 78KA97,^D*)JY @N^\\1$ M-(!VGA*.#(Z8* H)Q^*X74QT VBWBZJE= 43=2!A!=UY8B(=(#M/"48*1DQD MA01C01QN%1/M -OA8FHI7<5$(4A8 7>=54SD VC7*<&H53$1%A*,17&XF&@' MT X746/I*B;R0((*MMO$1#A =IL2BE5,)(6$8C%<+2:J ;:KQ=5,NHJ)-I# M N\\:Y@(!]#.4\*1P1$342'A6!BW6\-$.8!VN\B:2=0B*Q$'X6$]4 MT\\&D%K?5QH,I##1!1)2D/TE)H(!I+^40 R B(F2D$ L@I/%1"O =++A60!1 M0^DZ)GI @@JTRVQ@(A5 NDP)Q3D4,7$1$HJ%<+4-3*0"3%<;8BI1#VDPL,+$ M$$A807>HE3'0#;(>+J(6T7L)$'4A8P7:=>@D3Z0#:=4HP MZB5,5(4$8U$<+CS*83(H'<6TPW[\;-KF>#I.1';OL4_?^[;I>@D>J2&"N_$H MX2[AG@#NDFW91RQF'#+ XUIR#1D@Q[K2A);@<3FY1@P2[:#1+LFB/81BMO&" M"H\J8B;SQO0MTAFT[;YY;_:GAK704VL\L9P9(=Y::*&W%RH\OB:9;M>K%KMF MX7$?!=>LNHUFU0PT"X](V,'YK>#@*8Q9P,$7I'PA$_1E+^OE- MN]_Z,34G[%%+"DWS&M#X87_HVY5NG8MS:\M"!0C1=F MC\/+Y:O29TH>YO]H-AA)^M->4;CWU#'^L9/580 ML 2R<,#8Q\G&3@5@,?[_"5+2X/\U>(D[B91<*D4T>%FZ9$C90F?I >;;Y9?F M64*8@K$I\%)^$BGYV!1X^4,@2&DALRDZO,2C1$HN-D6'E[$$@I1S;#8%7LI3 M(B4?FP(O9PH$*1^PV11XN5:)E'QL"M8<;>Y(^1V;3<&:H]UOI&1A4V2.-B.D MM$,)UIR:*4L,[48D9*!32G+3&U&2/F. MS:;(3"U&I&1A4V2F-B.D6-ALBLS48D1*%C9%9FHS.BA_QF939*86(U*RL"DR M4YL14BZQV129IL6(E"QLBLS19H24#C*;4I$Y6HQ(R<"F5&2.-B.D7&&S*3)' MBQ$I6=@4F:/-""G7V&R*S-%B1$H6-D7F:)\@!<+VENG2C)66Q4[#FKG6DY&RW9!5KWFR3E@'HMR36 ME-,>66#)2,-BN4CY*SW9(UM.F=#6ZN8M^2-;19H7R4G/&61)O> MV>#B)_HMB3:]DX^2,]Z2:-,[&]R;A*,MS'F:I#?2T!M0S.F=')2<\9;$G*=) M>J$+_99$F][)1\D9;TFT>9H-[D-AWY)UM.F=?)2<[9:LH\W3;'"="/V61)O> MR4?)&6])S'F:'W)+!DK&G-[)0ZR+O1U:T]CR^";QSJ>6=>IX].'^R.GO^89MP$W^0(> N@T$GEQU3P4"<#-*YZ9M^N3" MI%INV]0<#LT[BS0]C_C>R>RS\;?C4-N"DC MJ%K,H.U$ VXJJ3N]\\B/*7U ZY[^)VKK\LP7\G.\Y<.2MK'CK1R6JJE:7;CY MI"O+L"^-<=2UY^;!N1DY4\^P^]33WCS01\_.3=?S.V/;O)MZ;;O'1+DG["^3 M=/5!B[O- [[X'Z6".WB9LPO5EJ'?L M94.?2+\2[OL"=WBIY[5P/W$,=VUZ2@)]SX .+VN/&.AH<58NP:,&7L99B^4- MDR"M@#"3]C0[G,/C/U[&.07?J6-[4\M/0E87TZQ*O*>(]ZEM!F#W1H9+Z,+$ MY!X3PYNZY#@4BG]A_ICY9]&#V9-6GCKU^F\6DWCR6--SRII:.[KMGJT\58F+ M_-R3KXB[D'II! Y[\F3!V5]>3L?$-7SG"902R[2D_B/_#U!+ P04 " 3B*I4XA-W8U\' 5,0 M&@ &8Q,'$P,S(R97@S,2TQ7WII;VYO:6PN:'1M[5MM;QHY$/Z.Q'^P(EV5 M2(2\M+D/"8U$ FV1TB:74MWUOIE=+_CB75/;"^5^_3UC+[ )M"5M^A*.? BL MUR\S]LPSS\PNC5?=UQ>GU4KC5;O9PB>COT:WT[UHGS;VPB?N[A6W&V>7K??L M;??]1?OY5J(S=\P.]H>.=64J+'LCQNQ:ISRKA88:>RN,3+8P$$.O[CONA*7< M]&6VZ_3PF*'[K*&GG=-IT>;$1[?+E>QGQ\S(_L!MG39>7+[IEI?;37@JU>3X M2POZOE;^*X)\F.GLM/W7J\Y9IUNM/#VH'S3VSK O-#T^KGZ<8O_DULED\I"J M/>!C.F]?=SLO.N?-;N?R3;5R]>[Z[;LFIN]>LNMW%VUV M\)3O'CS;YCM[!T=Q^+8YS,69E\BYDH8/J4RG5JUK"=J'&L>J,_9" MFQ3C=O]@.F%_2[1<2L6>\'1XPEYRK-+)HOJZ[,S/P]KO@#6']:#.&;35B>.9,+9AUW(D4L( O@T 0F M(KEB"8_09)A.I6-.AWX+'3(1"6NYF5"7E-^(:L4-2I-:-,:0!FLJ8@6T"'6( MI(GR%-TRC(0 MYAU"-AU#SQ&&85MZD_)&K,O9KY4A/P5>>2-F2VQ8L$1F,!(RN+E1U&# Z([; MIG1?9@G0C#M",9E%*H\Q)PRO9 U6*TD!!S";LCFR1>4FAEUM5+8D[VS-APG MEC1SC2PN5^@ 2]8P-[^>]0)%W Y8HO383LW0:#[=XZW"?&?LCUB2U,LJ!(A%$Z220N_;%W&#?" Q8,1O:4 M($-@ F;=4](.J#MU2P'0!-)T'4L;*6USC"/H-EH%2QL:'8D8S;"4;5A6+&"J MP7S:'Z,!S_J"-8&*U[F":IYT'VV+'3_6$V^Z"I>2LH LF#@MP @Z2Y8?#)&$ M^*V,8[DRW>89DI_S]L7%VZOF>>?-R^=; M^UO^^JK9:DVO[ZWP6,9N0%WW?]OR98-&]_K^LXS(7".NIKN"_=LJBA"-;FLZ M7['6?OU(9G,UNZW%GM]("F<+'?J5'NYH>'UV+ \N]D/*V1(64Q-[(0D]'_HR M#M2(JT4\ISBZXA#B3#T!EP[+%2Q,YP83(#*-I*5X%Z1 5Y'YR2COFY/ 2M)"!,7H6D-%,N64@<1Y8 M;9"%>)^/D]H*2.40EVGDD),9YXI3?(>"7I(Y)<2(0##+Q!C?>H(Z(@)CO(A/ MRB:"?]?!K?:\ ]\!IEMPLP@V5=!.BQLO6)FSR[NH] M,2#*K:YS^A_$\>3I8Z':,#=#P('UA#Z*M(F]%#Y%[(L,-%T!%7!'# ESJ OR MW^#YP"8Y!'O9^/Y:^W[T2'R_/>(JI\A81%[XA$@2Y*1R!$.V2W++6?JQ0LP/ MEW?2S5E!$+$? Q&J;4AJ>SIW7Q!C%6K"9[T%Y>W)DE(-NUVI8;UI1.MZ^RM\2/QUE8P_ZFWWG$HJK,66;*_L]1K[Q&?B7OK*,H->4R) MXR[.&L1)M76X28_Z,*&%W4R? K#M3TB3 00-._T+J2/X)6^3DPEY"R?";<3 M1!MP.TL-*-QZO!!QD4,@7ON=*=C"A"EY(U11.;XSJ/;-FW6R D;\V")#&60> M;X'CZ*NK7_Z15#SUE]H MZ1LP9YI*YX3X3%3M:3!9NA]+".@GV88M(WY9"I+XI!P8ZX=G'^)#+J& =[D\ MBWQY>&=3Y-K$S4V1JR1G4ZDBJ\0*$C!!)6&J+D=2P*\+ICJK,XT%OR'6&3(\ MSSM]ENJ?4$Z?PJR %J5@&JI!W(@@Q]*XQ&.,MF(6ECZ)+D5NBR& "&2?M*5 E.0 I$.E9X(W!T/=& "_);KPU4_PY&GY'I%WZY_ M!][W]2^P?#OO^Q5>GFGAM(^KE==\@H8:.]P_/%SKUX+6 "E["$3"S+;M3/'H MAAW4CS"_?_P2]N+^!Z5$XF::/"-%'NXP]NQ>T&/AU0< ##,Q+3)?>FEO;F]I;"YH=&WM6UU/&SD4 M?8^4_V A;052"!\M^P I4B#I-BL*+*32=M^<&4_BQ3-.;4_2[*_?<^W)!R&% MT (M-#R0S(P_SK6OC\^]GM3>MS^<')9+M??->@.?C/YJ[5;[I'E8VPJ?>+I5 M/*X=G34^L$U_<)E>RF^TS([L]MW98>W=VVI[M M;C/AJ52C_;LZ]&6M_$\$?&CIZ+#Y]_O64:M=+KW>J>[6MHXP+M0\/LZ?SK!_ M<^MD,GI(TUYE'=L_^!'&1")SPCSP-!TW+]JM=ZWC>KMU=EHNG7^\N/Q81_/M M,W;Q\:3)=E[SS9TWZWQC:VZ=-BGJ;?S&=L'\D[IQ)Q5[QM'_ _N#HI95%U9F(765ZJ$3<%94PV\4C5B>.9,+9AUW M(L5>0)//802\0W+%$A[AEF$ZE8XY'O!0ML7D4>(=LNE/L#I&(8.4"]FG='L0+R4:7]1/OSZ-A\6+)$9G(0<;NH4 M%3@PBN.QF7DNLP1$QAT1F,PBE<=H$XXWXP 5>*TD\NO#;\CG:2U@3QL[=;E4 M^).=ZQL+)Y;4N)T,P ' MS&!;<%8[1C.%2SA6#ON3&O,&#MN^-KFOC/VY@FE>=.^MBPU?UPMON@J7DJ* ++@X=<"( M.6<\/S@B@;FEHW+I6D_)M9Z2C0TR='X]H #ID_T7Y1N+C6G7CQ#['#=/3B[/ MZ\>MTS_>KFVO^>OS>J,QOKZWP4,9NQX5W?YMS6<-:NV+^[L0A*N(\ PH;M"%.KM( UGN*=2R -Z*+&3 Y#52L;<>;0=*V/)C20K9!"P7I1DU%)N25-ZGKN?Y4M+2,N8&,RTO@+Y&4&,8 M4Y:BHF"V@8R)=[C5&2>]QRTXBT)>(B-NXC$G@*HD[T@EW8@BAT5]$U=Z^O#, M$!CN6M%I=!3@>&WYI3"MGYL^Z,GZ>">*M(D]"A]!=T6&*$:!I?!$](D#J4B> MNF+)(M_LI!%[J%? M*%;2490;6L$S,"7U$L$/( /AKPN0Q_S#\^RER"O68D10JZ@-G>FD(:+3SV73K:6.5- M5WSQ"^9-Z]FH2 X:*(D*5J_PZ@?KW[];4Q!%)HC*/%O?QGM^Y7XS_ B7 .SO5\N M?> CW*BPW>W=W1?]BM\+8.X.-D9A)L-VI'ATQ7:J>VC?'V"&L;C_1"F1N(DE M;\B0AYN,+;L5["C>):[.O4Q\*W-^%>3O!'(\S]K3XZ;"_(WOLG^R+3#V?$EL MCKX\A6W1#W_"+X'H!T/_ U!+ P04 " 3B*I4Q-0I!XH$ #L%P &@ M &8Q,'$P,S(R97@S,BTQ7WII;VYO:6PN:'1M[5AM;]LV$/YNP/_A8&!! LCO M3=$F;@#95AH#3NQ:"M;L&RU1-E>)5"BJB??K=Q0E1VY7M"G2=O,2&!'$E^-S M#X_'>S2X\"ZG9_7:X,*QQ_@$_3?P)M[4.1NTS1-[VT7W8#@;WX#KW4R=-XU0 M<'4"W4ZBP&,Q3>&*WL%"Q(1;IL$"ETH6-G B3IT_=MXIQ$2N&&\JD9P #M\V M+(52(B[:%+U731*Q%3\!R59KU3@;G,^NO.IRS9#$+-JO]7NM[J ]1%ZT>7S,?YYC?V:I8N'F*5T[X,LT.?T5SOB4*RJ? M>)M&SL*;G$]&MC>97=5K\^N%>VVC>6\&W5=PW7);HQ:XSDAW0[=_W+%^U5[^ M$/=M%^SQ;.XY8ZBZ7CK\NO,29N?@73C@VHNA?>6XS=G[J7,#]LC3/;U.I_<< MW/].9R:\7O,%Y]173'"X8VH-:DW!YCPC$2QH(J0"$<(?NGO&(B \@+<$34ZX MWX)#/?@@"FXS<3H2<4+XYD#F;T> $\Z%C'&EYCM<6>:&;S,B,42!\H &<$FD MOX9^UZK7>IU>;\><6;NT9@%)(6013MJ"=*F?2:88>JQ1.??^FO 5!002LS35 MB/&G1P9$45A3246(P"TD9TG1K]];=@O&&4>>1FM&PWK-N4>;BGVD, M#YB-0 M]%U;*)RS\(A)O0D6))E,,\(5*%%- P63>1K0F$D@$H6HJ\/+0?KH%/9=(I>$ MT[0YNX_HIEZS_9QV?78L'$#R>?$&/G!QAR2LZ,F>1.!>':?#[E&]IK>S.#AA M%D4;\#%V(AVEV\B5]#9CDL:8KE.]S0]1(CS;8P7\=%] MW7]APBS.3]2I/@E[0N9^14:OB S&,17&)-]NS+R*,([9@9D\588-81+C)I$T MU1%BZ6X218@;4R?#O(P="89,:N6S0L8)]W4[&@Q8;EHG1!R512; 1$)EOF9: MK^UF-!T\18O.DB:5EMD:9S$1I"623X&V]F1S_CG2/'LX=6#D3*?NW!Y-KMZ^ M:70:^?O<'H_+]T<[?,<"M=9#.[\U:GCE#N-,_+?XT;Q_/ZM/R:0AT(#[3A;_I\P5U:#&]EE% M^,S?-]QV<\GP1DI(] 42CYY9_#J+EV1CD'512FA]]!2DM?-K[>QG7]8EEO]V MH>"M&1901@)B%)E*R_?S2DJ7YPK[MZ*Y*G\?I?Z@(O[R09BBIT8(%2RSI*(J,H!#.V%DM_'21A[@2D=)=$?+J M$<*C7BN4QXYVKXXN%3QJ8XULE[P[9ARK8$6&EKI,]@5"PZ+5 )P)\$ "9& M&@ &8Q,'$P,S(R97@S,BTR7WII;VYO:6PN:'1M[5EM;]LV$/XNP/_A8&!! M LBO:8HV<0W(MM)X<&+74H!FWVB)LKE*I$)1=;Q?WZ->'+G-L*1-U\U(8$20 M>#P^S]WQ>"?U+MS+2;]F]"YL:X17T'\]=^Q.['ZOE5]QM%4,]P;3T0TX[LW$ M?EGT&G'"EP6T02NZ!KF(B+,-)>)3 M0/'M@X502D3%,T7O5(.$;,E/0;+E2M7[O?/IE5M=KA&0B(6;TW]:,)--V%\T MQX>:!GW[X\5X,'9KQG&WV>VU!F@7K1XOLW^/V)]IHEBP>4YJ!WR1Q&>_@HQ' MN:+RF=TTM.?N^'P\M-SQ]*IFS*[GSK6%ZMTI=-[ ==-I#IO@V$,]#)WCD[;Y MJWSY4^A;3LVP1M.9:X^@RKUD_+;]&J;GX%[8X%CS@75E.XWIQXE] ];0U2/= M=OLENO^C9,:\9GB"<^HI)CBLF5J!6E&P.$])"',:"ZE !/"''IZR$ CWX3U! ME6/N->%0"Q^$_FTJSH8BB@G?',CL[@APPKF0$:[4^( KRTSQ;4HDQBA0[E,? M+HGT5G#<,6M&M]WM[JC+URZUF4 2"%B(D[8@'>JEDBF&C#4J^\Y;$;ZD@$ B MEB0:,?ZTI$\4A1655 0(W(1+AJ(TA$$3AE(D:QJ&\+ML(HSABM$ SADGW&-H M@6D0, _QH@FTHH*CB5M-:E^8$*A?2#6X\+[.^WD(F"I!L7K2!3URLT19+>KHG@;A7N^JPIA@IL)IJ!Z3$P[$&#*)F::PTF-@SMR<296.W^ZEL_Z&/)(6%H%[5 M.RKU+83TJ=S:H/Q$A\W-;/&[%J@]"&J@MDU>:R/,YHY6T,[XJ5!Y'^W]%-2N\:L8W ME=<>4CV<288<8Q)6^>J$:WF>2+EB?%G2/]I#_I<$*]L.UL6ZYO\A?JTL.?>_ M[\AYX#1YU#GTK/WUCY^<+S1>2LV'R+@KAE5>WJ?B?L[+0<_+RCW=0R@C;6:O.1%NE@\EDV/#XL-)"FV_ZC!A 76 MG10[(;]H\G&P6IWJ2A1QQ2*ANYW2FR=T1S6C:(]VWC-4I7N34J>.]A'E>;.!.* M\KN*L&)5J!@U?S50,9AN##+HNO.L $R J1V,>UV\9X1:^M-"_JU!?Y+X E!+ M P04 " 3B*I4T1^SC.@D 0 0*0$ "P &EM9U\P,#$N:G!GG+MU4%S1 MTRTZ@[N[NPWN,#C!@[L& D$&=R= D#"X!]?!'0:')+A#< _N[@&2W/R^^NY[ M]U;=/]Y]?6KM.M6[:U>MTU6G5^^J_KO\=PN IZJHH@@ H$ RW\/X.\:0!Z MAH*"BH*,AHJ*BHZ.AH%%A(V%B8E%3D"(2T1-04M#34%%1OH&AD;&)M/KY]_P*>(R*CHSS'0E-2T](S,+UG9Q26EL++RBLJJIN86>&M;>T=G M7__ X-#PR.C8[-S\PN+2\LKJ]L[NWO[!X='QR?7-[=W]P^/3K^?_\ ("$('_ MT_Z/O/#_\4) 0D)$0OT/+R""[W\"\)&0Z?E0"&2U4:W<"1GXP]"(Y)*+&K^C M,PKH7!&_]_B!0<(DN,U\_1]J_\7L_QNQ\/]?S/X?8O\OKU4 %B+P7_(0\0'2 M@*WL,'DMT%$B%5LQ%/#?L"325J##8"L.)?(<V2OD+4(T9XS/DX#OPX94E&T5*-"]+ (D?TD[=0_6*J@< #5[Y1AW6ZB5P_F:%6SW# 99#TU>;N )HWJ$U8 M&/5 G_4 =*J1P -0J"G+I#(4R/C(.8%+7I7/+=SP.U84Z[:+ZSA5*:3]?CC@ M[AU5D&BB_-Q?0,O=Z$K16U(5,$;'UC2*W\?!;+Q>>Q>&-.K:*41:B!24\8=X%L<0C\'FIXBEU>Z,\^AZDUDZ7O:N9%I$A]#*F&5"YLX'; M)T46_QY?DVN^LH?0=V.Z5EWBS0CN"%%@\A.]>'6$1WOWF?'_TEOP?M>=;0?<YY.*H6R 8BA[J+8"$> ?$#'<)'ZSMSRE=54EJ%%ILYMPSN94J_6&Y )-29*8,Y()O)@\S2Z*I([77 &&8<:;=I4J)L)\ M^W2-%0NR$K<:5BD.1X5QV2,S.ON&!Q(^1#\X!()^I+ /&:76H1/%!TS?E,J? M( -X>RI$A4OG Y/RBF><*U/>-AHR2JMF^52]#KK+8$4-(7R/P^A-MU4ICO%Q M,=,WOMA2_A7T#-2/:-WZM"] *$.RPRM.*#8"8^DC4PFG8Y*<-$Q.S" ;TM,W M-FO:!@[/AM+2IMB-\?_:F#3N3'?>,M@Q_G(5S %/X_CD]AG%>E3(P]34*V)L M^I;]6(:X.-S^EG.$*3EZ3!,2LC8LA_[&8KX)<[S"EYY2288#W8B)2:U]](@- M2+-]OM#,Y@ .6VT- DL.=#=LEM[@RAH)BSNU425WH1:8G-[-))]%T)MYBQ;B MY&\>_#FQOPL67N%:5?BU3Y-V6H#A0$/;YN#BLIU_]CKAZR5D\OU"5\FDAK&]R^K_C895@NWS;VI9BB,Z#H/%I MMB@BUM1^ M[8D@U,K5N[ZO,F/_XP5(73?GOX!*V"5F%R5@'HQE&NW^X0?/2LP2?P?W%Q0>7AP!7 .+]O'7\U/>TI@Q_6\PW3U *E&W]E^"#=1PB7Z%R>[4Q M- E$&=++&;3A<;/7;R#:S%JOSG#>-AS/<%'B:8TB6YG)T7,9@I7B(5$+=?%] MQIME?IML[A_5_NIP8MY]R/ M1ITOW'E.CMCU'2MU?V7S+.L0R(#V%*T$(C:V2LP4MMM&)]/%-OD<+L^IBVO M=01PLO_'9%&?(<5W/5_).JVX=>NJKL2[HK7 Q2KE7+SLVO#G]G0,/=;-VE!R MQ:A/$/!-U1 7G;8S52TQ\P"7([B?\5/#O84'A,&HS@C74K264JU2F 3:57SL M>;K:Y- JW9TA?RLL*GM?_T8SXD'U9E6JA+W'J.UB[0;C,(.!??F'CK/9S77+ M:^VKTFS7):;)$X\&G\6IR%>';JJ(M9OZQ?:86N;6[O96H_UTAO=16MWN6LZK M>L@3$>=H):FZ8#V9U%C)U9?A7JJN!D=E(6&XF66W-1(N9/_,50*WB'FQR-6? M^4_IF(^*^RV>)LS2_BN64*T!OJ];X[*<_P;](0W)^HJ59/M35_>VGW[,A*09G32P>L%04511PT%*N@;M)K^$H MOW+W\;,X2?5V8]F&&27Y@(5I4#<.*&_6:QKU"?+;&UQK::$U.=^((#*'Q M2_%%YB)>Z,#1$##JK(MV+YZB[S'JWHS4[SUG5L5>W?5,F3]_5=JU?[7_N2*W M=?QL(>LK[?>B__+[HSS\"M:;5P@Y$#O+>G>Q.S'HUFD8X1T,06EOBV%L^PO( M;VHE6HP-DEA4)C#N@Z MW#G.UWT!CDV,@7;D%CP"Y3K7DJA$NY4W5C@U!F^6M[8S9V8-_@+BSW8; MK_/.^*RMA<]P%L+6KNMM"0Z4;_=J^J!LM9P*_]9"*P4B+: "D8[+-V)8L4E. MO*($5J@CF'C!3Q%@HC*RK6!E$=3(D7*0W%,U1B"D$:;@(9(2KH):ZP*9@(SVT9:TG @)B73&^YV9[963]!9CXTCZH*U>C4:&07\I2HEY\E[H# MS,,QI!+B]+%U#IU0B,Q2 M(#??Q7(F/HA2)T)@@N!Z%4Y>%'N$R8R_@*;R";U=F#J!$E8B9VSW;BBD6P2C M4:'3UO1W_"ZBR^/>Q>KAB-_S5RL!H0S.>R3)4 M-0^-:Z$'>O&:;[V%C$S-1+F0 M,>(5_=DL@1A=**HF4VV!M/5&$E>.W:YS+$ M# W9(@992I+1D(R;$[ 6GF7'$8?O0B%>* 7H KOD MJ3@8%20*3 "UKN6FRVNU U/FB0I$*]P1)3;N3?KCQU90M*WX]%*$ZII\;10+ M%2( 4R;8YZX2R9&&O-='B#:WJRFQ !+R@"@Y#0%D>MJ@#.%>03=FN;27U02< MUEY9&LX;\?@;D*MN?G+:*S/#0HBT4!Z:*TSY,-HQ2 &&C!*GPL6AM##']>-X M5UO6[O=V[H^2R.^/'T:6S@5$,$]E*/@+OKC/5DZ/]R90>I%/-GJ.JJT\^7K]%Q H M49B[ZSMNUMNG(6P[5:6^?.Z]\N&?/^%<(],59"RSK3X6![S,/N]ELC _VL11 M S.R\PSOU7&LAA. *8DDG+E9N[^6Z MJ%9?Y(GTNV+_/*%ABM;.%YO=!!8(YKI"3J78R[Y6JN#DP58U'KZYII>('LYV M]]$2G+H5RZ,4,6F'_0C0J8^5>(-B:%0@]GU0;/M@WWVHU%_=T15H,0PS@W3V MYX#\#-GBQ_DJNA&WN]Z1.!(,^XID8KT3GHH\)7BT6+@GNG%UW6^/+9OUJVI] M%%B9:%J=9N+W0L9E:/$ZV+$C!^7?5J[BHJP93VZ?8VE@??E2^.OA>?&@LAP7 M_]CMEZ>*[84\@:A3 ,65_:OGSF?#<8I4&S>!)6*CI^8!-?>'Q',5\DYK"8R# MYY8U$?WW 9EQV]W-E963NUS\Q3X[(<2#YFVQ) MNN+4I+=.&"(RJTEQVRRA3Y2BX)W,U%\/*$=V+!-D'AVS/>BH"T:\YH1<;MM^ M4HK,'1^(XBX,-,3=2D1VR!XL_EY[M,3[]A.+H2BN66U]0I": UX"MFR6$JVT MX'@]^5/"+SFU2O$*,7K1.K_MLGJ/$P,30=]\MJ:KGY&RS M40;UBE%.#3$#Z1#S,+TBVU] 1*I)BH*#:VG2\*/:P[-.%(WA MO$?>C_/K#=G28SR'@(0LGG0J2T($%X-*KUKI_L>I3U^6YP.P>T[PF>_FH<8IT[T='7 M(5:C,*QP?&*_$:ZQV]4AD6K8E.O0K\M2.F:T ME;^PX ?ZWF;!-E_D_]YF;D>,'S]^8U&=S=93$,+L[]F'1J;]74&H46Q1CC4T&L:[+H[*7.[;B61<); MI?II_<7 ,";(M>3)!T5@HFFJASYN+_72@GSG'0E$BKWKMLX(5O?1&Q?F\:.( M?>SLJ%('W9A\M:SXN;7:N^+KSZQ'GH:J/'3$HL*KP! BPT9D&__)]7\M6Q?T MNP*1+N _?5N)H);X+&37-($J ;SD6BK_8$[6=&71WLY H$YA5UDOY_>&0D]9 M$MG-FO6#=0DNM<9'K:P$TME&&UM6Z'RO-%]-F1A+]Y#O9W36;!^SURIW=3/= MQ[!'#6PZ,IM0]SM6"$JI\&W;:IFBGQ,HR9S9:XC2(G)($6F?ROA$80X M;@S&F)[V,2142+@*^#+HE.TYNH\W[E:=L%*CWY;-.8+9<88M1+++XE T7*8. ML%.+H&"SPA'5DZ(4) MW!1)0G@$M.(UD#P0CW7737/Z?HSMOV7=IX%K?7NH4HVA2KR802(<=[,:F($I M4.V(?B,Y*9F?S_?L).0@+.@Z86]6PHL0Z+#^O0I((2%D&\5,_5:LGWQ .5I[59I]LKR202E >M ^LEUP5"9VZ:WZ&Y"NA4;?5A.:*I=#1GC! M!LXCR1L94ODMP*P#?';GVJ2 [&0F!Q:F,/JO9 :.\..ZJL[/;1E]G?V@I7D%G802 M$[BR2BV4Y4PTQKWF'2%,U0JFOL&*O\4/NZO[J$Y95Y98AZ+N $GM5J-C;!LW M6F4<95Z?/O.4(;7^8+XF'KA@#-1.UN1\VQN>\Z?7[>LW\1FDY#7.SV3Y+;K9 MWO)P)00HX/!SI;,+S>*VK8(AXY-I4<6D2 K?$/B@-_D7C?BM^'BP6I])P<6] MN=A9N:1MQ)Y!G 7P!UQTW'Z3(>9V),%@T,T:Z!.W.T=.-*^3V,D[HO1(!NWS M*OM#J""T?%;72^X'7=%,)S"K/'HO5@-.Q'9<='KS[-RWF]BE.?>J7W\<2FFN MX=SS25C!:U&:Y+X]#7.$OEW[]_9BDTOG[!+W#_OMS=F;G[^=2\5# ME((9:X_;2XOY3M?^>.6@1 3"/XOLFOT_D=9S![T^26\$D'#5,GU:YHZ[EEU+ M'60%))\N]E2\,ESMM?/]%$4MH]*EW-I,TK">+WT=E*Y[8]&G%!>.:8?*D-=5 M/[XTV^/=BV5,>'/29+U&5' %._L+. *Q'FN>)J.JW$M$2YL0;2TU\GS/$_1X M3BL-(;:2PK6G0WALIAW0^^U"5TG#X:;)67*J;"-[DX%Z;'%,VI>(.?BX47#2 M5Z>TY8IB%-9+A@-NAKXS,X<^V%^A@!/'.[[$!:_F4V(>?[YQMDO*_P[ZJ? U MK&6'\CHFE7I;3SB'K5H99Q'D>,T-"N,R0V-TP4;FD,FVD]UR?(L67L>;W(Y."-KO4E>*W"B[%R3GS__[;1CY IJ9'^_A M&OCG//@(02X&P]EP/1A;LIZXKX3E$A(A0SVNXA:;&."I[@#8#G,9"A7F?"#/ M=#*E; 55SI[+J1+LR)'(AQ/6^M>8_![L7HE I4GOL-K-61,9:5&4'$]( QZ) M:'\N,[H+9.1)'XA,5)V<_PI'C*10L_'VW&P\DU![@'7GRS-AQG]CWX-S9]8[ M=G9)-&WX&YSP B]EL'O"!N]$""HT>*UIX 8.*\R6ZW9M,/F/.\5UQP_.L]R* M!Q4#*B2YG?%WAT$]!*&<3!G7WZ:F:H)?#((WSFNJDZ2LSO6X7<[Z\ E&C)[G M],,')+ZU2W;-()W[T?!A66.^*A:XTN;_XGIIX&VORKAF:@+F-:;>TD+:#M]D M BW_ O3*R<_L@2G\%?8S>=]N#;.(>B>.9QKQ1]*VB=CJ-4K"E-972 M]G9"V4X""].)E-7P)_5];TJ,E@Y8LVW_ LZY9))^=A&MC3(H89)BB0H"+4X, M$RG-XN[+ES,SS&'M0LAC))BA_I5.VHLZJ&9:*#43T'$,85Q/'81/&.^2C_44 MU5+^ OAHTN[3^>78IX-FD >_N6!;?$X9)Q,5.S6JBE+:2S85;G2.9&)J9C\( M9;P6/*DFDK_<+8#9V;\=I>Z/'/U>>;_VV>52I'@78IE=6P(N'@/NA++H)Q=Q M*V(+_]PW0*P\U:T64.P7TF\F7^^>02!58'H/S7->F!>I)0*&SF-00)_EAS%P M^/WI7G[((H=R\N,>J[19W@D673U4>R.LFZY4AMXEY6+4!I9;+"L3/&QLFU,UCWW%<'Z8& N9]T.E/IE*KU"I><+4H\C)B6JP="ZSND7\O;X$JF1K M?F>;/;\SI8UN8QD=;JR!S.+AN9^NS\7E=.IO!#B]G2" M["$NT?'D7C?26 D2N5C>]4A4E:P=/CN?WPMJB@93RQRY*4(4;DO^ C)2*Z@2 M-+"]I4 %-'A7UP/N78.9=$%3#MXKP"?WXMZ1W?0]N@:J'B'1GID.D\#<58N? MBNUJXRF4Z;\2@)69I@MZNR^*V^^HRG9-3R9^8L;P,8QPAU?GNB!*GAH:S=S] M]EEE\VK@NN]2^^!)MJ4A6 CM,#-*"('PM 8*FMM%*B8W48-/J+MZO@0[B3$81Z#?C"LF& M*\IR:67! R-2;$MY[?-UIJZ6 ?,ZCITK?P&F%>;T)[*BWRKN?%?JC,[[$R5 MB#-+VOY6./77[UZ$94C6 29"NQ*V=6:-)H5==J"'WP;*CYCC$S1JE:)"YG6L M:7\!PQ/G!9>-8J_5E1^)UM>>RL_D%H&6S;]0ENNO#LF?%R]@Q:M^D#7C!4Y+ ME3)C0 QE,AJCV""W_0.FP.0*$U<6B0+J17.X=![K:/O%B08:0BOS-?,!K$RJ MP'-_ZH-EXUO2=-;9+DDU&35-%-,<1V_QA&P2_PZDWF"'CHH[9,I\YWWE.KFU M$?) 8HF$^1PC*J>/#PFXJ+-=R_4D(/-Y?7?Y>1KW\SNJAJGO'&C;R1B MJ#S6?W+\*O1">JC6-S%LZ!!:W]4W;WJO:$/KGZZRIJY]NZV7B9AZ>E\W//!< MFD^T8#7K-9] 5AA/_=WB Y,W:WOM/'R.8>',V]_IA\'-Q*@G@(K*%R&S[:T& M:A9@T)=[1U/GD^ G,#1_X:C3)Y(DKR[/4.U#YP\7[2\ @7V1HGJIK#;SMT^( MW!M2<*V\T5Q.17;[([;:C-+JR/^U2OP'\5WMDT18AU 9!_M&., MR\Z&B_\1GUEYQ'XS5)&PW5CS[9*YFXZ:TJ_H5M#84)MG%\;B,'% EL^A4)HB M>FTU'*TV-=^1?-E%J,\;36PG+;[[OE3+0_@VV_/-R;>*^;=T#:[!_8-3"8I,-?@$,?5K7=L;*-CWO$^LH> MU-CD>HHQ#GABCV!TP?3AU^XO)3F(S(T:.6;D.Y-PICQ%%YPS+VUM]:!D=EP7 M?7L$PW"E;P0$[-S,)%JY<<+BB^Z+?8?CCK;4)98PYS)]>HN MU![Q6[V.3DI]-,EKE0?;&(2!#LE)DP3A. 1B2 P):--AZJJB^_<@*NETD+$ MWZSNI\FZ0O:JY"]$ANKE8:8;"0\^YFE!($U66;%J"FTNH>G-6O'$YXRMBUV8 MD[T)U@WKN%.?T$LI]+CX:H[3UA! *R]#53AG!4QA&SHD8\CX"YB:?:_,13?> M=)L0WEDKMSFU27T=V<=M^K)2YR]4S=/GMR'K8\7VY5 %G&_(75_WMT+H?YP.>HTP0BQW]E>X[D\GNEC_3<".NQPQ6 MKY2&2QFJM//,&P(!"IQ:'::'UB. VXGXO\JYO*$I&.VCY]D%-\R>$[6O7=Z] MY$]@0Q#N@!K+XEOGP^LK_SRJ)V*Y*=@,VE^4WY9R+(*WW@8ZRIU"4G;D$*)FKP8!3;>'!1]3CEGJC-.?#N#F*N\N_>6 M[;Z":\\G+XHO3&=2((V. !5.HJR/*7HJ@QO7DJ7]O5H%3H0CL)E%927EX89> MWJZUSLY848CDO\B"(+0^5,_UHF#'Z"\V35:3EIO3>!,&G34FUDQ)SJ+0M @/ M%;A'"\JQWTNR*A6K-E%E:V@OH!%&(<7/7YV,&(J5+EN_?8 MI.ZTD%%*IY#9CY A]A1$O8SS)D/H$3H1G+!.6L@SRWG''M?;QDFD#ZWIC.W? M3TV>7:/5-YN]82<$DJ4//YH]O@;2Y,.#)7@L5[$HTJ=*WR<8LD$)6=WN*[P- M!@.%Y1UV3/U:D'Y.Y!#;[VNDTBR-EIFNFQVS#>.W4R:*-T'>8=_]!R<%Y7GCT1@I.+.%UF8 MFB\0OT#2MAV+3<*0 M&8^Q)1$2GJ],"21LVH8E;/^GG1&?VNO$$?:OQGQLA' M*AVELGZZ N*S]/ C!Q3KI6<@/X]KTN6^74U)=N;"(T1(99CL'V%]$8C1&+AM MSMTWA!D##\*L&'\#XRM0E?9:$;&O=]\UUS'WD33OAGUYPY#!\)6I9%UW.K9F M-^KV3%S'=#(@\D,238&L<3[-7/&"]XL:9MMR@K_3U?*19+6227@?EZHD5PVM M>A?!ER]?Z9/RT8IN%%90:KXUYISY-ICQ7_A]$45<;;OL-N.NV_RSI(X'X<=O M#=DEIGZ,(A@?)'G&RS8FL90.JG 3T/V^S69W+7F1Y&JL7AIBY>2-4.4L2&*? MX$JRJAGXNYPE%GT^_/=?P#;7B5*MX5R0?H6QQ<;Z>-.QJ_32(-O(AX>[RB)U M4I47$XFO3O[O&7A'XQ.S:^VVNZJG,3<)((Y3 M.;A2R!7'^&BQO;/;^ZO]0+ADNR+JS/-"^RNIJUL&7UD%\OZ=HG()XZ>$E1K= MTGC.E:S"I^*7_D2/#&OA3&!4(",F5M;C0?FC#[W#IU+I"-URO[2="F;.+*WDB0_\YRI M27VO8RV^?+'*<575/J [V^_+F%;P,TQ;^&WQCRP%(H.(?\54!OE_@NH.E4A+ M*> M:LE9DGCB%\-"!U*Y1[51JHI!_YLM2U^A#7LWH;*(J762.L[W\0EQ K[\ M]WB(5#CW$;N'0FT5O*^GY(D3CJ.20.(QGA$I2#0I-LMCVIX7,2\9>=FA()#B M5]4O:2&1\0P53-R,I.A0+FVT$?,/80+NSCB8TD MXA->%QVR7"XD#CD-!'0_VLMR=OAME-PAA+*F,W?E@%@8+=1]0]!_G.N@"U$^ M-1/\_J:T*33JL,A5J=K0WRFZOG=)7?W#A<=&N)7"I0#-G0:1CPI+"]6_?!VW M\=>D?=):^B\/OD&/U;;/G/JE(-[5/!E)QYAK5R@\-?"!WD<"3JD7THQYO8?/"BWH/B3R=5-9%K@YI9-(P17H"9,Q$P MID(YL5JYI(!W6[/'&_2!;]8Z+J@*==+H62KE<36K.T\YCJI""KZ2W$+$N#_$ MAIB4@@<="]TR\&J4>!TY$,VLMS:7W),67B CCG$G.?9DY0!K(0.R ^(H?3U_ M7YIP''XAC=2&LB'F,V8?!5&@KM7GFM7@[E''F5*]&()5YI*3E-SX[$ M-AZ)TWRUKEYK=L1J<"31ZG8WHTF)\X7-E69((ZS*?I!,-8/W_QIUDUTM+R(^ MG "^__;:7R38SI3:Y<"(9 ?]/M/1UMH$#J26DT:R+W!XQW'PL'/H595BAX'M M:&JZK+2KXIWCF*/MZ&W_SKI]>V1?W3_6[;?*%O(%NY1S.5+ZW333B_89N=0" M=6OM@RN!/=J#A[R=[_NS>KNN/9>0F^SI*\9BOTXQVW3Z>+SP"S?@H*<"B@V(M4E 9KX9 RH+%X.K [<;ZA7=U[I-ML+1I1]3!?;V(\2\[9D))3X-7 MF[F-%0Y9=VOF0KC6.S=^U+MZ\-'*^L NHD2NCC6&'A^:N.=H:<5RN21.R1 F M43[MS!L!!7IEA,ZH4=U+7;]O \^LT:^55DG#>,8 ,0YWLR0S!%E)!UZ!$0EO MIBML,P?"B7<_:J1;X/2VW.HM7WB((AM'CJG)=ZE1ZVK+0UJU8-NJ%_* MI=DD/E1'TB=2?OYXB0CUY0QQRA@VD&1+I['S$0+1Q%>?/O(^WQ9TEN^&I'!Q"8W^G"=/94GX6#7+%$X\\VUVR:HW_YXB]V3UQH M=+=3X4^2(3+Z^.W'\[Q_(.5;K>R\:@V=MO+'5',-,-9_)V43LE.V<-GB;-U/ MH%Y6T&R^.5$<:+:+*M%01XJ]$2.Z1ZC<@6-LA$I-V6NOAYC;5N-0KM(KK"ZN MWO+!6#P85-(-%0NA;30%=Q.^8ENB(ZE!V M9"YS_Q!]V2HSPMKS7*P2-$'5EARDNA'7\BMA;-Q)P U8RN*:>,0 V^;DNVM< M0GW?^@ 54*%RVQ^A90\;*>DS+;KRU:U &++*6KX"?LH)OF9%2_02G(MLFKHJ MC'\A[7W@TQP5Q1UFXT,@TF>O55#2U62J&:22C9;!NZ[ MT5D#\NN/DX&Q1':;-[?1;T@=/RCBA% 0&&H_%I9PY_FD!6 /Z4Y4545E"07> M%*0!L]U&CI#9CA4ECP 8O!KH@D_%/_M9B<*RE,:G();,Z.U);,#F57D\5$C< MO,>;/X:9>$A?R0?%[92 &C:,L]DLR30\VX K-@0]^ MU_K",IH$EJ/1J Q91 MU49@&KZ\[;[8P*)6G<301BNVEVHJ[MP*H\FWA'_@'CYP506D+16L#,U5)O#9O1$LHGPY%CFZRWL$)F!E\8@7WR#!+ [ MQ:>;%#9@C?/=BX]'F6.,F*WU9J4\>5YL.C@1;IJE?]UN$S 7_[*J]-D2^Q(* M>':G;3\FI$ A->O,UN*,0"Q;:\BD$P)H*/3H7',C'9VIG*]G?T#-C MYPCJWEH8KSRPB630Z>_D M#-.E\PWVS;_YB^QEFPN)3A'<&_#-K^,UK;Y=44 M3F7VYGURM/QBH;/X()/ ,!CI KT0*[&AGY1L>%M[786^#4\^TN(^Q/$+LRWF M"/7)9_VDC,1D&:QHWC3.E?>>=4P2 MAF M",>P;@5,+$3DK]V.+)L^+V]GWP"8VVO'5[*I2; Y5GR*?I5^O-3'9.,Z ML[;+W9^&_)!M*TJM2&:LJ2=;+BIUJ0DTB._):XBDV9&9@D]O0+Z1X+^6P.UZ M8:!61#Q0E:@(UP3LL_(%RZ)SH7KR+F)#1?'2^^10E_0^R8D4FPQ8PO9,8G:K M'QNLA/X]KFH2\SQE*G&,-P#UXJ!XQIN$F]%V1&BN'Y8SZAM)8T0N5LANF35Y)6G M<3YDQ+K;7W7DO-_ZV% "O)7\\>K/P[/?7\"<#?)Y8G!QRWW4UVO7_M^$DUJ/ M(B)69$.\_SJLS5R'YX\Q7NV$IJUMK,)OX=,%IP2?_QQ89?]+/T2>74V#O199+#ZQ5N' M/@,U0_@>E25>0+=[5HKV-',Q3&*_QX7,QEKP9'*TFI\1F7K*T'A1\+?J J=3 MM\@#95C6]5:.'+DCQR;6]S^6FGWQ+=_%Z7-5>WVF@B3;I&2:RRF$%Y/!6%[K?= M6L:AAQLUHJHWC6**\HNU#JT_(?/%G['B;BTB]NW-!F5OJ1.C:_]\+\WZO#^H M-<^ZKC)MLMB;9KI6@_E->Z3.XL)\PLUQH))EO_)H-CY9QV!,;QW,VH,'Y&SBY"1NW+ 8M>9]Q37#$!FT@PKFW_.MLUN_"1/;X M)F2 \JQD,P.L?=A3[^#+= ")T!AB/DA.[$G*'JL\@9V^50%Y2PM=[""4:T7! MVSTMSM\Q0>74G"41!N%;ZUV1]M'4.#=^YD[U/_@5I^(@M;-DEI$]E$/0/$"6 M4.A3B//1*.%I\L$W#A";/&QRN/>Y@GD)^Z[6M"?@ZH1)]0LY."OZIJ:K1^&" MQ^U'9.QB*,?NP=X!#,T4<3'[G"3$)$O%N=2-#1AM8^=4NKNL6Y+QD]7F[>93 M-;[<;.LAH_U]M< X,:QU=S_AG\KC'UEZ2XQ&S!&.0C8O=V:F8:R,* F1"*!V,' D5YG"2_A2W6F# M)WF4KMK*9FG2/&,-[Q>,\TDXJ#SQ_,9$+:5K:ICRR^=BI8Y0.RMK9)IIR8(B MD2\2$N]DU+5HG*!FR2:1T-?B%,2^H^XQ8#%(4(-D@TZ)'%U19VIOLQ*JZ"%[ M";WK6?PC.NN4TF_HB&TPRQ4+H86,)JJ>9NL]4_W(Y#LDY5-Q<&>&?V-07D.5 M1!845M'RV/A\) 4_EJ*\TE4H7S_)7LCJ["%P,O5Q0@@^D2;TTU6'M\W!E6OB M-#G#7+R>-RI6W&+7 M&3JV/+W#5B^M6WC[4*@UC_',./J?T9'_6Q !IXRLJ7 #.BHASPF-R-V^L_XQ M"$X*U)&Z3+.VS6EZ^25FHY0D(1R++2^.@8ZFGZB$#_G8_U"4ZIP:SE.MA.2[SO5?135F/_#A6U_Q!QU\ MGCU[2-'.CNRQF1<$S M)N2T8V\S:7K8M^*VMNQJ"=BT]#5F/G[60C+D)]+7%.!)0'@H^X[5OJY%\EA9 MXNCXU@HK180YWC1A=Q*\2@T%SR#)K90B:,@%Z+M3C\Z3B&:%!QC /DWZI(S( MU3CF(OX&&?8]N_?.$QB3CJDO.S#?/11BKU$>W6&SN]9]&>7FHWBF\'RZU$Y4 M#DQL_I7(N(L%UGW5_ T]//-9PIBDE?1CZ,O M8$Y!C9^& A?!GX@H9Y M&!B@)VTI8KAFUJC/R+1DDNV$5^QJOYU(C:LK0_XLV:WX1Q"SUWI121)D.) 1 MH)%,Y#[NUFP^?HMLL2!HHE"R6=3:M3G@00BW>?KTQI@GK7;H/&_YKA#+F.&# MIA"C=E=;0 0:H^NFF[H&(\-VL_38IUH%1J-IVJE!V!&@$&.(+5]W/Q\^8^_3 M).LA,#,?X)-JYY(\Z]MN?,*_;LD\ M.@@*+--QZ!=M>H'5PYA?;S5Q=]?V(UY/)C3*A[ MRO_PWI Z54TY>2 3_;(N['EI%DLDZK.7SPO6>Q F%8=-KS@5.I2[A"DB8O0O MR[HXG%-*DO 0/QF,!:LJ7]1SL\RG'4Z(&=TN&V:- 'RUQT@XR]>$;%\T.V== MI(;]\:!N_*-+M/$&=P^U;'/:02,QHTT'>=&=V$>./\X^1%%SE::'TKEANYEP MTGCW55"?-A6H.M0\^+=3\X)2R4'-]5@M A_FSUX7?Z76$FMW@PGX<%9<=17< M[,"/\*C]UK"+Z$JIAYL=TLA>)2G#YN(WV"#0[655-'ORE(#_S.?=>X\Z%8,Y9#Y)RU1_JE1 $K8($J: M'1SP(/X7 +#<',<79>T)"%P;IM&F:K#D1ZL'7=&M57;%W=6_NUD>2A5@6:*6 M!!UXLIN\O;OZBIXC"OU!C.3/M:ZO!D,;$0Z:-"%M)J$G$&+R@E0R"-8T(KXL M7AY;4(N?*Y^ZF;]5UU2'WB"D\NP:_?"#C*'+6PNMF3G,RI"R^E(MFBWNM5ZD MGUI=-ZT>$+,-)KU)5B!+$,) +0\HKRCDNT!,-91!\Z_@3E+#'R:KJVZK**ZI M<<]1R(Z6>X32L'^S"MB:(]K-=IWD&]G"2&+";E1A%2O% M8#I2>?[1^*4>#LIM*TYH =1^M1OI0.P!AL=/E'W>I<19*J??W-3%'Q8K1!DP M4)&RH<-I:5+-Y!B+A>OV2(\;FT*FB+R$?*8U8PP9;$0E$DT Y2A'?-YH.1J(,D3MH.WJYR'6)6AV]GDE5C3A\QCJJRM+"]H@%J9KMNLD@ M/MK!?#CBVF:*TI>7CYNUY4$V>GZ3 *VV9IMW^8I,]\3V4C*6P8; MH/UG,ODO()8HWM) '_AT7]694.:\SM5%0BU@?'U".@MVD58%'-5R,@6KX.I1 M#[JLVQN2MC'+%YFY#>P2CQN->I(92PQQ:VY0GYJIL$X*#30!$^\M9U!:L@V* MRHS\Q0,4#KZBF.W](2Z0*F!.$^MDOJ *&ECX"\ U;T^^L%7Z@(AW<091.SU* MMTW93]^7:(,#W&^19*SQ$4\_I/[9V];0#/3>+,E 4INR!^5;^ MOMZH3\'L6E&K^ M;BSO;'(KW5J2K':81$R1UKVSZ%SVX4HC5QUL:% M@]IPA>,@WP6F.JDH4C91NSNC9JG\4WGU66(C^";&H:;@H;G+,QP_@?W\Y@UC/2VT17\?G5N-%U+A<:M1+6A$6_M$>.3:0(&N>ZI23DL=?4 M'M;>@#AC?D_K/U8E2D>Z=LN3QE+JH5G+,JY:I^S"[4S]JL8.WA&:F[>E+8VV M$M_?U1&3C^:T$26(_]DSMQCGF!1LS !36&<,]Q@,TB&[T5[2R#Z4VV6?Q^[' M9TVM+/@)(W*7$*2/3 L=^69D'"EKD = MU^QR+V1V,<##'6K-:>D' \< M %N0(Q8]TZ3/MB5>6CSJ=YQ7##%^E_:D21_65NG!/FZ_YX%(8;;E_]D=Z86" M#U",.-T3-YX/2N>Z:L^N]1= 5J'AJ#@>E#FS_D."T<;[]%.#2S7H":FO.RUM9C]]*CA3Y]RJ'++#/=XF"![ MS3H+=B356((;+,TZ2SG8)!_P*SGG(N:7$,F.T++/_-///\Z#5%O[==1^O7G+ M$JF$GR0)*4O=\JQW6/)-LG#*,F\=,L0,U0QP?"I1F_,N"42)>0@GW3TM2&_Q=@FY2<:_<+EE'7/9'R1 $!D0^VX MKW$E.-)^^JA+XFX&'Q[MR$JU?P592%,=SSBHEP^6BR48;' ?,B4^!H-$!OXP M1P^HV#:L43H&:L-5P%F)'>7J\TXZJJMD$GAH8DBV4)=[IM 5L;N2@'.N@C0J M0O/,.5VD+R?LL'EKUGI5S*K66;=^.&+#"3MY>%SC()TW(]V>3KMQ0G$27H#. M'%Y4)IR91T%:5?<'<,./A"MYE(W:#Z6'9I7>W673@9'ZUDSZ4S%ZF=*P!7S= M9'O[ U>;9/6>IUC@Q'U#]09#I_+>&^AR;OV[ (A,G_ZZ5G#+>J+E5FUV> MY1!5]%P&MZT!"0'(Z5^7J'(U(=)DJWX2^B%+4]5 A4 MWQXUR= M6F=H!']YA@)&$F7^!V=OV10'%*WI-D[0X$YPA^ .@1 :=VC_Y)X6B0-*]$@RMY*RX>M.Z^;9-5_W^$8#XJ7/.$1D^ MF^8^?9!5))B$:@"904'L_7[L3(<,0 MCEN,H$[1?*0Y\]U8KTFUK#F/@ MI7C*'>LN#( AE*HD\DJC%J'&U&AI$7;6$X)(C8'U+:E9$4++HS\)?%6V!651>X9X1,GC=N1*V!HR:<\\??NH89HB-HR#7P/+( MC;U#?^0?K"1ETGZPP%/Q+<8->MUH^^LX>@[F='*=YMEW$,/:WJJ_T#*V_-:J M52=Z5@6LK^>+GE$ADOEQR@>=#47\\HC-M?"#)?D8=5/HC&^U2W* M3IT-17N%G(5QV@(#?,*]J]^8+KINE4(3XISP4SBMK?YQL9,@QP!90A.]]KMG M$O?1S^2734H7Y:LTUU1TB=PSH0LM26:: M^KARA3^9:]SL%#..% 9J)C=21@A%GAQ3"J:SUE62?$P[T"S?"J3Z:O?"X#"?"/T-@4K+LC^];*Q\DM MYT2/X\\$KUY-[-'8ZW<7ZJ!%MR3:IGII2*$9]?X*-5O<_@L8>M#P=68J-.:" MQNCH<:ER0SERG =D9/V:T@;KP7HS0>8=?3V^\0SAGOF^]0D*/TQ;TZGT>OQZ M]!YC1&=LG,QF;0U3BM+UG4U^D'6E:EDL]?YJI';W)J:Y5M^/QQK$XBH]P M\ISY;T/0W/]H,O^[2M/CU5]0U*OD=X*<@[X2$'?%V2;1VZ]MO4(16D,XMN5V M-*S0+;GNTW5-O?[#;"Y[9F:)-GS?% A9^G?TJ<9,P+K73HBDOB6T\T^:Z=U! M]C!O]?R\SM+JM#.^=80C^'"ZRRV_KEV8FRY91MH.I;C>;T-.#;CZOM.5$Y?K MXCZ3VD5LYXW3OK'Y\O:11%KH'R^/V*>^EH-KO&:R7$:X#:UU\*^Z9=)6SEQA M"9@3MJN4SQ,GM_#6Y=MZ"IPF"[0!6$(OZ2#[[=1GKF&RM@=D,28SXFLS>:&[ MPR'@DLGX!<$6$=$#?G6MUZ\HPP*9;,VT\(.0$ >?<2IRUUD]"0#_6&02&@L>J_MA*HM(&-[V$DK9#=Z>\+MV:G K MJJ,\Q>\*T8B,_XK%S8)K%0=FDN\=&A 9_@7\R'"V>W]1/3[L,[X#\MXR4?*_ MGV#QZ\1@T Y$KR&VW\R99*U9WW!X^-W7\$8UGJCR=<-P.!%K+__BJFSG2I4* M-W/TYC52#MD!Z+??%[YV^!>8N]$--I3P\,]SSNP5S%#CM=/"'-,)^(PI"D_F M['V)Q+/\D^)-8:8@+IGXFTX_CI4^?QO'PM_:13I7_,+Q M%'*U0?C#5)%'RR].8%:*X]LSD]$<(G31_=OLZ.+:F4)#[:;8ZGL-8H22Y9YQ M;6!9LAC2[-IO)$/BQRK(D7]N(*42]6%.LI+@Y/=(QZ!1 G'O0O,6R[."TZ34R<*$8-HE6PW&%Z-N1L&/$!D^O<-DR9B0M5N27<9B M6285*I?,.,RZ1\(+X:9-E(Q%F*((;NH@DM2,8EL*N?8W ;R0:!:&#-@2+W]_ M&$^SE)Z@-;-U7%>32U'J,DO[JXCN(O"E>]V!KCF'D,13[D!? M2R3)!ANMX[EX_/?6./Z^V0U99N4P$EFD2*4CUJ,/Q%M ,DR&&"#5'"NB/)FX M/:+,3'U; UJ,"3.M)SE,DM$3/5BYB#*N3O#AL/7^27!BX.?79WM%X3%/; MTKA0VMX6+^CK2/[[MAAY7SM6 UG"]8MD$1UM3J4&5]L,;NE4W]VC'0UQT$IB M'ZZQXWX?CYEJ4NV&D/+OV=-)0QNV/I=>I5,V9(JK\W.5X9JE+=[#[&*AZ=., M"4Z&KD<7O/=X=\4W&BX&%YIC^91SD62%A_7U?787%S*$(RZ5O#>%3F, *P&] M>3FCU85$4X^#M/\P]H#-JG2C^2=MX*P-J6VF_#? MFH :.=M,5Q*<1L:OG[U>^]7B$E!S]>_EZO"0])UOHE>J).>DC$! M,&0U-)'H T94&\E4FT.1PSG.45+1Z)(^_V@M94C2=$,N(!JFPBHN<@)4IMFG MMX92&:"/V7$6CM:8G+XBM3;XXPYVK9L)9.-71'40&P'XY>+$N5U:^9J)_P:! M2FJ9] FC:6W*7ZYU;\]-5'BCOTU1V[58+Y4E*;WJ[#J81Q?XFD,12)Y]6\?9 MF^0)(:=M7=H",F8V P&W)'-F@=K-B6D7\8":&O+G_/@&//3YCFIN1H)&0+K4 MZ26O S(OL6*9)/QZ[FD>7;2Z#2<#OK2?R'8R W SW"0O!^$O'8TM]F+9+3XK M5 WY4C?*A]:@"#SI9XPQNF&B*\%(<>Z3/RFZ>$;% V[S'GTZ*Q9=KB[3#TM< MFOWN24#[,]%"G]V%5,AW.N,@BUN\F"3'D-?D>X'N5SJ'3XWV^4M7%L9G2!*D M]CHW^3^-WNO["52WL*Z@U=?NT$A9]'R:JYIJ4\3VVER!_S[*>1,?+,6X+7\( MJ\IBC!IV"7&>LDM4\!HF2O=>*;U930W4@=/>G0"C][WCX(VG"+5G<9_?8['_ MTBQL\69W&K)T!YR3<4@!K=QB;TFU&WV(I*FO;PA1TU0!0CS^S+[]N9)TR_<=^2DV[(=-KC]8'T"7X89?\GH MJ=?@PCM;S<8U(#$>F:2>1'7\&-W<$DWMG+W7VO'E6TWU(>3XF2)D.YK TM19 MWVIB(>2^U.O!_]&<_1]*;4 10Y1![RK$QFB<%_[0!(0-468F2%WLS03WO!3, M OX"*"=[-AF]3D9$H,,;#I05VP7"%3108U&@2L.H,Z^X"!!)\>"HKPHN>"%] MK)@^&I NP=]AP5M&,IX2^P=]L)K79_^AM(.4O7=I]6GH9QGX=\IL M[_Z?U_BHQW\,_@*^#?P1+/H1_HO)^ZGHZ?>[T3:#"F>#J37! ,6#7>/X=Z\Y MW4<@P@CW>#=7+N0$Q4?M*J%/X-^K)DQ'B49:5CZ27O@Z*O(DX%?%I?'L7K6; M7'7_JCWO_#^8Y%D9PF(KS89R<6SG1YJ^1Y7"QH*>W,',\8U;9VL^^NCDCC8_ MJ$3";Y\P!Q52U#G+FE(W-L@^X(QV/@G-GC^0?'7+:9GPJ!'7'[$C>EB_T/H% M= V,@!RY%IW'6P=&B#!>:H#;<9#?&\G4=YPZBVU;73)@O2\$?*&14DLBMW8D MEDPF 50VVC-KW5=?G>E^T,^@T[DCOU"WY&X)>S&<(H[1&5+@$$W*3P# M!R$U4NHO):X_QU?REL59OZ/AZ(K.P/-Z4-P/Y@P M\*6DG6@R)3$U$0[C7,?3]*Q-OJ]_\P1'$I=KI324#MSX%<(^'_EB"510&G\>0]17HV2 2I/-\^KP1 M'/NEU?);7KDUR1%.^,M7D,.6HS8VO'\:;K-&MTG+^$JW(+5[^W>% M++(]U*ZTBP?*ZZ+Y^]89P%7:E*B8DIV!VQ-8D:*@8KPQ547234S !CQWWI'$ M6I2DH,I.PB>29"=D7]_N8SDKC0.*^/V/\T4,7&U=6Y8T.48R_@M!3S,H@P3 @07&>O9/ M4/5$-\,7=+HL4P0U,03A6)01YHH!N_]ME\M_%R:;]K5BD\P%<;P7A3KF;RUY M=L/O$FMG.GOHT+>QQXMO4Q"D\HAFHI\IT'J95X"-XZGVE_U<7Y+T,N)[]EDU M-ZKROX#"FW]YS"YRD>!/E]R=M3R)29J&I1EHDU]C6HE'@U70"YR?RP8C21/^ M7^X-4]&(*=$ *(>HN6<]5'8[4@,F*/WU86I+K/ CS(2;J!FP78X-Q(\3*V+, MZ*?G6K+BVO>AQ6Y!F#Y6V1+,97C6-7[LM?65X;Q"/PQS^;F.1^;^2_SP\G': MN;RA@?6 KRCF;*-](MX=DXI]Y;!?^D_:EODJMQ6O5Y=.PFTV8N_?2+>.3G(- M"2@"-UGV<^OVW"\(C3%H]EL9&FK@O.O7TIZFIH&*?#E3O1 8L00#X(0?$\C M5&H2K+K2YCLE$?[J<=$3W3Q9R]0WXC\8/'K_ D;K9XAYWZ\B+9=C4 @56>79 M/,XN.AU!W0F-2I,V4IC JWY4A'MW#%IB,W[Z77DV7O:)!W?U?ISV']9Z2-T_ M%ZKY&"5RTK1DO,F:P^P]S8)U8^MMOV\4.^JM7M8Q(F]1<+7@5WSJ.)9RHLCL MT_/R''4&4^D%Q*6KQ6,<&U F+9:U^$U%G%T9?9KJE-#(AC_I&<=XE)*GL-Y6 M!5\KS_X%"%#:.(WDRL'G45,'6H4SYL+ 697.QGX>>;'%9TK4I7P3$X)4U1YR M:?& (\&-DXLOEV]Y?!X+]5WH42[CTY\_W1UT%$XJ%0?< ,4IOP]GDUW\21Z4 ML(07MNRZ[ D#NZE"C!?#Q5X^)%SA9[C;,FEQ%3_:=U3*$GT[A=@-CL ^R!$* M>':U)T)V5#AF_^A:7R9_A!-L*D.X?6X %4VU\_/H&@C6>2'LCDMND[J9+,YY M^#N+;G-\4^7[@PG![F4,34YYM9&71<%+0W UC'#*A5+F1K)C5VE'$]VWK542 MZFX#$?@PG:?2L /"M%MRK[<.R)D2EAVCJ(]VNV+I0,OQ J-)PIU=;DZ1J&G6 MI]R*<0BL/7(-_#]=!HIP)+>\J*C90K _K:(UV&B=F;*4^6.I-QB%#^,9-]2T M3?HWO[OBYTL! ]*WMS(9+5 9>YT0"EV[K\=AA4.M,A OU<9NPIJO0]J#$R1K M!I;,W6T.*-"%2Z2N=(0D*GOWQ&'X/-3OB/Z,P:!A[R\(O#PC< MBLX:'5P"6M,,G(%HOSU!T\Y,W.WJGI8:#_8MQR"]$ M<#?"2=ZN^?,V(NI/+L 05,1M)[[^MM']N.+_7=;">&L,D2.5)Q1X-[_%]-9?EF)O>D=N>K1KNX<@8EB, F5SX?7V!]" M#1C)?Z\PZ9\W1\[2@^+YC%_I8(T;)5EU8+%GK30#@]]6[=$Z] M7GJIN13&GO=!J3!M@KOIK?!J;<6:O"!F5WVQJ1P."3<#VU'MUS0%HB"\3&)[ M\<=O6^.V;]X7^4MJ_2.,_YC0G^#_C\LU_RMZ'9D9@E VWZW.4;P(9J1XHFK8 MR4A\2,((/>K4> 6E-'AWH6_^AC]%57_VR+OQU!(4O:8O"B/V1)4KRJGY MR'J,7#?#4'\Q7>8>O#JI%WJ]%NO-CC@;^U+QGA0MFV#:2$,S@ 0GT3:\:]+S M8KNXC7Q6W^&/[^<9)._#-BHF?R%1")X(Q\]33B%&1WN#]4\4>Y5]GV6V51TA MR.$TW BIH0]D;MN#^92X.8P9JR1FVZ+%[42;TG:I'NP)_,H>TIKB>^$L:02! M^H@@?*,JIDK@1 J=AU+56 XSU^;%4XNJ_CF,_7T?'$F;0B" BCPQ3+P=_$4B M#L4S6:H&5@HT#DJT;W6P->1+R6XUH?F+XFF.7(4:7.!5AJ18T KYG*W&9#G$!T;UE)N+R8++RP*9&:WO!H< &3 M6H.6E?;L/]-[[0;NM0P GYY19)T#XD873D,/?&V8@&L,Y);J;OM ML2GV,&./G +?+A?$UU2C4"79])50&]X,I$:E2Q"I_(/#/(?EE@F)P:1B#RD. M]LO46@G1K27DZK\ 9[)VA]4'=_IC1&5S@]+L/>K246<^=(( ,;Z;:[ G)L7/ MH6C5$\@42(46:X10(:/7TT^Q!/T9B!YXK\9'/0W6*1CY_//$F-(U_?VD\,$_ MX/9#]='FF!9VH8J2(=N-&:*WEP@X6'&]S?52!LWA>2\[J6S8.WN]2R&9"+,W M5^ ,=&W&*'1 Z5KB66\YBF?0/3X: 4*?MF*A=W4P9(W&(?I5Z)1,'X[WA M,-XK($-)9M23/@II2VB4?(B3<^Q"C\"_3#9!(+V##I=;&(.!/4D25, '.9Q=2?3MP#/[#V4D[H+:9\-_ M-#?3UZ$BP4U6?W0A[)H6-H>@Z$O^5C225)6%J##V:)*:F3I2]51>$E#V$"Z^TE*DM;#6:=70.9,A M^)K-;A*\F!MO8\,ZI4IR=J4.V%"O)=@\3ORM5Q$[%?;Y4DH-H,4A5PH<%KB[ M+_W-8EJ]F(A7"A.,(\HAYMDU')R]_&V7%D,DMJT&D&ER[U1<9?*!)46*K(GO M%4=2!8'0R*8_T_9"#RO2S\>/41K*7#^(K4HY2Q])XSJV,V[73.9%U$]SJ^M# M^?6![.36(\(?\#XSYC8*JM:KR>?GK\YK5YHV97)QAG"#];#*EDX2/,T[I_O!\*V;3&5A^?6,ZZ MY5>/0^NGJU^1PJQT$(O2"^$XN/![Q_A&^<0B"DO:)-TS=_):.H?A0VYKY\L= M])A&L:26:C08(5!M&[/JXABY'^FX,-K]((&3.]$(WX=S67:3;T[]Q)=3$5J@ MH2IL6?BXLR3(U*FXF?AWVT:K87 M,(EY%:VSTGA7H!RD)CI#,'0YZBQ]9=@75*O"&6B==*B:;3T@B+14YP>!#%$X M2N16"4SJH+P141Z$"W$K:#08V*VM\@O/#Q4_U(+!IG2$ISHQHB^(*M7?\VA? M"@Y2PJ@9D4%<6]6BGJE_M.W>=W7_\F<-()N^E2^N M\H&)EYK4/N-K217ZVT7QV?C@@+ GH#[5_ ML/,PPL].7:R7$B UYS22H0FW-:S/R2J+N[^X7&ZU6=I"U#5^@6#.2K&A*,,_ M]\\9?6O,%*82'?&F4R/'.Q<],^I2'=W3+D\MMZ$$G&:ULSW4F:IEJB4-OY$U M*@0KX!EVH+0;37:L)=S'V22RH\6Q7L8#^J]?,2ID2P3Y2J[\!<0\)"C&)XU9 M'-S72Z],"*WSO'W+[!=A,^R8CRSEW+&X9=4&J$5#02%&6C$(G%P'X1RWNO>0 M#GZ;Z@UCWO0B7A4J)G7,^9P>X26@4C/[,U6%.BKQ*%S@BZ\4D49WD"^AJ,Y# M=;W7I4_\X7*:P3&T-%P4\I_N3KFQ_TMG9P9>"=RJ,OQ-*[#8YD!7JO=TI1#; MZ74UA=A10_T%=@A7 !@L*"QML*8WT'''>J%S+[OB2/&WO M%T0,BJX>NQ(]1N1)Z@MT?F+3'=$ T)&BXFAS-:GT=NWPK?K?11*B@RI*0 MY/O>ET.4K0^9K8#%"R17O>S,!O30;RO&G3M7[!Y)SJ M7;_LPGAQW4>,%.7JR7[M=(!W+I2Y32#":#I\B9*^G;S^5#2;A@*/A8@KKDCY MZ-FT6HTTWDHV2L+%''Q%">?MIUXM^I6$#MTWIN$62R:DZ/\"+/!E@(Z8+,W7 MD0XIML=I?8CVFDF^*[=0>/H+X+L3"MV;T1L$\M;PIU1P>[JBZ[T__:5A/2YIK+RFE/)_.D]LP'Q[?VL46F'+@E;6X$]?=(1P_'76@8TIO:R(SD_I3S4">2 MY\E*7CFI!J6^RRN@TH/,K'VN$#-77@F,XJ-^;M7775)[Z4AG>7FV9]R&^TH$0V'C*BNGG!$D/2S M2IT^?CH(*OT21^_0XOJ\TS B[R-HUQCY3=L^WIKT^Y'6_ JDA$D#2T#4XUU, MC8:76RF_5(\+\H69N!ZK%U-Y8BWGAL+BM'C]0ZP?/#79\TS)TH,K]-NAQ(P5 M]%/![X.59L3H;QN+T@/J?1IV:O:V5]1.1&*6R2W\OJ?>?P%6<(LEJVYG7\7E MH<<"1%57#]]IFA,'[%")=M5#^@16"0$E O=Y_8SRIE/&>1_9&Y+YV9$^O44; MZ86#GBH>^97FB$<6SS%BI1=RI.>GEJ0X';X9&P__&$#.(;?8T0G.<7-5_B1\ MW,:&4M#1G6Z,SS),':'"53 [7J8-7%2I9+Q?>/T,GQL#'97$DI9+! 7-3<:ZKEF:XUZD$%&1W?.)SP5 M3UK-7VA)_.87SF:^;:H1Q/2)G%U2R_C-CR0GPNY'LA77F,_)7$0"P^ M72NMFZBY"O,XCTE\\*]\YVZI7*?QWM>Z;?:6J4Z8E0:P<52<8^0B[[9U_JL; M@OZZ7XRA-B[[;:5"*@A$T23;PT,9[OB2N_; MJNY% QCCHMI/(*@<3IUZ;MQDB66J6=/97;EM(,(6GMV=4%+1'8[ZC:)Y363, M=$$JHB#:._[!>'ZES6\5+""W C>M1Z1;NCJQ,%:ZT&2MH@S3M9NBQ3\;#B/JF(3;RF@Q3LB0A MHLH LR/==Y)?N\U':W\)#ST)#/Y YKUYO@SQ-IT0U7'98DKKV>!+&Z]6C@3K M+'N.N956(,E;4GZ!)FQ"#W".2:@A_Y)^2<0I^T<<>T:2.F-&+#;'Q3Q-MQ1M M_3I3Z75%Q\"*0FCML0\UB])> EJ<4'(FBZ4V9%%->0F\'VR>G^)09-DF)3&"%!:7 8J8D@RQ;J1CK3'O-W9A$>!]P* M.4Z28)V64\*8"VJCGEK-M7$Y^7X"3;&U6M1H];)Z(ZJBM3LX\^_K,BS)3>2\ M=)\H/=KA=$AIPU&;"YY!;'V5=<(K/Z:9UF>]9TP@MX%E6,C)G^N(X<>?+CK: M64_TZ9;KF%P4L41*JKQ,J7RY33=;ITJY? 4X&I]GH#PQMJ/QU\HFT_4A^$XEDOSR_;,:%0[F%9/C_TH?HB;.3A0' MG0T/Q*1)4]MQL/(GM\16EYIHNZFM7A^]E0MO?>'3)'1& BWN-NO-C\].ZNKO M_(CM5^K-W0AO!&[K-H*^G'\CV4QH?7R;S3OQ3/?;[LLVA1PU_FQJO$J3"'\[ M32SG/3;-.J8\!*G[/@ M-&3 =GCU1WKYVB#'M'#8ATV"^_ V*-F2QHES(R;K'CILV5 *8^(;/1(<>U+]JMY7F*^V"V21F=2R1,)J8U91=.P]Q) M@)JLOCXBBP,DY5?TVJI.:^B/E>ZLDN>/_48W&2&#Y4;^6MV?TCJ'Q2.\H/=D M09TYK: ,R?&,@W16E(>?0WTVJZET#W(!F9:N9@KOPO+U!*5].K$4S98]#N?I M40[OJN@()&A)%,]D<.+G&0*;A$5\B$_T10TIDB^T^N'9+QHMTD*4WW9KI\B]+ M^@=A?#T- K32OHQ7^BBU)ZO2F,O ]LH85WZ[Z07\7:$-]=!%R2_>K@NG8-=T MDQ%I6:[:FR==6!47V$6[0]K2A;+V7[__VG#K>YHI0K%NL6 6X\>+LWRK ,AYS>7%P*=H8]2'&\Y9A<8@!]G!*.8Y;GA;=E< MB]CM.!BO$!%2%?,Q@4Q\&F2 Y-N#DODD1>DI'&@@9[\UG07[A9(G7A;9VH6; M:Y,;,9KG&:@2?G$@L+/3M,_D6\U?); MNBA$Z!#:=?,F/ C%T'WG0@#4W02'%62HYJAFT)UBGG-:7]R#"Y*>*>/2".TF MV 1&M*49GFA>ZBC]BK@0:EWD:S6W<^!;2%=.BYVQW.XWHHEJ1TA7V+I]J[95 M]M.ONWHL!_N/:=PM\=7*I*-(7]ZWBPN'O[VZ3?,-]/7#_'#SZSUX5;B0H;MH M:NGN.X7@CD;A!V-#[RL0_6_T-,N@794SZ)+OL#8:[KF:C_AE3L7W-H+Q/AJ! M#4PY)>EGB[WFJN[Y%G.8F[S.76P\("4=5G/B'TIAJ"6JTYM1+MNJ]\_5> MB6E?L/^1&/J&<'N#GNJ2V4"=ZM19>G5$V(SJQRVIN-1^SX]--PX@:MP+&W8> M9)MH0<<<[KK?]J293,\ I+HL4IZ+G%+INQ:JS!*.YV;B,%WU\T<"N3S+[;;" M?;$_?ZE(="*(8,'@:P^FG&GLGO<)(S0VKX=)G5YPS-$=RA;S&,//;VM#[%8& M35'.SSQ%/WBLC]_5ZXRL:)YLLW:UMI@VC"5UPIXZ;S'O/ODRK?+4&XD]U&F, M ^Z)"QG#L$[;LRGCG;2Q<\@^M5T7*7-%;MMCR?$QAS.4"3=,/92B5]IH]8M. M[.@<\O6_Y[2=X22ML$HXT0Q75K26:E15=+\(C/S><,O20L3?B (A_HSS%!0/ M$M2#520F=$^M]#\!8BWAE&D"V'/XH-K5E3HWO#@USO Q4H? MA*SI^T?)@T %+?.CO.LZ*7.(SLS&[EA<5^&P=2$K&J.]655S!)GZ2(A#-U6% M;\G\&39MR>Z$VF"@F5_MHJUT0,\I-B0 &!BG(5Z_??G\QKTV,61=WH*8IG#C&I2U NE6H MA7G,=HRY>?%STD; PIE1=O:[TV'-+%8HR>RZ*JVMK4(J*U7C@%#G M\::I2#8.4\.I!I5C1 2T&_OX94/+:&GC;6[P!/#R5A,CJQ4YIEA_D5;T__^P MZ+\D;>WY7D\U).ZN5SP,M=Z%,3<;!)I.#N&\Y2GT1FD4*9-;[0GMV M9*&?QCGLAFM5DV6"2%B#-@-/-8Y'PJH7JOL58EH'%+CQNLF:PY<[OC, ?8+7 MV\XLQD^M](X47CM,H;Y+&A^[, M!#TGT']'ROF)4=,*83H4>F2]P-D8UB(7)&#*!&9(T1JOHE67J02"-'*H UWX MD\4I_5&I\?*)KDR:M1/X/0GZ+?M'Q9=/M,)V*401[P+STW3'-P/WX]O1R[G/ M_\S>[^G-.I=^?#1=ST]#SR#LRP!3X_ !J+WCH7NFVE=RR51J0HS)].33->"A4:;Q-AI:RNZA0+)VQ/G/#[5;HSVFP1= MW#83>T4M:]L&Q@;R[B1S[]B?.F 3XAM/0>\P3W(YOHUF(,9$\*)*"S.GUKZX MMU)Q R5J@UX(5<)!0K)=[YR.\.,N5U4;FOM:DD^IA#=%J"]I[X3&DA45BY=N M?\'HE"17M#;GT1^2A2 -SM6NK<9>!FC.\K*=H)Z9D@1F?:Q^^Q!?1&P"S#? M+M '$VTZRAWQ[M/3*H_+6CV *1<0SP9$<=&3+FR9L$P=]&,[B^2XJX@>R,@2 MO3!FK[2)' SGX_8Y-);F2WTS;PF7%1@ ZB4#F$@J&,)C,LQQBT MF4B?&'TV&^NI'\KC^8C5F)+&S_0KVPJ#PHDM=$6,I)Z&FCCMW3UE*++)T@29 M2F8YA3EC)[R^R1JE.SR [I]LVU)%3)"T''_KIHC]S,821Y$AO;WUH[4FI.@& M'?#&KA\Q9&&D#L%D<3NUDI&3LZKL'7XJXC,K.&D+QF?+I>6.OKMP-=IF&GA] MA<59VI)OZM"6@?R*;^(7=++WCE-R+@(-73\[4DP:43+NV.U,NYWZ>9 MRG=7#-;KW1$ZA*><3&;!U*D]&=KRJ/)_ 8$>N@0_<98HAF4[<>G%:.&0ZQ') MSYENWJOHU<=V(Q6'-1\:1NA>LUZ#<]N%9MMA1:P*[6SQTH%\*]4#Y6M<<=T2 M"C,MM *F,Y!JG[/7E_.#'RWUP+G6HN[GW(9>/,S2]J$.]3'.5\*@D.XF\%$\ MX'KE_WY(EXI&L0_P@FNEOY+ZC94C05_AYUN(TP;TRWS9'?%O"*=R!Q\&O[&P M:"+\JB]6WR;X;K1/KN':75 M6G\6>?!#'.O1L;N[H 3'4M/&&T1V<"P8CF.]F$U!4G#)3Y(]F7: 97 /Y2ZC MSW4$M\MJ VND6ZBB32([!?MM8(Q0 WAB40]8AQ />*)^Y:2YJ*CN1;88;2@0 M;2:E!I!*=,Z?B)3B8.3**$AKGQ3/39=P.:P8D0SDB#W81X13?"I#4DD/VHOD MEY:9[FMAJL&8+,;74<@3+,-$K@H# [SBD,91I%L92#_0D:#^7B)EF$9N'!77 MR<6$)^T4C8936O-W*W&%<]R.R$E&8@:&K)_$!R\9&:453(=UZUE'NBJ'"4RQ M8Q7>(C'G$YJITUHWT2\$Y:I >Z8J<YE@ON7DSEK;W)ZAJFA<0._H0CLQ[ M,+OCH:ZB9\:N709>3W+7*-[?4C' 0]=O8[F?5:J:0C;&@=\K3F:\ M_]!<)YRX=;W]M+#?D7B1O!N+&N)>O+-0 D;E11N XFWP2N]K:4OQV994[_\M19FJSB=]+4W M:FE%L"X9>Q:8F5U:'6S,O>-K2TW9&9AE\/0O3UO3#3]QO M#E)R.\^LB%'6>]>SF)N[]IF6K2O2B.0IUF!3!/!5(/T=<26= O:,Q?7"=Q[C M5)J,Q)\F.S_II0"S.L>*!US:( M8'5&/0LI>5U*];,KU0 MA&G/(J.25[F8U!G804=]L411DT+QMB8UI,K_:G,4K,*NVM".>,V"DMTZ%6&6PYG?0 M<@KN^H1M<76'6M.L:OK;2B?L65L:2$YF3H;7C\&A SOO$ZW I:ZLR#6HE'&O M^/V5ZV0YP:74+)L(F6?^Y5@;&U,Z<9]7&L,D,4[C73UD3#M2XIV 5E/6K)>5(;PI3VH@_+<6*;=\22\%Y:3S;!B35][<.2D[N[T#;M^A% M7HV%4:XD\+D]ZV.:C/?%GN%HQ$A[L/]\CA*;_#\]1_G?2=O&GGCGU87R=]32 M5)HANC?#VFE1RCO$U2+*95 K/B6X#\57YM,0P]] M^_(3WD#0:^A9"Z@%.TJ/7JVZ1AR/\SWJ^$QPJ*7VC118>;R=%"O7[0=YQ$I^ M.<<^<7^!.N=PNMW>4;:DMK7#1!7_3L2I@"%LE%[20ZPB*>S30G)AKT/P#X$9 M7I+R8S$ WC*1\DT?HZ3."JK?-T8+/#ZE/N9':^HG311C/UXO1] &^&83K%UK M>[^SP/D8-K+:"E"ZMUUO^4J;>1$/,-G!JJSE6N?L)H817]W$B!9CF_EX'NH< MN^AAYTV@? 1-)P:@Y.LNK/_PFKF4-VF+0:#D!?1,16T]::*"M*] M8R[TC>R2@JO;]CO*?(IS>!3?*=>[6ZAMT#//R=SI#28<_K@MORIL[_$J[SP1Z U[ M*:7#/E(3Y392._"6#""'HUEW")-%/$"M]=.,%-PK%.@-BR:B,C3' M*/'_ DP!@K2%6QR0JA+'K@,@U9FOUR;&&-UR/QY8IQ,5)6W.:5' L8(PWRX6G?BUD][\!?A"FGF>/5;%2"E-4@H_ MPOS;C5PS+RF=%0V2 XTJ? FY;,90M2+6Y7UVRW/GM3.UCAY$C/Z4/GV@-0NB M7=:Z#1IS,554 6.="5'!PTG>@!M6C'.8K<3!N5>*,\NF!,I42&27)3)*3\/Q M6ZV0E?FJ(O(LS;!:O0F66J#MQN%HCMWI\KPCVXIJI81>NMWE2TVG5D9^EX"^ MI[NW27O[%YM*J-@2Y"CG%B+.)A,A/G5LD'['@4R(_?DPRB?N5;Y>0W7VXG MAIPM&QG:>M@57[$W6P[/2I&C0YDSDBG[H@QS#*,9:>'>2J7>@T5T(..3'$\! M%_),NG'9.RRNU6[@R.LG8RLPQ)B[8+F)4L,MM=ZZX"?YR0\LIWDU^VHM"GP? M?]3ZGL'UE+B#GUKMWG3?UL?YC(,VE7Q%(-B6 ;..P(_^RE"6JVR?T+MRAZEB MX62W@ ]-+G2HZIEIZ\W"1[OB=FU_ /8QYC1SG-?3K/:(PT(_99O &B M22%X#SQ803CGN$F!D%3SZXAA'VV1\OS"E2\59QP/R;BV;E:B/-W;RYHPBH$57)[GWQQ959/6WPE(XR1(M0HOJ2*W3Y%0L[;W\:HL&= MYB"U7K32$3QE).M>>@II,C8#"G]XG!R7&D]G-M\14*HBX7<;(RNT2?;>.%M[]2_ZM[Z&(W2N M!I1IFN89R;__0R/VXE:"6T5OQ6SU(BY5"MM4F#0P_6%_R5%E+.)$P MO7%1R;)JS(%V\J+BV)V16N^%?^@B?IH*F_*/74*WA-CM\M>E",78;54?6!#Y M86-C"\&'-S-_ 4;+NZM5,]SJAR5YEBYN50XJ%GBM]D_\"%F/W-#%.G1&, M]>?W0-[$S@KD;4P>-Y>R+>D]=)1ZN\!1%2_Z;\M@M=2R02R'I:W7=V;R6OIR&-J&,&D B?=$>5<\Y74B!)N,K4*^^98\2V4OLU@],=3WG8>*X() MC8&."'X43B.U [K1!8QUU/I=1T?AQUH;-FYDIB(/?.MS,L[FBVA,UC#Y!UZ5 ME-MLGP60QI3C[!HM"/"O\,$3-[:6^7SJ=6.]XL0>P\,U(B%;<*3@_D_K_T[& M"Z(V$&Q-3PA0\",!*%IGI1MBJVR^E07> IG$@OV*L?SYI[P9FHPSDI<9#*;W M!4*O&(MK)T+/=[B< />5O>M)Z].V<>2H\VA"2\RDPW55;D[6;MST2,DJ?[*X M>](GJ% BOA%/Z.GY*S^EV!:CA4#FJX$#;BUI_ M($N@\>;^OG:(\&J-V!3OR4S 0F;8X.64,(D-G7ZS!+K?[]621-#A+;-$J@DA M$59WDJ63YR3W%$I;^X:_Z%DR)^6=+80%QPO-.0H*%5 @D>HSW09-Z0G<0,=H M6YO!L,*H^(DL]1 !LTE^QN1 DCX0':@74KDBUFFUF/E4 [9KT@Q>HQ!JM'@9RB#*V9<@OF#,&FTX<(1,1?,UP(^LH!;0+L/#UW MGY3&WK$L.@>_5I#KW\':"T:I'I4474G\.$'\$>7$M,[&!;=0\<(0E%3#"XE^ MX1L_?F2F-@G+VL]!G"N7(,..=S_ MX(//*C FK1DH/HA79"HV?TI4^]8KU:H2@)!7 MRD8F[ X=F-PVFC]G$$"!,Z MK96:3:.!A.=A:577_0IWMH[:]%%SB\W1AQM!M &S\($FK/*>1_>D39R;1!Q9RKYE"73\8 M^1TU+P^ L8P6WG\6?7@MSX>?[5!::VB*P+:=64>]D2=&.G#]K_>Y] :0Q5-G M[#5WUV\V/X2_7W\[,YWZ]1?PX6NZQ(S.$)2GBOPOP."K;TJOAR"(O[3\C_D8AD!+;ZL#L'UN5_4Q6?JL"\@H- MR2/>$C0S7U($RRH0CETQD>T,:Z[_JEYA!O3D)M!+H9R+P/6(UWFL93SX19N\ M?U]RM0XQ=AA>5HQ"@@U_>9NX79"9:#V>R^.^GGV M(*O. D?^.H>QF@^IG\NCO" S@D["-=M.AM6VDI2SK*VL3F;+T0F$3B+\ZC:$ M66C-;05!?MGI=25^#>32=YIXWNKDT"PE%4^V->*(C0CM'T/ACCDH7Y2U>"X! M>\4E(TCFO?%QN1(.N6J'GU\6+#@[FZ#2W"'X.XVN-L,[AJ"RP"#!2>XNSN$X.YNP=TU 9*B^ZJR_ZIKNJ]UY[]]YK.5-O&\7:="7E;J3$]3]51OW*H/F _"M!AF&IES!Q M3Q)#GHLML7DOIQ*BP\X:@O+7Y3CE8XNHZ/?M)XBU$NF7_/Q2@'J*?",10G9L MD@F.KR4X0L/SK54M]D*;OR69-J54FS[)CUGE_DYI'F2CJZ<8N%QN>D<*3I%547]($C(XDQ/+?6MU M3N?;_,PCMV#'0 5YU56/A&-4MJVM^>Z'HBA:L?AAY8+3SY"CR!IB/*&$]W;U M[N[E[2VLJ/5XGPM$3Q*QF6B*E2'&5=5H3Q.Q=HZY7BLP&J0^)DH7YK&&EW0Q=)*Y[JL4T?M^0? MX.+#\/EG<%=\,@NJ$[I ("A4X/?\_#S5Y]W%9W-\R#,&3W<<<[UD)+'/L(N[ MF2]*RJ=86#I$M9;Z!LDGIAV5[8,%!95D]5#UI(Q1M77PQ&_VY2*NWZ&_:CD> MRB;396',JT8Y9D>NZ^+-B($7*KGC5-: MZSE3:B>ERHVJS1--"OC^/80_I[67,HCU6:E#/J!4&G^Z31[A?>L)6%FH)*KU M-4?D+=*02V#W5Z(.,^U[9WA.XX ME.KB>!Z38D]"'QL:NSK."Q/=';PZ/C67@%IE44(UU-D8BA]RTX7@FVLP4W[E M_0+S?"FL^CRGI+FS7')8Q&6F5"]3.#6!U*;^ ^1_I:GJ4N9<1\3_?*&59_5XJ'DGXCN^(1I>& M+KD@5Y3MZ:!C:^U5A?+HQ"[C4,_Q:DD+76X,M#084E#/D8\/;:^:*&E9Q0G? M^W.-/!]L:2=7YY9W)5X3P0'^&Q0)0#(V"O&DK(S4RC>2623P=U(P D"&N,Q='6Z28.'G2AGBX ]$);0J MNVGOS/#\#V2\G8KQ%/M1'6V*]]:LG]\6\ Q[6MG%IZD,[#9 TYL_%T)H>:;% M O50XO/*2N%)OLH16&YV0KP6DZIBPU-?/K-DE,F[8"WMV+R0VH^0X'+YIPDO_RO"\1S:"/K]-V\*8)34] MLYN2DW.AKFD/7@1P1O+I2H1]I_1)+'@XYFD_GJI#N7,?SM111*" !/IA\?N& M\Y2][7!RK?SZ^KBXD5?]V%Q!B9CM& M3OW+"L?XY>CB4^UG/2>XQ:M\MW\ W>\3O4X!"T 9M_9XZ<@HP?9ZB"%]1,(# M?O(L(:,5,^DOA%ZYMRS'TSVD-.K MEP-UT_?HK=E3+)5&D" JD-N6[N+?F=:EH!111Y0T1D#JF-'-,_0_;C/'6=N4 MXG/I$0;YM7SK_-GK$I>LO:.'?:X'LM'A'OS9$?YVWF@[(EM'0'/*IH&Y@VQ:\ 9HD MHEC!CJ!U$!-$U 0<]?F3>([791'N:1H.,%.D"Y7'N'Y;8[P>+R:9+?\.:3R9 MF$\#&]1Q(6G#]E&I4883@[RJ)=U\GFN*MLQ*6B#KIP]F(\!T?=F1#ZR]SUGN MY=\S;?YC(%SVVQZ[3QG:%"O:OZ!+PRGQ^2O6+P..\WEGL,?PTJWVCC9T%U*WGO=B>M42ESPP"_F]AU:4W9\R4- M#.WE2;L/&T1:)*O,A'P&)_<[SQ4,_P>UE?_OLI/_&?"Y']21]?>S68^SG%QN]J7^7*[H9'"L:R8\BF-+-K]1 M)<+[NC@&$Y(>5ZT/=>-]ND;KI*)2J][L#0JVU+^W;Y0S8B&F+Q=4ED4(W4GK M9>L70=1I!8-2LRV$+I2Q1- _DYH+IY*80XWDG"E! 7:5,QP*A9O"Q^$)\FD MX2Y62G K3<@ D3%@A58,E0D !9I_#"UCV*;F)8GX-("UDLE=:%.++Z(O8'&K M61Z>Q2I@/P6HF&6TKQO?.,!&9; 8;_*,GB@E-B/ 1+^2KN)80W*01"/6JL%W M)]M=FF4IMYOB/ENJGSFV,D7+-!5\^%PXH(4YK(598@4FG_)P8VT:Y"P,TE<2 MD!7>O-"13NJ**<5%K(+ M8O*53Z,UOFFG.C->2J ]3H,4VJ>2#95A\[DB>8IE6SF.?D/M*27<+TFY:)#< M3<+Q!O@P_UEE(LEO2 K.WK8!!0:F%H'/-"N+ MG>AG5J4%H0>TT.- G6SR<1TO6SS>,')^K7DG6UH[O)EMC5+WJTK;$BJ-B3^2 MAVBQ]1S[=NP8T0W#/"IA4&% N\FB;W%00P'RK\S'J@0U607?BO7,Q.M@*W$1 M$(]5XBQO"UU0'O%"ETK%KN*MS[5X?[F!H8PKOD;#QYH4"K0+&*.2(:U07:DI MF=#54&H+]"]T+)JV3<]YB-!(###O;^[Y*M\QPQ0B/#'11_=[;H@SKD@ M&^=?>(7)8,+)C5^BHWEL_P#*R]? UM9@-W6A5Y!QX;OP(E]EL0Y*UU>*K+(3 M:N7%M87B:E\D8;EM)[=LE](:ATGQXT3$L[)&FL\%-J$7IA*)%:>K=Z/N-8ZU MP)-\YER:YWK)GO;VEC_]L48\$C;TX2;O.]ASKB;YET>26[D!*]JURJXZ@2.0 MR[FV[_-3D/0,G].^G&A^=Q\N1B80\ELT_\3D[:*[U? ML<+T1RSQ^AD1E/+?*C@/A@6I?."-3IA? M+JK)K+(_]15*O^WKE+[O]BJP^2_C"(T_T%8\?^_+E?V_O__!$+_K[C"?U:P MEC4X\>JR6QO:>J '#ZC44_*]8_3 ]'L8O6Y3BI-G-VD=AVE%Y#FIFG;; M95^FY58NH&QK(KE>9FDU;;JT/*Z/#K+2Q.UW=;6N>1#BV/U1J]LI"WF8&D?T MK$MD4&#>L\U^S7^_EVSB''_/@#\6^&?"^-JU'Y3HYSB8871)=F">>1#Q M72I1^;O[_H]_ #38K%R[U4;$ XD!PKRG:2OSB(]*(7$C>L?)]#3X(_F2J@+P,5#VPY#P4J=I5<0=Z6?X[#2GHIA:6N,X5F!2-.? M@YT6,8WJS8L ^\B/'*LO?9#JL$\Q 2LP7$]MF6[;/ZXC"L.?T*_UHM,"$9 Z MXG.YZQ8EN]4^[O40-^'TZ;7M*SWO=U#'[F!FJ$>_?5';XR0,7B7SFEW(&"8[ M&-_EP!]LD^'=*8KZ\8/:2#O";&"I=+?6XWISA-%QX0*KZG#$N/"QUA4*-/9K M5D_4]8?%2/*@))+68 8JW\FEIY6;;O] ^U%F/D4AC+Y=7G!0-[:\V$UA]Q]_GH#.\HK]_DK5J M[$JH&=VI5-AI&-P7SWAVC7S,D5+HJZM/[ M]T.&[X OUGMU$5W90FQ<'-\KJ9[:RWY%_^ RW52N) )Z7W@/X?8$H\[)&KG M%5=MGOTDJ+UVY:0B=[!"*V@G*?D5OO]9U/@S*Z7(/\ ,FQLZTN.T4O6PK>^= M_C8GK7&<-99/\H]IN8,K>M6&<-64D7&.0T$$6F+$^+E.CAL7C,=1JY6V_JD) M1&NTXG"UJ'75G(%.B;+2-YMRM78H,[&$T;V<(8\)27$$,^(378_1=Z+((M0% M!L#8.;0GW7/8,_M[PKM@L8WX_3C-7Y3?'^I_?5=,U;NMO6KQX)DFN]'7B%VR).0]UH75B2X[1M.Z+.\T?[2.!&,%VEAL]KVL3J8N%RBCYVBNEV92- MF)T'C*6+]'9R#W ^+B>E-L:;XO^Y6XV)Z,A:[FH2"VZ@15, B.W;,E36*%UM MT#\"PPN^""J+AA9F5$G;O63/@)/&E'IF%&OG7+@QBOA2\UOS,B;KX?+S&3UF M;O3H?>4"23\#3$T %(\4CSGT#X!RI29(&4KQMW>/XY.IA&6\T0YV)X][JLDE MV6S,.Q-W\Q('U=\M-U@Q$^$I-KDLUPGI*2;=MVVWGT87Y>8JBGW6T'^ R$22 MB?%BDX)_ *\EM3MBC20K%;;('W_/ZDXF(T.W$17^(NA>L]CG_**#2,S47FJB=]K@L,7.BL1F>C2D2%=Y9M=[)) @A$/;*BI% ME>9>]1C!-DFO^F4@DGJQ[^P.<-=&:06?2X&=@P%H&OS-#<\W:LYO/Z!T"KY\ M@ 9CXV+!S!%UX7(5_A:4:K(0U(H#]L7F+S6 >P(=SHBF-KRYR%D=2>*4/6A" M]3#!6+Z3!9_?)R-FA-3_BI2 OR)[)W#(YFYLDQ!(+3S%80[Y4PZ3&D MZ,)0MI."M5+8*F[_ 2)L>IN67+Q5#*\B>QAV>3@1R,H]"V6HHNU%/I>H=C,5I]VWY:H&*[=D38R%*Z'Q_;*PF?M;.%=[L?[W[ZQ+^>O9B=\. MT=&C+']H]H3K31,OY1D2NE[RO2+W+:I' _%%#[% 0: M5Y0)W" 6[2&_]N;.'1$N!371TB-^R=7\$'SS2;F5,Z-BTR@NZY*3/K03C/98 MTK)8WTHS,K("'GBR,4-NU6B-\1BKW4I4QOK@CXCUQ+.^H^+^K-N2N860R.9* M]\W=TM>:9]@3S,Y4=&U&,G]EH1T//<3!)GW5F@\1=\_NI$JN5B%(&2U7/\_W M;SNXK_K"^E[Y[?MP=X7$UZ5B.G.NZ BZ7K;!MGSKN3WD&Y4'=S-WDH\\%90& M:$\Y*+'MK:K6DY+<9G82/K'+40G3_-K04#E339\'S12"RFO6(6O^N[58T[P: M20 20BUV_WYH/^&(9GFXTDI:3K:<< 'B"#-ZGAI2Y[!H*X!:654;R@S'*F>[ M@>P1H,WZUQXZ=OD*I:F-BJ]RQXD[$\QWE3EK]F8@3)FG8U?/$A*?1'VWG MR)F(#SKWX=WMO3P_5:+6-QP=O:+V3;(HO"'[)W>?8F^"5+Z4G%:Z'JTE(4RX M9Y_Q<==K."TZ7N'-1'MDYL3KUT545M/T3NNU0,=-T!WVHK3>YI!?!PUN_4"J MG;FJ?*>%>LZ#T/';E[CC.U!;_E]CG!E0PO MZ_MGW1 M,^_1V[_?4=N6?MLF>5F:,E97RI6",T!QN$1W")W?>R"?TQ0E0+35!EG%QM5T M+H!T_+3[S3+QM$S-Z05]/7 MZO(VB+X>O39L 1.% MW8G=^5J?'%VH.+HZDE*A5]G+%/U-J@Y?ME4^_K!3J_VV)A\?XIN'?WMIE-#T M<0/XE19S$5PE ;Q++^4XSBETT*]XC1Q@KQL*JAX-J-*LY?<:.#UM%:JY_.\$=&2S5;+]]#J>!X_/#J4--M=A=%0C2JP>__FE+W7>@71=$95>(7Y#: M_X1W$0 K1(ZV".6XS,%(HEE>O%/_,H9VKA.=2QEZ,%-D+Y!&=N&J];']YL1K7T=\K%:X+/[ MPM(4H*N +5#/J#=3JGN(+"I)HJ4>C\]YQX0 64"M<3JD MB7]HT4];A=EG#\IV-B30&__V44U<6YI%Y:\BYMXZ'$EQ$<;R1^Y50+Y>G&R+ MI8O/_7OE_CM[X"ZXVG=OTY&X#7?\.39=&,[IZD/I]]72^1XY6W! ^*7@?"A% M]1R_PO)QL1?%V*:$=7+'<;EVCFYJ:/S5# 29W(#S\B#YFMEFJ[MYV%U@<:F7 MG0>\#X;FWFVVVLCA=O>Z"=I_XA31'?J=(2>U7]:T[;+0XO<\S1:39S"D4]K4 M8#J(& YRYC/ GTI8[[)IK,E1">'7?*"U?J_6OM U9/ R"9$7*@M1Z=QK;!%X M]6,_J88;EDU":E/ZR.0\O:9+C'TX2J 9OLKNT&/H0F^H@0L#%* "TS?H$)VF M@K\"ZTI:W!)&*_GSDEESFY,@0]IMRM7NDO@6"8L:C,>7+(0_A.D1=@K\DPUN M@,G2/2G)O5$S ]FXKLPXN7>Z+O:2O-W0'OQ#I!'/8 ]4Z1$YO;!A_*C^M ]X. MYZ8T.F%XGIE+:>QQVRHP('3^K@H;C[328%JH-YLH7;T](A&)JQ:2R:V MV*9O'+L478ZAZ>A2FV;*0/U+;03;DL*/_NHR*E0]-^5BQ_EA+%I*8$H/N[U;(' %9"JY#'(PSS869;8U MA$XQ0@%'_X5HF8B-O2*8"8JT!WX*7IO7DFO!:;!%7!]I?,=RB_<&L>A MK:##7X0H=]$C?0963=8SU MQ&G.[M0H#?$8 63YEES/X]\RHM]E:BYP_"KYY9T;!G:,"$:FJ+CU6N,VTW\% M[G67?_DYZ@5(=4",7U'[!QCZ;'2_X""75D)WY*,ZSTGRECW0N?K1I47%E%'_ MP\KR2R&EIT)#4J!,SUW:T=$_ (PO@>Y:>\/KC)PG[;?20:_S>1]PX?$+_N<\ ME8L6*,&:4W$$@>WS?L_]RZA(Z=^D;.\IHN$D)-B1P@T!=D >=DQ EV%ISTI; MJ@J9DW&TI#G5<4XQ[9NN-[(QD03J4JLS)B+WN(>L33VSIZX7Y1?-\+VV\JI8 MF7-,3K%CK=Q5DB"IH V^#1WG-_8%_QKQLV3'C(93;8?J!L.)M]DZR)^(6&^K MFV97#%E@F6)R';=KK M$]$Y%75+(/-NU/D\3)]EQ.TS9&M'8J6.T_G:UD"VK?Q%3@$0H.]1S#A23DYI MEE#[\\(H$>KU1UDN?8'/.;8E*'?YK3I!<#"/<'X7]M<8I53T?=/OA10K@.Q! ME!K7'+P:$+G=H2&HJ=UL7X9IMA#D6@4F8K,_W-PQ+G:1[3"Y?-5YQD/2HLSL MBAX*9A5\!1Y/&1G;O?KC8PPN81N90HY'#6X9>FY5.-:A3](F,SGJOIZ_0+C8 M"?R*_.O\NC"\A81ZK"U:!J-@;].W+ M8E(5&T&*"RV9)7*-*80/="A<2H3'>8RQEG=V%3%5E<>Y'!)?\"'$(DLB0X42 MRVB()E[]9X:K[:D0XA2S+6>>"5\<<<< W5QO.YV*+'NY5D&C$JTGP#7_!9%B MF?-@A.8'MJA;M:1T?Q?%PX^$FYL?< DIE>K9>*OJK>O1R8GI_AQ.:=#5,6WO M5V^.M@0NE_X&$=[S?SL,0(G/\S_.510Z@+J2OI0G=H\=-S&KD\5;!"[<%HN? MP>VF2F(@,V5_YBTLQ_H*:&GY6A2"F1.]PY8*W7WWJLKCO3T7Y$(^#[#K7E@[ M:/7,XY@K66WYE;?Y5^(*B(USO58WQ2^'7!&/30YFJWR7G[\,7@6BBMC/:/3T MZ-MU[E6\\Q^8XBA4:@0>JR7^])%8/@67&_[4L*XPW;Q:II7$%F.I?,)D'-7L M#;O?%W\1N,J$/M:UQT&M'!X4'P/%C?>QVBF?:QFS*^!V$MJ]O25H5J[X/L*K M4$:5/H^P'2HP"UNI@2%4Z+?7E7XOOBMUJW@4W2ST?(V_F ;_ 6RA*VP"W+)_ MK>H"GPOWP>*&8C7W%2Z<+;B%YPI*'O:@^0$'+ MUGK0K<*07"ZA,^BN@&(PI09]H>*U*R\)?:.XX\+W/:-3;=.> 2T0+\4:_\V([80PKX,[. ZLV_\'*_7#[S$;EK.4U&ROPPDO=/.KNT%@2SP4W[)/^ M';M'V-:+L[A)PD%8SSJ)3?EAH$N^&:"FC3-1S+J-4K=F5?'#$&_^Y"]3'J:. MV5S+),OP]EJN$OU'6H65EA[30C!1RO:O\,&N\_7S] +_!K9=Q7[/8>]7A4BO M!,(--2R4HHX1C"8/=T/?OTBWW5O\RTOP*M'.]TDGQ_Q%(PLRC8-^Y3H90]G8 M474W:T:3?#DVR>HHHP&7?!R\ZO,'7=!-,\%[-5Q+BOKN5C D@#&RUM!XT-\! MJ?8[SDB/\TN5R)?('O$R\S]%,TO5D1M*5A[,?EW::^QN?PEOKWOKUB":Z^<# MD^K^:VK4]?RN(P&8=6G@O6VR%9 LK\6$R/6LEEE:\=EK[[TA^7 ,A^S28 MU41V PLV7XE?4J'[,NP=$)F77R=#X!O7Z_QSRMQ*!.V8_P_KS1 50_-/O+(< MN^X??^\H*PS2@**40%##)&&!>9^52?Y C=E4LG&>G!VZ)?94E>0(,B6K($S) M"BZ6[<+,6S\W*M9IOCS_Q7'\!A19GJZ4UH2LR>HHWI9.GN;)O8O6E@0DP@3V M-^0=W!SRS-IM,$J'CR'SYW5CKO=MAB3005C\\& /" R;%K\/\ ?B_E[PGN M9-(A+$+;FN/ >AJM^Y'>*F-IN8%<*[ZK"VEX9ZE#I61Z0 B7G/4D8O-6LX"\ MZ$I\Q*S/0K.3ZKTXDE9W-QZP479'KX.:K[SC_T CP6%YE,?-R+0U5T2 :/8I MWZ0!W6UOF"IW$_M^)S:>B8SX3HY33CRF2-A)Q[1/0/3U5=C'[<^+<]7U+-"N< M*[YT9X?&]\.AH'=WEC'&VWQ^ 8G.FB!(XHWSM(1$CO8JG!@5>_SLN3K3VMH8 M&&]0'W4E(9@,)-3')&&BW AAOT[[#2)YU=)JWF+I_X;<2@ W\7]:0//^VP(: MPEP$M;3X;W+9$ E@D_1!G;E$6 PCWD.-V)JIL25'LR]L9MF3;[H];WD98H;< MN'C%J+^Z)WC+:=-^8S*2_YDSJ]+8?-.R-+*=]:#6E\?@U!PWY?Q%XZ=]_5#. MBV]UN'IHB]DSS0#DW\(!$0JN9&[CP<3K2]/+P<3-_H#?;X+*'NPR< MWO#3T$BT(#!10BSK2R /0[J"A<#"!-)#'C\25&67_$+;U4'YL=91^2<#XX4B'X%92'< MC)^+LP7H"4^=:'PU8BYJGYOZSY$Y"E[F1.@/C_#1#3) M><"G2.>$NH@Z>2J9E2X^TYH"/=V(X?(-XZK=",3E,8+FT#70N!W_1_K5@IJX M^7B=2 MZBO65Z^2\6F ")2Y !$NSKY5Y2B-=(:E2DD,#:8#7(C0B:1T6$*N[8KO4[3> MR7JF(_^RP16H'4FI3S8)I(4.CGOR7U,]UQID>EO9J7@Q9_& M_PH[L-#T_;P!NL?%<=CW)KI%#O(:58:*!EY,#O8.6?A4'OBSQQU_VFE7U?/3 M5_$G/KK#%U MAD_#*CECZ/B3?\,:#4>S#O=ZJR)$Y$;N1JZ#/=0<@,^GE108@O\ 64Q<4Z5 M/A:CC#!7&E9,\MF,+%VZ?P LB+]S;3$\'?>-DKN_2]8H\F:MMK^1@4%\Y),X MQ*B#Z%L&E2YZ)*4:3R 8N*;7IZ5;U"MPJB/,5 ;1JMVM,OI2N2VJC1*6Q_3VF4$AGB:\V4H0T52B8_%CJ!5E.> MY$LLFV>>^ZC['$I:(;JN,@1W=.!AUHZQ'+?7W+&FLW?X!/I9J M<\[X4H9B.SUH/934#9Q1^J(>7BK69 M)!4N_R4BF #.AL@7+0;MI6*K/BLR$3'@L33JS-J#="#>^ZF(%]B=6;?6O-R5 M#4@G]WB1WK<2:R$=!G5\S]'*'74F54PZH.^54.)YXW&_4N51<>FV0FO,ZVL! M%)H>*BXE/E>-,>A #L3/.82R2$>V"_X!\'VK9'&+&Q:?1W5BW<0EHI8E\ MQ.7L3 =96AEW$6,H#E9:CCA11^N06VT@IP,,AO:<2C/S&UUNLSN,1KGV<251 M:D+C2)WFP%B?(6$AS2YB;_HQ MR.P,1YCT^_S4:;H9FNF*&^2*&_+;"7_3@/>3?/M\"6'4O8_5<6("N,YP4H_P M(:PRY28GGX<'JD*G!80&%<^;B,RMY88WE7.4+8TKRS>![GL9-'#C!2A&0N$X M>LURH,ZE929;>40T9@3<_Q$P^/I_%S" =9+NSLLQ(JZ /EGU0F_&#>ECPC3_ M 0B]VS_AT!HK'@;+0FWH,VTVHNDGG-+2NJ0#M=B#*OT6,!4D/Q-1 M4K$Y2FX6ROY%N# I&*A0O9=XZ270*<72$61,!Y2;*HE"$)ZJ\J[[/(G%4H"[6@OX"$'F"Z\5 MS=W5A \[1Y%C2! 1(F/@8/G=M5\B V0V=,\.:1UD4^RWF4, G>1."PB$#@N@ MXH&LH#S8P*6D@XE-NO#LC,\]6DC<5TQEHG, W\:CL/I6/&,3/O-NJ]B?.R7Q M(Q?==G.BV;!CE>90BCC8$AP%3@U/-;O3C$@*L\%V*[[[1Q01M"Q@!S)/0[]1 MV/%>:;+8]RZ1.7BQ?X"^E+U\46,T3.8$8"%;9FMF& G]8D?;D.HE(/J-\4=;.F[B'&->^'. MM@-Z1DUZH&Y*,('J$C%86H"34 M6,E;DUH_5=T(Q0[D>/[26P7% 10I\EH*96U$XU-$YS[P3YW1UZW-FD$$J&QZ M$K^B]>"HT'-K=HAI^U-STZ !;'N2T]'F7= 7^0OFQCT$Q_9P%5!8BPI0\Q*T ME8O8G.A3Z;T)X AF*J1'QY_*E:N!RH8PXALX-:F&2#:8R()"K,U:]'<^N))\ M=MS4ER\1OB5<"A@[00M$3$50#R8F]R,%@@+DR&^>R=);:$UBR6,SFD2N7>+5 M=,^; >G^_4D/+6@=#UM\:V/"NRQ5@G<]P*/0Y&BIC2[F(-GFK!4&F#CG)3.I M8DSU7R*#Z,C:K :/3L+\+TZ3UKY4TS/SJ>%+V3D_FD8_1>E__.V,2[OXUOJH M:]YA24ZH*05.7QG%>#VD#;GG:>AHBB7+ZS9P M'JS4F(P[HR'0 Q24)U*N417O7VSR'N'\F+/>1YVPNA4@87\5C'VXWRL7^445 MIXI$O4RL3SPW&J]-;SB)UBGV-.A7,@G:8">,T%.Z^5W;"T2.35$WWT5[%-28,<"75R2N(G-D$ !:TO%O2S9'!"-#&@3_H!2"0,F:C MC(\>*7/W%[N,3 ,0:+0]=\*&@0I'@SS@.1WSCE71SS%\;!"88,_Q'?BDX#S55NN2_[@_4UZ]:;Z6I2&[+ M+OA'UV[NH9(X:IZ' W1^+XK;!'HRSS4NS%6!\."56;%V? (M&J8;JJ5%9X^% M:W\,:,^NYJH%D6V7*/WGZCQU;"EE'AN4&.F/^OP85@:'8 ;@6/!^]C?G:SM+ MALF8N2\H-[IISW#MGMC-*,4?U/V'N7<[NG#;,-P**FV[3:>21G"P$*@>)_U= MF1(*M07J&=[0@HH;Z40952UXO8YSFY02\9_BPO)Y8(^,_ )NX[DO%?OX?&PC:Z)\;([)+Q(6-B(28I-W' MXY3MF!" FT) XN5B [([=UX:&U,RU0#7:"]1 ZZI&1=30$K?LMRUT;4W(CY. M-=ZZ"57]2R^X# &?H4;(/U%,RQW71%TY,QF%DH>E8;,AWGGLJ3KYM"NBOO,V M;YE[X3@F^-X]=$F31W#S$&F6K]%9&QD!JA>!$3KV5(&"8=R=\5O%ZY1;ZY=2 M^#E9ZQ2$B#@)@"RCCG<0M%F,II'.6A^6!9++]7(5#GT^[HO#OB49R]$2 MK0,"\BMK?$4-+%;ZRA1R!_VL/K,1R<1R&Q -6RZR=M%Q-T0.A*95[$O%BV--?94V-[XJ MG[DAIN")PY5M.0+IJ^P1H("FX[VMI%PMP_GSNM@P8S[-#_]K FW*B@(/B98H M)S^KH9^.25%OR=]&>EG7I5(, _%#?X'(=[T IF,*TR%$W7%^=V2ABY7U.=,0 MP[QT0@>3"")-R$(\%,:/5E2. 9AA.X*H9(-$D]'E#14_Y!46FV%RX5W+B4<) MU4318&QEF^;XEUM$7*@B-AZ'4"YF6S=:0['\24L14,>/0\@WI,0_A!Y G<5POR@[R:2)6<5A'E7ZLN1RD6C[J2E;1CDW4EQC_< M1075"_.M-CW8[C"]\TH2&VNV;R$X,_WJJ-AQ5$E?J]-#!L*>T,#)E5O3G3D5 MC^7C5D7T!$#/I9>B59Q&,^>$")J17D')A]8G-#BZ"FQ(U-?E&# MN"MGEM=&UHU /^&ZDC(WCFS Y@G@55LYI_P^X-$X90R^-U$X5C7TW[4J"S1< MV2YHP0@:C))(JZS8CHN3=33_&CY&5W[[VMF6G'N8JOP-"RR*X$P/QT[7Y*5# M$3]Z0Z$SCK?-[!2"/5&B_[ZQG$NL\A_[D1H^K!;HB-%VQ>X>MFNK6,L0J64< MJW[,/Z:%:@^'JG0R?\GJ_R/M&Y;]6 M=NFQBC/K+D+/\EMC&O0/X$LA1[25?F:*>=0DQZ98Q;.:7=E0&Z0IAVL T3JF(R;48DB@U] MHNOZ6Y72*6A+W)A6/I4"-XK&$F>%9WK?>+!20CQO=CX.E&J#"9]I^]5]:0:? M3G 9-F:/SQLG2)Q\\@]0FPSQJ-1_%\3.$=V>D,BJ"Q+VSZ$>-N7,$$RSV+U+ M7.FD<)IHK.<_U/P^Y<\$+79S&U$Z0L+>EEII9DA2W/&*N/D'2'=4MVJ;:"?. MXJ'>HZS$2+<\ENTS2D-@B-!B00,L1O34^< M%!2@A)'B,X5NA.2HNT.;^:=4X D1D%OU4DZ^;-.?2>)E#5G3>.H?\]86>)-, M:T6N!J2;]R]7MV5?.#ELXFBV(W">@PUH[$X#])T'3/ F$B9O.VKKFW\XH_-R M^S*1\JL?5E]Q5>K #%9:7AAR_SPJE76A4D_GN$X5/-90(Y,"VY:X%V<^?2QU MFG4!ILNDTMMG3-O^LOB,I5O\6=;*\EJXA._=W =:7=6XS- M<[E;'YC+[XW'ZV =)E26*2FJ$_KG'T#9=&OQP&0\-S? IPS1L;R;7@%CD[DNYPJG M C Y30#WXW]+<69/D$5/\SC-8;90HUY>,?S!CR/UL08RF2[(BMII\(B->79G M<*;50-V3:=>%$B4=XG^C2XN.S\Z=F$[;HI]0=,TP5I\TY?@@D&@5+ZSEP7"E M$00'55S)/8"Q#=A+#IMX2AVGQ:Z'")>5*1@E$>>2Z1VZJV]FHZ )$0 B)<]6 M,@>/9@.^;).*'6=/H+F+\\!C2M;2QSKU3O!U# MIDER@)NO5AZ"P957D?PYNZO0_##R$X8-T0TS4PE-M)9$%6O=!Q M8P#"&0;602^G#[B5-M7QG@O'V&=HHG:\RL M%+33FR_@EEI6(S-1)OA?F M/2R#J[HDP;5+:])#?0'8R/WEPWUA;:W\M&O!_=0(_3FFK3RJ*$PMX7O,MJ&- M4O.O)K8/._>;5VX%2GM5HO6$ M;W%I,XN/UJ/\,)Z7NDL#$BA%P:#VG8Z06P>Z@'I"Z$9E"RZQ=3TN= M)AF;4%)&RY*,EB>-]JWL_@J@TW@A\50(H_'E&=- $&?]=C18PASC,9JG!@#7 M='^-Q<+V*9--GLS_" Q8Y#LMZ]9[D[Z2TF>P 0?%Z:-4OXP5?,"A9\5$N6?Q MCR,DZ>>G:,52=3(/1=5=&O:OKKHM#P,:3 MZT=R5#>>ZK#EQFBWOD? BFE#!3T_0PM5L$\9]TZD@6JH(._5!;1MM4$! >C8 M'&\7PJ+838YX0I4FHJP(IW"B>[7 F/$EOYLI-SOK4+.?7MM"OP^FE^%(Q9V+ M-M/)WE\^TZ/?^A8A"\SG?=7GN#JL?7$?=E9-MQLE"6-"@EVF&K0UU;8G&$DE M-0_FU[$9G$;O!6<>OF)6C_:@Y;>:UP#]*$7\#S>UE=-C2S924*9'.UA/& M,0^"I*I#3Q3#(W5"% )^)%E6E^+(\G9G9^-V3CQ73 OA5=_G:B)ZSCHZ2HSM M/C"(S]9R-'?YITQ\%[1@I:85&V3#TR@U;X^X?3Z@[3LJ1^\&EK MU/I[\I1\81:ST)(DR/[?B1AI2&(%@G1V.R2[4@[KT3IT;DP:3Q*-'G]BK3'T M)2,X#PHR=KBG<2 417QDR]%/QBQLG*3(7HB5W/6JFK\O1J!8'GK+Q7++]4Q1(( SO+%WJHA.A*A.5'Z#H3[Q>^*.["5J0*#^ M06=N" !F> (P>;H;\87.AY#ZJ[[ M^X+LC<4GDH)F-MYON_CQ^ISTB0QK&8^$0)Z*V!\N:H[J+N2HU:EGJW*6R$5/P1;);-%SKCGDA-+!L=H_!M"3X1^UE?=)9X MHE 2D=RSPV5[82BV,)"XAU!->M;UQ#3-.EZ>^+GBD9(]$HMK>DTBC=UK9,JY*.&[@8!$ M\,UN)$5N\W/P!"JA21MR@/%TH'K*.3XYD6B?%;+RA"D/RW@RA?5.OFLQBL'8 M9#YG"]".D0)GU+8WJCA>LC7"*L0/C6@>WJ:9\U-,"N M?ED:28OI<-"ZA@:$,- A/(W2?./QUU*CGLF79H. GL;:@;1H/*)+PZ[DG&S+S;S(YK20"0:V=K+UH/:'/-]L MJ^#@N#-04/-(0-[RC%;V,P?W-ELCS7*,UUAI!N<:P)NQOH5[B/@*+Z3WJRZQ M()(1,+H=EC3[E<)=ZT\\3RZWI$CCC88@46-26R,A4R4_NN(B1<\Z MZ0_X$-:9E<8!1(T4=4P!I,U$]O?RRB*_!?1Y"O>$&M[T:B5PFP /0OBB,X < M&H9PL)/.T>2V0%1UZ.1DD]WJ3*+S'5R _ANZ@R%;['\.B6@0G_LA1#E;ZZ H M7=15!Z9/-C,#4;7 Y3XGR6O*D_M^"="!KS/ [EYI<=D159RJC_>I207JH6)#%YG,UIU MY%YG)8@*3WU1@K.2/0D%S#%O)?>G&3C N\LUMR,#H8&PN6J4.C-H9 !+S>X7 MZ*-G8&WF ZV$7H/X5S>USUC4BIGM'J9ZRLHR5)(G%P;J0ZT0LQ[85<_[CSA^ M6T$.4\1H]9:]A>P *$R>H:?U9B>$ .\^J0?JU?;BRW6)'D'U9+4#AX4=_.1> MHD.=7GX, 92ZEHP>)MPE;)_6^NVSAN#+<0DQ_F^H#I&_UQ(D+'QM0^KT5 LQ M.><>C#]\K#>()*6!X@Z$" V[FZ$N]%RD^@Q>>S&5^MY5\Y7D6GC5(_!4.ZP] M-MS--<2U5%"E.4OJO2ZAH%HFZPBX<9O3ZYM,72N:P)Y(CZKD!^K4Y'JX9TNM MM&C[$Q'G4(:E#7BMTI0*D/'@SA25+$,5_Q/=ST( 6J,$>VKE<))H+/WX+W[3 M- @K)=K<\8\%*/&JT?3"?!7MY V5]R_EI%&[R-.)RJ .](LQ4Y*7UP*(CW6H*C])[DK5,MEBUZI"^0?P.X&34_@L M\:2$F^%MV-)F[Y4+;VOF*ZA,@M,L#]1+5D3C4:A\+%<5V[046Y-#QBUUF$8# M+ II'QXN*RR:CN;S%4^(5>4M,2(%GDV4$+VY<:<0KY2JL$2H\>5S*A"L63F\ MJ*!EN(*NE'S%)Z4;7:9JUWS*D/P15[6! J>@/*.ZC3-MX_3D0]%$ +31$N-Y MI8"RY^F+QOT XV:E($+G[<)ZL0G(CSW\9K_XOQKXJ* XVRK)Q@KN[TTAPAS3NP:V1X-"X!+<&@C702.-NC3?N MDN#N'BP$=Q((20A)_OUG:K>V:G:F:A_NT_?XU;WWG&M'_\W$PS3-RTYY+!;< MD_95SPQ+$4D;H/&ZY[&>\*:SC'-Y$J550HJ037XM9V]']IS?>/0Y#SJDZ:"0 MR>CX!U.VQ9FT;5%1Q*5WL1OG_4WE:$EU[3P[?BM>::[TT0:4T=MMPG"QR$6\ M@3F?ZHCNEKM\4DN#S1G ,V_A+1ML/J2/3;-<2Y$21-8CRL![W(W4]93#9R?K M38U*ZJ/KEC+3.#)E*"W(.5SYF/B.I!4- 0/ \*\LZ[K[/"PG MO_GD=#V]\?%=)=L"I!IONH,V,8*%JD,8I!ZJ(L8"N6KU/-U#LN-U M/.76\9\TWG9U.&2,TEED7-^LU:'M(.Y >&VC:.%=2E]-4'9ATP7B6&K7M[6F MDB*TS/0O3CL&-B%'\21DC]PC ZY%8, M-X'_+%ZWF/W^;HS/F#XF58:N^.:"VE+DH^?,-(6*QW;/P:^"Z=:W&IH18Z%A M*Y,!XG,H!ML>F\@L--[L@?=5#%\(I>E,&:7EW=I#X@U.#XY6&I-H"%X:[4.9 MZWA(V*=V8M+Z+1BT^JO" <'8G9$SMU7OWZRTC;EQ\;Z<\Q^! 3(*W[)Q*"^* M3=N9"R1B%)G"RHQQ&*)-N.AW,A6R5Q7=M*5*R=J'JV8?_GZW9T_[BAI4V!/[ M0+Q3AQ8X@7.TW_O'Y'7E$;XVPRF/R-UUF'-W@,C#S@T#V]OBYA_\2[B5:<;JW'N84T\IW+.:44*8]5A8Q6LA=HN4U8?LY!, M.7.'(K2DXZ))$2^=A2.*I!9U"+L(FJ$U0FGC;X]I*?]:PAJSG\)7(*2DWD;] M TCT5P7X"OS_+/^F_M 54*"Q.3R4TG?Z&(_3Z61HU>JD:EV2_%E^Z1R'+]XK M>W687)6&W[]@?E5 =4"BZ^BG&KASR3L+?1?O26ZD6WS1'M;&KP(T&*YNIF@< M5G,_.U[(R.RQ@Z7JX=0$5,[RSOXDF.[V6X5:9"54XC+ Q'&_EQI.>;90TA]M;J8E=)^\&A M-EA7B?:]P6DQ%!![377JMZH0^-!BO'))MBNSO0UR@!+GSPLE>GH5J-G?MTSL MKSUQ%E4OO\ -7<(DF^5(.]DI%3;VV_\FJK7K>N^[:Y+W#-A&.)SDA&><<#CJR):1=B MV4;S %6V_6D&]]-WJ?U&1GI".6R^I?Z&NVT3)J6^C*V:XKT\33>I:VAT3TL- MI*P.6T2/9,AOE4#BO%",[6;U+C&\6/] KNRS3-;WZJI1WUW1[;H61O\ 5TS@(K-[<#HUB359S>AX0AJ#&$0X3D&A,+:?H@@ M\W&P0)>A2QCA159DQ$ -2\DC0ZLFY9#YPU09/NG."R^VG5GLT](P M=_^ \&5*5NI!P1Q'[71ZP)FT>$2-0S H/?P,<0&B..Y&N.T,5>+_*&@&(E/S M2;'V]\ --I>7_2A4N>PO*OG+ZJODVI%W[)X X%2C7OZF?+UO!P^?<>0LL'A! MG3'.(OGT.)X"+73?U!F72-0B%2_*-8>UVP5ER1@LSE#>'4.(^\*JN+-8UI.; MT5T13M;65.CNS7+@/QY@ESO *YJV].!_B+(YF=""5EY9RB3D+1/\KJ0L/FB4 MV\Y>%0QZ_>DU(5=#\/4]XR<>.;0WJII@;F%$^&51@+@I!7^0.('.(F)>1Q$# MWQ0S.6:+4G1CM>Y32Y[GKN@AJ&@L?FF$9]*Q4W26T?)5YQF[C(-4/'6R0,VWY8RRM%.Y MG;4"I9!;QT;VG1H(=7@KS"WX4])':5/0!D6V!Y.7?F/;)P>F:\1-(,/DDOVT2_48Y"RO0=UZSW9') ^V;1]QF1_*,5-^[ MH0:\6A.VP[N.%+)]D^Q;U.(54S)ES2;L]\^:*9+PY6 M-)H';FG8.T-V497:*5+CLF@MO#?D$]@G0UZN!@OJ6OE\LGB?6]!2EF'$ FJ$ MK% :9)ES+ A;E8^S ^"5_5 !]R2F4+L@? M_NWGD^'\-"6^!G[BTG%)IXP:%6NZ_[]X1TDBQ\.VH+7C=_\38QSID/DQB5Y= M%3]KH< #LQL@<2<"9:%]O1WJ7'6?24E/+P"OKD@]M.#:RPD4DSOO=?EV"&7\ M'O / !SI4D?+9$+,C]0/I,0DZRCJ4C+DZ]P=5^0#',3N0SDA=D$FB:*'5?:, MW1$K/*J6&F]H5.4)E7(UOG11TUR>#0)>#]-2Z63N=RQ[OX/(JX>6=3]822(\ M:5E\"_KZ I:@ _=QC!I<4#+]#TY)ZG/'#Z_[]]G?Y/[[BL$A] 0_:#FP+[P7 MP2EQ5I4[""C#S?47Q*%8M764+4+\W'CWTL,(ZOLQ+;0H(J]LP?^2!X-EZRFE M]@D7.'*1[*-^UT[WO2'($U,HAF-WLJRV9%T'N!\XO[N$P0&?V39@<)A/#_I6 MWRJBT&31%W>AS;"T';+XHPA.:!1_\<69+_;J"D3GKTVP">BA=SB#N5V:GJ/\ MBV+OHRW4U-S]6ANH,GK';3I6K9%J.:*=ZLJ[2YB>=1V@20H1IUY,.! G_M1WBO;AU@+,*=-'VQ,ZTC_H5^/U^/H]#C4<%?7 M%?NP5+A6;LW#TPH#1-&\LB]MS#,D'Z=*0/2CM*/)#9WGYIY^J5.:*R91)_A,K[>4V&NO3M#X:92[6>PG5]$)>WCL%8C4?)R? M+/++R2(*7/S.R=A3<+)3U./R'\# -@73:\C7)[ZWYO<])[5H\]Z$;2]X,=J>Z25OB)%6*%U$FR7KP *(CO-"S3H#69N!\:9[#ICB= M)CEYEY(JZVKCP%Y&Y53#;V4DWWSK +)KY&\'&@L[#L/SR@V'$4633Z67+%[( M@JAQS"A#:I6XG7ON2V^DU8!#-+UCR7JK7*$1B\OSY$J/@-?]E=6'OZ-M".'X MO0"6\X8+&S@1=9 H0B!829KE2\4,\:\S>UT7-Z+6!/V=)+E-93EW2 U7L6/@ M6#+L3%# (9ESA]]]5VMF@E-C&)>>HKR.".^(FR(9JL:#/L.7Q2*QNVJXA8AE M=3!RZOIV,RXA5>1T(O5+'[TP2D#M;+%3FXZ5.8CIM#QG"=J$R%SPPQ+NZ+\P M&=V%UK168S#=FW/TI'6H.6LUSH M;X^I:"D-X6-$+^IJFZ)=%TU7?]LU[(7+?ECG=(W7NP/G^X=$?B5B*]ZG&D:X=2H2;#W9D=GII7_ZJ,_JR.IA7M)@2X,NYDQ@J& M[^_<4/\J"J+ZJG!?XN4C:JV7&OXRZE!]Y;;CJM\D52#[]1E3,;"<3]SON*E# M;F3CE<2MV*7FA!1-5[^IO+8%FF"B!784'[/&J MM^-90\##R32*!V=&DK;)RBEX>V+-CM4#]27WU]N\J5ENB@(/;1?DHH_9J5T' MQG;-0+'I[:K^N]]MA(VBV[GF&>A5PK:L3X64#]DGC OKD94&?Q>1EJ(\'M/S M G]J$49= <^9::^S*5=QEI:5 3.[)OU\'3*^$"$;%E^+A]6LM[3JQNF:P>P@ M] FAB,M$>C7>\6U-)J/?$;RD/@H.5I0<13!E8[(]WDDQE]/#]"Y==<-WBU)E MJ[X/AB59 +PH Y@;+#2M2!\]3Y)E>@KIBK*W:G][ ^^XX%J*!?D\.Z3 M0 &H+G")@2GD2W09!::@Q/($%"ON]"I&IT;2B5UVTO MV_X8XWZ'QOG]C7#7W5U@=9[ L2Q8?>]N!4J)C*?@%W*$M(7OJ"I+U)&_81M#YGK/8 ' &8XJ+PA \&S:X#(E+W);QOJL=C>C M5[>3.64_D!*V/+E&_7OG%5"^W7V!931)$9?53CVF4OG#ZT6$APQBORKS,Y^E"8I^"FQ+$T!M;@99;^FTM4WZ$R T&4S)OV M]Y4OKT#8B:\?3MLTJ/R67L1H/UIWDAG2[J)9/LU=OF,PUS MD8H4N@_>Y4.(*H^=KR":[\M6-K,MQ'LECTU]R@SJI7LU7!TOVE:CR86T)@U,G7 M_*K).=1_HY*%6Y/BC(?6[HV)K-]K:$MV^,X>]U&1-*$K, M+J,B]JH4#'A[(/_^:VQ)UJQKW/L@YOQX-U'V 0CS#SVIZCTM]E' :Q[T4<)/ M8;5_@;7WM[F.7N2,NGPV(>FIM?XF*QH%H&K1Q?UQ@/"&T2NR]I=-P2A\UX^G M6"&,3[5TKIEZP TJ?MF"5OK"8-JJU(&C)7@66JAI_#:Q2(@RPU&PE@@ ML5#BH&6;M/D'>*0V4XHR_B(AT>2GKKK%N$C0V=J ^9T0@U#TL(+R<@BDG:_5PH:\T@)5]^#!:C9I>28B8: M(K4SR=7U\D6&%=7(!OL8K-@OS R""9PCYPBX,11\P;3&8.N"DE;X[@NB&IAP MW$Y>1+%9+M+ENO)(^B8TY@P;<4.-UT-M%([U3X8: XS30G0V"T=XI6BA$':7[R_H'\L?Y?\,16 MY4+O_^:5='\QFR:7I9?F&RW=8\*R(J8*A%OTW6L3FNG:4UO9XHHL)NGJ=I)\ M#I,0YPFBX!HZ+R5^4> WL7$?MZQNO$KI"MIH.0EWI_CTVS?SM-]K<_1E"A"! M[KRKOFA#1<9)3/\ #L=%Z]=J U_J;)@YD!X(T+-)X&-YJ,DO3;%8)P'XDC\F]VNW5YPV?]T55!<^K5F&++I M)SC.2W*E-62]QYO"\I;F^*RN"D+9HD'+E&U^,4WZD'(]%XPAEN^:]!!M_@<2 MS?>1UOZEP!1,[M=CS2AE=KNW"N?0\QD2Y&5G;K$MD1\5[8;+6FJ8/BU7L4_Z M&QW*KUO[PCH0@W51M8YN@Z7Z])CANQ)D-<14?RRG%N"0)K06Y;!+9]8#H?AK M4:G?:T%@)LK.'XSV =@KO]>!.>G)7,@7<60R7GPX9%R;(NH343_\+% !5-$K MP)D[#JHTP-E>X1G!EP;8/3B@)#!:Q*K9*1RJOY_6+X;)29R>SP^FJ.](3NCQNY/8DQ$LN/WR, M^W2J\6MHQLR<)Z8/0%OH4E?=I=EFTU\*KLL/?S M-"?I1"BY.5U3#]EGVU:@]=^'7V;,5)VU/V-^_[W5K$C,:!.><%MC8MKH]-2A M/7KFX$XYZP0/2S!,0"%>7I62TCDBOOW_0A+;U8YO%DUW5.\5""#66GE6<<3--]DJ@ M1)#[T>^UH[2!8Z4CQ%QUHW;^S[,-2284Q.G&7:VXT.SCO0^MXM,RAK&\&NK0 M!/R.A[7 NFP);$P[T-7KD!0-G'V.!WC'R'G41COPEZE(KRJ//T=;W"NM[&]7 MLW&Z2*42$3>8!MVA,KV=/YA,[,Z;!FXT:5! -:36%V;!EV2EH8?D-Y/X#GL5 MD+DWK_+]/O>!HP?O?7[ML2O,PT*RY]_L1'C_ GT")AD@U4!-S6]';RQ$F0*/ M3BC3G@*T\?\WN8MNR6H>&&X^Z'0ZWI22A[+L'-W3UW9;&DDYSYW MX5"* JV0/^6&=IBF)O%=9GL;'-)UO4G@/P1NPP:4 [8.4T74"0U>?S0LNS^[ MK]M9971#C0 KA3P\,1^LI0)"R 7@S,;Y 5&4'#JB[C5-AV%4J X5V%PV0^^N M_YUY*-'FZB,5L^CB6Y^P [I/!4(.:?Y8>(-\Y^<-*L/M7-]555E#&EWLYZ

+["B ^2PN?!?CRD#-$9!YF&1M M@/XX+TZ!]=2Z. C@R>XFP^4J[]$=#6N=+*O;$$]T881(W$GOE+H!XOF"1PAX M*SI,U;8EZM%N7]-#AQV"UOW:,Z M+C>6CM@#SLO^OUI$2?\18M4] U#J/?HI/".\]F7P2Z5J>2\MRZ MBJ)-N//OA:W0ET7,:XW@R CJ^O]+/$[[#O":.9K.JGD+_:>OK-]^J>>0)BJP MWZ)D\/A:FMVJM<6 T)T1?O[8A-3BV,NMZ&5)>6R85O"UT$+&4S,8URXDG+J= MH.(-MSKYZ-V!6<=K(\X +%KQ+,0$B/:TJ:K>C)8=?:"^QX7UV[+"Q^#I_SWN]6&>2F)Y&WR#=P/K(TG8HY M.UT2*YJ8.KWO,T$H&-X?F\X2\^'GT[-;72.' NL56 MQI*\R

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

7LO,I^5%K8@L;G[>E MG;7"7"H=TK"NJ\B")U=K590J\#TH P&\/V-PR1F1&C"\1,<$TEQ;:;:"WL[; M2'&"2\J=JM/>Z!,[W=Y*8;A3M4,",4VTU&"U,DJZD;I6/$>./SH BN-0T>TM M#'(US;,3]Y^AJG<:S9SKYD?V,0J,98I:G;7TY2>%=L?/S#@5S5U:Z3) M\C,<9R%4T :L^KVTT)B"+"K=&B %8L=E;KYFD4,V.?2K+6D2P"7S" >"8I)Z >E5[66")52:7:AZY-'VFW\UFMI0_8>U M &@,-,J;6*XYQ4[[8K=F*! .F.M5;+4K*PC/G7223MVSTI_]H1W;=(@BMB20GC/2GRS1F;R55=PI1)!$XDEG4,/NK0!:CBBMHS M))M>?L".E0_;KXPNH954GM56:\+N7=U53T-0/(S1$%L#^]0!-]JG0@B-G([C MFM2TN;JZ9);R3R[5.0O0FL9#+##E)U&>Y-.GE)\L339!Z*.] '02^)1OS!;1 MB/.%)%17OB+4[L*B3B(8P-O:L0*\[>7PJISM7M4J%)\B(@B/JII@: MLNJ'4;@RSR,($&(XQQ^=-MI4+L5 Z_+FLG[3OZQ[&)X ]*LK(QV@C:!1Y ;4 M5Q'%=J7(R?2M8746>*Y1IRHS''D=V-3)=X4II:T(9-\))/-,"Q;_O,CG&<_2L+6!Y?B_39 M;,XNI!B4+T*>]=!;KM&>B]36%H@%[XAU'5.J)^ZBSV]:JUP.OM>DH!PO:LR> MW#[]@YSR:E:\58_+0\]Z5+B-% []Z0&5)8.$Y'-59+3 Z5T0=6Y/2FO#$XZ4 M 3BJUY6.^A2MJ4Y9/O>]55(^3HU<['ZU8%T\8CA1\+GYO>@#5:PW -TY)]:0V2*I)<@ M>E4I+]DFV*W&.*MP:B"0' )'>@ CTRZG4BWC 7^\U6+/PN4&^5S(^>U"ZEYN M5:3 !XV\5?@UB&!E5)QO(QS2 KS:' 3@S.Q_N5A-5(+]VNF MWLK#/W@:H:UKL]YK$-NC'RH\ CUH Z!86FQ%#>[D(^;=VK/G@!U&"3>&6,;& M&>M4[O48S$R!#$$&2ZGK7/Z=?7%R\\@D;9D[2>U,#OM$M[*&YFF6;8"<,0>W MI6W;^3<0DVMSL9CA0_>N!\)ZC;6D%W/>/O 8\>M:$MW#-!)JFHWB6D*C]Q G MWC0!N:E:V4L\4%[;PNPX:1>]5+W^R[&)X((P$ R MX0P6:I&@&?UILNH(S*EN MF^5NN>@JE?&02I'YN7 R<=J (7\R/!+ 8["I],M%8RSSAFC/:J]E8OW\JM,$VH!0!GZ-';D;)]-,^)#^]_&G M:G+-:^(A=6286)?WD8]*L6MKK=K;*D,\:PL^XY'-6H+.1=4>ZD93YB[7![T M4+&9-3UN:X4%E*]%]:=KD8%U9)Y85MW;J:LV>AE+JZDMIO)C(."!T-9R6EY+ M=(US)N,+':WK0 W63]HNX[:W!40KO;GO5FXOP_AS9Y&= MG?\ B''%,32KL(L2M^X#9S0!2DN6;3$MU)>56Y/H!6I<9F_LM@QY85I0^'FM MA->OMVR)M5?<]ZA&D726EF7D4^4Y/'>@#.2ZN].U2ZN(CNBW8?Z5=\.+%>I&4;)X MI,2\!(SD^E.6WNB2 N .K4 3A[>%F8L,BJ*S1S,P (3-/2S\V;YLD=S46Y%E M:(6C<=Z19&^Z> MHH:\"1!8$+R-Q4*"<.3*N!0!-N.:>K]C463GI2GIF@"Y!+AABM.TE^89K$@/ M/7FM2 Y H Z0 2 (.C*17-^&G\NTO[5N&BN&_+-=%8MA4)ZBN <9K0$BD9WBN36Y"GK5F.[P M,9- '2J0>5J0#?P<5SRWQ"XW5.%%%% ,=ZT-(L6OK]$_A4Y-9_ !)[5U_ANU^RV)NCUDZ9KEQ-2RT-:, M+LU-0E$,2V\7"*,<5ARN2=H'U-7+R;YF8]ZS2<'.>M>/-\SN>E%60V0X&*0# MBDY9L>E+FDQA0<>E%'>D B]:D,I!P*3'%-(H N0W)"_>YJ]%>&./._FL49%/ M#8//2@#H+.\8R%B<@UI2,MQ#C'(%2?2K^DV<]S;DR,(K?&"138='D3E5)&><"K\T4[0B"'*J.J@4 :VC MVMA!&$6,3 \9/0>]:DVD:#>ZK&JJ7VKEPQ^7/M5;1="U.2!?(0!0,D,,9-:< M_A;Q%=.GS00!N/E'.* *>HC3Y)1;3:JT,2<"WA.%%9-S<6^CV[F&:.0'^\W) MJ?6_ EO97]K =49[F4YD!':LZ\\%C5=7D9)6ATJU3#S-P">] %(ZO;S0ARH9 MB?RJ"ZU&VMGWY$DQ' K3_LRU.AW-Y!:L+.U!$;D?ZPUR5A9W5W(\L=N[S2? MZL <"@!(C-JEZ6>3RX^IJU/:V%DA\R9Y';D"I[72;S2FDDGB,EPW\..!6>=. MN;W65A(*L_)]!0!$MTUQ,L5E%M'=^XI;FRN)[P119SM^9ZZ&/1/[.5XDR9Y> M"<5;@TJ\BMU\PJO."<*+._I0!6NKCY?(@C$4>.OE1%A;*@92[,./K5^3291%&;E_+;(Q&.:T+F&)%AVVV M]\8SZ4 95EIDMU)]HF8+$O)45JQ037MP(K>S"6J]9#WIKO#"JKM<;C@L#P#6 MO3+8 MZ>IV9Q))ZFNB<3:U"T$;"&T0;BQZM5P1:?H6BP[8@\\AW9'6@#$>RBT_3WWC M(4?,U MN\GF*(4_CI_]F6V]MK%PG7'>NK3[)'8-:PQD%@.13-/T%XY3(>1UVT W5]@5V/RCVK.O;*16+M)@'M75Z^D]C9AU7=-(<*N.@KD+J.[CMF:Y)+$YQ0 M R/Y8\YW4\(S$G&*6P!E"_+Q6B+;!]J *D40_&M&W0@BFQ6Y5LXXI]MB2ZX/ M"]13L*YNVIQ&#Z5A:TAMO%.G7B_=F4QM[U?:\,7R1D')YK,\52G^SH+@GYK> M53D?6BS!21?NX=CD8K,F3':M=[^&Y@24J?G3/2LB>4L2H!P.F:+#*9/S=*=D MCO2,<#I0BY'-)@3*6.,5;1F48Q4$.5SM&34PW=2: )HV?GYRM0R75PI($A=? M2G$LX.","J:[]['-("W'>N$ *.%'>BC[S!0.3Q M4RE9#2NRYIMFUY>(FTE.I-=E.\=M L$>=H'%5=%LS8Z<6D7]XW(^E1W,I))S M7D8BM=V.^E3LKE6=RSD&H'YXIS''7FF9R?:N0Z!%0#G-!PIXIW %,/- #LTN M12$<"@T .) %)UI,$BE7@4 '(HZ]:":.U #T;:W6KL,[$CGBL[(S3XY"&H Z MBSN@<*35RY431\+Q[5SEM.%P2:W+"]R,$<4 95S;.H(85GO;MSC-=C- EP"> M.E9T]@RQ[@/I0!S/E$<]#3=A"DFMUK!N-R?,:IW5JJ*>>1VH S$Q@MM)^M/V M(P&X QJSISRZ'9-+<2+ M<7#?-QTYH F2X#,(8[)E ^\S+Q5?3[Q9KZ:**%2ZGKBH4U[4V:22>)%B8' % M9FFWKV,S,^?,F)( % 'I%E<:HMOF*:!5QC*Q9(O(L6GNI#$S="^: .D_M>V\2:[#=WRF'RQC*UH:S? MZ7?::N@Z9/B(MND).-QKAH?M#VBI;+(J'DRE>HIEMY2SEDN!)LX( ^;- '5Z MQ_:&I:?;^&M)$(48$F#]T>M.6PB\/1K;0WT!>)0&.?FW5SVC7]OI$ES>^8[S MR-MSDYQZ4EO#%+J-U,HQ GMWFNV&%>1>A]JKWMBNL6%B]RZPPA]QC/ M)>@!NBZX^KRW%Y+8[8(_NLPY-4]5U.Z:]\HQA4(W#FM^S%YY5T;2WB9E&$ ^ MZBXZFN7ET:^UV\MK:T=I;IG_ -(EZ*H]* ,6W?4-?U8>1$?+B.&D'2K&I106 MU]%&NYI6//%>GV&CV'A73FTQ6'VB4[F8#-9NFWEE+XDF-Y9)]FA "R,GWC0! MPCZ%=75P91"ZQ#@;AC)]JG.ENI6#.6(Y'I7=:A>+/J5Q^3;L&=.I["NHO=5M[*>>WAV M8/5N]8]MK.D6D_E_8?.9CEV8313*P17+KDLW.*U-&NK."*5;H"665< MIN[55;5+&624O9E/EPB^E9@O+:WL7293/_HYPP/6@"]$]T7-Q<@$GHE:%C.^ M#(R[<]JQ_-EDF#%NG6K(F8MNW8]J .GM;Q(@'8D@U #M)MU%NI8 $5K+;)(F<5#:6GEVZ!SDGI M5N:5;6 L>PI)78V]#*U:XCL;8A3\Y'%,[J MZ:E"GT,E49UMKK316L:^<#%3RVQ0@]![U/H5FUQ&#C-:&H6HW[">,5Y-6"C+0[:IXXHK5T/3&OKOS"/W4?)K+4%RH M49+' 'J:[?3+22PTY82-LKC+#T%5^516&[DY.>M6 M;Z57G !^5./K5/@L23QVKQ92NSTEI$,$]Z4#'>D'3GBFD^]) *\@'&*%7+9) MXH],B@GL* D;L#I12;1US2T *.*0FEZ4AI %+SVI!UI>E !TZTHQS2=:3.W MK0!+&V#STK1MKLA>&K+'(IZ-M'6@#J+:^PH#'(K313E<=#?K]!ZU@26?G76R,^86.":GAOI'@E97Q+)U?T' MI1 XM0&C<;@I&3WS3 :+9\R+ FZ./@O[TVWLY;B0IM)43P)Y$+A/5J +4=B#,7\K:H&"[=J2WE@96B1P51LEO6LJ]OG\G[, MDKO)(<-CL*1FALEBBC!Z?-SUH Z>.^LX6,L4 8@ZG?74L?G2[B6RN.PK1U+45-HJ!=F , M'/+FN<@94E,A8_+T!-22 W)21YN_">E &M;W[-"C."6'\)K9\*.+KQ/B1%=% MB8X8>U@KJ=#T6?PYK5SK&HZA"]FD)2!5/^L)H MZ" MMTNB:O-IR1RWPE/EE@.!GWKG=?N]:NO+L-9MT3Y@V !C]*U]%62]\*ZK:PW* M6MW/(6A!;!QFN9U3P[K5C%'S2)R\8,\:#*!CUJUK/B1M&U/2)XKW?:BW5)XE(P<]: MR6&F^'O&EEJ-O*LEG>MYA;.2A/4&@#)NTN/^$R,*1)]G2]Y'J,UVB"P_X6!> M1S-&I,(%JK\+OQ61-X/DE\4MJQU6(:?Y_G*=XX7KC%96JK+XQ\97#:7.D4,9 M 68G&XCTH!EW6[W5U;[)KL:A5X MIFM&:S\%3Z7K5S%0-ECT4GI6WKVOQZ%>M#:QJES)@?NQR16;K5Q87T.DZY;LL< MH989HV/(4'J:NZ[HR*F^X2,%2_45E: MQJ>I!$BO8TMT+9SQ\U.\./*QUJQENHHK@H%C)8#)K&O/#>H&-6U"ZB==P Q) MG%,#I?$%LTO@Z&^CD7[=&01CJ5J#4;(IX$@O'D_TU2&V M]SJ4C16VQ4X!QUJA$D0PJ F0<%O7%6V2<>7MC '\1H M228O7DF.21\OM5&X MGFDW%?NG@T7+-YA=\Y'2EA ED&.5QD^QH ;*L]RD5E;HP(Y)[5=2RMK"/S+F M0-(1R*D7Y(A&1DL?EH8/;Y'FY/IZ4 .@25%=6 $F.1Z5&\<:0L,EI&Z^U-BE_TC MESO/4TZ]G6#( '(Y- %29@L6T 9;@ 4L5L(8?G/[PTR!1+,)7!"IROO4B*TT M[2-D<]* +,2!(\^O:I43=\V>*M6@ZPD M,0%45&&2%3G@BLV;[3<,Q9L(>E %V2_-U)C+)"#U]:JVSO=ZL-S$JGWOI0!UEL 0">H%9FNW'E6K#^]6P/+1#)T4#K7&> M(=1%Q(T<9R :Z*%)REGQC=*H-,J>R3S+I$]Z=[(E?$>G>$K M/_B6O(>"!P:I:C'\Q=Y-HSTK:TM?LOAYAG&X<'UK$DA$Q/F-N%>)B/C/3IK0 MS4A@D?=O'')S39IMS;8R H[BENK6%"5#[,\512Q>$-M#UH ?YP'\9HIOEQGG%% '/&D1=TJCM117 MTO4\9[FOX>@274!O&0C9 KJ+ZY*1RR 4!8U%$Y:+/7 ' YS110 D$C-- MN)ZBB^NFMD&YG<'H"W HHH 6+)C2Z=B2?E !Z"FWLOV50Z@L&[,U%%#!!B.0;"TV&&,;N*SKS53I[?9 M+9"F[C>#S114@R]!9A;/[5++)+(1U8YQ5:&X:>79$2K#JS'-%%,![1>9*EL[ MMACN;GJ:T0B!@D32J.X+=:** ,AR?[0DR2"3C()J74[IX(DA9F8MCG=THHI@ M10Q@WJ1[F^YDG/)I)[EIIRJ$I'&.0#]ZBBD ZV9[A"Z$1@=A4J)*6.Z4FBB@ M!J2,T;,^&Q5NRFCEB \O!SUHHH KZC>/;SJD8'UJE/-+-(I=\\=*** )7E7? M!M7# XS3[B%5DDE;+''2BB@"N)TF&Y4VD4K1K.4+9X-%% #]H#8 XJ8!1T%% M% #@3FI)Y?LT:.HY(HHH A2^#@LZ9Q4(O1=7 0IM4>E%% &TT4$>G;T3#^M7 M/#]ND-O)+C)O:E&MMIMK @ MX*@DUSMZ,*&7BBBO%K?&SU(_"8$\A>XR:5KPQ+@+116116:=ICDTN.1110 J MXQTHHHH _]E02P,$% @ $XBJ5!GWDE8M&0 ;"\! \ !Z;BTR,#(R M,#,S,2YXKNINM&4=^&8\GN21;MF5[E/AM+#F99&MK MBB8AB6.*4 !2MOSKMP&2$D42(*@7NWU1U=:.0P'@\Z ;C4:C ;[]Y\/ MT:$ M<8\&[S:V7VUM6"1PJ.L%O7<;-^W-@_91J[7QS_>6]Z M'5M'=#!L.Y[587; NY0-K!_#P3^L3:L?AL,WC<;]_?TK!\IPQV.$TX@YA(L' MUN8F-)@V><2(:/"-U8F(=6Z/K>TM:WO_S=[VF[T=ZZ9S9.UL[>S$57YX^\#? M<*=/!K8%P /^YA%0)V][! K4\\4+&J+*UN[N-K#QR8 $X0F@:Y*N'?GANXUO MD>U[78^X&TDKG(6;X7A(^*2QKLUO7U'6:TQ^DFUN6*'->B2\L >$#VV'5+P] M;M[W@KM)0=$I#[?,EZWO;&WM-L3/MS8G:?&'0OG[75EZ^_7KUPWY:UHTXBK< MZ2\)[*1E7M8L@-AN_'E^UI8=.RD+&-UP4CX+>:\1_Y@6=4-63@]^: @4 L36 MYM;VYLYVMGE/TRE>P$,[<,C&>^L'RQ)RMX. AG8(_2R4YP>A0/+Q<.@%7?H^ M>00/10>]23OUFG0MV65O!)!W&]P;#'W1U?)9GY'NNXW'8#,5V5^^??L*$*8% M;.8PZA.]-!I#1H>$A1YT=T:8LH%"[5F:XN<&O)/X9U/ &XUX>"R#SY"1)^<# M[^0PYJ2LV&?$/EP0<_DI:M&23_&TCWU"&6_J:".I=!N_EWWGM31I(BFBK MSBI)OJ+^M3E9Y"JGLFC,"..]M70I_75E,V#?)Z$'B+B!T/(U]#+&UH^S M[_A'B5#7$LWT9 M\N &9]+-"BOE2Q:Z8$=VNF>@F1;A%N];E4/B+T (\2:P M(]>#TFOYERW8SX-(5*^: A3R.^K; M08]PRPO@.77NDG?_SW__MK.]_W]6C*%"M&O99GOZR.;]$Y_>*P;EY.?W108S MTMR;9SB*UBW1_'HXSF].M\SLZ=9&F:LQ(\-?=3(TD5QN9ER/OC)17MAAQ CM M3N>B0YM[G':O,O3MP#VE7M #$3B$!1D1SU6]8B[=!V$W/>[XE$/;\(_X);,S MYL^6?)%XF'V5!>^RY,NLY&UK'[=\1HT& YN-:;?M]0*O"P,D" \$["/G4S(C*O M4^G';F_E19(4EWF'%+UE/DR5BO?9Z_9!V;S@Y(S8G M_(!S6'M#=\I_7M[Z7B^>ES)B-:]3+=;MO%AEX\)F0O-6W+X5OT *63ZQ,N]8 MN[%E;NQ@X(72BX0^ W]!S#8DR$U\NE)Z3V9[)R^U3%M23#.MK0=>J9]RR\FW M"(@>CT2WS7@DN9^JA]%NT?E(V[#B1M8^1KDX5C^E?4U-(6J9?-+7C8E M'N#/8FLU;A%6=\G#TH7=6F2&+G['OO7G_+Z^]6/\AK5P37W^ MHB!51?1"^]7$^=>*Y[L7CK%#7Y!9W9H5#D@AE%)[-: 3]'I5;'/M%((]=?PKO837(A8I?V[DPV@-^\2!&1&&*;&=OB.F2M&Q LB]Y_NW MQ'9=XH84RKD,'D _,S"L<:?#V*(1XR&SA4F&WX@]H-#"HZPOK6Y6/Y[NI94K MLIU"T&D>]1+5$E*B'L"U)"_Q#\',FJ%F"6[6+;$D.RNDLD)*T *&5D)1&BT@ M::4L-P5-*\MS':$V6SF4F"EEF2J35 AYE:\>M,9G+:*)%>"B]^A0O#@4F>2V M,_4*2\V&MD+5QL].,3ZFE5YN;,MW6_'+K>S;UU(VEC*G42BRN\4I R,I%RM4 M2KD0:9M;RF#%IV]?2UDOY7LBIBGBVB/PQWND:WML9/L1_))T9@^&3"CF=#(8 M^G1,B%@0NAXC3D@9=R,&G0S3X9C8+.+QW[>^[=QQ!V1'>-S*D,$$'/0&U"6^ M6H&>"XMV$;-3C!?64B(P-8@W"T\0E-%F0B;":97]Z7$> MB0QGS317NY%*HV@8]E3H7A:/]&^E0L:08D\UGA4GJ-9Q4[VMC+N.FSD]ZM)5 M[FHA0%K/XB3OK79VUK(MD1;U@A'APN(:B#9?6#^3%+/,YI,KM2:O7C175M+O<^PNGMVF M'/,I-(LF+0$Z:PIO[=55>'7Q61@ON)E'+\QK5T8M=PM1R^7IB#,]\',SA[JL M]<5XV[,X6=2N6C59[!9"E?4W335SQ7!\S[[U?$]O M&4SK:MW!W4)<*L5 ML8_=0K1U:?H88[<2\(D.IO MB=\" IL9!FNU6_C,0M%G,BBLGS<+05'M 8;U MVKG648:R[*#R$I6N;#&,F3_7L,[WJ1)/DSJ14.R#P#T&I0['K4#]_!"'K;F+FB3#R,'\U<9B8?PU-O,*0LM(+" M[7*:^]&L^#Z\,QHG%VFJB']MIO4VQ:/-[9W-W>U7#]R5=S[51R%(QY=.U4.1 MUIL'A>J*NS($/+VY+ENI9]M#6:=!_)!/FI%7<'-]+^:_/YY_V_OVO/YUA]/ EV'OM/NZ/>E_&P4TSNC_=9Z_W/^[\?=,9 MMIVS<.OKR/X^U\&?_Q*HM//Y+KQF_OE\/#\SZNC\_/7O_WQY?/Y]H?QKUN[WWP>7)*+ MB[LN^63??/(^7H2]_5YS?/S3CG?W-^E]&_V^/XY^_PZMMN'?UXX['/_X^CN[@NYV+L:M,CY];>S7O.7K<'G]O;G/XYNSK[]L?4[ MOSMN/[0^;1_^M'W'FG>OQ^W/T]Z*RY.]ICXYV/QZ][X>U/W(Z\\Z/K M4>_TH]?<_W.?G__Q[MV_K:/VM;B5,Q%17[$G[Y1\ \^@C59(!L(2;UAV4NK=1L@B<3V>+ 6>N$?=CJSG1BR9 0,O M]M33LAQ<#)BU(O'K*:/1,'V)!\U/G)JG)3L[,E3=+O<"+^6&?">S<8NORZJ M-M[78\LOI]E:J-F6 C5B^SD)0S]D&CTN8=93)E MA#T N/%NNQCBLN%6FB.#KV?G 6^FMDG& 6Y[I$69=8TJ:=)6FE:!F&4)R&K] MSB0U'.22&O!1-0&;\?B58SK>%VT%+XI\+=1FGL5E&L24L=(X=@I-GDUW@O!U M0PW,U=J?FWJNTWT(V7:'L &TG"O33'8@KNV0G% V"P=A?ZV.HIF.G-8E068?BHE<.3367'S\X?N02 M]X3103;&69' MH^R(PO(3Q YE#VG@\J.(,?G!@I6Q=!AQYZ>I1ZTSH6D8ZIKXXG;OK!&F@8.< MMA%XC3'*!KL#-VEEX@K"+'39/7"<:!#)'YIDR(CC)4,/:9MLI\GT0P=&);$<\ ;5NLEII\.+P)/.FJ MQ%X97N+F%+3K7N%;BZ JZ(ET8ZXD\KBF_+'IC3R7"#6+CVHE&1IQ.%N6N(J8 MTQ;KH:^,0&E%U'9PL7_@UZXF.T(TYZ0J:Z7D],D M\?H/KRTU)6 ^&F#^A?>[;2*6^(#PRA[+>3G[0%CP%Z09QI0T%M,!)X7+9#B8 MJ;1>#%YEJ4-"XY>F<=AT&TS\0[M7@K='ZE-1#:0C>^C!*LY[)&YNH=."F0EF M\/ @A*7T;22WUU]4)RU.33VNXKWR9!:/G9]L\L'S==E")F@Q5IJA=TU$/,9) MOG@&EDX&@EK!B?< ]JU/62@.]!S:P1VLG2@,=;2ACSF8J(9>NBT?7__>(0_A MH0^^<,K<#=F;,'WXI!Z]"IAN69,8XBM;Z@(Z2GIX!AD!2TSV\W/)?O)P$Z*^ M>@[21CE%YLE*>+MT;@[5J0K%.RXO:$B2YB^9=+ YRDZIB5S9%8KO R1G$I]X M>\ -W_2A)G.B6](J!$R4,"MC1R4U1?JP> 5_[CV0:H F274F>4R8U-<(;_7X MKVR)K-1N79U+ZY_R MVG0T4Q32#M*YB>@@XYF5$7>-;(I,@%X, M\ 8![)=D?YZS=ZH/Y(A1'F;/O(A^^:M)Q6&JK.%RY9/G.)"C1;B(1:K_ 807 M9$IJDUO(3:CQMIBI4Q9\&W.)_LFR?; S/PZ/?*<;AXL[#I,EHIS[JS/ M@[EBXUC$$;U ]FD3UIBS:N#"DZK^MGMJY"9C, U4,] ME66<1/'<3')HM(>_9DB#VSJ$^?/9"2A0F5D(7A0=,CXE !>:1=0?)'E!$Z^2 MQ*).=K'=ES25:N%K$M;*C%G'"^7V.W' -P['^0DHHX_;ICVSLK7WP@3,C(7, MR!=35Y-PAWDE,;UGYUX*L::S!/9S+)I0N"1UC,732MP,NL;MJ/N-GCH?B,%B M75?(4;E.7,D[T1CF%;/3>F33-.:V[=ML+%/R4D O(:O8E(!2M^3E&S>A/&$H M*J.E6@"JRXFN^?V7.3X_@L4>K9ZJ:OI;Y9O1&*>G(:E1Y=DTG.E)KJ6=0EO) M1GT%:K.+*/@R3VROYO"Z$K!NUKFP11H631/[0'D.;>YQVKW*7,PNID)8AO2. M*,!D0:)>R(S/PDQ6U$UHS,=2.%3>@Y6>'I(I>O3*7O4IW<7&C ZTTDT1B&#! M3 0S?Q.?+<5''.' MT?ODC!O><6R 737/3^ZDB'=GIFE]^? QHO6'#K,R0B1SP,2[Q%GB(*1LE:[, M@N=3BU!UEDP53<5FM?0XZV_-X[%&U0AUEB>]$J%5R+%Z[@T<#3*=0I;FCQV( M*&9/ECL%'\1DS9&(AJ#140B MK54(9$&C9@)1.1G-)+-<)2DVSYUV4PY*NSO$B$/!ZXDIRBWZZD:;MTN83)>P4-,6[DJ7!J=G%[Q,Y/_LA*)+4JO#E;=O>)Q M95S9_Z6@-'DZ\4R-BD(9)O6Z<'H5?. FY#'I6B5 Y5PE8_WBB[)IT>5.6DO9 MSU'#TZA<>/N#5!:C1E#B:J_3R)9'34B'3J]"QQHT4P-626NF M!N]0F=7P(NA-P&J\WMD;.0Z"(++]]$+ ZTP>?6+^'7&UXI.Z&94 ]1- R??6 ML<4[=2AKD\,3[*S"9^!IX7(7E<"4M[Q/O\S9Z9,D>(<[-*F!K+M+5G>F[N#! M>WIEA-'F>H" )U$PL^-_$JIZR.5WCW$Q*T6GOEP#_G;!K(I+@V$>$C=X3JXT M >T/9D,;8SLG@=CKE/<_._1QX=9ZTXA+^0@09 _6:6-4Q23&3'E*;N1A8 M%="H<2?A?12H9[&H;47IIY#D7X"R[+XTT6P\(39FF$@ MH *E]"3RY87T.@2<$;O;14FH!&"EE%"1,05.Q:V^6(#GP&BS"7;W,G=S84!? MBDA'X9ST/->E'\@CN#Q^$K' P$0'3&-C+\B]^'02N*@]9@\P$"E%I,T I@&J MF:($C\K&7E#I71$4WE$>C/8;P0%!X]7EL&AV) -\L[("DRZ-(5<#A*&@H8>D&0[H@$@LDVR>3U3 &1A78M%G'(C5,3._A&,2+@4PI M(D,*G3[#L9Q38-*=4Y27F\O%*QH",W#,L!."(K11BJA2B?BQ3T:H"&3Q* ]? MRJ(G7A=7Y\\"4D_8:>D1GH&;1:/.;HA+PAA'A'N*Q@ W,GV9150]6&/SBDQQ M\I@JK692 YT:S6 R9(&-@9GAE$7;W@,V]%-()F-YW+FGV!A,(54PN/ 0^9Y9 M- :X<5G1'*)J*XK)Z^QN6JM6<]-0/LN!0G#ZE"\U'9RUE+6='UW@.R MCI\!5.4G=S!![]2P,YV^!S,"LO5M$93>5XC+XW(Y"Y@JK4]2 Y7+6WB"SC$J@#(A@I:BJ0Q;$Y1@50)LJ$RS'*03(2 [9YN0#*1 RX M'*,V@S&D\LNGKPA%2CE74 . M"6QXO73#D80<%9AT]SH)>XLF#;" 1GUKFRB))H&Z@$:-VWO E_FG J54_7QY M),Z0!I=6(&C4:!;+/%=4H*!1A4YCCV#^D_=3^N*,.XK!48I(-SE#A4Z?1N(* M>'&8)5FF,AY>#@+O-N*M0)R&AW4KEH."\P!67]]\3[\21F'DP?_BVRHG]7.? M\T7"O29#N@#E[=X!?'7I(*>([C MJ$"IYO?,=WH.M-_IP4&N'EBSKUK-M(.,9ADVG4Y^0G,\Z5/Q;)+V4D7X/PZ MH$T4,E##TG5_>HD!Y^,_TP'XZU53DD MI1N8+8XDP%8.R8@!&A7* ]*KT#$^%2I"T@K@&)\*%2$9,4"C0GE >A4ZP2> M(B2M $ZP"2 /2"^ 4RRP3TTZ^Q1;9^HJ0C!@@DD$1DI;! M&3X&14A:!N?XM*@(R8@!&O.?!Z0W_Q?8X.%?8H.?!Z2'?X4-?AZ0'OXU MHF%[G3NLJ0:-K<_S@/3PVUA@MTVL8QM;9^_ATV^'E >O@^-OAY0'KX ::%=Q&/ M-L BMSIDX$M.?\'4$L#!!0 ( !.(JE0U+&L[X@L #J# 3 M >FXM,C R,C S,S%?8V%L+GAM;.U=:W/:NA;]?GZ%+_?+O=.A/-(T32;I M&5Y):1)" VF:GCG3,;8 -;9$))O@_/HC&9N \1L90WL^E1);:VNMO;?>XO3/ MF:Y)4T HQ.BL4'E;+D@ *5B%:'16N.L5:[U&NUWX\Z,D_7'ZGV)1N@ ($-D MJC2PI ;6)ST%2GTB(SK$1)?^9^C_EXK2V# F)Z72\_/S6X4]0Q5( ,4F40#E M7TC%(BO0+;)! "_P1.J;0+J6+:E2EBI')X>5D\.J=-=O2-5RM3I_Y8]3#:+' M@4R!Q.Q&]*RPA#0;$.TM)J-2M5P^*+D/%N9/GLSX%RO//Q_83U>.CX]+]E\7 MCU+H]R KME+Z=GW54\9 EXL044-&"@>@\(3:7UYA139L)B/MD@*?X/\KNH\5 M^5?%2K5X4'D[HVIASILDG1*L@5LPE&S+3PQK LX*%.H3C1MD?S$%% MSE_Y8%[ ?U_0#_*C@1'%&E0Y[W59X]7HC0$P"A(O]NZVO:C "ZL-AAI7K<3_ M5@I\M?11K%UMYH8ZZ!GLLPY04M.\;Y<^"J:M(=/QN8:?$]JU>(T;E"EAY.EAFT0#S;)E28% 9J1J4!U"#!@2T+P]XF9%V)R]3 MA'>^H@Y-PR1 APCJIFXC3V2+LT9-I *",%)X8&@:QUXU,44=-T=;.)LB:XJI MV3GJBM5VA0H)T53%HC+A5-:X#C6C(1-B,=:_RIH)!!L?#]/5>%7E&EFMG4P4USKV<47B M]9;(>:)$35VW2RM"EAS<]X<$ZQ'J&3@QJPNCI<'F["Y<( 1<$F;TV<<%D"Z@ CHRY%+,Q=;Y5C M,N>(]5Y J]PEO(MJ6%W69S08+.\,3+A_V/@=(+Y5B,+;H)%KHRDK"1.K2:#& M'AAU6&<\$W<+0\K9R6(KNNQXH4<^J&JK;0S86P%A/M&\PB9:+ + [M@=KVM MM0^?Z4(3:BST+V3J9H-S4],:F!K7P!AC57PBC0'XFF9V2XDX7 6DS5VL3HQ& M(W@LFL[9W/G+*SY_>L9$PMU&TGX5B[:R+A3,4,$;=R9KXMQY!(\-4 M_G3UNA*0S3C0!V #]W?'8UW9XH.P;(>N'I"<^Q+!2OD-6+T$"1@RO* ?/8 @ M)@W,!B?$@*S\.D:JO^/XS,^$OYUK$(:3&UWSP,GAU#VT6V! 8B\UW@PT.+(K MD.'B3QC/(-Q\I[3C)V-@G@*FBO>N!G+;)SICY'2 M@U9[*6[15G9C^TB\W&=@0C4,[N'Y['IEY2\_ RN,8:ZQ(RH?CAB78 M:7P -MDP@W4=([O,3/;&>(O/U )NYJJ0FZIK'5EJ+910YY M0]:6<$5WXZ(!\YU-B2=,'-Z$QC+KSLL0 ;4E$\2:>\JZDZ9NV@U/$PRA D7W MDF( [H-0<7@+G)?0=A5Y?CR%+\'45+YAFAJ\Z"EPMM,) MMCP*+=>^2(APRQX98WHUY9S9RG()0S$9D(/(]S# MWF1$:';M#$ %;\9*CM+9U8;01'O MENWZIGT$_*_[ZZ^'?__U39F8LP=T>*R^'$U'#Q:Z:YK/%T?D^.BR^O.N;U'M M:*J\E+7/1LGH@<\O1P>/LXIR992_GY]7>Y>EZ:S>>"A/U1[Y_@#1X.5[7]&. M'O0O[X%Y<0]N2Q_4AWK]^ENW<7U]_.'+P_UUY;/UOGSPI%%T SJ=QR'X*M]] MA9<=8W0T:EJM-U7X^!.,GJ:?CBSSC?)P/CILEZVGT>S^^>G#RW=+[M6_=11R M/[Z3 ])%;ULG4\ZA^H[UL?WGRW1C?5^UJY=GE0O;AX/CO[ M6VKT;OD!^/Q3>C,74TH>?X '' MMF2YX,_I721)T!)F-G6KJ3Y,:]D:IX4J+.NTB:GGWTAG=VC/3!EYB(%=&6+5>AFN/S% MN8G4%)+%+OH74C ^G8Z@1P)Z>;YF+)]0$#^JC,#;\_8L!J&.?!^RDL^SI7L; M"GHA(A1T;G0J@F&@'6G_"^VRES76$;LXSA^ M4]Y=\07N(?'8,=_",N]*;TEM'\A?*HK]*'6%/-@DBGV[U:\GS.TADI^&L88D M_N7LH3!)6')E>9=M? 7>(I=5='FOG]LW#9/PZ6IX*$C# (OYC5@TCX4G/^#4 MW;BN4)Q,2$'B%B.#*)0#>S7G%$/U7KF1)0'#0WMVDBRD M3+2677RT2E[B+K;FT7*E8&Y]56R3L6^ Y><0R4C)H47P T[?(A"L *#:^X+L M\S+.8F-K!H@"*5!%-P21>+LZ-Q.BM^=2KBA"Q5Z@N4!K4VKRB?2;X;U,^%JQ M:'^, -O1!B&%;GY,"CU:RNWTW+5_RU(;@8JS>\INBY:_6'JR"PC$JK=OW)HI MFLE_&8A]&,MH!&Y92]8:#H$BNB^W9>/S=JM\M/+L@HH]B K(BJ/H MZI4&4?2).9>WBL,-^NLZUX -022PXQR;)46P;/O?%DFW)/2=;\+7= M2?#A-,_(MN%_'[%ML@./7V4J=FUH )*SXJLV_!:R>V@/.-05/'(Z+7'H 2N= MMW[_ %!+ P04 " 3B*I48\XK30I "X\0, $P 'IN+3(P,C(P,S,Q M7V1E9BYX;6SM?>MSVSBR[_?S5_CD?KFWMC+.8[.S,S4YI^17QC.VY;659&=. MG4K1)"1Q0I$*2-I6_OH+\"'Q 1(/-@C2?$ ^ MPE:$G(.[S<%QL%K?VN[!#%M^. _PZN#_1JO_=_#R8!E%ZY\/#Q\>'GZPR7=" MV\4H#&)LHY#^X>#E2])AWN4Q1K3#GP]F,3JXM#8'KU\=O/[QYW>O?W[WYN#C M[/C@S:LW;](F__&+Y_I?[ZP0'1"^_?#]BP*EQSOL_1#@Q>&;5Z_>'N9??)%^ M\^='^H?2]Q_>)M]^_=-//QTFGVZ_&KJL+Y)N7Q_^^_+BUEZBE?72]UE_K67]$\O7[]Y^?;U#X^ALV61?,>)MF2* M';P[3#]\0?$Z./@%!QZZ0?.#9(@_1YLU>O\B=%=KCW*>_&V)T?S]B^_^2PKT MJ[TVX\WYUL6OI-A!ZY'Q7M( M/SML;'KX7_KX^G)M8>1'2Q2YMN6%'=BL]@3-]3F992MT&Y&?5X2.)*?5UH<0 MPKY=DB$O \\AYN#T6^Q&FQGIX$V WPIPU]+X,)GLL/ =6^'RS L>)'';-DMX MTBG05]TD^BI#K3.+5U848Q3,IVMJMPD'X9$5NF$POR8FF1!*_F;YSH> F'S" MD(VP+\"Z4K!/-;=^&[$U#H@H(S+BL]CSCH,PND31,G $ MN!3O"\H2W+B+913,/X;H I%%,IR$(8I"0CSY=7KGN8M4*06X%^\+SHZM5FY$ M9SDE0R8'U3>RZQ)3V[;60!/L+D3?8D+@])Y2$9I*E2904-7GX]$F^4ED]K0T MAN)/S(;,K#L/T"1EW4'L2.H&1IS7IJ80? F;%&%V97L$F4K"MD5X&+(]PE@$ MXMPXL4>6>[(?M@E29)U'EKVT*7Y42RG%!]?S[I#E.,B) O(]!Y,_$*W%A*-4 MA0F7Q <,(VS109#/D+4*2 _?D_8)PR)ZUQ\S8%9BRW)()TVPIB0BZC1;]DY8 M4F-O[0AJR\*B1MSXB#J^](2@$]OUCL#9?D!4MLBQ[LDF=8'FEHOO+2\FGV0L M+ AT$5411/H.-@C1F>2X&-E1@$,GQH0WHCT;9.$X3'^^\RS[*_'V"8=AVLL: M$ZOL+U:!@SQY1$SQ"+)Z;$=!3WD0T4)*B\Y),BX+4\;I-$LX<,,PILZU@JY+ M=PZO2"F]L-N<;>X%QAME4"+>UST*J:)T8+?:":SJQ-G"'"0+\\(*U]N%69YG M;F? ZZ&]M,CFFTR[CY"C$.\5?H4*4H?>7WAT0V'EVPO/M>YT^.<%6%N%:\2 M4FMKD_B8L4\V^#XQO-2^>AZEWQF6[M1@#*;*(=8)BBQ7Z&2Y2^\@,T'(F10? MCUQ_0$M:SQ+0QOPAZE.,O270+M=(2]2O&A2'<)-)26XS%QY@4Z@9FA MY6,SF;G(;MD=Q)/ CNG )[YS2H8=;K.;R$J L=;F.^XL;(LRV'!/FE]S MT@O2=PGGCDL(TWOLEPYQHV(O>G&0D2ERO.W#]:-#TN0P^\YAO7DF8LV\!G1/ MH,QJVEHOL$O2!;;C._1R2UB.7U8'A3V,%H 38%ZNT.H.84ET2TVW:X4.+BW/ MD^.--MAR1/24;*'HS+H@M$M4""TOL$L$/!KI$."\ M?[)30][[%W'XQS;M;SK($QXG=Q1!]B.ZI"%^MA 73 $XFB-?@\X@XI6O+=4X?Z5$K(BHQC98( MZQ2-",7MQF;0LA+"+I/IQ&MN?KY&@MHF39;BACG1'H8CQ>IB D_$5>:2J=^_2P-<"; MDRR'Q_JNN!@::S;!:%,8J'!13745+TB+80&I]8VE#+1/5/^)F1'?U=6QMZWJ?WJ+1"Q.1*PE=1U@%I%270 M*T^RM[]%OAO@XX XQ#AR":6CP'?8AZ.,4YSVUN8FA!C6_.$+>)?*B\,-BER< MSMIMV*'&0^DV$I4-KMN/7ORABT1NCD<\#+UR5XE[)T]I-SL='G7G+IF9UF M0DKI,=58%?D)7RZN":O.B[;7'Q'$2 M'(B*6*YS[A];:S>RO ('T.<$?()&G1X9.8F IVF3=D/?I_K(.;4PS7\03FP[ M7L7);O&$@&:[T*9.@.!HY"8"'G#H83.CVI>DD1[WL)#*)Q-TL$!A!TDV*=IE MQ"4WQHT>'\-<>BU7UO05[F'Y&>[N6;/VY[G5%-5[_EKWN_\E#S*]<1=$J-EQ M1#&,<3HO&<\U1H1RFMJ 2@;B.Y-" M]L;&@$CX2R08ML9H0.%DPMUS=G36B)F^'061U'H:Q?CEE5,;I-S1B MIN%5[>B+!*Z/%#P_OW%ZJ%8M0F=J4734Y!$Y4.YX5IN2KZ M2EDY\GTMC>\$.' M0K21,FN8).34#IC(:[U.82LIIQ=!"'VCR*)@\*A61B(L;,!?WA$'/1%])G/B MC@L_!6]J9]0K$0"X;W[G\)X.M+ MGM>E?=C:[O3. HS<1197;&]FN^SXE",ZBXYH)FPTLQZ!38T,96-O@@6$IX2D MKA7BW(\0V1E'Z;S.&2=;U-PZPK_H%B(YU)DGAQM_.5'?WU,%.2.*$[Z/:(^*#Q])",AW!#W"6_.B>U.(LIH-9H@.3S.AZ/%1]##Z? U1*.4 M8/.BE5DFK&0C/"+.Q1S\LK^)RAAL=B-" J__E41"^-&V=R_W/0;X*V@(O.Y7 M CT/W?,@(4%I4,7R:/1P6MI2N%K=I]EB1IA#R;JK*X!B1Z"#"[;M+:OEHX?5 M4@4N<'U.D2$[.81*O82CK)%!D;+#WGU!5:)UGY#MB5G$E#UTI> M*T72*HTVQ2PMZ6RI?BRC::1F\Q1&6"@>MGIY':!%. Y%13)8F M@+3D(-GC1P^<+7)SD#STHJ';#1^6HRV(?Z,7#9AQ_"SVG3 M$H <>LY\:WF( M./+A>OW1=Y-7L2D?W(M0\9Z&K/QRD(!7%TGF7!H2>)*4>K]&V TR>LF')^Z] MZR :IY^6Z+3H-T8VTLK1#3TFBLU<(+#G5=:X.6>62JO2'4VDQ#L MY+!;QP+52F_(4U8"-5WG_:UZU:/$B@2'D)Q)15XET+2ED6U3EN2SZ3JY8CU] M1-AV0_"H=GGZ8Y5G&Z3:TM;R#;T9^;8Q,(S'0NI3MEW&S?ENH:=OGIXJY>?! M)^[+TEW7=T-:YW +$Z.>R&W@\M,=*L[F:QS,W4A# $.AXQ',OB(, HD*^W]] M0LO*GGG!PXL.&ZGM2YV\,UU5*UI)=5#6IQYP(R,J?N@->*+-B?-7G+IMX2P@ M7GS@VZZ'2L1G 668S";JZCE'FX\A?3BU#>>?V!%Q I-,$9IJ?^M@<0BKBJ F MZ!&1MH)5S7DC.FM"/6^$(1'JG#65,M=2V2.D#]!V YG.L[WH!VSY9'$Z"_ M MPO>N+7"6*=:+P2FG6U[B2.JZ$2@FDYC.3]!==.*&2>F&:XQ6;KR"-LI<>F:7 MV[YFJ #NVJK+[1XBY0]8BH^3X!^2\.GMA\P%F.$08H_R-X))&#4LK.EQ2@_"L9:%E> 8KSJB+1?1;I55VJ<$4'F0SL2AHGK+ LLY!0V?T\77,K M R;WD@5PA4V#H.A[C)[6UR+!O=QEU6$7N^CI-F^SPG*WB+[F\VUT;6V2M*_% M/]"H.(6I+-SU_IEK<=3U%.QALH$-:J@OM)-0B2? M[L(NA[Q O2'E*VG!0<#?5XL2?LH.F(H<^#6-@+7A/(EW[N/^6X&!843GB$>?+4QCV32\ M)V@C-L0=4P("ZVD<&50UA8$2#F@_]+M][WET7W>#5GG ML6MG+TR2'7KQ#X5OIB^5JL=MIX^V%],,"N2'I>4OT U9FD[GI-4ZCP,R+ARY M=QXZ"GPGK]DPB!&_9$F?(4A+NG=FGZA5F0 MYUL(.XN_4^]/9P7H#K28!V&V\.>K%YTJN(RP]&=MCZ_7Q^*2&TDA!SYL KL? M24-7IDF8)=YZZN@]TMH1 8Z("5X=6?[7[$$:W[HI=#EP 2GB!'I3W:@DNVM7 M[?.J2,KL*M1E5I4 $SDZ[6<%N;(BLDP&\T)),2MTPV!^3;9 A-GD;Q99 0.R MPI+EQD;85ZPIG<6XTFQ29,VR-697:2:DJ/XI2M,"2M!>6)V X5!HKK!*+A0# M'Z%J''V4^XE7*PMO@OFMN_#=N6O3D*S:Z%1W2R-6ZE8\9@3D(]+^*_ P!(F. M2?E%<1S,A*AG=5A]\L(XV+XP#M-C;C(%*@_)PPYZSYCZFC2_C9+R MM?X%(IB@[0.=%"==RL\A9C380T".1?WGX29ZI=;+*>IJY::N.5']M,SV OF9 M6Z!TU;_K<5+I4?^]OA3M;E7>N'1T311)X@8O+%4TH5HU3@;FX6RJ;N.[$'V+ M::7"^^38JT,R_TI7NER,)C+*U5TK'6IS)1KIF'T P!%;R6]HAFHHCG/=NS_: M)#]M.JCVB ^0JD7<4RQTZ3B/FL$< E+'15S4M 4;D6W^='X:1N[*BL##Y"N= MF\S=(R6.*BB:GB\PW,%4\'HGC3!9L\EWI"0F#J7@-9NT,,\L%R>U4"Z)5T.V M7W1WUHF.Q1A*(*GM76=BA8^(>^K0NK3(#]/,UTEP4')Q:Q.FW/NDW%^F M:=#;-P4.QB)A)73!HZV_^U_R%VJM4Y016-+4;@06LVW4_$*(TC$]2W'KJR\X_&.'@H<8N*PQ&1"):<%?2Q(TN3'=*\KCRULYMQ= M*-$B]NCGFV+M%&([BX4:M*Q+,I3')%DI1/F)*&7]29F@J^QC? M$B[HM1CY#!7U(4%6?$$SP9/1#'JB"Z4180WH5+P6'Z$X9?-BYHR^+JHU)-N+ MO[?VH%2#JZG;63VIK 13LSQ%K X5MSROK-@R^!:+RSUCRYL\ND('?Z1QP8J3WW86O+E?C5N M)6F)[?@.O21_)4ZDNRO$QY562>FHI%J0 3][9=+Z[$;+Q%^@H15+=ST+3HGE MC#8GB9G5(1\.16VGM;FP7CJEH:4RXVIHH[!X (+F$5+@X,LK0T+4+D8TMV(O MZD>.%$7HXH+$3FS?^5V6MC.-RU'U^R9V61W,2+8VU4:M)=?6;G/'/OQC3&^Z,VSFQ$2;;@%(4-=]'8OW+(/LY,'"3G%>T-NH]#B( M9O](_]:[A>K W/BUJHMD1"X)E0^7BNJ>9A#(;E?H643"3YX/4?FL2)G$.,0. M!"?_>K"CE6"^8)G2G S)=%FW]UJ3['6YGA2+YU9DMV M/,+Y+ L=_TIT8(^_M@>U^_;\*T=H!XS^"'\QFB9O/*2>@PE"J*,Z2&'%37*A MAMWJ3$AV-X(G>PH8"1Y+#>D)7R?K-=)'?"7)EM^B91G]_&(!-N5MNW378WC) MUQ$\^*Q1.VX^(ZKUR)G0.IF+5/-G"*\(1W1P]'Z89GQ6EJ=:_Z,3JB*,\+DO M=RR=Q323S"7!;A6O$H;R4C_)@5*2_X]XA)Y'>:J^+E45-R!108W'L$8F8'RK7&[ MSXS0&1P,C>TQ6.H()2G0+&7\!M&%)7"E!(291%,7779>)3%XJC@!6D@B$J_ M%4YV_?5>(SA:,J6(V,GF8*V%3L@6=/6X-N;+=Q>V:Y@FP<"0:LL9J8\XS ME<>6.6;8R"1"):GLDYY;ATN 4! 7=>$N[B&XXP#.BK*^18C27H M&;#S>S!R!#?(O5N3'R(@!>A:YXEB31S'35,)\J1<^;J9\,O1R+,*+GA1FH1 M\9VDF !++0QD@QF?$,L8@Z>[V))QPW406EYX%N!;Y,UI#9DLG$Y0LBT=/ M: M1-!M$A!-?='K.7I(0WN"A$,R8#^T[-V5LFSR<&:,44TV#10E#JH!:"A82W6R MJF\CY?K7MT$2>T"I+.C&)Y:2^'9_A*EX:I7$,VLZW"SW/;AWF$I3H'BZ4<%. MV\DB^VG#A$8P+M+,'T<;=J#ZCD/?H?[7E;72AD%OP<5)L6&7F :E21A(Y5E=*K9B\V"V]@6,=3W1.K-M(QFSQ8HRTNY6-M MAEDH\3"\@6@:5_8.:AI'(74_B#MR%6O0!WC^!O*"MM/>4Z/TM%@/0#XK88*E M)YS#U;U6K@?TO&9H6MDN;>!K 2C^,RZI_S!(FUCG[]DFMDJ/>_QI6,M&9!-% MN7ZVB8K2%CBR-:&M'Y+WL^?^-<)NX Q,*2O,/>M>N^R GSQW][&8? [)* )R M/IAG]?VH)J3,A=YX]VX9SP(\1RY]^D+?L)T^KMVL:O5 C26?WSU3T>[RU9.J M6SOC0[*P6L=B+)!KI!HM9(9;]RFN I""?^R%A)5E]?G]::K=S-1"X/=4:Y2?%8[JD)I M'NM)'AOBMC1-G,Y,ZLI^JYPCLQX;-N ,I]M LU["S/K1UWY2H3Z'J/40HM;O M;.T2QC:4\*/![':>0]B>0]B>0]C&$\(&;%@U+$LZ.-S/Q4V+K(>FE74^>UPA MNW&H\XI5:(W4: R ]+!9NGU&@G9BM:=EMKLJ&EQCQZN(HBD\I.M;22VOG+I5 MI85P3Q;!"H; 49+;WL7C_T5D5(KR-U3_C3F#:N,%]G,J_8-4:ZLB:J@.FPB> MX-M]FK$ER9H]]9DJRLI04_F^R;PI&O>#>3Z;*CJ@1S]; K.'0 K^W??W ?X" M.GJT?T;@EM/_8@L#J1-ZET 1(/@$0RF1LR#&4D(H-#!;K* O,101XJ<941." M>R\W$PH-]D0(!81@ZUEM2=RZCU(RV'U_'Y:# CK M+ =(+0JG) +,Q:+!&'F-1:(FTDSWL+'B#R)/< MHY::[(4TRB#ETH [>DZ*T2#?PFXP6[HX0L+SHZ'9DUZOFZ#*Y=+F2JO[TA)" M83;:A[6CBE,N$7BW>BXOCE(;5HXI3+A"@AZDE]U):'I5&^R"/*DZY M/,!]\0R[L>NR;ZX'P60M)3$ZB$7VFKS::I\6F/JE^1NHG&152M*7 M)?5V>[3 L.[2W[1Y]9V$(W^I7F^W1\)A7;&_:;MC[R0V3#6+[^6QV^?D)-WM>O-MN'U;X&52X7#;Y^ M2DO:UZ\VVQ^QU'W]MQI\_826M*]?:;5/"TS=UW\+[^NGE.1]_5J[/5I@6+[^ M6QV^?D)-P=>OM=LCX;!\_; MS)0R2+DPX'W]E(ZDJU]MM =1+S6<\@>)0/EN*H*7]?*KK?9C$U;#*A<*M)>? M$9)U\NO-GOY2PH JEXJFX'MY_[[6[.F+A0%5+A9X_SZC)?W O=IL?\3">.D. M[]^GM&3]^VJK?5I:ZO[]WZ'\>YIPZ))@MXI7+'$H)5@J]V=DG]R0ARM/L509 ML4#2*GE0K4=84$O]#1+4\HA%LM])VH^KP+]'880<0&!S M81(*GV30_U2%_NDB_XD%.Z3F0ZTW7*&!$1JS^KQB"QLIE+8MG#]A#:/3/WL70OX*>*4E?@.B/TZVY7:43>(2HY\?)Q4 MM+*CV/)F"*_>Z%#R 8SJZ1Q@\^? . 62.!GII1I84Q#*J0'Q/5^FWH-6B"4 M K'7FGH/&;]6RN_<\$&H9 ,U'$QLLFL"IT8 MDT%'2[1!%H[#].<[S[*_AO:24 K37M9D^.2S5> @;UNN3WH?SZ^KV/]H:GK5 M[!T,FWTUUVJ(8V*4$1R+.+9%!768W%I-P:&BT.@V#I%9L&J&LH>D,S>B-1_. MR;)S[SIDJP14V(+=K\EJ3P,7??DDMT$L(L?DW57@LQLM;Y"7%DU?NNM9<.I' M%"SA\DVRRL&AV$.-B(:2&ZW3HU%8/ !!*QHH< !2Q$-%B,9*?>B0HVB!H?VN M+S0JLUN 7D"RSV6)GLL2:;!5(GB"ER5ZCD)XCD(8313":;8&"%Z#5[[>?S+1 M#KOLS&FMCAC<$4B#%W(RH7AX1[6),8WL!C!K\-":"W50_('NA<)S_QIA-W"2 MWTZL")W[$=D%A:[]B>ZM?^,H)YP-@G# M>)6.Y/1Q32!&S@F=\\AW;L@PAJ+YPOR:"(K;+[T75QW@2GM:.?\4T,7-(X(; MB]I7.#80H?:L]TW:(Q(<85[W;]SPZQE&=*U"&(71T#6?R>^SP3>A^&S5X0=3 M ;.U3F_DYFR-(SI=2^Q<"",&G$%QZOGFK0%M&"G'@^D$NZT=4BVHQN*A5?D M_MFM->#6"B@5OXYJWX%T=F'@=A!&1$86'3^-"TS1=,E$MWP;A=L(./AH*PDN M:@+M$BJE1%?A$14L*V"18M(T]2VPBE%>711'/#Q+7C;=XZKDC].O<;!&.-K0 M4.)HXCMT,&M*)'G.5KO>9Z@,OP=]"@!TKZ\ZC3)E$,!0QTU(*]DOK# H6>E] M*07%&+BXEU%0$6%\$8YMTB2/:@1 %XD8N/C7) _!&"7%^]>04#W)=X.2E[&L MMF;. V5F>^4ZE@D :'3?N.]EU=!5NXN51/4C\4N">^1,7>^#%69*/C?_Q)'[X\"/^Z^OO-^BP^@6 M_?;]Q[=?'U_;%]&K/\_.WMS^?GC_>'3\QZM[YQ;_^8?KWWW_+QWC^:?71W][_16??/UI<_LY?CR]^^U=?''R]OX=WKSY_?2GQ0?[Q/WST_6I M\S5W-RY?_I>VA7:H-843^&UIVPJG-!&/ M/2L,I_//:<]3?$./31K<^LX3DD-,W9PP.V9XYGI&T.^+*SG)%5FFD76EQWN3+4Y NWTA1_#M154$5GN7]765A7N5*2\)&!I206'P\I M)R->-+2HP,/LRSRI_]@6=G\%#T+8;7I_\I;8J^2'7TP MQPK]!HC0R4@49"B*;'-+DXDTQ1%N&;F$\O8^P,:U0'A8H-$"5[?1?"MOI:IL!JR1KA!F0K:7<%)#\JH!DM,I(%EM M,VPD:R/,D&RMG*9@)B\5%IQJFP$CR1IAOC$'=W*N%+"LMADVEK41YEC"'N(0 M2E,%+*MMAHUE;80YEJU^C@J6UPI85ML,&\O:"',LX9Z#9I1N%+"LMADVEK41 MYEBV^CJR6#(/X4J)HK[!EIJ*A^=A&._" MW'BJG7]]8+=''(W>#E(H,;^Z&M.7O2X60+.AV5@,1=.H10ZZ.B) ^1^ ^1^ ^1^ :BL!]CG'3$N,V_A@E"4R? MHY6T8/HJS\%1.E#M*4R*V.]O"FM5MRNZSGRN,)E=O'D MQ,<&"CRTL-5H<&))H2MWJ/%@YF4]K/0[2D'#$7@#)VL7;ZA2-O H%&+3H6M3 M.5][L-."V J>S/<:L!9G&5?)QV0E65CA>IMT-0]<4\]E2WHLI7$]BSWO. BC M2Q0M Z:N(0R86K@[S\!;\6AL0"XC22UA9\PXJ8ZT>EZCF(P>4%4?I! M98>05!ZF96IPM"F\&M(0<]=&29O.B 3=Z9^&Q%N412EZRMAZGRUMEQ,?R&\W;M4/>&70"GB1DX_ M^MM1J8H$OE#,L;5V(\MSOR/GUO(LO*&C#',D=@#PG6#1C@R5=NAUNRR.*O_\ M2V6JYP5T$[(%9H G=2,9 Z;9R/QMQAGTM>[.7-PC/T9G9,#'Q$?"9-7Y[$;+ MXSB,@A7"IX^V%].#[TD8(O*/,[,>PF\O@ZDRH$3V !+%B]I>>;0]3_R#FV4_,"AJ3@S0"4@]]N9@9MO7">EV?E\=E)& M(N,NSD=;E,7^.!\@IK+1J8!R\)Z=BJ%(&]19:/$Y^W86*,^$.7_A(2LD_X0H M"HFSX+G6'57KDJL@:1V2X)]@_C%$%[3O<))WGOPZO?/<10)+6//D^$S5'+I& MD],/%VI7:CIY$XN.T<^!KNT4*T:F5XW+UH >9 @0,:.RZ)Q1::$+E]BVN$2;M+A'6TNK;\"G 0":@B@D:&L<0!2^#>'W8,J5-B]")IYZ FO8A#?',<;I?AMR>>,0,R5P864NKEP\ MX+3L3QJ(7@6^W:? "O2,'6]""JV(GW9C&6[)2MK(0D,CA_M2B+<.6_2-;+]) MW1&U^\BQ[@G;"X01Q2*WY1'"*V+)*]]QW- .8GH[$:%Y@,OF'R8"X7-&<9)2 MO,FY2C"E=4TFOE/YSDG&U0WAZBS %3$HA"OHXP'$#'+9@WX%+4U^ '= VO6H MV\AKD0*\417B-LZUY !<@_JPI//J(O?WI=/.9Q%),5@W2[BE>)^5]; M&WIB'<:D.^R3#8;EV\CSZ)K0O$XH+Q-G"?W+E'X"Y75&_R.E3S8XQSOZW5<$ M$'+J![,7],H?-6SF8 IRL\?R,*SA\"0=N34C4?4F5:+K1B 'X4I\4&4 )E4B(2^Z4"]06A$*@EM M:95D>#D+8FQ0*1+R ]@@#D$M4E% IU52XL2]-VDI$O+/2E$0!71I!%E.)O,( M8<.:4>;!C'ITG4PJ6E#!7E=DB"@[AJ1O]@*Z3WD#5^H2(D_L678N@9S31YM\ M=;*BO_4I[$8>GOA4;\8>NG 3Y\JHGXNV)R#.1OP$]VX]'.-=673K$LPS5@,_ M/+)"-PSFUQB%9(C)W^A3W8 ,XS@@NQCL9W?_*E'C'5QB1:NXP2_H>\8(>_"M\ M,K,]@[X5 "W1;A?$8%['V%[2L,MU%G+94).@N[O53LQ4;"+T!D(46^@"V%V2:O@(%GFPQE8X?;NN:>%.S#<9-OX]7*PIM@?NLN?'?N MVG3IL)/#&#+^Z\!S;1>%1<=8.IY%AH*X+ZS8K;R1DR(DYNPJ=-EKTOYN(LML MGPIN?2?9)VS2O5$XG4\69 .4)'@2\5R9C8SFR%?7TDQ<;!R@[UH8A 2]T(9F M9C+6<_2F 5()SQ($4P%/L@554]ZC,K!"+J*LPY[MIHDW=6MY:$M1T$?D-#<4 M'=8^ W.GG#-R;<'=Q\%J%?A)Z2>R4Y[BVXCNJ3Y97DS#A6^79/<,O&\5H6@L M!5#GI5@*5SVY\2:$60!=F7D5 ^*\B^' 3XZG,G-MXO4[]7PA;E/IV?8-F AD2/\$NIXDZ7YS(H2QVS79 MN=.B<-#[L19"(Y63"(2YR]QCIL*/(9K'WH4[A]X*")$:J U7U_QNU"X9FOJ5/!*K;UYO]=GPA#G5V6QY[[CWKM.;'FB=H\T+DB&_+:32G._AO.#BQNV%FA +V.9 M=&CUF$0#J,(LW?4L."7[01G#)BL<#D4SX0A<]6P4% ] 4#.GP(&8_=,@1",F M49<<=9C$[0WB@X4=]I.?[G>TI;Y'8Q(;H-&3ZS>YASVR0EK89[4FO%LI*)@6 M#$KNCHXVN^]D[SL3SG;L^0Y],J"MZ($6%LU8VE:M+]TW:!$+<.283F;!=Z[: MM,CH[M>((H%'RA7.UBS?=BWOW*?54]GQM!"GE$PJHUL@&N'BOP]0D4[B7LH#3$+UD$:GRVZX8ZF.*DC MI,& -=,9FP%K08Q?1QA02#HM&9.2X5J-7$WE"DGS*4,+35T6KEE.1JT=E*C M_7AZMGQ##Q: [K9V?6GRR>#OL@K#%PD(5D*7]7I0'=]2?4I#MT\UI2G!J:G< M9*5_D+NB*J*&;H%$\-1VBIZZ*UQMX.A=.[1NXW IT=2.@^'F+1TS0/-QT-LW 2> M:BB]8"H3TV*>V#2,GN4+*6GI\1(;)RW!@DQ:X":L42K#."[J)!A-A>?_O/H\ M.;\*@$H4B6;(VMY<)FM1@,N>\PYN+"^V*V$OMZ.#,-0P5;W2F6*NPI+?K7-* !EC35'M?562SJE8'RW+7Z8\$,8G"/L^@M! MB+D=&,CX*P\X'X8<_38'3.G%QZ[DB)8+FGK_^@*3^!)I#9)KJ,0B'#(CJ?ID MM_S1DC=AAU7CQ*'AJMTKD* M_-/5V@LV")VX&-FD10@@(O%NQR G"9"@2X!E?)#_4596OGL7AS!S2:9+DX9- M1$Q2\,!FPB),G- T:,AW;I#KWZ.T9@I-C) 4N\I3VXO+1[([L[Y JW1D@1$H M3&MVO\-(4M!U:1WHD!J"$+BN[S"'T73(UV(#S E&1Z*D]MO[ 6JG+A#:0Y2 M3G;H4\E+@M7^C-P0-[P@SA^'5D8,'8>?D+ >84$M]3=(4,LC MUA"(/UDEU2 F=)D.DZJ&ST)_"!QT/EA$-M#+K2E8<%:X6SM7TJ<:"Y' EIQ6.#N#.W]+X7CX&H; MB=0-#Z"&#>U&ZD);H0!.D$FI17$6$:=J]\W M<2P @'!UU*"/3UD;%_$@J):FHS4=+6CPWYXJ0"]CG\M?'^.Z5QVQ2$%NA6ON MI"2U%TEX=\Q&X[08[/%#/T^]0@\?"2#7.%A@BWF*SD"9V6B<*+/'+_"$51)G M2B2+.Y""NJG=2#<:C3 (E;LTM>C(1HI&]/J[;(EL*0S!KS#.?1LCHFGG?D(AG,31,L#N]UW]]D9S MTM+4S!23AIXS?H$H#K7LH(3'\S",D7,2TTAE(EXW<%+Z>2!@+8@)/F^H&A?C MFE3*6.LI4I;0O<;$BX"6YJ[CD0FH@ CLB8SP@MNTWLX07H73>?*S#G%UYLE M6%PW.7>7 G0&,U&V[JILI?NK\$-REW;NIV8E^>V$+-MGEHN3E9OOP.MF8#Q+ ML7Y9"-2\D-4?I?6%KQ5JW?9__*,D9T7,0(L2Y/I&3$MAXRTV72MM1H(Z:[30 MN=].'Q&VW9#F=T^%R@6TWF(,JQI[J-SS-'G[DIJV69#/!!6=%>G#Q(&;"NI" M>(@DC5-3['2GRC[2:%;N2JOQK,@-HQ8Z7Y,^T\3(#A8^];R+R_]Q$$9NE>VG> M;3\,LT_#U]!GJ4H\C,2,=02:GQ%/Z4S"HO<>Z:.RG8Y-Y\FS),NNS[[N)PX" M%,[ MK7H9'>,OA[LA$CI?MX/_I?SWTMC18Y1D%LGY*8W^.VD1N-X/=K Z3$;]T5_C MX!XY4Y?L#YT/5DC49DT3D1#.8\^CQSZ7*%H&3C;<%XJ[>]+_I-C_9G(71MBR M(^C]1R,=)2T^]VTO#MU[FJ[QV J7DU40^_R[J89F!E.:(-)V&(HI!H;_+KE)BV1?J6H*/*9KWKT=-*YZI.\Y3(D@S6 M7R3]U>]-N\^G.@&S3RG84BEMUAF8:'L$42:6!:A!'X4V$#&9WTI6##MDH),R M;#.A4+,PI68A,0C3.S+Y?>2<^Z>/Q%'S%^@LP&6>+ESKSO7(4@XLKBZ<&%PB M^"+M!+%(1?(>5@_JK[O)+0I=,HX#G_**?)ML> KKA?+M2-;UI-JU&]+AQAAI M6D_D:"OMA2Z(S^VS%AG&!JCX7;/KA9)0LLU0:<0:\O<<6?[7#[%%SP01F@4? MR$8<^Y15+K[-+8VF_^V =0L6 BM&%^##63"-E@)/:=FMQJO>#2B(Y#%6VBK1 M[G?\0N^1*KT;S6^G+)5&K(33F,O)A"S8R%WXQS'&A+U-(8Q&XXV;(-&13BQ9 M:+D/X)2V(L1UI__2HZI[R\M&<;L,LV"OL5DE*?W M27)YM2.K[,*&T5/M>+KUVJJU Y7$1NP^9_0!C2I#:6-]NFEY7OWT7Q#TE:8CN^ M0R_)7XEW5MB>\,154KL\&7X#,#HJ#2AFOH&4#H>BMM.G7%0OG=+06K("%?6S M458\ $$3YBMP\.65(2%J%R.:6[$7]2-'BJ*N4^.*J4@R+0E:1IF'& U41F(G MN6")2 =*/.+&L9N ^IQ-#*,HJ* <\0@;0FCYB%D^* D9,':0\A$S<$H155G* M. TVK=2U-E]>AQDK@Z+KN).=K0\8?*/[MC8E8^$M;HRZXPUN?QB(&]EDJ8$N MNH6"6 3$*ZFIFW_C=5>X&Y,6PZ^Q(LCL(9@M@YA>;4]\9_9 J&W.7!Q&U3JV MW;/*^\K#Y%P44OUP@'TF',F5ZA!I(]Q9E460@>Z'%Y"5!;^IP$U M U:P!G;>NH1?8$O<[8Y#^?4$B#6M+7@4.9J0S. MC&5(ZG."LB0B4G%8VLG,,U-/Y[,ERLR"6-KPEJ:C,**'H(R3H)[#C1 M"M])-VWG_CS JT2/9..R'.1^R?LK=%-#AS'I0V3_L CNR7C==+Z3'W;3G-NQ M]*K1T",C5*L[F\40KGYBN$0%0=6T'0F(Z"U9N:1Z>(,6+@UW]"-ZMME))LP. M#9RLR(J%#03P^Q!*:(8MARP$MYO57>!U@KKQ)ULX^%?R0+%5]'(61Y3OMF6M$S79K]^.0B0A._%<3LM*9$/853#X=:.5+4YJ MXV[0.L#4@:5E).-NWD5KQV/0^'9D0(O@[,B=N1["QV1U60080OW+_8W)N%>0 MX)?)4=U&ID>I$!L==H^CL#@-8(@4Q5%'?K>E.B-_@3G,J/8Y!DO3B(= S9QN MV*?BAD:_V.L(#@5:(.'7SU%>D*X059PS_@X"%:TO-]RX=89-G]#O] H145V!HV!6DO$4T+"85]J;LQ&'L6 M"@(%9U3M_+]B"T<(>YMT!PMBY:M]C@'V1CSX=6C4#RAIRHX$#$#P:YV.P]0W M8\*O-*-J[\]].\"$2,(9==S0,4U&BC?'@0-Q_]'>_PAV/D(P"9274170S'H\ M=VBP_-RU$^I7,>?IAZAHFGH>QV3AH -=EF9'%&C+\FC'=1'$=A)'E_>FN@79-S&Y' M<4C:!HM("1F%^WA*#R.K,_2ECH9_,E$>-[]>C"RN%P$]Z5L&/@+8<=8Z&X4R MUR$0JN(B#?4MLF-,Q/GZS2)YYM()ZEIGHX"Z#H%0 1=EJ/-LZIW#_)@=CF#; MR 8B!UV#(YODAJ3)6>_1B159V:4QR!$#L^/Q[%J:D,F% 7BAN[LW!CM&*'0V M"DM3AR /$U0MO//+(25P9X6(2N3_ U!+ P04 " 3B*I4$]= !J MX < $P 'IN+3(P,C(P,S,Q7VQA8BYX;6SL?6ESY#:RX/?]%5B_%Q-VO);= MW1[;8\^Q4;K:&G>K-)+:_<83$Q-4$57%:199YB&I_.L7"9 L'@ (@"3 ?KL1 M=DNJPI$7$IF)1.)/_^=Y%Z)'G*1!'/WYLU=?OOP,X6@5^T&T^?-G[^].%G=G M5U>?_9^_(/2__O2_3T[0&QSAQ,NPCQX.Z"S>[>]6 ;I/O"A=Q\D.?9[MOD G M:)ME^Q^^^NKIZ>G+%6F3KH($IW&>K' *'Z"3$S)@.>19@F' ']!]CM$[[X!> MO42OOOOAFU<_?/,:O;\_0Z]?OG[-NORO/X5!]/'!2S$B<$?IGS^KS?3\D(1? MQLGFJ][ MMW>K+=YY)T&49EZT@@G2X(>4?O@V7GD9I60O7$C8 OXZ*9N=P$?(6CQ_O9*B,OWU1BLPU=_&16R#0A%%SKZL2Z$ MM4Y?510,X>^W!)X&I/@YPY&/_1)6&$'"3CH!%9YR7!@Y7C7&#$$LXJ0?M_W64$NAV.LN7Z,HB(2 5>>!.G 0C2XB'-$F^5=2F7$G H*&LO M?:#P%.-]!J*XK7J.J,RM[H'V7_?_Z)@?"7(YO@ST72Y)67K$H@R:\] MB!4MOEK%1!'LLY,&CNLDWIEQ.8L-2/.5L0 NTA1GZ5F>)&2:D26M.3:#<52Q MRN+,"]]*9*L!@4"([F$0M&)MD$=[N!47+D_JY$!TIF^KB(L9R MZ*XTR79D70K8M%*VSV?3$>\V SGZ-O >@I!8+G@B8X,S@8N=I N&DMD1'KNY M%0,QG^HB(<#2>$^HC3?9GL"?P[8VX$(A%9$PCC8G&4YVLQ02^=X@QG8433*= MA+B4"[DTS% &>C@_D-]W6;SZN(U#'R&1X6P>S]O#H7 0;=CH;^-T;+N<-T-QX&@QF-<%0B K\!4" M'J&8]8DCY\$\,8\:H3P!CLVE::!38*1+ M%9')'A'KJM?IJ&YN4E[C;#+MW!S;A>?<@$ @GZ0-"LG7+L61RX6Z M '41&=_V)I8BUB(FSP?N4//3(.?+06&H*A>C:W5/GZHCF7-T&5',UA&#I)*N M4^_].V\?IW]$;!">:>TV9Z>?WX*DG1X*&;II=UN/<'699Y"#",F:8TM=9WQG M0;DV) +!*J-%Z/,@0JS3%X[#-22%B][(MJ):8(X'B2SXR:?T)T7HEW4? MTFPK8&L:,J'CB/R9+IZ#L:TK^5QC>\%*FI\'B6!A%AK]V)8H=])Z+NF8,OYQ M5;H0]0$> 9E MU]F+IX3U"N(I(M&XXEG'.#ZQ'-?# &W"-=E=[Z(SD=")=Q7 MD% 1E0PE%*: _\$!6M$NRE^!RS MGQ?/JS 'UXC\LB5LP[?$.+E8K_'H1JAEX,=/=>E=*G8QE"RWS_VB^Q=?!<6 ML"_ *GS!UB(^3DR3)9(*+/J]X]W"C9S7U[,#5II&)0:!.JL";((I@1R1.+@/=J5<[BEB-MJ2ZYZ#V@J2# ><%5 TD M!)/O.++Q":KH2<3CY9!@7&O7BR- MHVZ+U2K.(>=CKN^W^"Q.LW2YOO!6VS.<9,$Z8)5E/@1A>(H7/G$L[V/2 M[CP):)+0;; I8"+BO,R3.P),L-EF;X,(+W8Q&>$W3UQ0Y+>(2MC+KUF5F?^P M#HT%F;6-D^@ HX !MN]LB]$*P( _, $$K>J0H"CPI9 W-7PGRJL1^#&J8$GR/L#WJ#/A M?P(7AB0%"DNEG![N2?<)\D%49AQ_@;D;?!(]K=[\GGP0'9& M6FRBDR4RI](Y7=8J%<]I4<,\]ZB=4G@=9WBR?!'I9';E3 Z,,&5$E&4*G6?B M?JCQ5'[IM$,+70%K&$ET_.4>C!I:WQ,.Y^)(X,]*'8B^D2QE'>G I&"\TSNE M**9#H*PVAL#2=F5H*_*Q8R2K4&A =:DSM,N7!'#!I*I>4>/;5&/-5+C(^RI2+ MD$(#[NE KO>IEV(?TG0QT5TP$ M)MF_M-8$Z5!;#^2OXUIHCF4A MR84))?'J19L/)"] Y[:9Z4M1YQI3\ M%R.IF5K8V*$_8 AO8W_QB!-O@R^](/G9"W/R3;%MOR%.0091\HO=/HP/F!:C M.0\2O"(CI^=Y0O;S^RW^._:2]RG[_33T5A_)% 3SM%!11">1[][%/B&HOO'G M$$@;UZYF@JN"O?I4 '?B,>C0FH"''@$^^+HT9#<,1#C*PB60].S*+\%$/H63 MGG0="*0O4)Z6?S\ M"AEX!9CGNP9P&@'$,_MD,O](NI8WH[%:(A*JML^<'Y' MD/&2A,58V;17:9K3NZD&NL1D=!?.I0&<"@MX51N5GDG35UC6*STKQ'I3.\CZ".^?8;T\AO*(AU4,J MHUFIR:<+E8)BRHM14%Q(U89(U;X::68GT!I\[6@K57J9FD2W.(1LTQN/2')M M7YW -)+-9+4VI 00@>@5/1#M@NJ64]?;=W*WK)>'S:ME3+*/Y7QK/&33I<#0,$-5IHZ. MS2A%5%S]R1S]'5)C4.M!"'78%+;'8S'#D!8*\HZ25G]2:59'?_H<[^R+FC34 MM^&:$Z3EP(=>&11VM/6:B 0&^2O6+4GBOEEI5V3ZF%"(A13= 0;191 %&:97 MW:ZBK+CKQF3M]/#.^W>@6[[P@*I?'/4YV1%.VVH A"%?EH:K999RT M5M3P/+\18;#MSTZ&B4:2'BJ3]))R]D))TQ>F8;/OM/0+&!"9&J,U64\M!2^R M.^>2>C>^V/9EUHW,VJ&&\66>$@58\HM<&KN/H#%*:0M*7 M-!^\8D>9SD'6R1AP*RS%-9T&[=@\Q?+;%S.A'*9"41R=K(Z3J:XX5PMN3 'K MK*W1V&*<'O,6DPVV-71E&Y; G.=X9-M->5H'-6Y589,Z"D36"R5(MAOILG#\ MUKTF_YMQ#@U"&==^C7>[@-6P(QL->WEP@R.H378,S$T41=.;VW*>EPYLHMRO MXQC4/FJ,@FI1W'FI( M")&]4#5'K+WK[%55GC5NKLIP-K!I?1S\ZSQ>Y64.M41.4KSZV+1T5#1A.8/NE F(DH#=[DX:)M6]5'^EGL)(5EXN,7[ M.)$M?W6VML>T]Y"J!(H^=E?-$6OOR+17X$U;$'B(#ESA-V4MNW/B((\B$\T1 M+=Z,$0+1)Q"L,2*M$31WK0JX+&F+0A=!S3.3^F"7Q.+P0KAO>$D^D07'U<6@ M/:8;U=""HD\26',$[1'MX"K0IL"=MD3P4!VZ_4-Z50"'WB/N&9U!IZC"KF0: MM #I-1.J]NV-PY7-(&!/QW[@(:KK3L" %\1+R'[ MA%-I\>-M$.%7(\@,;U0'6H@#AEQ0BI8ORE\0]$'+R/F>)6%34TI$* _1+=TQ M7T\B(Z_G(2.O363D_BF>GXR\5I61UV/)R!GY=9G!)2&].N2RR 0E$\ MH /8+=#%\3XC9 Y7+EJ8&GK$C2&IN;-,Z/.ST6H,BU5OV MFX>H"!C&E1<>XF,(S4V<9E[X2[ ?R4GB#FLYVBJ&1%%>6!]$.K4=(9?BPF45 M5UBZ.!M$84%#+1+L#1:,QD V#]OJ$XO.]RG?29L6HRWSF4?KDK,=+(R.V]Z2 M;\*;;1SA$7S6SF"6%WA[?N$3,Q UI^TZKJC]M2SB0,EG+E(&Z_8.K_*$R,RK MUQM:('80ISN#6>9T>_Z^$KZO7G^^^0*5O5RR6\2&DMU+E6^"L>:]KH$\T'.W55$R X%2![QN9=YQ32CG(%Q!W8A-7Q0 M^HZ]JCZ04^.58N1>:N0<:Q]R"3$?)#6708B3,R_#FS@YC" LS?'<'&4U8) + M!VV*RK:NLB@DK&A*01: B)&VBAV5$C=%H?A> +2&,Z%_5 'H$<]0$N.&#A2$!P^M/1#&[-! M5@%<"8)DCALG>L]CAR*?9P:$W3(B:(]G5(XVY12^^EFT0-'*WAW I7G*ZBXBAQBA< MD6/.]Q@W.(2#VM8.(D!$9TM%B**>O=^YS&'_J*F'1=6QDPQ9DS7?O!# +HJ, M?:^C/JK5T*80#,6K'<5=G\[E#J=W.S@\XM_N:.,[*.!)1DV\\"KR\?-/> Q+ MLSVBDVR$%A ]9@1KC&AK1)J[=4D%+&G9"1P$#8ZSCK&-T7*K:X,Y8?UQ_O[X MTPS.J44VR8JN9J ( ?PY;D0@I%#V& RO"Z;IFG91']1O_ M8A3-'W0_\](M%*(@/^ %M4"_R+9WA;%,-3HMD6)U,*ELJ,%BTA#;"$+X32G@BSKJP4 M4PR]74J5!F/K,J9*!M/"2I.+EU":[(J3LO30AI5J(7)5OD0XOZWA47][+XH+(!"P.=Z:[+Q5,U=E1WOH7U1ZE*&HW'- MRL6*%E9,2^U2&_@:9].H!;4Y[9O-2G!)50=7EMSX8CI\;?AFRD08ZZ'&RQS. M(-/L'Z13RBSTM?5$Y*U5]>):TA&5RYGK3"$+3]-"1JAW5R\"$I= MM+(K\C(J2NYJ1ZMSJ-@D%2DPX)$.>+4V(E\?SI,@) TVUP2#2?9)V4SV=T<) M-**CJZ(A2H(-%:RD>,>Q$K 7*,+TZ2IOM[_^=W+WS-U%H$Z>WWUA>N(IX(LU)59'PGU7PTJ![H--D3BBYUZC;*]F&S"T7=O?'- )Y?;S($+G<1AZ2?J%FR/\4:2CT*H#26SLG93: M_(;P)ZNK]/&M1.E4+J(6,H"T=G$U)?OMJV^8DOWVY>]=JU45MC<#93VD&N(> M\Z2:_!YB^FAOY"]V<"/G-_JY$)#Q/>AQP'+B9(\"NBB+3E,A._+-1Q6JEOL^ M'GE-/?S&*Q;T>=+E^GWQ:N+8SKUT+OM^O0P[J1@:T0;)5,N6=*&/]*48WIDCK$4/.,+KP*T$*?"QFT@D1M_T M.?':J[Z13V\T;./0)\R _3$[3/70N.JT#H[D56$3%=BI/0T-7D9] )H!\MT? M$1O(Z3ZGR_C&"UXZ%#(]LJ]-,FTNI&0BVWE'8E!ZLB*Y#TJ[,?G[^280I7&3 M),O#O1OO "=ZTQ[OMB9Q=Y[;!$3L.-+&\)8@M';[E*"<4;SS6@Z2^N'D.QP% M<7(61X]PG$B&.XTCGY\\DPU.*^Q5F08(@7+"O"3:14^J9S9'M+0)(9X"BI^M5DSG5< M2I&E'0N\CPBF=SY6JR3'?GMZ"]R-AQLW?)V=;:OB3H MCF F'SW"Z2UESES6HT92<(3E3Z/-"4W3GZ?)+.:AP&H68#XDYLA_F7FR,%/_ M?$XRJ?N@TC6NZ /V4@/+>;1;PFMQQ%M$FM&M%&+:/<0C,.TEAVO7->;$Y2#% MB^LS4A33L>NE@:M-[.Z+W3Z,#Q@7>1)MKBT 9 H'K*3I:QXV]Y+T".T1O_YY4MBTR[R;!LGP6_8_P']X>7+%R_9 M_RAE1=Z\#+TCG-^BKU^]0$""']!5FH(+3^^J'FNF_8!^_^VW+[[Y_NL77W__ MBG[Y];>_?_'UZ](6AXD;Y*?F7--YC6@DX=+3C]@E16P5V M&#&*W-YXR3*A;R3Y=.0;G-!J==.)LG!&!]$E!; T9;Z65X>(36F>[-LI8'G4Y--IA\Y,;BQO 31*RL"K MFL]$K$3<$X@3%VE#([LS+-O;IY:?8A87,4$!+$J2$]"FLS%'>!R3RDP-U?&T MCEK5Y%'$QE4%916 E 0HYE9,GH,4"5(6=4'8_L;F&'^\2+4GAO,8Y@VK=DVE.\)FWNO>>1-Q*=F5WL*QKPB6H(LQ&( MTBD>]OT7W:?,=G#JZ;DB)$T,:2(H(&>*T_LENM:)$K9@%8:Q')N MI I, M$@71%L;2^.!^A0#F15BW0[,K9UN%686\IT,% MX,ZQC+)Z4A[(WE&_!E0"\2J[GWBL?YF QC^!L^T0ZO*N4%9:-#&]C-::A+V% MM5R?LQ4X]9FO[NSVTT\T(3273X'Z8S.XU7F&,E+7AB9DU*\0<)E'?LIJPF/_ MDN!PYX5DDS]/]_OW44 3UME4O5I2?23+EIPR8"+/$?H73P$0$0-&HY0, ;OQ M^=W-#4"8DK$,0B(P6R_%4/>P5U)' MG]#JOC\V])-+/5\*?1R>0V9S?H4$;YO@WW7F)E4.4N F)6&%L,I$&[:"RP2 M)M$IVH!=0L0\BQ$N!DM?$!\2-N,XJ3TR27Y-64T+>#QW%>\@9MXN[32?!: H M2ZJ:O8?0 ]3[31*O QI7'EF^:P,[>>>TG+TGINM6>KK4;SV^4$=B"G5'LWDL M:C8VGXLSQ5ZH^E36 Y3X@TH(4/./J2SF;KF_OJ["7%55>R;]9@,A8X@?DW)_GC\%K9X&M)H)D,PHN:Q%*@Q7%\[)\>WA.K\2JJ4E,7 M<&&?E92>IE2' 0 .]DE]*$67Q\ L6X?Q4UJZ+&55*Z\:PF5^C[D\U.76D%RF M._?"_W?.(E3I?7R+ _J\Y M<76H:D_*6>F;8F":PJ?P._5X!?DN[&W\][Y7/CNO5")]MI:/Q!3G_0DXLBZ5F_/$FE='2OY,[?+ MZ4M-JCQO;(Y*)#+)*SZC5T2NHN)9L:A1FE/C;I[J.!8O;2F")%)^[.X,,E0Q,!L(C,08RV!PL#GF/V\BFB=X)Y7+CCR MI#R0U9P05:@,WTIQ)4VZ7"O$28L:NEZRROC7(\K3=4NDYB-3U\9B16RPKFC- M3KBZ7%25K^NNB V7L>)EC;NRU/:-=Z /M=<_@&-\ Y%3'MJU!*H"*BH&7"]3 M#J]K-2\ SD$&=;DL%$DM4@VXF,J9M_Y^V0O]\CFX.RJ'2?Z/.T35"-6:V M+A0JX#ZN@+5>&+(A8^TI[=]\[@?*[$6IV4B:@*N]PL:C@OEE1,%ARQ5-VW5X MA"<#8#Y'>!(H%8_P@G*$>1_A*'[E,C_ $TQ4U$-P)L0R ^0BQ!$I% M(5Z7(\Q;B!7D04&(^\AE*L1DGA7&?DIO'5E(^>Z?SX5MV0N5^($FVH\)9/U> M#KLZ7AR>.$TC4^9P*S]1@2#&!F=]>,@5 E=IN?Y0W&6:4.0XD[E)895 I"1K M0='M*&N]]R$=RYZ8SR+!$Y#&.%DVW^]#^N"N%X**O21;R56TCI,=C2=-]:Z3 MXJSVLQC5 !-%>6J]4;K:8C]GUQ97Y2Y-C,QJ,->ND";K&_F,&F0:D&U2#@TO MXI%?CS9KY'.V?C@ #.,T3_!$4CL8'.OB/!1BT66",I.AYC(11>3*@.T-%TJ3-L9F;,]$--N].&Y?L710RV+*A0ETO-V?TKS9($2_\W;[/Z*-EZ)] GFTS?CK_$18)AH:HBRDG5&- MD.*9"WC-Z>R8-74:1WY9"G.194GP *5Q[N-E )7EWWCI347Q_D2AP3-8S?@8 M#*XPDE6-V\E/(Q+-AD9>-3;DL8&4@^4ADG'K24AC"4N9GC0*K0T232#1M4KQ M9!>7[N/R5FXZ6.('C6ZYB-,@8,WSB'4EW;*@CR$?I9 /)K#YF=LM64))L"*C M@U4/;V23'_#0\:,7XO&C;KW3V;_WT >2[-R!/I5>6LM%>Z<&ABH[FP\.*1! M__I$<]BK:!7F/CNS>(8:>G&2$=;L3KWHXSG>Q\1RZ5>;!D-:M0STX1,(UW$@ M5(09V%!@V*YA,)3":"3\69227 ?M +$JTI;A(,49)SO,9) M@LN'N\AF;U/XE( 8[8Q@B#RJ0"H\D:5=RP>^:I<@9R:M.B(AEU]E:@T(^G=G M90_1L61_2P+,F7(.VK,+EN@!LO@1)U%Q/LL-[<]",L6-&(7(AV5&-9DE?#> MAI@&X^NMV^/BLZ.UZA/.8HMM0R4U^/C'D/-15AQV*JBJ-O9#RCIZAZ)02G'D M4T0(#U SDC[52C[=[SKW(H?GT:E//%XL1EWNU,$37N&HSM5 Y16AYP-+K"O[ M.LVFT^9\([-.CSX&551JYY+K\R0(R?<;HFD74)&=UF,02":OEHK&6",F<"IM MJ1JPJ4F:7XR!DH!E%Y7E*[I29SW89\#4LH"*)IE,+O >9?JJR@FXBMY'9.T^ M8M_DO$Y_1*OFG#9XPH<5R]X0U\N+_GU';W9%SYBYA0":T6I(#N?QT;YW&!X2 M&CLILS.^_3.T#@S"8U_Z@MY=XQU&-X:6 *IH^W6"\\,8+_*NH2"*99/7)YW)0UU("CK! 9=D'013O MA*C^HIOK4QPE1C8K1O:A/T"1W^+,"R)BH!1O94XB3X))7*1%\ 1WW//=SDS M3WV\#E:!4Y=(SJEF[H,02\,"?M=>EL-;O44-TC@:.[[#F3=T>L#+?Q.#TG &7$]=51L7,;*3C\DEA7DX_V$0! M643@@+."'E P/0[)LL+I/7[.3DG_CR.+E>*D3EYR4 )->"5MM_.2 XA:;1QT M' B5([G>[?38WKB-IDX@$W_ZKKC(MUS?;S$D*Z;+]86WVIZ!@P33@LQ_(*[\ M*28;,.0IDG9UWY[!!.>!>7*7)1[$V#3B'Q<$<2GSYKJ4C]ANDRM-SLM+R5BB(W6QNL?IKQ+].K7JK/%0H5<_8*"I8[X*5HHKU0J0,SEKH.$&Z MCU,O3&E%\G!-+.DTW^TU>"L9P#ZKQ<#(.5_V0^LX0=#SI-;569:T*H<:@M%# M D-'E8;;MG'H$Q9U)W,TE.>U?255&3*1H53K_SN/\.R/B WC M,A:BS>;.LUW*%#'/5SU:._1%L%,OA?M^QTD?AZ(#E@5WV@54/=K0XC.GAV.3XF!S M\>0E?@'4,L_2C#A:Q"6XSB<(5H\/G_5%,S8&HB H_9*N(/KDX0M4Z_D"7="? MCM?05,+66%*3T'L6*^P#!A<;^PLH\KW!94V\FR0XRNS\UIT4:B?!7CNX"=9I MV045?8ZU\_;0JV_9?NH+5T6&)UK.O-D='&B\:TNCV'>K_ M)Z3NI6'-''HY-F5/'8/ZOH\UG\WB][49?I' (;T2G"*?=D'0!V7Q#PX#;PI\ M:+R#)<;6-,@R4%3IXX+I5<2>RYZ9&=$"[E.T%IHH*!OOQ9N/K7$W'Y2F47L3 W\84M[CBM[?%G7 M6O8CL]311GP9)VL<0)X7/))Y\;P/BE2O.>J(27%Q4!G?*<*FBH1.@_VOSJ!8 M?1B2WPHPL/^I1PQ&60QCV@[#&6S\?,!0]5>",DM%,B[P<]0#%$X+9WDTUX7O4SN:ZV"@[-W7>G[J.[50S,;&-W_,@=(LN'R+G6--9'-<]*Q@!85VZ-EEN&VE>#LW_JAZMCB4-YX&I.. MHT:)]6&@3&.V\')=2S?1Y$B$W_Q1Q/=">3 MU7YC)[O74ZSU&6#E*I;K M'O4^)]4KG-2D' >\RI'0&&PQNCS _:2FOYPI3W<$U.H7=R#-BP\S+'FZUYW M_>K(SUZ8,V\]+>_UI=8O-PT ;BX>K#D*"M[J4R$U)^7R7GM!@A[)T+C^CMF& MDSU"$T6.:2-%=B041@ U\ +E:?GW0^@1ESA=;0D-TF+,$S#WH<$N]K'SBES3 MR'6?'SR0L].ED6FEMM"_SKT,7Q%%$T1IL +XYQ:&5H/Y4SL,4L*J9V<7+/T< M-J+P $N4A;2\C*D!Y),9J+]P'HRY)7AG6&FZ%"^B/)R$+T2E'T_6I.WQW?J$ MM';R9H!U>9QLG0H9,&0W[03:NL ]Z"@1B)V]LA+T'@70V<2QQ\"F;],,@T>< M4H^T%8!VZ85.*H#]<>71Z.XJDUAZ?ZIRD"L>>O%3#4'5 DRU M:%1?K.E3VG6'2?=T(2KX4JBNBBN!BF7'9 M;.,I;![WC *QPNG.JC8TK6]-CWS8Z.R>+ZMX%Q03N(D+C2HBG3K3@\@[=K#5 MRBXU&X=,_%J6H53.1M&KZ^-!CLSQS)!;L+00Y'29T"=^IWM#PQ@.!Y)H"JO* M87G15U0AU/71M9F0"$ZI#:BG7]G[+/32M-+(Q:B-;)?JRVK.7F/ :%"K):@, M !3ZP$7V-.VF<"IKN5#5 /Z6%:Q,B:4OC<4PX/L&$=7>YYUX+$?>!-UL2A0? M!)'756RUM=8(FCMZ^51.]4(*) B.I'5J&76&*J8Q@L4 G H\HE?H:QG@IW@3 M1#2Q\]0+P>YRY0PHLT>F(3K(F]P0*O4*> C85U4$97.+3\ T9Y:O^Q2Q5NYV M!3Y9FRN]CHK9$S!-L4B+NC6:2[OJYLX^*$'HXRJGVH;C_;Y-<^YZ;:!G[PEB M*1S(4DN[="=U05G?"M 8$ M,RMAS3,6[X.,PH!7>4)F;KN3M;7Q2E/5&4Q@T6P<"JOP:>0==I.^-B*#9ZV,)5SQ$:(\ M(!_1)#XV=B*3&0PN+M@90:H4>W6:CC!(".H' .;T/1="KJ+G+ M0T?W[#1]((0_'W$_#Z#V!)# N;OIJ8[*T#.(Q2H!*LYS+.K^-L/TL["LM)@K M/])1I9#QO==E$"XB_XV7WB3Q'AX;K9E U#6> =G,/!)O'V1> M"*65[KS02PY@KZ1=?=OO?Z@.9&^3U8!*E(I[[(Y2VK\M7-:=#$U^E2Z%#AU, MKS25%Q3IV+491U9XPFFL7X@70:(@3=4%V8X\N=!7?9RK:R8IT@,"M;?X$4A(#A*6YRYI1TVBK70(9 MW[-*"[!X>K?43@?+#D1[?E'2!Q4/=T:7A+3%[L=%Q-S'<73Y5@&Z:\)Q]U\*,Q=T+I:HD,]I$5:(Y+T<)U[VTYT^H0C0\ M6C?#<-W+EB2I4\+PVNA;,.7PD@6.HLU;3 :>[*"K9S('6[ <(F%EI\V6WD/. MB6,0TB[((^-DS$.@GZ#X(0PV7OO6IX,-5XW#]2U5@2B#-LWFR M*.:(4WP;> M UBE<+AF6M%!>VB[Q_WF@"KLJW$Y9"&!=9$\#NOLM&(X_SN[JQ$139+5FQ.Q M'/CU^W+*?M]5WMUJ$%@.B\BKY8J6,P=7B1NEN]N/KX$R:XY:$SCE0]+^$>RJ MIEYX%$6CIFI^<'3M29DY7!$1H6Z>2<0=_G"6)PF.LI%-K)[)')A8QM_(W.00*;&UD4743XE!=E6K+!>=!2[!DRT1,D3B/*+E,HV-*[/Q75E8 M1M!JO(+">>2(R2@!;T>MKDY+OYB7%H)%ZSAIR_<F=9'AJ JG_X%=M+;2?^IJ!NE:7"K$"5Z3:-')<7SPWF(C'Q):$ MPO2SDV,.D*IRW-#4,Q9)P%3X,0?.W8TVF%LJ(DUJ\ZC@%_ J&S)I.AG9LMD)A[XOYV)-.*(JCD]J4 M,GO%F<$ROJ1UK)B1^3(@,8@7FZT\B1*H\QQ?DPGOGW#XB-_%4;8=.\_6& S; M*4*F@ K6#Q#"M>,Y5 3Z0OW*Y#%/&E&=]N_$<+Q_BAT);SF[_9LPFA"*A?5K MEWEIAEPVD<\Z(48\"15.121Q[%<$].>WGN*K#:)8,'\_OT-1)68;"V=%#@N; M/TQX2=CO4$+I]"X\0ET@Q2+ZC=,\.5->FPIH10OC>(76;,&C2_U)IY^]=!(@ MQ=+Y[:&TMG28O)I7.Q)DQT+*)-&.8LIPU(13G)6YQ@#QI^&GL^5P), M!+=+G+'/D.T<'L\@LEO!TI/W7L9M(?]3%MYRZ1;U\%+AQ'B8+)W%NUV043(L M(A^N^I )<+2R4GM"\&.;W3(@CO('Z$E(QGAHK44G9?/< U3#6K#A? M^J(LP_[5&3NE(;\58SM[V<"ZI([Y&J0:8X:\R&P"W'4<,?A82>BK"(J&T&VJ M>NU@+LM6!=1/:L4J(*2Q6-MO4WQ*ZU)#"D=9DJJ4G^)4Y'W-W[IX7I&FBQW\ M93-L(H1A3*=5?049P2HL2I&F/Z ]W/J+(Y3@/8$94VL;!;M]GM4JI\PXLM(G M),J1%2GU3)*5KK[^IJRE=1MLWF%01+W)1MQ.5F_P\" 02-#5R=??H*I>&&F- M_L':_]/1U0P9R8NL&R%Z!KGQ9("[/=&:-UZ2I8H,YO6QF S&F5Y\#171IHBV M[;+6=DJ6A-H%;T7(F;UY0"N9E++"[G,I\ECNT9(<*FWO[%;A_&!XSILS \"1AL@?!FL)Y]P0%"5 .A:(EH4XZ .+ 1 M)$RJ6P B) =D332&9+;R]$+2F,=!"%$(C)K(L![.58LR"X4BU$'=Q(J@-5R6 M$5:U(%KMK>XIKT&3@(&3/Q_BG68N*QO0,F5I/+ MF4B:S8:)'?HVF-A$R)R)D$NGQ\9:#YN%C#JS]W 2&L[ CA=1N;9 M.)!XIL7,6@?+I=#:\\NY">U<^]LB$C7 MI-U,>-DA<9.7380&\/(N>-9BY;&]@ZVRFES.1M)L-EMEA[X-/C81,MXJ[Z"F MKQX;:SWL;Y6UV7LX"0WGLE5RJ-QD9@LKTZWR N[M:G&SWL,^-VNSR[E)&\Z% MFQPJ-[C9QLJ4F]>!ID=9Z^!DLSS.+^0NFFCYW6[V<>+4M(!3"3GP^.PL\]3&: M@]\ 3Y=&/W09W>KD8!-N0J 0C9K3)LRG>3IV*B.529:V=(=;HYR'EK@:#$ M;W[&E---NR=UBHNF:7RS&$PWAZK3S1FW%9.I2FYS7,5%//63\;J]G.W>2NG9I4,YQ\W.^1XSWDS M'\VAF[=^SE:WGSNF*V=P%4P7)'*Y8WI?,AKYG@5_.:G M>CG=PWMROKAH&N_A<+BM&4:K=W&RL&L ]%U'@98S"J-QJ-VZDM)";< ZID-I MA]%:O=Q89TT@E'@\HS :G_ [->X3,H;/*(PF(C^/Y^.%T>AX^F&T=C<75T>;("CQ>UYA M- 'M.0P?*XS&!M,.H[6[.>.V:ABMX/:LPF@"VO.X/5(8C0ZF'49K]7*X>:N& MT1BW9Q1&XQ.>P^GQPFAL./TP6J>?N\U;/8Q6,'Q&8301^7D\'R^,1LH- +XS6Z.)B8=L>V)G?#2'; ZGAP;.TB3[USOV_B&/R?R*QZ13K=HQ^>M8Z;@[GD7/JS.Y@.U%&^?6N)#X MP&@^,F8W<*_CZ!&G&?85%W*[O57_JC6YZ%&@.#IAS6:@H 7T+=8K#R%=3XI* M@_<\[CIMC&=[G=8G%ZU3UF8>ZY1'_&J==I Q6Z<_ZRS2G]LKU-8"_;E_=?XL M6IEVUR6/GL6B[""A;R255>15GQ1IM[>J55N3]]3XG\%3,0+J%NSCH6,0G2J' MT>3@D8&VV:?$/=?'0GRJMC@WAE&CNP(Y7>P>#'0!D)@WTL7HP,21KT@!:B8' M ]4XB\@_#Q*\(JVTE2RGK\U-4@)'K^XE75#59P;FK0(_VFI9@+7^)OL^VB?Q M(_:70?C&2V^2>(^3+%!>\3W=K6[!_E0L%Z.KHGF)/)_KJLY.7UL:L[N]!+->2Y;W)97MIC6Y

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

    FXM,C R,C S,S%?<')E+GAM;%!+!08 "P + -P" !4 0 " ! end

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end XML 52 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 402 253 1 true 156 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://zionoil.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Condensed Balance Sheets Sheet http://zionoil.com/role/ConsolidatedBalanceSheet Consolidated Condensed Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Condensed Balance Sheets (Parentheticals) Sheet http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Condensed Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Condensed Statements of Operations (Unaudited) Sheet http://zionoil.com/role/ConsolidatedIncomeStatement Consolidated Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Condensed Statement of Changes in Stockholders??? Equity (Unaudited) Sheet http://zionoil.com/role/ShareholdersEquityType2or3 Consolidated Condensed Statement of Changes in Stockholders??? Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited) Sheet http://zionoil.com/role/ConsolidatedCashFlow Consolidated Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) Sheet http://zionoil.com/role/ConsolidatedIncomeStatement0 Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) Statements 7 false false R8.htm 007 - Disclosure - Nature of Operations, Basis of Presentation and Going Concern Sheet http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcern Nature of Operations, Basis of Presentation and Going Concern Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://zionoil.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Stockholders' Equity Sheet http://zionoil.com/role/StockholdersEquity Stockholders' Equity Notes 10 false false R11.htm 010 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method Sheet http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethod Unproved Oil and Gas Properties, Full Cost Method Notes 11 false false R12.htm 011 - Disclosure - Right of Use Leases Assets and Lease Obligations Sheet http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligations Right of Use Leases Assets and Lease Obligations Notes 12 false false R13.htm 012 - Disclosure - Commitments and Contingencies Sheet http://zionoil.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 13 false false R14.htm 013 - Disclosure - Subsequent Events Sheet http://zionoil.com/role/SubsequentEvents Subsequent Events Notes 14 false false R15.htm 014 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://zionoil.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://zionoil.com/role/SummaryofSignificantAccountingPolicies 15 false false R16.htm 015 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://zionoil.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://zionoil.com/role/SummaryofSignificantAccountingPolicies 16 false false R17.htm 016 - Disclosure - Stockholders' Equity (Tables) Sheet http://zionoil.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://zionoil.com/role/StockholdersEquity 17 false false R18.htm 017 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Tables) Sheet http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodTables Unproved Oil and Gas Properties, Full Cost Method (Tables) Tables http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethod 18 false false R19.htm 018 - Disclosure - Right of Use Leases Assets and Lease Obligations (Tables) Sheet http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables Right of Use Leases Assets and Lease Obligations (Tables) Tables http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligations 19 false false R20.htm 019 - Disclosure - Nature of Operations, Basis of Presentation and Going Concern (Details) Sheet http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails Nature of Operations, Basis of Presentation and Going Concern (Details) Details http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcern 20 false false R21.htm 020 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://zionoil.com/role/SummaryofSignificantAccountingPoliciesTables 21 false false R22.htm 021 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization Sheet http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization Details http://zionoil.com/role/SummaryofSignificantAccountingPoliciesTables 22 false false R23.htm 022 - Disclosure - Stockholders' Equity (Details) Sheet http://zionoil.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://zionoil.com/role/StockholdersEquityTables 23 false false R24.htm 023 - Disclosure - Stockholders' Equity (Details) - Schedule of stock option transactions Sheet http://zionoil.com/role/ScheduleofstockoptiontransactionsTable Stockholders' Equity (Details) - Schedule of stock option transactions Details http://zionoil.com/role/StockholdersEquityTables 24 false false R25.htm 024 - Disclosure - Stockholders' Equity (Details) - Schedule of stock options outstanding Sheet http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable Stockholders' Equity (Details) - Schedule of stock options outstanding Details http://zionoil.com/role/StockholdersEquityTables 25 false false R26.htm 025 - Disclosure - Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model Sheet http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model Details http://zionoil.com/role/StockholdersEquityTables 26 false false R27.htm 026 - Disclosure - Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances Sheet http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances Details http://zionoil.com/role/StockholdersEquityTables 27 false false R28.htm 027 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants transactions Sheet http://zionoil.com/role/ScheduleofwarrantstransactionsTable Stockholders' Equity (Details) - Schedule of warrants transactions Details http://zionoil.com/role/StockholdersEquityTables 28 false false R29.htm 028 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants to investors Sheet http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable Stockholders' Equity (Details) - Schedule of warrants to investors Details http://zionoil.com/role/StockholdersEquityTables 29 false false R30.htm 029 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) Sheet http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodDetails Unproved Oil and Gas Properties, Full Cost Method (Details) Details http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodTables 30 false false R31.htm 030 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties Sheet http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties Details http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodTables 31 false false R32.htm 031 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of changes in Unproved oil and gas properties Sheet http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of changes in Unproved oil and gas properties Details http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodTables 32 false false R33.htm 032 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) Sheet http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsDetails Right of Use Leases Assets and Lease Obligations (Details) Details http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables 33 false false R34.htm 033 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities Sheet http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities Details http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables 34 false false R35.htm 034 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of weighted average remaining lease term and weighted average discount rate for operating leases Sheet http://zionoil.com/role/ScheduleofweightedaverageremainingleasetermandweightedaveragediscountrateforoperatingleasesTable Right of Use Leases Assets and Lease Obligations (Details) - Schedule of weighted average remaining lease term and weighted average discount rate for operating leases Details http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables 35 false false R36.htm 035 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of future minimum lease payments under non-cancellable operating leases Sheet http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable Right of Use Leases Assets and Lease Obligations (Details) - Schedule of future minimum lease payments under non-cancellable operating leases Details http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables 36 false false R37.htm 036 - Disclosure - Commitments and Contingencies (Details) Sheet http://zionoil.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://zionoil.com/role/CommitmentsandContingencies 37 false false R38.htm 037 - Disclosure - Subsequent Events (Details) Sheet http://zionoil.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://zionoil.com/role/SubsequentEvents 38 false false All Reports Book All Reports f10q0322_zionoil.htm f10q0322ex31-1_zionoil.htm f10q0322ex31-2_zionoil.htm f10q0322ex32-1_zionoil.htm f10q0322ex32-2_zionoil.htm zn-20220331.xsd zn-20220331_cal.xml zn-20220331_def.xml zn-20220331_lab.xml zn-20220331_pre.xml img_001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 57 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0322_zionoil.htm": { "axisCustom": 2, "axisStandard": 15, "contextCount": 402, "dts": { "calculationLink": { "local": [ "zn-20220331_cal.xml" ] }, "definitionLink": { "local": [ "zn-20220331_def.xml" ] }, "inline": { "local": [ "f10q0322_zionoil.htm" ] }, "labelLink": { "local": [ "zn-20220331_lab.xml" ] }, "presentationLink": { "local": [ "zn-20220331_pre.xml" ] }, "schema": { "local": [ "zn-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 485, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 169, "http://xbrl.sec.gov/dei/2022": 7, "http://zionoil.com/20220331": 57, "total": 233 }, "keyCustom": 72, "keyStandard": 181, "memberCustom": 125, "memberStandard": 8, "nsprefix": "zn", "nsuri": "http://zionoil.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://zionoil.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Stockholders' Equity", "role": "http://zionoil.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OilAndGasPropertiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method", "role": "http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethod", "shortName": "Unproved Oil and Gas Properties, Full Cost Method", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OilAndGasPropertiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Right of Use Leases Assets and Lease Obligations", "role": "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligations", "shortName": "Right of Use Leases Assets and Lease Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Commitments and Contingencies", "role": "http://zionoil.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Subsequent Events", "role": "http://zionoil.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://zionoil.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "zn:ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightlineAmortizationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "zn:ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightlineAmortizationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Stockholders' Equity (Tables)", "role": "http://zionoil.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnprovedPropertiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Tables)", "role": "http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodTables", "shortName": "Unproved Oil and Gas Properties, Full Cost Method (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnprovedPropertiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "zn:ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Right of Use Leases Assets and Lease Obligations (Tables)", "role": "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables", "shortName": "Right of Use Leases Assets and Lease Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "zn:ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Consolidated Condensed Balance Sheets", "role": "http://zionoil.com/role/ConsolidatedBalanceSheet", "shortName": "Consolidated Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "zn:NetLossAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Nature of Operations, Basis of Presentation and Going Concern (Details)", "role": "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails", "shortName": "Nature of Operations, Basis of Presentation and Going Concern (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "zn:NetLossAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightlineAmortizationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "zn:DrillingRigAssociatedandEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization", "role": "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightlineAmortizationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "zn:DrillingRigAssociatedandEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Stockholders' Equity (Details)", "role": "http://zionoil.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "2", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c123", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Stockholders' Equity (Details) - Schedule of stock option transactions", "role": "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable", "shortName": "Stockholders' Equity (Details) - Schedule of stock option transactions", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c123", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c124", "decimals": "2", "first": true, "lang": null, "name": "zn:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Stockholders' Equity (Details) - Schedule of stock options outstanding", "role": "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable", "shortName": "Stockholders' Equity (Details) - Schedule of stock options outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c124", "decimals": "2", "first": true, "lang": null, "name": "zn:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c311", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model", "role": "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable", "shortName": "Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c311", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfCompensationCostOfWarrantAndOptionIssuanceTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c319", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances", "role": "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable", "shortName": "Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfCompensationCostOfWarrantAndOptionIssuanceTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c319", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c325", "decimals": "2", "first": true, "lang": null, "name": "zn:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants transactions", "role": "http://zionoil.com/role/ScheduleofwarrantstransactionsTable", "shortName": "Stockholders' Equity (Details) - Schedule of warrants transactions", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c325", "decimals": "2", "first": true, "lang": null, "name": "zn:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "zn:ScheduleOfStockholdersEquityNoteWarrantOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c357", "decimals": null, "first": true, "lang": "en-US", "name": "zn:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants to investors", "role": "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "shortName": "Stockholders' Equity (Details) - Schedule of warrants to investors", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "zn:ScheduleOfStockholdersEquityNoteWarrantOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c357", "decimals": null, "first": true, "lang": "en-US", "name": "zn:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "zn:DrillingRigAndRelatedEquipmentNetOfAccumulatedDepreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Consolidated Condensed Balance Sheets (Parentheticals)", "role": "http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Consolidated Condensed Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "zn:DrillingRigAndRelatedEquipmentNetOfAccumulatedDepreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "zn:InclusiveNonCashAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details)", "role": "http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodDetails", "shortName": "Unproved Oil and Gas Properties, Full Cost Method (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "zn:InclusiveNonCashAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:UnprovedPropertiesDisclosureTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c389", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties", "role": "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable", "shortName": "Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:UnprovedPropertiesDisclosureTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c389", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfChangesInUnprovedOilAndGasProperties", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of changes in Unproved oil and gas properties", "role": "http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable", "shortName": "Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of changes in Unproved oil and gas properties", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfChangesInUnprovedOilAndGasProperties", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details)", "role": "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsDetails", "shortName": "Right of Use Leases Assets and Lease Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c391", "decimals": "-3", "first": true, "lang": null, "name": "zn:OperatingLeaseRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities", "role": "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable", "shortName": "Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c391", "decimals": "-3", "first": true, "lang": null, "name": "zn:OperatingLeaseRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "zn:ScheduleOfWeightedAverageLeaseTermAndDiscountRateTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of weighted average remaining lease term and weighted average discount rate for operating leases", "role": "http://zionoil.com/role/ScheduleofweightedaverageremainingleasetermandweightedaveragediscountrateforoperatingleasesTable", "shortName": "Right of Use Leases Assets and Lease Obligations (Details) - Schedule of weighted average remaining lease term and weighted average discount rate for operating leases", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "zn:ScheduleOfWeightedAverageLeaseTermAndDiscountRateTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeasesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Right of Use Leases Assets and Lease Obligations (Details) - Schedule of future minimum lease payments under non-cancellable operating leases", "role": "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable", "shortName": "Right of Use Leases Assets and Lease Obligations (Details) - Schedule of future minimum lease payments under non-cancellable operating leases", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "zn:ScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeasesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "zn:BankGuaranteeToGovernment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Commitments and Contingencies (Details)", "role": "http://zionoil.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "zn:BankGuaranteeToGovernment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c393", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Subsequent Events (Details)", "role": "http://zionoil.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c393", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Consolidated Condensed Statements of Operations (Unaudited)", "role": "http://zionoil.com/role/ConsolidatedIncomeStatement", "shortName": "Consolidated Condensed Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c14", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Consolidated Condensed Statement of Changes in Stockholders\u2019 Equity (Unaudited)", "role": "http://zionoil.com/role/ShareholdersEquityType2or3", "shortName": "Consolidated Condensed Statement of Changes in Stockholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c14", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)", "role": "http://zionoil.com/role/ConsolidatedCashFlow", "shortName": "Consolidated Condensed Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": "-3", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestrictedCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)", "role": "http://zionoil.com/role/ConsolidatedIncomeStatement0", "shortName": "Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestrictedCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Nature of Operations, Basis of Presentation and Going Concern", "role": "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcern", "shortName": "Nature of Operations, Basis of Presentation and Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://zionoil.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0322_zionoil.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 156, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security", "terseLabel": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zionoil.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_MaximumMember": { "auth_ref": [ "r153", "r154", "r155", "r156", "r169", "r174", "r200", "r202", "r315", "r316", "r317", "r318", "r319", "r320", "r339", "r380", "r381", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable", "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r153", "r154", "r155", "r156", "r169", "r174", "r200", "r202", "r315", "r316", "r317", "r318", "r319", "r320", "r339", "r380", "r381", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable", "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r149", "r153", "r154", "r155", "r156", "r169", "r174", "r197", "r200", "r202", "r236", "r237", "r238", "r315", "r316", "r317", "r318", "r319", "r320", "r339", "r380", "r381", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable", "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r149", "r153", "r154", "r155", "r156", "r169", "r174", "r197", "r200", "r202", "r236", "r237", "r238", "r315", "r316", "r317", "r318", "r319", "r320", "r339", "r380", "r381", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable", "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r121", "r301" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable", "http://zionoil.com/role/StockholdersEquityDetails", "http://zionoil.com/role/StockholdersEquityTables", "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails", "http://zionoil.com/role/StockholdersEquityTables", "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.", "label": "Accounts and Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "AccountsAndOtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r26", "r305" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r28" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedAmortizationDeferredFinanceCosts": { "auth_ref": [ "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of debt issuance costs.", "label": "Accumulated Amortization, Debt Issuance Costs", "terseLabel": "Accumulated deficit" } } }, "localname": "AccumulatedAmortizationDeferredFinanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r9", "r146" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Accumulated depreciation (in Dollars)" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r17" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r65", "r66", "r67", "r242", "r243", "r244", "r268" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments required to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r43", "r51", "r170", "r285" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount related to convertible bonds" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Common stock equivalents excluded from EPS as the inclusion would be anti-dilutive (in Shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetRetirementObligationCurrent": { "auth_ref": [ "r148" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.", "label": "Asset Retirement Obligation, Current", "terseLabel": "Asset retirement obligation" } } }, "localname": "AssetRetirementObligationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r11", "r62", "r107", "r110", "r116", "r128", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r255", "r261", "r271", "r303", "r305", "r361", "r370" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r3", "r25", "r62", "r128", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r255", "r261", "r271", "r303", "r305" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r59" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Assets held for severance benefits" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r205", "r206", "r207", "r210", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r230", "r231", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable", "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortization": { "auth_ref": [ "r343" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of the capitalized costs incurred during the period of unproved properties excluded from amortization including acquisition costs, exploration costs, development costs, and production costs.", "label": "Capitalized Costs of Unproved Properties Excluded from Amortization, Period Cost", "terseLabel": "Total unproved oil and gas properties" } } }, "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable", "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r8", "r53" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r25" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash, Cash Equivalents, and Short-Term Investments", "terseLabel": "Cash equivalents and short-term bank deposits" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r48", "r53", "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash \u2013 end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash \u2013 beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r48", "r276" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net (decrease)/increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r14", "r15", "r16", "r60", "r62", "r80", "r81", "r82", "r84", "r86", "r92", "r93", "r94", "r128", "r158", "r162", "r163", "r164", "r167", "r168", "r172", "r173", "r176", "r180", "r187", "r271", "r399" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r193", "r203" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise Price", "verboseLabel": "Price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r193", "r203" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r30", "r364", "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (see Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r150", "r151", "r152", "r157", "r389" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockConversionFeatures": { "auth_ref": [ "r188", "r189", "r190", "r191" ], "lang": { "en-us": { "role": { "documentation": "Description of common stock conversion feature. Includes, but is not limited to, conversion price; conversion right; timing of right; terms, event or change in circumstance causing contingency to be met or adjustment to conversion price or number of shares; manner of settlement upon conversion; and method of settlement.", "label": "Common Stock, Terms of Conversion", "terseLabel": "Common stock shares, description" } } }, "localname": "CommonStockConversionFeatures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r65", "r66", "r268" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://zionoil.com/role/StockholdersEquityDetails", "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r187" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16", "r305" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, par value $.01; Authorized: 800,000,000 shares at March 31, 2022: Issued and outstanding: 466,593,391 and 364,322,883 shares at March 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsIncurredExplorationCosts": { "auth_ref": [ "r346" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Exploration costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities.", "label": "Costs Incurred, Exploration Costs", "terseLabel": "Capitalized exploration costs" } } }, "localname": "CostsIncurredExplorationCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.", "label": "Deposits Assets, Current", "terseLabel": "Fixed short term bank and escrow deposits \u2013 restricted" } } }, "localname": "DepositsAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r51", "r144" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r265" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "Change in derivative liability" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block [Abstract]" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r40", "r70", "r71", "r72", "r73", "r74", "r78", "r80", "r84", "r85", "r86", "r89", "r90", "r269", "r270", "r367", "r377" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss, per share of common stock Basic and diluted (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r87", "r88" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Gain (Loss) per Share Data" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Employee Stock Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r35", "r36", "r37", "r65", "r66", "r67", "r69", "r75", "r77", "r91", "r129", "r187", "r192", "r242", "r243", "r244", "r249", "r250", "r268", "r277", "r278", "r279", "r280", "r281", "r282", "r298", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r363", "r390" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Escrow Deposit", "terseLabel": "Escrow deposit" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r123", "r124", "r125", "r126", "r127", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r171", "r185", "r266", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r399", "r400", "r401", "r402", "r403", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Useful life of drilling rig" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r140", "r141", "r142", "r143", "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r272", "r273", "r274", "r275" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Foreign exchange (loss)" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of transaction giving rise to foreign currency transaction gain (loss), including but not limited to, nature of the transaction, the foreign currency involved, the accounting for the transaction.", "label": "Foreign Currency Transactions, Description", "terseLabel": "Foreign currency exchange rate risks, description" } } }, "localname": "ForeignCurrencyTransactionsDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r38", "r107", "r109", "r112", "r115", "r117", "r359", "r365", "r368", "r378" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss, before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r63", "r76", "r77", "r106", "r248", "r251", "r252", "r379" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r50" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r50" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r50" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedLabel": "Other deposits" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r50" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Governmental receivables" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r50" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other receivables" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r50" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalized": { "auth_ref": [ "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest capitalized during the period.", "label": "Interest Costs Capitalized", "terseLabel": "Capitalized interest costs" } } }, "localname": "InterestCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable", "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of nonoperating interest income (expense).", "label": "Interest Income (Expense), Nonoperating, Net", "terseLabel": "Financial (expenses), net" } } }, "localname": "InterestIncomeExpenseNonoperatingNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryAdjustments": { "auth_ref": [ "r23", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.", "label": "Inventory Adjustments", "terseLabel": "Equipment and excess inventory" } } }, "localname": "InventoryAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDrillingNoncurrent": { "auth_ref": [ "r10" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentOtherNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of inventories of minerals, materials and supplies related to long-term drilling operations.", "label": "Inventory, Drilling, Noncurrent", "terseLabel": "Drilling rig and related equipment, net of accumulated depreciation of $887 and $704 (see note 2I)" } } }, "localname": "InventoryDrillingNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandPurchaseOptionsDescription": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Describes contracts, agreements and arrangements that give the entity unilateral rights to purchase the land covered by the option for a specified period of time.", "label": "Land Purchase Options, Description", "terseLabel": "Area of land depth, description" } } }, "localname": "LandPurchaseOptionsDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right of Use Leases Assets and Leases Obligations [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r295" ], "calculation": { "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total undiscounted future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r295" ], "calculation": { "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r295" ], "calculation": { "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r295" ], "calculation": { "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r295" ], "calculation": { "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r295" ], "calculation": { "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r295" ], "calculation": { "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r295" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: portion representing imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Right of use leases assets and lease obligations" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r27", "r62", "r111", "r128", "r158", "r159", "r160", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r256", "r261", "r262", "r271", "r303", "r304" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r62", "r128", "r271", "r305", "r362", "r373" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r4", "r29", "r62", "r128", "r158", "r159", "r160", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r256", "r261", "r262", "r271", "r303", "r304", "r305" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r5", "r6", "r7", "r12", "r13", "r62", "r128", "r158", "r159", "r160", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r256", "r261", "r262", "r271", "r303", "r304" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Long-term liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_MultiemployerPlansPlanBenefitsDescription": { "auth_ref": [ "r199", "r201" ], "lang": { "en-us": { "role": { "documentation": "Description of the nature of multiemployer plan benefits as well as who is covered by the benefits. A multiemployer plan is a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.", "label": "Multiemployer Plans, Plan Benefits, Description", "terseLabel": "Waiver program executed plan descripton" } } }, "localname": "MultiemployerPlansPlanBenefitsDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r95", "r103" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Nature of Operations, Basis of Presentation and Going Concern" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r48" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r48" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r48", "r49", "r52" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r33", "r34", "r37", "r39", "r52", "r62", "r68", "r70", "r71", "r72", "r73", "r76", "r77", "r83", "r107", "r109", "r112", "r115", "r117", "r128", "r158", "r159", "r160", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r270", "r271", "r366", "r376" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow", "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1": { "auth_ref": [ "r54", "r55", "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Debt Assumed", "terseLabel": "Non-cash equity receivables" } } }, "localname": "NoncashOrPartNoncashAcquisitionDebtAssumed1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1": { "auth_ref": [ "r54", "r55", "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, classified as other, acquired in a noncash or part noncash acquisition.", "label": "Noncash or Part Noncash Acquisition, Other Assets Acquired", "terseLabel": "Unpaid investments in oil & gas properties" } } }, "localname": "NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_OilAndGasPropertiesPolicyPolicyTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for oil and gas property which may include the basis of such assets, depreciation methods used and estimated useful lives, the entity's capitalization policy, including its accounting treatment for costs incurred for repairs and maintenance activities, whether such asset balances include capitalized interest and the method by which such is calculated, how disposals of such assets are accounted for and how impairment of such assets is assessed and recognized.", "label": "Oil and Gas Properties Policy [Policy Text Block]", "terseLabel": "Oil and Gas Properties and Impairment" } } }, "localname": "OilAndGasPropertiesPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_OilAndGasPropertiesTextBlock": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for properties used in normal conduct of oil and gas exploration and producing operations. This disclosure may include property accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives.", "label": "Oil and Gas Properties [Text Block]", "terseLabel": "Unproved Oil and Gas Properties, Full Cost Method" } } }, "localname": "OilAndGasPropertiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethod" ], "xbrltype": "textBlockItemType" }, "us-gaap_OilAndGasPropertyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Oil and Gas Property [Abstract]" } } }, "localname": "OilAndGasPropertyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OilAndGasPropertyFullCostMethodNet": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Oil and gas properties, net of depletion, carried under the full cost method.", "label": "Oil and Gas Property, Full Cost Method, Net", "terseLabel": "Unproved oil and gas properties, full cost method (see Note 4)" } } }, "localname": "OilAndGasPropertyFullCostMethodNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r107", "r109", "r112", "r115", "r117" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r290", "r296" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease costs" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r288" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total undiscounted future minimum lease payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r288" ], "calculation": { "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable": { "order": 1.0, "parentTag": "zn_OperatingLeasesLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r288" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 }, "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable": { "order": 2.0, "parentTag": "zn_OperatingLeasesLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Lease obligation \u2013 non-current (see Note 5)", "verboseLabel": "Non-current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet", "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r289", "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r287" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right of Use Lease Assets (see Note 5)" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r294", "r296" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaverageremainingleasetermandweightedaveragediscountrateforoperatingleasesTable" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r293", "r296" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaverageremainingleasetermandweightedaveragediscountrateforoperatingleasesTable" ], "xbrltype": "durationItemType" }, "us-gaap_OriginationOfLoanToPurchaseCommonStock": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow for origination of loan for purchasing common stock.", "label": "Origination of Loan to Purchase Common Stock", "terseLabel": "DSPP program raised amount" } } }, "localname": "OriginationOfLoanToPurchaseCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r24", "r305" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other deposits" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r10" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "totalLabel": "Total other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Aggregate guarantee amount" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostAndExpenseOperating": { "auth_ref": [ "r41" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Cost and Expense, Operating", "terseLabel": "Other" } } }, "localname": "OtherCostAndExpenseOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoriesSpareParts": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of components of assembled products that can be sold directly or indirectly through sales of assembled products.", "label": "Other Inventories, Spare Parts, Gross", "terseLabel": "Spare parts inventory" } } }, "localname": "OtherInventoriesSpareParts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r44" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Acquisition of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r205", "r206", "r207", "r210", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r230", "r231", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails", "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r205", "r206", "r207", "r210", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r230", "r231", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails", "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from the sale of the rights" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r45" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from issuance of stock and exercise of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r45", "r241" ], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r33", "r34", "r37", "r47", "r62", "r68", "r76", "r77", "r107", "r109", "r112", "r115", "r117", "r128", "r158", "r159", "r160", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r253", "r257", "r258", "r263", "r264", "r270", "r271", "r368" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r147", "r305", "r369", "r374" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentOtherNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net of accumulated depreciation of $615 and $604" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentOtherNet": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Property, Plant and Equipment, Other, Net", "totalLabel": "Property Plant and Equipment Net" } } }, "localname": "PropertyPlantAndEquipmentOtherNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "domainItemType" }, "us-gaap_RegulatoryDepreciationAndAmortizationPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for systematically allocating capitalized costs to periods that benefit from the use thereof. Includes, but is not limited to, methods used, such as composite depreciation, descriptions of regulatory treatment for estimated removal and disposal costs, and description of amortization of plant-related regulatory assets.", "label": "Regulatory Depreciation and Amortization, Policy [Policy Text Block]", "terseLabel": "Depreciation and Accounting for Drilling Rig and Related Equipment" } } }, "localname": "RegulatoryDepreciationAndAmortizationPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r198", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r198", "r299", "r300", "r302" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r198", "r299", "r302", "r344", "r345", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r8", "r53", "r57", "r360", "r371" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "us-gaap_RestrictedCashAndInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndInvestments": { "auth_ref": [ "r387", "r388" ], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and investments whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.", "label": "Restricted Cash and Investments", "totalLabel": "Total" } } }, "localname": "RestrictedCashAndInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringSettlementAndImpairmentProvisions": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.", "label": "Restructuring, Settlement and Impairment Provisions", "terseLabel": "Drilling costs, and other operational related costs" } } }, "localname": "RestructuringSettlementAndImpairmentProvisions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable", "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r192", "r305", "r372", "r385", "r386" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r65", "r66", "r67", "r69", "r75", "r77", "r129", "r242", "r243", "r244", "r249", "r250", "r268", "r382", "r384" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r104", "r105", "r108", "r113", "r114", "r118", "r119", "r120", "r195", "r196", "r340" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Legal and seismic costs, license fees and other preparation costs" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable", "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r292", "r296" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "auth_ref": [ "r254", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.", "label": "Sale of Stock, Description of Transaction", "terseLabel": "New unit program, description" } } }, "localname": "SaleOfStockDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of stock options outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r209", "r226", "r229" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of stock option transactions" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r193", "r203" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of warrants transactions" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Compensation cost of warrant and option issuances" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "auth_ref": [ "r205" ], "lang": { "en-us": { "role": { "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights", "terseLabel": "Description of options vesting" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yields" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rates" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of shares, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Number of shares, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted Average exercise price, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Number of shares, Expired/Cancelled/Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average exercise price, Expired/Cancelled/Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Number of shares, Granted to employees, officers, directors and others" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value", "terseLabel": "Weighted-average fair value of underlying stock at grant date (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares granted under stock option plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant date fair value (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r210", "r212" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "terseLabel": "Number of shares, Outstanding, Ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r210", "r212" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "terseLabel": "Weighted Average exercise price, Outstanding, Ending", "verboseLabel": "Weighted Average Exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable", "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award", "terseLabel": "Stock option plan, expiration date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r205", "r206", "r207", "r210", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r230", "r231", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average exercise price, Granted to employees, officers, directors and others" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r208", "r233", "r234", "r235", "r236", "r239", "r245", "r247" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Number outstanding (in Shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Exercise price per unit" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected lives (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual life (years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balances (in Shares)", "periodStartLabel": "Balances (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r58", "r64" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r14", "r15", "r16", "r60", "r62", "r80", "r81", "r82", "r84", "r86", "r92", "r93", "r94", "r128", "r158", "r162", "r163", "r164", "r167", "r168", "r172", "r173", "r176", "r180", "r187", "r271", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r31", "r35", "r36", "r37", "r65", "r66", "r67", "r69", "r75", "r77", "r91", "r129", "r187", "r192", "r242", "r243", "r244", "r249", "r250", "r268", "r277", "r278", "r279", "r280", "r281", "r282", "r298", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r65", "r66", "r67", "r91", "r340" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r15", "r16", "r187", "r192" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Shares purchased under option plan" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Value of bonds converted to shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r15", "r16", "r187", "r192", "r216" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "terseLabel": "Funds received from option exercises (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r15", "r16", "r187", "r192", "r246" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Value, Employee Stock Ownership Plan", "terseLabel": "Value of options granted to employees, directors and others as non-cash compensation" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Value of bonds converted to shares" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r31", "r187", "r192" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Funds received from option exercises" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r19", "r20", "r62", "r122", "r128", "r271", "r305" ], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balances", "periodStartLabel": "Balances", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet", "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r61", "r173", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r186", "r192", "r194", "r267" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent Event, Description", "terseLabel": "Subsequent events description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r283", "r307" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r283", "r307" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r283", "r307" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r306", "r308" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalDeferredPurchasePrice": { "auth_ref": [ "r54", "r55", "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.", "label": "Supplemental Deferred Purchase Price", "terseLabel": "Purchase price" } } }, "localname": "SupplementalDeferredPurchasePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction [Domain]" } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r123", "r124", "r125", "r126", "r127", "r171", "r185", "r266", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r399", "r400", "r401", "r402", "r403", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnprovedPropertiesDisclosureTextBlock": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unproved oil and gas property.", "label": "Unproved Properties Disclosure [Table Text Block]", "terseLabel": "Schedule of changes in Unproved oil and gas properties" } } }, "localname": "UnprovedPropertiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r96", "r97", "r98", "r99", "r100", "r101", "r102" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r79", "r86" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares outstanding Basic and diluted (in Shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "zn_AcquisitionOfDrillingRigAndRelatedEquipment": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Acquisition of drilling rig and related equipment.", "label": "AcquisitionOfDrillingRigAndRelatedEquipment", "negatedLabel": "Acquisition of drilling rig and related equipment" } } }, "localname": "AcquisitionOfDrillingRigAndRelatedEquipment", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_AdjustmentOfOptionsGrantedForServices": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment for noncash service expenses paid for by granting of options.", "label": "AdjustmentOfOptionsGrantedForServices", "terseLabel": "Cost of options issued to employees, directors and others as non-cash compensation" } } }, "localname": "AdjustmentOfOptionsGrantedForServices", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_AmendedAndRestatedCertificateOfIncorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AmendedAndRestatedCertificateOfIncorporationMember", "terseLabel": "Amended and Restated Certificate of Incorporation [Member]" } } }, "localname": "AmendedAndRestatedCertificateOfIncorporationMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_AssetAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of asset additions.", "label": "AssetAdditions", "terseLabel": "Asset Additions" } } }, "localname": "AssetAdditions", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "monetaryItemType" }, "zn_AssetDepreciation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset depreciation.", "label": "AssetDepreciation", "terseLabel": "Asset Depreciation" } } }, "localname": "AssetDepreciation", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "monetaryItemType" }, "zn_AssetDisposalsForSelfConsumption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset disposals for self-consumption.", "label": "AssetDisposalsForSelfConsumption", "terseLabel": "Asset Disposals for Self-Consumption" } } }, "localname": "AssetDisposalsForSelfConsumption", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "monetaryItemType" }, "zn_BankGuaranteeToGovernment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of bank guarantee is when a bank offers surety and guarantees for different business obligation on behalf of their customers within certain regulations.", "label": "BankGuaranteeToGovernment", "terseLabel": "Bank guarantees to government" } } }, "localname": "BankGuaranteeToGovernment", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "zn_BankGuaranteesToOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of bank guarantee means that the lender will ensure that the liabilities of a debtor will be met. In other words, if the debtor fails to settle a debt, the bank will cover it. A bank guarantee enables the customer (or debtor) to acquire goods, buy equipment, or draw down a loan.", "label": "BankGuaranteesToOther", "terseLabel": "Bank guarantees to others" } } }, "localname": "BankGuaranteesToOther", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "zn_CapitalizedConvertibleBondInterestAttributedToOilAndGasProperties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in lease obligation non current.", "label": "CapitalizedConvertibleBondInterestAttributedToOilAndGasProperties", "terseLabel": "Capitalized convertible bond interest attributed to oil and gas properties" } } }, "localname": "CapitalizedConvertibleBondInterestAttributedToOilAndGasProperties", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_CapitalizedSalaryCostsUnprovedProperties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Salary costs excluded from amortization base related to unproved oil and gas properties.", "label": "CapitalizedSalaryCostsUnprovedProperties", "terseLabel": "Capitalized salary costs" } } }, "localname": "CapitalizedSalaryCostsUnprovedProperties", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable", "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "monetaryItemType" }, "zn_ClassOfWarrantGrantDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant granted period date description.", "label": "ClassOfWarrantGrantDateDescription", "terseLabel": "Period of Grant" } } }, "localname": "ClassOfWarrantGrantDateDescription", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable" ], "xbrltype": "stringItemType" }, "zn_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights", "terseLabel": "Exercise Price (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "perShareItemType" }, "zn_ClassOfWarrantOrRightExpiryDateOfWarrantOrRightExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ClassOfWarrantOrRightExpiryDateOfWarrantOrRightExercisable", "terseLabel": "Expiration Date" } } }, "localname": "ClassOfWarrantOrRightExpiryDateOfWarrantOrRightExercisable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable" ], "xbrltype": "stringItemType" }, "zn_ClassOfWarrantOrRightOutstandings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding Beginning Balance.", "label": "ClassOfWarrantOrRightOutstandings", "terseLabel": "Outstanding Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightOutstandings", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "sharesItemType" }, "zn_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding1", "terseLabel": "Name" } } }, "localname": "ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding1", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable" ], "xbrltype": "stringItemType" }, "zn_ClassOfWarrantsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "lts represented class of warrant expired.", "label": "ClassOfWarrantsExpired", "terseLabel": "Warrants Exercised", "verboseLabel": "Warrants Expired" } } }, "localname": "ClassOfWarrantsExpired", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "sharesItemType" }, "zn_ClassOfWarrantsOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "ClassOfWarrantsOrRightOutstanding", "terseLabel": "Outstanding Ending Balance" } } }, "localname": "ClassOfWarrantsOrRightOutstanding", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "sharesItemType" }, "zn_CommonStockAndWarrantDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of common stock and warrant.", "label": "CommonStockAndWarrantDescription", "terseLabel": "Common stock and warrant, description" } } }, "localname": "CommonStockAndWarrantDescription", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "zn_CommonStockExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock exercise price.", "label": "CommonStockExercisePrice", "terseLabel": "Exercise price of common stock" } } }, "localname": "CommonStockExercisePrice", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "zn_ConsumableInventory": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "ConsumableInventory", "terseLabel": "Consumable inventory included in the rig purchase" } } }, "localname": "ConsumableInventory", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "zn_CostOfOptionsIssuedToEmployeesAttributedToOilAndGasProperties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of options issued to employees attributed to oil and gas properties.", "label": "CostOfOptionsIssuedToEmployeesAttributedToOilAndGasProperties", "terseLabel": "Cost of options issued to employees attributed to oil and gas properties" } } }, "localname": "CostOfOptionsIssuedToEmployeesAttributedToOilAndGasProperties", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_DividendReinvestmentAndStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dividend Reinvestment and Stock Purchase Plan", "label": "DividendReinvestmentAndStockPurchasePlanMember", "terseLabel": "Dividend Reinvestment and Stock Purchase Plan [Member]" } } }, "localname": "DividendReinvestmentAndStockPurchasePlanMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_DrillingRigAndRelatedEquipmentNetOfAccumulatedDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of drilling rig and related equipment net of accumulated depreciation.", "label": "DrillingRigAndRelatedEquipmentNetOfAccumulatedDepreciation", "terseLabel": "Drilling rig and related equipment, net of accumulated depreciation (in Dollars)" } } }, "localname": "DrillingRigAndRelatedEquipmentNetOfAccumulatedDepreciation", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "zn_DrillingRigAssociatedandEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Drilling rig associated and equipment.", "label": "DrillingRigAssociatedandEquipment", "periodEndLabel": "Balance ending", "periodStartLabel": "Balance beginning" } } }, "localname": "DrillingRigAssociatedandEquipment", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "monetaryItemType" }, "zn_EightBoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EightBoardMember", "terseLabel": "Eight Board [Member]" } } }, "localname": "EightBoardMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "zn_EmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee [Member].", "label": "EmployeeMember", "terseLabel": "Employee [Member]" } } }, "localname": "EmployeeMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "domainItemType" }, "zn_EmployeeRelatedLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. For classified balance sheets, used to reflect the noncurrent portion of the liabilities (due beyond one year or one operating cycle, if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date).", "label": "EmployeeRelatedLiabilitiesNoncurrent", "terseLabel": "Provision for severance pay" } } }, "localname": "EmployeeRelatedLiabilitiesNoncurrent", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "zn_EmployeesAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees and Directors [Member]", "label": "EmployeesAndDirectorsMember", "terseLabel": "Employees And Directors [Member]" } } }, "localname": "EmployeesAndDirectorsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable" ], "xbrltype": "domainItemType" }, "zn_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EmployeesMember", "terseLabel": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "zn_ExercisablePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercisable Period.", "label": "ExercisablePeriod", "terseLabel": "Exercisable period" } } }, "localname": "ExercisablePeriod", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "zn_ExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share.", "label": "ExercisePricePerShare", "terseLabel": "Exercise price per share" } } }, "localname": "ExercisePricePerShare", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "zn_ExpensesFromRightsOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses from rights offering.", "label": "ExpensesFromRightsOffering", "terseLabel": "Expenses from offering" } } }, "localname": "ExpensesFromRightsOffering", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "zn_FairValueOfTheOptionsValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of the options value.", "label": "FairValueOfTheOptionsValue", "terseLabel": "Fair value of the options value" } } }, "localname": "FairValueOfTheOptionsValue", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "zn_FiveSeniorOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FiveSeniorOfficerMember", "terseLabel": "Five senior officer [Member]" } } }, "localname": "FiveSeniorOfficerMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_FiveSeniorOfficersAndTenStaffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FiveSeniorOfficersAndTenStaffMember", "terseLabel": "Five Senior Officers and Ten Staff [Member]" } } }, "localname": "FiveSeniorOfficersAndTenStaffMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "zn_FiveStaffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FiveStaffMember", "terseLabel": "Five Staff [Member]" } } }, "localname": "FiveStaffMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "zn_FourStaffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FourStaffMember", "terseLabel": "Four Staff [Member]", "verboseLabel": "Warrants and Options [Member]" } } }, "localname": "FourStaffMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_FundsReceivedFromSaleOfDsppUnitsAndShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value stock issued during the period as a result of dividend reinvestment and direct stock purchase plan.", "label": "FundsReceivedFromSaleOfDsppUnitsAndShares", "terseLabel": "Funds received from sale of DSPP units and shares and exercise of warrants" } } }, "localname": "FundsReceivedFromSaleOfDsppUnitsAndShares", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "zn_GainlossOnDerivativeLiability": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "GainlossOnDerivativeLiability", "terseLabel": "Gain on derivative liability" } } }, "localname": "GainlossOnDerivativeLiability", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "zn_GovernmentalReceivables": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of receivables that are derived from government.", "label": "GovernmentalReceivables", "terseLabel": "Governmental receivables" } } }, "localname": "GovernmentalReceivables", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "zn_I35DrillingRigMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "I35DrillingRigMember", "terseLabel": "I-35 Drilling Rig [Member]" } } }, "localname": "I35DrillingRigMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "domainItemType" }, "zn_InclusiveNonCashAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in the sum of the inclusive of non cash amounts.", "label": "InclusiveNonCashAmount", "terseLabel": "Inclusive of non-cash amounts" } } }, "localname": "InclusiveNonCashAmount", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodDetails" ], "xbrltype": "monetaryItemType" }, "zn_IncreaseDecreaseInAccruedSeverancePayNetOfSeverancePayFund": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Accrued Severance Pay Net Of Severance Pay Fund.", "label": "IncreaseDecreaseInAccruedSeverancePayNetOfSeverancePayFund", "terseLabel": "Severance payable, net" } } }, "localname": "IncreaseDecreaseInAccruedSeverancePayNetOfSeverancePayFund", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_IncreaseDecreaseInLeaseObligationCurrent": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in lease obligation current.", "label": "IncreaseDecreaseInLeaseObligationCurrent", "terseLabel": "Lease obligation \u2013 current" } } }, "localname": "IncreaseDecreaseInLeaseObligationCurrent", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_IncreaseDecreaseInLeaseObligationNonCurrent": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in lease obligation non current.", "label": "IncreaseDecreaseInLeaseObligationNonCurrent", "terseLabel": "Lease obligation \u2013 non current" } } }, "localname": "IncreaseDecreaseInLeaseObligationNonCurrent", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_IncreaseDecreaseInRightOfUseLeaseAssets": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in right of use lease assets.", "label": "IncreaseDecreaseInRightOfUseLeaseAssets", "negatedLabel": "Right of use lease assets" } } }, "localname": "IncreaseDecreaseInRightOfUseLeaseAssets", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_IncreaseInSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares increase in shares authorized.", "label": "IncreaseInSharesAuthorized", "terseLabel": "Increase in shares authorized" } } }, "localname": "IncreaseInSharesAuthorized", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "zn_InvestmentWarrantsExpirationDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InvestmentWarrantsExpirationDateDescription", "terseLabel": "Expiration date, description" } } }, "localname": "InvestmentWarrantsExpirationDateDescription", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "zn_LicenseCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark.", "label": "LicenseCost", "terseLabel": "Accrued license costs" } } }, "localname": "LicenseCost", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "zn_MegiddoJezreelLicenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Megiddo Jezreel License [Member].", "label": "MegiddoJezreelLicenseMember", "terseLabel": "Megiddo Jezreel License [Member]" } } }, "localname": "MegiddoJezreelLicenseMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails" ], "xbrltype": "domainItemType" }, "zn_NatureofOperationsBasisofPresentationandGoingConcernDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations, Basis of Presentation and Going Concern (Details) [Line Items]" } } }, "localname": "NatureofOperationsBasisofPresentationandGoingConcernDetailsLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails" ], "xbrltype": "stringItemType" }, "zn_NatureofOperationsBasisofPresentationandGoingConcernDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations, Basis of Presentation and Going Concern (Details) [Table]" } } }, "localname": "NatureofOperationsBasisofPresentationandGoingConcernDetailsTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails" ], "xbrltype": "stringItemType" }, "zn_NetLossAttributableToParent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "NetLossAttributableToParent", "terseLabel": "Net loss" } } }, "localname": "NetLossAttributableToParent", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "zn_NewUnitProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NewUnitProgramMember", "terseLabel": "New Unit Program [Member]" } } }, "localname": "NewUnitProgramMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_NonEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NonEmployeesMember", "terseLabel": "Non-Employees [Member]" } } }, "localname": "NonEmployeesMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable", "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "domainItemType" }, "zn_NonvestedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-vested [Member]", "label": "NonvestedMember", "terseLabel": "Non-vested [Member]" } } }, "localname": "NonvestedMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_OfferingCostDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of offering cost.", "label": "OfferingCostDescription", "terseLabel": "Offering cost, description" } } }, "localname": "OfferingCostDescription", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "zn_OneBoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OneBoardMember", "terseLabel": "One Board [Member]" } } }, "localname": "OneBoardMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails", "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "zn_OneSeniorOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OneSeniorOfficerMember", "terseLabel": "One Senior Officer [Member]" } } }, "localname": "OneSeniorOfficerMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "zn_OneSeniorOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OneSeniorOfficersMember", "terseLabel": "One senior officer [Member]" } } }, "localname": "OneSeniorOfficersMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_OperatingLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OperatingLeaseLiabilitiesAbstract", "terseLabel": "Operating lease liabilities:" } } }, "localname": "OperatingLeaseLiabilitiesAbstract", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "zn_OperatingLeaseRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use to underlying asset under operating lease.", "label": "OperatingLeaseRightOfUseAssets", "terseLabel": "Operating lease assets" } } }, "localname": "OperatingLeaseRightOfUseAssets", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "zn_OperatingLeasesLiability": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "OperatingLeasesLiability", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeasesLiability", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "zn_OptionToPurchaseSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option to purchase shares of common stock.", "label": "OptionToPurchaseSharesOfCommonStock", "terseLabel": "Option to purchase shares of common stock" } } }, "localname": "OptionToPurchaseSharesOfCommonStock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "zn_OtherDrillingAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OtherDrillingAssetsMember", "terseLabel": "Other Drilling Assets [Member]" } } }, "localname": "OtherDrillingAssetsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "domainItemType" }, "zn_OtherExpenseNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OtherExpenseNetAbstract", "terseLabel": "Other expense, net" } } }, "localname": "OtherExpenseNetAbstract", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "zn_OtherUtilityCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other utility cost incurred related to oil and gas produced and sold during the reporting period.", "label": "OtherUtilityCost", "terseLabel": "Other costs" } } }, "localname": "OtherUtilityCost", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofchangesinUnprovedoilandgaspropertiesTable", "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "monetaryItemType" }, "zn_PaymentsToInvestmentInUnprovedOilAndGasProperties": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from investment in unproved oil and gas properties.", "label": "PaymentsToInvestmentInUnprovedOilAndGasProperties", "negatedLabel": "Investment in unproved oil and gas properties" } } }, "localname": "PaymentsToInvestmentInUnprovedOilAndGasProperties", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "zn_PropertyAndEquipmentAtCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PropertyAndEquipmentAtCostAbstract", "terseLabel": "Property and equipment at cost" } } }, "localname": "PropertyAndEquipmentAtCostAbstract", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "zn_PropertyPlantAndEquipmentTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PropertyPlantAndEquipmentTypeAxis", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentTypeAxis", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails", "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable" ], "xbrltype": "stringItemType" }, "zn_PropertyPlantAndEquipmentType_Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PropertyPlantAndEquipmentType_ [Domain]" } } }, "localname": "PropertyPlantAndEquipmentType_Domain", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/NatureofOperationsBasisofPresentationandGoingConcernDetails" ], "xbrltype": "domainItemType" }, "zn_PurchaseAndSaleAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PurchaseAndSaleAgreementMember", "terseLabel": "Purchase and Sale Agreement [Member]" } } }, "localname": "PurchaseAndSaleAgreementMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "zn_PurchasePriceOfDrillingRing": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchase price of drilling ring.", "label": "PurchasePriceOfDrillingRing", "terseLabel": "Purchase price of drilling ring" } } }, "localname": "PurchasePriceOfDrillingRing", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "zn_RangeFourtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangeFourtyOneMember", "terseLabel": "Range Fourty One [Member]" } } }, "localname": "RangeFourtyOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangeFourtyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangeFourtyThreeMember", "terseLabel": "Range Fourty Three [Member]" } } }, "localname": "RangeFourtyThreeMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesEightMember", "terseLabel": "Ranges Eight [Member]" } } }, "localname": "RangesEightMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesEighteenMember", "terseLabel": "Ranges Eighteen [Member]" } } }, "localname": "RangesEighteenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Eleven [Member].", "label": "RangesElevenMember", "terseLabel": "Ranges Eleven [Member]" } } }, "localname": "RangesElevenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesFifteenMember", "terseLabel": "Ranges Fifteen [Member]" } } }, "localname": "RangesFifteenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Five [Member]", "label": "RangesFiveMember", "terseLabel": "Ranges Five [Member]" } } }, "localname": "RangesFiveMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Four [Member]", "label": "RangesFourMember", "terseLabel": "Ranges Four [Member]" } } }, "localname": "RangesFourMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesFourteenMember", "terseLabel": "Ranges Fourteen [Member]" } } }, "localname": "RangesFourteenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFourtyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesFourtyFiveMember", "terseLabel": "Ranges Fourty Five [Member]" } } }, "localname": "RangesFourtyFiveMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFourtyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesFourtyFourMember", "terseLabel": "Ranges Fourty Four [Member]" } } }, "localname": "RangesFourtyFourMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFourtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesFourtyMember", "terseLabel": "Ranges Fourty [Member]" } } }, "localname": "RangesFourtyMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFourtySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesFourtySixMember", "terseLabel": "Ranges Fourty Six [Member]" } } }, "localname": "RangesFourtySixMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesFourtyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesFourtyTwoMember", "terseLabel": "Ranges Fourty Two [Member]" } } }, "localname": "RangesFourtyTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Nine [Member]", "label": "RangesNineMember", "terseLabel": "Ranges Nine [Member]" } } }, "localname": "RangesNineMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesNineteenMember", "terseLabel": "Ranges Nineteen [Member]" } } }, "localname": "RangesNineteenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range One [Member]", "label": "RangesOneMember", "terseLabel": "Ranges One [Member]" } } }, "localname": "RangesOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Seven [Member]", "label": "RangesSevenMember", "terseLabel": "Ranges Seven [Member]" } } }, "localname": "RangesSevenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesSeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesSeventeenMember", "terseLabel": "Ranges Seventeen [Member]" } } }, "localname": "RangesSeventeenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Six [Member].", "label": "RangesSixMember", "terseLabel": "Ranges Six [Member]" } } }, "localname": "RangesSixMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesSixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesSixteenMember", "terseLabel": "Ranges Sixteen [Member]" } } }, "localname": "RangesSixteenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTenMember", "terseLabel": "Ranges Ten [Member]" } } }, "localname": "RangesTenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyEightMember", "terseLabel": "Ranges Thirty Eight [Member]" } } }, "localname": "RangesThirtyEightMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyFiveMember", "terseLabel": "Ranges Thirty Five [Member]" } } }, "localname": "RangesThirtyFiveMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyFourMember", "terseLabel": "Ranges Thirty Four [Member]" } } }, "localname": "RangesThirtyFourMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyMember", "terseLabel": "Ranges Thirty [Member]" } } }, "localname": "RangesThirtyMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyNineMember", "terseLabel": "Ranges Thirty Nine [Member]" } } }, "localname": "RangesThirtyNineMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyOneMember", "terseLabel": "Ranges Thirty One [Member]" } } }, "localname": "RangesThirtyOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtySevenMember", "terseLabel": "Ranges Thirty Seven [Member]" } } }, "localname": "RangesThirtySevenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtySixMember", "terseLabel": "Ranges Thirty Six [Member]" } } }, "localname": "RangesThirtySixMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyThreeMember", "terseLabel": "Ranges Thirty Three [Member]" } } }, "localname": "RangesThirtyThreeMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThirtyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesThirtyTwoMember", "terseLabel": "Ranges Thirty Two [Member]" } } }, "localname": "RangesThirtyTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Three [Member]", "label": "RangesThreeMember", "terseLabel": "Ranges Three [Member]" } } }, "localname": "RangesThreeMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwelveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwelveMember", "terseLabel": "Ranges Twelve [Member]" } } }, "localname": "RangesTwelveMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyEightMember", "terseLabel": "Ranges Twenty Eight [Member]" } } }, "localname": "RangesTwentyEightMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyFiveMember", "terseLabel": "Ranges Twenty Five [Member]" } } }, "localname": "RangesTwentyFiveMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyFourMember", "terseLabel": "Ranges Twenty Four [Member]" } } }, "localname": "RangesTwentyFourMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyMember", "terseLabel": "Ranges Twenty [Member]" } } }, "localname": "RangesTwentyMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyNineMember", "terseLabel": "Ranges Twenty Nine [Member]" } } }, "localname": "RangesTwentyNineMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyOneMember", "terseLabel": "Ranges Twenty One [Member]" } } }, "localname": "RangesTwentyOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentySevenMember", "terseLabel": "Ranges Twenty Seven [Member]" } } }, "localname": "RangesTwentySevenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentySixMember", "terseLabel": "Ranges Twenty Six [Member]" } } }, "localname": "RangesTwentySixMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyThreeMember", "terseLabel": "Ranges Twenty Three [Member]" } } }, "localname": "RangesTwentyThreeMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangesTwentyTwoMember", "terseLabel": "Ranges Twenty Two [Member]" } } }, "localname": "RangesTwentyTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RangesTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Two [Member]", "label": "RangesTwoMember", "terseLabel": "Ranges Two [Member]" } } }, "localname": "RangesTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for related parties.", "label": "RelatedPartiesPolicyTextBlock", "terseLabel": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "zn_RemainingAmountHeldInEscrowDeposit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining amount held in escrow deposit.", "label": "RemainingAmountHeldInEscrowDeposit", "terseLabel": "Remaining amount held in escrow deposit" } } }, "localname": "RemainingAmountHeldInEscrowDeposit", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "zn_RestrictedCashIncludedInFixedShorttermBankDeposits": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "us-gaap_RestrictedCashAndInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restricted cash included in fixed short-term bank deposits.", "label": "RestrictedCashIncludedInFixedShorttermBankDeposits", "terseLabel": "Restricted cash included in fixed short-term bank deposits" } } }, "localname": "RestrictedCashIncludedInFixedShorttermBankDeposits", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "zn_RigSparePartsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RigSparePartsMember", "terseLabel": "Rig Spare Parts [Member]" } } }, "localname": "RigSparePartsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "domainItemType" }, "zn_RightSubscriptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right subscription price per share.", "label": "RightSubscriptionPricePerShare", "terseLabel": "Subscription price per share" } } }, "localname": "RightSubscriptionPricePerShare", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "zn_RightofUseLeasesAssetsandLeaseObligationsDetailsScheduleofoperatingleaseassetsandliabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities [Line Items]" } } }, "localname": "RightofUseLeasesAssetsandLeaseObligationsDetailsScheduleofoperatingleaseassetsandliabilitiesLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "zn_RightofUseLeasesAssetsandLeaseObligationsDetailsScheduleofoperatingleaseassetsandliabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right of Use Leases Assets and Lease Obligations (Details) - Schedule of operating lease assets and liabilities [Table]" } } }, "localname": "RightofUseLeasesAssetsandLeaseObligationsDetailsScheduleofoperatingleaseassetsandliabilitiesTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "zn_RightsUseOfAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RightsUseOfAssetsMember", "terseLabel": "Rights use of assets [Member]" } } }, "localname": "RightsUseOfAssetsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofoperatingleaseassetsandliabilitiesTable" ], "xbrltype": "domainItemType" }, "zn_ScenarioThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScenarioThirteenMember", "terseLabel": "Scenario Thirteen [Member]" } } }, "localname": "ScenarioThirteenMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_ScheduleOfChangesInUnprovedOilAndGasProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfChangesInUnprovedOilAndGasProperties", "terseLabel": "Schedule of changes in Unproved oil and gas properties" } } }, "localname": "ScheduleOfChangesInUnprovedOilAndGasProperties", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/UnprovedOilandGasPropertiesFullCostMethodTables" ], "xbrltype": "textBlockItemType" }, "zn_ScheduleOfChangesInUnprovedOilAndGasPropertiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in Unproved oil and gas properties [Abstract]" } } }, "localname": "ScheduleOfChangesInUnprovedOilAndGasPropertiesAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfCompensationCostOfWarrantAndOptionIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfCompensationCostOfWarrantAndOptionIssuanceTableTextBlock", "terseLabel": "Schedule of compensation cost of warrant and option issuances" } } }, "localname": "ScheduleOfCompensationCostOfWarrantAndOptionIssuanceTableTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "zn_ScheduleOfCompensationCostOfWarrantAndOptionIssuancesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of compensation cost of warrant and option issuances [Abstract]" } } }, "localname": "ScheduleOfCompensationCostOfWarrantAndOptionIssuancesAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of future minimum lease payments under non-cancellable operating leases [Abstract]" } } }, "localname": "ScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeasesAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of schedule of future minimum lease payments under non-cancellable operating leases.", "label": "ScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeasesTableTextBlock", "terseLabel": "Schedule of future minimum lease payments under non-cancellable operating leases" } } }, "localname": "ScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeasesTableTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables" ], "xbrltype": "textBlockItemType" }, "zn_ScheduleOfOperatingLeaseAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of operating lease assets and liabilities [Abstract]" } } }, "localname": "ScheduleOfOperatingLeaseAssetsAndLiabilitiesAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of operating lease assets and liabilities.", "label": "ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "terseLabel": "Schedule of operating lease assets and liabilities" } } }, "localname": "ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables" ], "xbrltype": "textBlockItemType" }, "zn_ScheduleOfStockOptionTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock option transactions [Abstract]" } } }, "localname": "ScheduleOfStockOptionTransactionsAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfStockOptionsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock options outstanding [Abstract]" } } }, "localname": "ScheduleOfStockOptionsOutstandingAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfStockholdersEquityNoteWarrantOrRightsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfStockholdersEquityNoteWarrantOrRightsTextBlock", "terseLabel": "Schedule of warrants to investors" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantOrRightsTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "zn_ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightLineAmortizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization [Abstract]" } } }, "localname": "ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightLineAmortizationAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightlineAmortizationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightlineAmortizationTableTextBlock", "terseLabel": "Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization" } } }, "localname": "ScheduleOfTheCostsOfEachCertificationWillBeAddedToTheDrillingRigAccountAndOurStraightlineAmortizationTableTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "zn_ScheduleOfUnprovedOilAndGasPropertiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of unproved oil and gas properties [Abstract]" } } }, "localname": "ScheduleOfUnprovedOilAndGasPropertiesAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfWarrantsToInvestorsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of warrants to investors [Abstract]" } } }, "localname": "ScheduleOfWarrantsToInvestorsAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfWarrantsTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of warrants transactions [Abstract]" } } }, "localname": "ScheduleOfWarrantsTransactionsAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfWeightedAverageFairValueOfOptionsGrantedToEmployeesAndDirectorsDuringTheYearUsingTheBlackScholesOptionPricingModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model [Abstract]" } } }, "localname": "ScheduleOfWeightedAverageFairValueOfOptionsGrantedToEmployeesAndDirectorsDuringTheYearUsingTheBlackScholesOptionPricingModelAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_ScheduleOfWeightedAverageLeaseTermAndDiscountRateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of weighted average lease term and discount rate.", "label": "ScheduleOfWeightedAverageLeaseTermAndDiscountRateTableTextBlock", "terseLabel": "Schedule of weighted average remaining lease term and weighted average discount rate for operating leases" } } }, "localname": "ScheduleOfWeightedAverageLeaseTermAndDiscountRateTableTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/RightofUseLeasesAssetsandLeaseObligationsTables" ], "xbrltype": "textBlockItemType" }, "zn_ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of weighted average remaining lease term and weighted average discount rate for operating leases [Abstract]" } } }, "localname": "ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingLeasesAbstract", "nsuri": "http://zionoil.com/20220331", "xbrltype": "stringItemType" }, "zn_SeniorConvertibleBondsCurrent": { "auth_ref": [], "calculation": { "http://zionoil.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of senior convertible bonds current.", "label": "SeniorConvertibleBondsCurrent", "terseLabel": "Lease obligation \u2013 current (see Note 5)" } } }, "localname": "SeniorConvertibleBondsCurrent", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "zn_SevenBoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SevenBoardMember", "terseLabel": "Seven Board [Member]" } } }, "localname": "SevenBoardMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_SevenStaffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SevenStaffMember", "terseLabel": "Seven Staff [Member]" } } }, "localname": "SevenStaffMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value", "label": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue", "terseLabel": "Fair value of stock options granted" } } }, "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "zn_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price.", "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice", "terseLabel": "Range of exercise price" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "zn_SharesExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares exercise price.", "label": "SharesExercisePrice", "terseLabel": "Exercise price per share" } } }, "localname": "SharesExercisePrice", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "zn_SharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of common stock.", "label": "SharesOfCommonStock", "terseLabel": "Shares of common stock" } } }, "localname": "SharesOfCommonStock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "zn_SixSeniorOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SixSeniorOfficersMember", "terseLabel": "Six Senior Officers [Member]" } } }, "localname": "SixSeniorOfficersMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_SixSeniorOfficersOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SixSeniorOfficersOneMember", "terseLabel": "Six Senior Officers One [Member]" } } }, "localname": "SixSeniorOfficersOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_SixStaffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SixStaffMember", "terseLabel": "Six Staff [Member]" } } }, "localname": "SixStaffMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlan": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlan", "terseLabel": "Shares purchased under option plan" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlan", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "zn_StockIssuedDuringPeriodSharesStockDividendReinvestmentAndDirectStockPurchasePlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of dividend reinvestment and direct stock purchase plan.", "label": "StockIssuedDuringPeriodSharesStockDividendReinvestmentAndDirectStockPurchasePlan", "terseLabel": "Funds received from sale of DSPP units and shares and exercise of warrants (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockDividendReinvestmentAndDirectStockPurchasePlan", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "zn_StockholdersEquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) [Line Items]" } } }, "localname": "StockholdersEquityDetailsLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofcompensationcostofwarrantandoptionissuancesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofcompensationcostofwarrantandoptionissuancesLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofcompensationcostofwarrantandoptionissuancesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of compensation cost of warrant and option issuances [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofcompensationcostofwarrantandoptionissuancesTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofstockoptiontransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of stock option transactions [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofstockoptiontransactionsLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofstockoptiontransactionsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of stock option transactions [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofstockoptiontransactionsTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptiontransactionsTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofwarrantstoinvestorsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of warrants to investors [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofwarrantstoinvestorsLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofwarrantstoinvestorsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of warrants to investors [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofwarrantstoinvestorsTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of weighted-average fair value of options granted to employees and directors during the year, using the black scholes option-pricing model [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofweightedaveragefairvalueofoptionsgrantedtoemployeesanddirectorsduringtheyearusingtheblackscholesoptionpricingmodelTable" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) [Table]" } } }, "localname": "StockholdersEquityDetailsTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Tables) [Line Items]" } } }, "localname": "StockholdersEquityTablesLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "zn_StockholdersEquityTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Tables) [Table]" } } }, "localname": "StockholdersEquityTablesTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "zn_SubscriptionRightsOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription Rights Offering.", "label": "SubscriptionRightsOffering", "terseLabel": "Subscription rights offering, description" } } }, "localname": "SubscriptionRightsOffering", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "zn_SubscriptionRightsOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SubscriptionRightsOfferingMember", "terseLabel": "Subscription Rights Offering [Member]" } } }, "localname": "SubscriptionRightsOfferingMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "zn_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "zn_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "zn_SummaryofSignificantAccountingPoliciesDetailsScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "stringItemType" }, "zn_SummaryofSignificantAccountingPoliciesDetailsScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of the costs of each certification will be added to the drilling rig account and our straight-line amortization [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofthecostsofeachcertificationwillbeaddedtothedrillingrigaccountandourstraightlineamortizationTable" ], "xbrltype": "stringItemType" }, "zn_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "zn_TwoConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoConsultantsMember", "terseLabel": "Two Consultants [Member]" } } }, "localname": "TwoConsultantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails", "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "zn_TwoThousandAndTwentyFirstOmnibusIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoThousandAndTwentyFirstOmnibusIncentivePlanMember", "terseLabel": "Two Thousand and Twenty-First Omnibus Incentive Plan [Member]" } } }, "localname": "TwoThousandAndTwentyFirstOmnibusIncentivePlanMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "zn_TwoZeroOneOneEquityIncentiveStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoZeroOneOneEquityIncentiveStockOptionPlanMember", "terseLabel": "2011 Equity Incentive Stock Option Plan [Member]", "verboseLabel": "Two Zero One One Equity Incentive Stock Option Plan [Member]" } } }, "localname": "TwoZeroOneOneEquityIncentiveStockOptionPlanMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember", "terseLabel": "2011 Non-Employee Directors Stock Option Plan [Member]" } } }, "localname": "TwoZeroOneOneNonEmployeeDirectorsStockOptionPlanMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember", "terseLabel": "Two Zero Two One Omnibus Incentive Stock Option Plan [Member]" } } }, "localname": "TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_TypesOfAgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TypesOfAgreementAxis", "terseLabel": "Types Of Agreement [Axis]" } } }, "localname": "TypesOfAgreementAxis", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "zn_TypesOfAgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TypesOfAgreement [Domain]" } } }, "localname": "TypesOfAgreementDomain", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "zn_UnitOptionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UnitOptionProgramMember", "terseLabel": "Unit Option Program [Member]" } } }, "localname": "UnitOptionProgramMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_UnprovedOilAndGasPropertiesFullCostMethodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UnprovedOilAndGasPropertiesFullCostMethodMember", "terseLabel": "Unproved Oil and Gas Properties, Full Cost Method [Member]" } } }, "localname": "UnprovedOilAndGasPropertiesFullCostMethodMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "domainItemType" }, "zn_UnprovedOilGasPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UnprovedOilGasPropertiesMember", "terseLabel": "Unproved Oil & Gas properties [Member]" } } }, "localname": "UnprovedOilGasPropertiesMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofcompensationcostofwarrantandoptionissuancesTable" ], "xbrltype": "domainItemType" }, "zn_UnprovedOilandGasPropertiesFullCostMethodDetailsScheduleofunprovedoilandgaspropertiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties [Line Items]" } } }, "localname": "UnprovedOilandGasPropertiesFullCostMethodDetailsScheduleofunprovedoilandgaspropertiesLineItems", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "stringItemType" }, "zn_UnprovedOilandGasPropertiesFullCostMethodDetailsScheduleofunprovedoilandgaspropertiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of unproved oil and gas properties [Table]" } } }, "localname": "UnprovedOilandGasPropertiesFullCostMethodDetailsScheduleofunprovedoilandgaspropertiesTable", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofunprovedoilandgaspropertiesTable" ], "xbrltype": "stringItemType" }, "zn_UnrecognizedCompensationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The unrecognized compensation cost related to non-vested stock options.", "label": "UnrecognizedCompensationCost", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "UnrecognizedCompensationCost", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "zn_VestedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vested [Member]", "label": "VestedMember", "terseLabel": "Vested [Member]" } } }, "localname": "VestedMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofstockoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "zn_WarrantExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share in exercise price of warrant.", "label": "WarrantExercisePrice", "terseLabel": "Warrant exercise price" } } }, "localname": "WarrantExercisePrice", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "zn_WarrantTerminationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Its represented warrant termination date.", "label": "WarrantTerminationDate", "terseLabel": "Warrant Termination Date" } } }, "localname": "WarrantTerminationDate", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "dateItemType" }, "zn_WarrantTerminationDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants termination date.", "label": "WarrantTerminationDateDescription", "terseLabel": "Warrants termination, description" } } }, "localname": "WarrantTerminationDateDescription", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "zn_WarrantTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantTransactionsMember", "terseLabel": "Warrant Transactions [Member]" } } }, "localname": "WarrantTransactionsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_WarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants issued.", "label": "WarrantsIssued", "terseLabel": "Warrants Issued" } } }, "localname": "WarrantsIssued", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "sharesItemType" }, "zn_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantsMember", "terseLabel": "Warrant one [Member]", "verboseLabel": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_WarrantsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy of warrants.", "label": "WarrantsPolicyTextBlock", "terseLabel": "Warrants" } } }, "localname": "WarrantsPolicyTextBlock", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "zn_WeightedAverageAnnualInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A weighted average interest rate is an average that is adjusted to reflect the contribution of each loan to the total debt. The weighted average multiplies each loan's interest rate by the loan balance and divides the sum by the total loan balance.", "label": "WeightedAverageAnnualInterestRate", "terseLabel": "Weighted average annual interest rate" } } }, "localname": "WeightedAverageAnnualInterestRate", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "percentItemType" }, "zn_ZNWABWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWABWarrantsMember", "terseLabel": "ZNWAB warrants [Member]" } } }, "localname": "ZNWABWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWACWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWACWarrantsMember", "terseLabel": "ZNWAC warrants [Member]" } } }, "localname": "ZNWACWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWADWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWADWarrantOneMember", "terseLabel": "ZNWAD Warrant one [Member]" } } }, "localname": "ZNWADWarrantOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWADWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWADWarrantTwoMember", "terseLabel": "ZNWAD Warrant Two [Member]" } } }, "localname": "ZNWADWarrantTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWADWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWADWarrantsMember", "terseLabel": "ZNWAD Warrants [Member]" } } }, "localname": "ZNWADWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWAEWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAEWarrantOneMember", "terseLabel": "ZNWAE Warrant One [Member]" } } }, "localname": "ZNWAEWarrantOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAEWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAEWarrantTwoMember", "terseLabel": "ZNWAE Warrant Two [Member]" } } }, "localname": "ZNWAEWarrantTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAEWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAEWarrantsMember", "terseLabel": "ZNWAE Warrants [Member]" } } }, "localname": "ZNWAEWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAFWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAFWarrantTwoMember", "terseLabel": "ZNWAF Warrant Two [Member]" } } }, "localname": "ZNWAFWarrantTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAFWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAFWarrantsMember", "terseLabel": "ZNWAF Warrants [Member]" } } }, "localname": "ZNWAFWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWAGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAGMember", "terseLabel": "ZNWAG [Member]" } } }, "localname": "ZNWAGMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAGWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAGWarrantsMember", "terseLabel": "ZNWAG Warrants [Member]" } } }, "localname": "ZNWAGWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWAHWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAHWarrantOneMember", "terseLabel": "ZNWAH Warrant one [Member]" } } }, "localname": "ZNWAHWarrantOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAHWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAHWarrantTwoMember", "terseLabel": "ZNWAH Warrant Two [Member]" } } }, "localname": "ZNWAHWarrantTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAHWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAHWarrantsMember", "terseLabel": "ZNWAH Warrants [Member]" } } }, "localname": "ZNWAHWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWAIWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAIWarrantMember", "terseLabel": "ZNWAI Warrant [Member]" } } }, "localname": "ZNWAIWarrantMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWAJWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAJWarrantMember", "terseLabel": "ZNWAJ Warrant [Member]" } } }, "localname": "ZNWAJWarrantMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAJWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAJWarrantTwoMember", "terseLabel": "ZNWAJ Warrant Two [Member]" } } }, "localname": "ZNWAJWarrantTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAKWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAKWarrantOneMember", "terseLabel": "ZNWAK Warrant One [Member]" } } }, "localname": "ZNWAKWarrantOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAKWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAKWarrantTwoMember", "terseLabel": "ZNWAK Warrant Two [Member]" } } }, "localname": "ZNWAKWarrantTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWALWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWALWarrantTwoMember", "terseLabel": "ZNWAL Warrant Two [Member]" } } }, "localname": "ZNWALWarrantTwoMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAMWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAMWarrantOneMember", "terseLabel": "ZNWAM Warrant One [Member]" } } }, "localname": "ZNWAMWarrantOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAMWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAMWarrantsMember", "terseLabel": "ZNWAM Warrants [Member]" } } }, "localname": "ZNWAMWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWANWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWANWarrantsMember", "terseLabel": "ZNWAN Warrants [Member]" } } }, "localname": "ZNWANWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWAOWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAOWarrantsMember", "terseLabel": "ZNWAO Warrants [Member]" } } }, "localname": "ZNWAOWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWAPWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAPWarrantsMember", "terseLabel": "ZNWAP Warrants [Member]" } } }, "localname": "ZNWAPWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWAROneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWAROneMember", "terseLabel": "ZNWAR one [Member]" } } }, "localname": "ZNWAROneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWARWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWARWarrantsMember", "terseLabel": "ZNWAR Warrants [Member]" } } }, "localname": "ZNWARWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZNWASMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWASMember", "terseLabel": "ZNWAS [Member]" } } }, "localname": "ZNWASMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZNWASWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZNWASWarrantsMember", "terseLabel": "ZNWAS Warrants [Member]" } } }, "localname": "ZNWASWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable" ], "xbrltype": "domainItemType" }, "zn_ZnwaaWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Znwaa Warrants [Member].", "label": "ZnwaaWarrantsMember", "terseLabel": "ZNWAA [Member]", "verboseLabel": "ZNWAA Warrants [Member]" } } }, "localname": "ZnwaaWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable" ], "xbrltype": "domainItemType" }, "zn_ZnwafMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwafMember", "terseLabel": "Znwaf [Member]" } } }, "localname": "ZnwafMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwahMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwahMember", "terseLabel": "ZNWAH [Member]" } } }, "localname": "ZnwahMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwaiWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwaiWarrantsMember", "terseLabel": "ZNWAI Warrants [Member]" } } }, "localname": "ZnwaiWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwajWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwajWarrantsMember", "netLabel": "ZNWAJ Warrant [Member]", "terseLabel": "ZNWAJ [Member]", "verboseLabel": "ZNWAJ Warrants [Member]" } } }, "localname": "ZnwajWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwakWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwakWarrantsMember", "terseLabel": "ZNWAK [Member]", "verboseLabel": "ZNWAK Warrants [Member]" } } }, "localname": "ZnwakWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwalWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwalWarrantsMember", "netLabel": "ZNWAL Warrant [Member]", "terseLabel": "ZNWAL [Member]", "verboseLabel": "ZNWAL Warrants [Member]" } } }, "localname": "ZnwalWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable", "http://zionoil.com/role/ScheduleofwarrantstransactionsTable", "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwanWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwanWarrantMember", "terseLabel": "ZNWAN [Member]" } } }, "localname": "ZnwanWarrantMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwapWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwapWarrantOneMember", "terseLabel": "Znwap warrant one [Member]" } } }, "localname": "ZnwapWarrantOneMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "zn_ZnwaqWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ZnwaqWarrantsMember", "terseLabel": "ZNWAQ Warrants [Member]" } } }, "localname": "ZnwaqWarrantsMember", "nsuri": "http://zionoil.com/20220331", "presentation": [ "http://zionoil.com/role/ScheduleofwarrantstoinvestorsTable" ], "xbrltype": "domainItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r103": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450678-114947" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r297": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r308": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62014-109447" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SAB Topic 12.A.3(b))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=123726384&loc=d3e516343-122869" }, "r358": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "360", "Topic": "932", "URI": "https://asc.fasb.org/subtopic&trid=2145654" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "340", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=126944050&loc=d3e29293-110302" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r394": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r395": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r396": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r397": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r398": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r399": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r400": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r401": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r402": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r403": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r404": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r405": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r406": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" } }, "version": "2.1" } ZIP 58 0001213900-22-025253-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-025253-xbrl.zip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